mainbody.htm

0001117768-14-000444.txt : 20140516 0001117768-14-000444.hdr.sgml : 20140516 20140515212505 ACCESSION NUMBER: 0001117768-14-000444 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20140331 FILED AS OF DATE: 20140516 DATE AS OF CHANGE: 20140515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HealthWarehouse.com, Inc. CENTRAL INDEX KEY: 0000754813 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] IRS NUMBER: 222413505 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-13117 FILM NUMBER: 14849604 BUSINESS ADDRESS: STREET 1: 7107 INDUSTRIAL ROAD CITY: FLORENCE STATE: KY ZIP: 41042 BUSINESS PHONE: (513) 618-0911 MAIL ADDRESS: STREET 1: 7107 INDUSTRIAL ROAD CITY: FLORENCE STATE: KY ZIP: 41042 FORMER COMPANY: FORMER CONFORMED NAME: HealthWarehouse, Inc. DATE OF NAME CHANGE: 20090818 FORMER COMPANY: FORMER CONFORMED NAME: CLACENDIX, INC. DATE OF NAME CHANGE: 20080107 FORMER COMPANY: FORMER CONFORMED NAME: ION NETWORKS INC DATE OF NAME CHANGE: 19990413 10-Q 1 mainbody.htm MAINBODY mainbody.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

________________

FORM 10-Q

(Mark One)

x	QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended March 31, 2014

¨	TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number 0-13117

HealthWarehouse.com, Inc.

(Exact Name of Registrant as Specified in Its Charter)

Delaware	22-2413505
(State or Other Jurisdiction	(I.R.S. Employer
of Incorporation or Organization)	Identification No.)

7107 Industrial Road, Florence, Kentucky	41042
(Address of Principal Executive Offices)	(Zip Code)

(800) 748-7001

(Registrant’s Telephone Number, Including Area Code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act of 1934 during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer o Accelerated Filer o

Non-accelerated Filer o Smaller Reporting Company x

(Do not check if a smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

There were 26,550,380 shares of Common Stock outstanding as of May 7, 2014

Tale of Contents

HEALTHWAREHOUSE.COM, INC.

QUARTERLY REPORT ON FORM 10-Q

FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2014

TABLE OF CONTENTS

	Page

PART I – FINANCIAL INFORMATION

Item 1. Financial Statements.	3

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.	14

Item 3. Quantitative and Qualitative Disclosures About Market Risk.	18

Item 4. Controls and Procedures.	18

PART II – OTHER INFORMATION

Item 1. Legal Proceedings.	19

Item 1A. Risk Factors.	20

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.	20

Item 3. Defaults upon Senior Securities.	20

Item 4. Mine Safety Disclosures.	20

Item 5. Other Information.	20

Item 6. Exhibits.	20

SIGNATURES	21

- 2 -

Tale of Contents

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements.

HEALTHWAREHOUSE.COM, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS

	March 31			December 31,
	2014			2013
	(unaudited)
Assets

Current assets:
Cash	$	59,800		$	67,744
Accounts receivable, net of allowance of $59,534 and $250,828 as of March 31, 2014
and December 31, 2014		74,767			307,211
Inventories - finished goods, net		246,151			277,300
Prepaid expenses and other current assets		40,612			59,143
Total current assets		421,330			711,398
Property and equipment, net of accumulated depreciation of $608,109 and $576,590 as of
March 31, 2014 and December 31, 2013		593,116			624,634
Web development costs, net of accumulated amortization of $24,745 and $14,643 as of
March 31, 2014 and December 31, 2013		108,544			83,780
Total assets	$	1,122,990		$	1,419,812

Liabilities and Stockholders’ Deficiency

Current liabilities:
Accounts payable – trade	$	2,926,669		$	3,310,000
Accounts payable – related parties		78,246			83,691
Accrued expenses and other current liabilities		441,574			621,052
Deferred revenue		78,790			95,792
Current portion of equipment lease payable		58,266			56,323
Notes payable and other advances, net of debt discount of $212,830 as of March 31, 2014		487,170			-
Note payable and other advances – related parties		78,095			78,095
Redeemable preferred stock - Series C; par value $0.001 per share;
10,000 designated Series C: 10,000 issued and outstanding as of
March 31, 2014 and December 31, 2013 (aggregate liquidation preference of $1,000,000)		1,000,000			1,000,000
Total current liabilities		5,148,810			5,244,953

Long term liabilities:
Notes payable, net of debt discount of $29,133 as of March 31, 2014 and $269,998 as of
December 31, 2013		70,867			430,002
Long term portion of equipment lease payable		94,862			109,964
Total long term liabilities		165,729			539,966
Total liabilities		5,314,539			5,784,919

Commitments and contingencies

Stockholders’ deficiency:
Preferred stock – par value $0.001 per share; authorized 1,000,000 shares; issued and outstanding
as of March 31, 2014 and December 31, 2013 as follows:
Convertible preferred stock - Series A – 200,000 shares designated Series A; 44,443 shares available
to be issued; no shares issued and outstanding		-			-
Convertible preferred stock - Series B – 625,000 shares designated Series B; 451,879 and 422,315
shares issued and outstanding as of March 31, 2014 and December 31, 2013, respectively (aggregate
liquidation preference of $4,344,987 and $4,270,257 as of March 31, 2014 and		452			422
December 31, 2013, respectively)
Common stock – par value $0.001 per share; authorized 50,000,000 shares; 27,729,592 and 27,708,303
shares issued and 26,550,380 and 26,529,091 shares outstanding as of March 31, 2014
and December 31, 2013, respectively		27,731			27,708
Additional paid-in capital		27,721,737			27,166,147
Employee advances		(10,715	)		(9,001	)
Treasury stock, at cost, 1,179,212 shares as of March 31, 2014 and December 31, 2013		(3,419,715	)		(3,419,715	)
Accumulated deficit		(28,511,039	)		(28,130,668	)
Total stockholders’ deficiency		(4,191,549	)		(4,365,107	)
Total liabilities and stockholders’ deficiency	$	1,122,990		$	1,419,812


The accompanying notes are an integral part of these condensed consolidated financial statements.

- 3 -

Tale of Contents

HEALTHWAREHOUSE.COM, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)

	For the Three Months Ended
	March 31,
	2014			2013

Net sales	$	1,716,964		$	2,409,916

Cost of sales		731,408			1,235,156

Gross profit		985,556			1,174,760

Operating expenses:

Selling, general and administrative expenses		1,217,661			2,389,103


Loss from operations		(232,105	)		(1,214,343	)

Other income (expense):
Loss on extinguishment of debt		-			(2,792,900	)
Interest expense		(73,536	)		(71,123	)
Total other expense		(73,536	)		(2,864,023	)

Net loss		(305,641	)		(4,078,366	)

Preferred stock:
Series B convertible contractual dividends		(74,730	)		(69,840	)
Series B convertible deemed dividends		-			(1,532,722	)

Loss attributable to common stockholders	$	(380,371	)	$	(5,680,928	)

Per share data:
Net loss – basic and diluted	$	(0.01	)	$	(0.26	)
Series B convertible contractual dividends		(0.00	)		(0.00	)
Series B convertible deemed dividends		-			(0.10	)

Net loss attributable to common stockholders - basic and diluted	$	(0.01	)	$	(0.36	)

Weighted average number of common shares outstanding - basic and diluted		26,546,832			15,609,892


The accompanying notes are an integral part of these condensed consolidated financial statements.

- 4 -

Tale of Contents

HEALTHWAREHOUSE.COM, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)

	For the Three Months Ended
	March 31
	2014			2013
Cash flows from operating activities
Net loss	$	(305,641	)	$	(4,078,366	)
Adjustments to reconcile net loss to net cash used in operating activities:
Provision for doubtful accounts		(41,458	)		(31,528	)
Provision for employee advance reserve		(1,714	)		-
Depreciation and amortization		41,621			35,846
Stock-based compensation		162,763			330,021
Warrants issued to 2012 private placement investors		-			487,200
Loss on extinguishment of notes and accounts payable		-			2,792,900
Imputed value of services contributed		87,500			87,500
Amortization of debt discount		54,035			44,363
Changes in operating assets and liabilities:
Accounts receivable		273,902			(6,238	)
Inventories - finished goods		31,149			85,519
Prepaid expenses and other current assets		18,531			10,451
Accounts payable – trade		(383,331	)		(91,216	)
Accounts payable – related parties		(5,445	)		185,999
Accrued expenses and other current liabilities		25,172			(340,265	)
Deferred revenue		(17,002	)		30,441
Net cash used in operating activities		(59,918	)		(457,373	)

Cash flows from investing activities
Change in restricted cash		-			725,002
Website development costs		(34,866	)		(25,490	)
Net cash (used in) and provided by investing activities		(34,866	)		699,512

Cash flows from financing activities
Principal payments on equipment leases payable		(13,159	)		(11,759	)
Proceeds from issuance of notes payable		100,000			500,000
Repayment of notes payable		-			(2,000,000	)
Repayment of convertible notes payable		-			(1,000,000	)
Proceeds from the sale of common stock		-			2,526,973
Proceeds from offering prior to reaching minimum offering amount		-			125,000
Net cash provided by financing activities		86,841			140,214

(Net decrease) net increase in cash		(7,944	)		382,353

Cash - beginning of period		67,744			-

Cash - end of period	$	59,800		$	382,353



Cash paid for:
Interest	$	25,523		$	367,978


The accompanying notes are an integral part of these condensed consolidated financial statements.

- 5 -

Tale of Contents

HEALTHWAREHOUSE.COM, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited - Continued)


	For the Three Months Ended
	March 31,
	2014		2013
Non-cash investing and financing activities:
Issuance of Series B preferred stock for settlement of accrued dividends	$	279,380	$	261,084
Cashless exercise of warrants into common stock	$	-	$	6,934
Warrants issued as debt discount in connection with notes payable	$	26,000	$	315,300
Accrual of contractual dividends on Series B convertible preferred stock	$	74,730	$	69,840
Deemed dividends on Series B convertible preferred stock	$	-	$	1,532,722
Common stock and warrants issued in exchange of notes and accounts payable	$	-	$	3,625,900
Conversion of accounts payable to notes payable	$	-	$	40,000







The accompanying notes are an integral part of these condensed consolidated financial statements.

- 6 -

Tale of Contents

HEALTHWAREHOUSE.COM, INC. AND SUBSIDIARIES

Notes to Condensed Consolidated Financial Statements

1. Organization and Basis of Presentation

HealthWarehouse.com, Inc., a Delaware company incorporated in 1998, (the “Company”) is a U.S. licensed virtual retail pharmacy (“VRP”) and healthcare e-commerce company that sells brand name and generic prescription drugs as well as over-the-counter (“OTC”) medical products. The Company’s objective is to be viewed by individual healthcare product consumers as a low-cost, reliable and hassle-free provider of prescription drugs and OTC medical products. The Company is presently licensed as a mail-order pharmacy in 50 states in the United States and the District of Columbia.

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information. Accordingly, they do not include all of the information and disclosures required by GAAP for annual financial statements. In the opinion of management, such statements include all adjustments (consisting only of normal recurring items) which are considered necessary for a fair presentation of the condensed consolidated financial statements of the Company as of March 31, 2014 and for the three months ended March 31, 2014 and 2013. The results of operations for the three months ended March 31, 2014 are not necessarily indicative of the operating results for the full year ending December 31, 2014 or any other period. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related disclosures of the Company as of December 31, 2013 and for the year then ended, which were filed with the Securities and Exchange Commission on Form 10-K on April 15, 2014.

2. Going Concern and Management’s Liquidity Plans

Since inception, the Company has financed its operations primarily through debt and equity financings and advances from related parties. As of March 31, 2014, the Company had a working capital deficiency of $4,727,480 and an accumulated deficit of $28,511,039. During the quarter ended March 31, 2014 and the year ended December 31, 2013, the Company incurred net losses of $305,641 and $5,489,892, respectively and used cash in operating activities of $59,918 and $1,024,781, respectively. These conditions raise substantial doubt about the Company’s ability to continue as a going concern.

Subsequent to March 31, 2014, the Company (a) raised an additional $50,000 in debt financing and (b) continues to incur net losses, use cash in operating activities and experience cash and working capital constraints. See Note 10.

On February 13, 2013, the Company received a Notice of Redemption related to its Series C Redeemable Preferred Stock aggregating $1,000,000 (see Note 6). As a result of receiving the Notice of Redemption, the Company must now apply all of its assets to redemption of the Series C Preferred Stock and to no other corporate purpose, except to the extent prohibited by Delaware law governing distributions to stockholders (the Company is not permitted to utilize toward the redemption those assets required to pay its debts as they come due and those assets required to continue as a going concern).

The Company recognizes it will need to raise additional capital in order to fund operations, meet its payment obligations and execute its business plan. There is no assurance that additional financing will be available when needed or that management will be able to obtain financing on terms acceptable to the Company and whether the Company will become profitable and generate positive operating cash flow. If the Company is unable to raise sufficient additional funds, it will have to develop and implement a plan to further extend payables, attempt to extend note repayments, attempt to negotiate the preferred stock redemption and reduce overhead until sufficient additional capital is raised to support further operations. There can be no assurance that such a plan will be successful. If the Company is unable to obtain financing on a timely basis, the Company could be forced to sell its assets, discontinue its operation and /or seek reorganization under the U.S. bankruptcy code.

Accordingly, the accompanying condensed consolidated financial statements have been prepared in conformity with GAAP, which contemplates continuation of the Company as a going concern and the realization of assets and the satisfaction of liabilities in the normal course of business. The carrying amounts of assets and liabilities presented in the condensed consolidated financial statements do not necessarily represent realizable or settlement values. The condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

- 7 -

Tale of Contents

3. Summary of Significant Accounting Policies

Principles of Consolidation

The condensed consolidated financial statements include the accounts of HealthWarehouse.com, Inc., Hwareh.com, Inc., Hocks.com, Inc., ION Holding NV, ION Belgium NV and Pagosa, its wholly-owned subsidiaries. ION Holding NV and ION Belgium NV are inactive subsidiaries. All material inter-company balances and transactions have been eliminated in consolidation.

On June 4, 2013, the Company formed a wholly-owned subsidiary called Pagosa Health LLC (“Pagosa”). On January 14, 2014, the Company closed Pagosa and decided to focus on its core consumer prescription business. Pagosa had a de minimis impact on the Company’s operations or the results for the three months ended March 31, 2014.

Use of Estimates

The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company’s significant estimates include reserves related to accounts receivable and inventory, the recoverability and useful lives of long-lived assets, the valuation allowance related to deferred tax assets, the valuation of equity instruments and debt discounts.

Net Loss Per Share of Common Stock

Basic net loss per share is computed by dividing net loss attributable to Common Stockholders by the weighted average number of common shares outstanding during the period. Diluted net loss per share reflects the potential dilution that could occur if securities or other instruments to issue Common Stock were exercised or converted into Common Stock. Potentially dilutive securities are excluded from the computation of diluted net loss per share if their inclusion would be anti-dilutive and consist of the following:

	March 31,
	2014		2013

Options		2,514,150		2,451,483
Warrants		2,492,846		6,047,119
Series B Convertible Preferred Stock		3,714,445		3,407,313
Total potentially dilutive shares		8,721,441		11,905,915

Recently Issued Accounting Pronouncements

The Company has determined there are no new accounting standards that are expected to have a material impact on the Company's condensed consolidated financial statements.

4. Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following:

	March 31,		December 31,
	2014		2013

Deferred Rent	$	43,704	$	46,254
Advertising		75,000		75,000
Salaries and Benefits		178,393		132,048
Customer Payables		19,697		39,618
Dividend Payable		74,729		279,380
Accrued Interest		46,429		45,616
Other		3,622		3,136
Total	$	441,574	$	621,052

- 8 -

Tale of Contents

5. Notes Payable

The Company is a party to a Loan and Security Agreement (the “Loan Agreement”) with a lender (the "Lender"). Under the terms of the Loan Agreement, the Company borrowed an aggregate of $700,000 from the Lender (the “Loan”), including $100,000 during the three months ended March 31, 2014. The Loan is evidenced by a promissory note (the “Note”) in the face amount of $700,000 (as amended). The Note bears interest on the unpaid principal balance of the Note until the full amount of principal has been paid at a floating rate equal to the Prime Rate plus four and one-quarter percent (4.25%) per annum (7.50% as of March 31, 2014). Under the terms of the Loan Agreement, the Company has agreed to make monthly payments of accrued interest on the first day of every month. The principal amount and all unpaid accrued interest on the Note is payable on March 1, 2015, or earlier in the event of default or a sale or liquidation of the Company. The Loan may be prepaid in whole or in part at any time by the Company without penalty. The Note contains financial covenants which require the Company to meet certain minimum targets for earnings before interest, taxes and non-cash expenses, including depreciation, amortization and stock-based compensation (“EBITDAS”). In connection with the Loan Agreement, the Company granted the Lender five-year warrants to purchase an aggregate of 1,050,000 shares of Common Stock at an exercise price of $0.35 per share, of which 150,000 warrants were issued during the three months ended March 31, 2014. The warrants contain customary anti-dilution provisions. The warrants had a relative fair value of $392,500, of which $26,000 was established as debt discount during the three months ended March 31, 2014 and will be amortized using the effective interest method over the term of the Note. The Company amortized $49,435 of the debt discount as interest expense during the three months ended March 31, 2014 and $212,830 remained unamortized as of March 31, 2014. Including the value of warrants issued in connection with Note and subsequent amendments, the Note had an effective interest rate of 40% per annum. See Note 10 for subsequent events.

The Company granted the Lender a first, priority security interest in all of the Company’s assets, in order to secure the Company’s obligation to repay the Loan. The Loan Agreement contains customary negative covenants restricting the Company’s ability to take certain actions without the Lender’s consent, including incurring additional indebtedness, transferring or encumbering assets, paying dividends or making certain other payments, and acquiring other businesses. Upon the occurrence of an event of default, the Lender has the right to impose interest at a rate equal to five percent (5.0%) per annum above the otherwise applicable interest rate (the “Default Rate”). The repayment of the Loan may be accelerated prior to the maturity date upon certain specified events of default, including failure to pay, bankruptcy, breach of covenant, and breach of representations and warranties.

The Company recorded amortization of debt discount associated with notes payable of $54,035 and $44,363 for the three months ended March 31, 2014 and 2013, respectively.

6. Stockholders’ Deficiency

Common Stock

On January 15, 2014, the Company issued 21,289 shares of Common Stock to an employee in accordance with an employment agreement. The fair value of the shares was $10,646 based on the closing price on the date of issuance.

Preferred Stock

As of March 31, 2014 and December 31, 2013, the Company had accrued contractual dividends of $74,730 and $279,380, respectively, related to the Series B Preferred Stock. On January 1, 2014 and 2013, the Company issued 29,564 and 27,630 shares of Series B convertible preferred stock valued at $279,380 and $261,084, respectively, representing approximately $0.66 in value per share of Series B Preferred Stock outstanding on each date, to the Series B convertible preferred stock owners as payment in kind for dividends.

Stock Options

Stock-based compensation expense related to stock options was recorded in the condensed consolidated statements of operations as a component of selling, general and administrative expenses and totaled $151,853 and $312,444 for the three months ended March 31, 2014 and 2013, respectively.

As of March 31, 2014, stock-based compensation expense related to stock options of $1,476,372 remains unamortized, including $584,803 which is being amortized over the weighted average remaining period of 1.5 years. The remaining $891,569 is related to a performance based option where vesting is currently deemed to be improbable and no amount is being amortized.

- 9 -

Tale of Contents

Summary

A summary of the stock option activity during the three months ended March 31, 2014 is presented below:

						Weighted
				Weighted		Average
				Average		Remaining
	Number of			Exercise		Life		Intrinsic
	Options			Price		In Years		Value

Outstanding, January 1, 2014		2,543,150		$	2.37
Granted		-			-
Exercised		-			-
Forfeited		(29,000	)		3.22
Outstanding, March 31, 2014		2,514,150		$	2.36		5.7	$	-

Exercisable, March 31, 2014		1,398,475		$	2.78		4.1	$	-

The following table presents information related to stock options at March 31, 2014:

		Options Outstanding				Options Exercisable
		Weighted				Weighted		Weighted
Range of		Average		Outstanding		Average		Average		Exercisable
Exercise		Exercise		Number of		Exercise		Remaining Life		Number of
Price		Price		Options		Price		In Years		Options

$	0.30 - $2.20	$	1.11		1,339,400	$	1.58		2.6		573,725
$	2.21 - $3.80		3.23		757,750		2.95		3.8		507,750
$	3.81 - $6.99		4.79		417,000		4.66		7.5		317,000
		$	2.36		2,514,150	$	2.78		4.1		1,398,475

Warrants

Valuation

In applying the Black-Scholes option pricing model to stock warrants, the Company used the following weighted average assumptions:

	March 31,
	2014	2013

Risk free interest rate	1.74%	0.88%
Dividend yield	0.00%	0.00%
Expected volatility	171.0%	164.3%
Expected life in years	5.00	5.00

- 10 -

Tale of Contents

Grants

See Note 5 – Notes Payable for details regarding warrants granted in connection with the issuances of notes payable.

The weighted average fair value of the stock warrants granted during the three months ended March 31, 2014 and 2013, was $0.23 and $1.38 per share, respectively.

Stock-based compensation expense related to warrants for the three months ended March 31, 2014 and 2013 was recorded in the condensed consolidated statements of operations as a component of selling, general and administrative expenses and totaled $264 and $504,777, respectively. As of March 31, 2014, stock-based compensation expense related to warrants of $580,525 remains unamortized, including $3,685 which is being amortized over the weighted average remaining period of 1.5 years. The remaining $576,840 is related to a performance based warrant where vesting is currently deemed to be improbable and no amount is being amortized.

A summary of the stock warrant activity during the three months ended March 31, 2014 is presented below:

			Weighted		Average
			Average		Remaining
	Number of		Exercise		Life		Intrinsic
	Warrants		Price		In Years		Value

Outstanding, January 1, 2014		2,342,846	$	0.96
Granted		150,000	$	0.35
Exercised		-	$	-
Forfeited		-		-
Outstanding, March 31, 2014		2,492,846	$	0.92		3.7	$	-

Exercisable, March 31, 2014		2,242,846	$	0.70		3.8	$	-

The following table presents information related to stock warrants at March 31, 2014:

		Warrants Outstanding				Warrants Exercisable
		Weighted				Weighted		Weighted
Range of		Average		Outstanding		Average		Average		Exercisable
Exercise		Exercise		Number of		Exercise		Remaining Life		Number of
Price		Price		Warrants		Price		In Years		Warrants

$	0.25 - $0.35	$	0.27		1,900,000	$	0.27		4.1		1,900,000
$	0.36 - $3.00		2.91		562,846		2.91		2.4		312,846
$	3.01 - $4.95		4.95		30,000		4.95		3.5		30,000
$	0.25 - $4.95	$	0.92		2,492,846	$	0.70		3.8		2,242,846

Services Contributed

Effective January 1, 2013, an executive officer of the Company waived payment for services contributed. As a result, the Company imputed the value of the services contributed based on a compensation rate previously approved by the Compensation Committee and recorded salary expense of $87,500 for each of the three month periods ended March 31, 2014 and 2013, with a corresponding credit to stockholders’ deficiency.

7. Commitments and Contingent Liabilities

Operating Leases

The Company is a party to a lease agreement for approximately 62,000 square feet of office and storage space with an entity. The monthly lease rate is $10,671 for years 2014 and 2015 and $11,975 in year 2016. The Company accounts for rent expense using the straight line method of accounting, deferring the difference between actual rent due and the straight line amount. The lease expires on January 1, 2017. Deferred rent payable of $43,704 and $46,254 as of March 31, 2014 and December 31, 2013, respectively, has been included in accrued expenses and other current liabilities on the condensed consolidated balance sheets.

- 11 -

Tale of Contents

On June 7, 2013, Pagosa signed a three year lease for $1,000 per month to house an office, pharmacy as well as inventory and is located in Lawrenceburg, IN. On July 8, 2013, the parties agreed to extend the lease for two additional years, such that the new termination date is now June 7, 2018. On January 14, 2014, the Company closed Pagosa Health and vacated the Lawrenceburg facility. The Company is currently in discussions with the Landlord regarding termination of the lease related to the building. The impact of the lease termination was de minimus to the condensed consolidated financial statements as of March 31, 2014.

Future minimum payments, by year and in the aggregate, under operating leases as of March 31, 2014 are as follows:

For years ending December 31,	Amount

2014	$	96,037
2015	$	128,049
2016	$	143,700
Total future minimum lease payments	$	367,786

During the three months ended March 31, 2014 and 2013, the Company recorded aggregate rent expense of $49,229 and $45,719, respectively.

Litigation

In the ordinary course of business, we may become subject to lawsuits and other claims and proceedings that might arise from litigation matters or regulatory audits. Such matters are subject to uncertainty and outcomes are often not predictable with assurance. Our management does not presently expect that any such matters will have a material adverse effect on the Company’s condensed consolidated financial condition or condensed consolidated results of operations. We are not currently involved in any pending or threatened material litigation or other material legal proceedings nor have we been made aware of any penalties from regulatory audits, except as described below.

On February 9, 2012, two of our former stockholders, Rock Castle Holdings, LLC and Jason Smith (collectively “Plaintiffs”), filed suit against us in the Hamilton County, Ohio Court of Common Pleas, alleging that we had breached the terms of certain incentive options we granted to the Plaintiffs in connection with our now-terminated oral consulting arrangements with the Plaintiffs, by among other things, refusing Plaintiffs’ purported exercise of options to purchase 233,332 shares of our Common Stock at an exercise price of $2.00 per share in December 2011. Plaintiffs have requested that, among other things, the court require us to permit the exercise of the 233,332 options. Plaintiffs have also provided an expert report indicating damages of $2.086 million. Also named as defendants were two individuals, Michael Peppel and Gary Singer, whom Plaintiffs claim acted as agents for us in connection with our purchase of shares of our Common Stock from Plaintiffs in September 2011. On July 19, 2012, the Company and Mr. Peppel filed an answer and counterclaim for breach of contract, alleging that Plaintiffs breached consulting agreements with the Company and undertook a series of actions that damaged and hurt the Company. On July 24, 2012, the Company filed a complaint against Dennis Smith for breach of contract in the Hamilton County, Ohio Court of Common Pleas, which action was consolidated with the earlier case. Plaintiffs filed an answer in response to the counterclaim, and Dennis Smith filed an answer in response to the Company’s complaint. On April 26, 2013, Plaintiffs dismissed Mr. Singer from the lawsuit. On March 24, 2014, all parties filed motions for summary judgment: (i) the Company and Mr. Peppel moved for summary judgment on all claims asserted by Plaintiffs, (ii) Dennis B. Smith and Counterclaim Defendants and Plaintiffs moved for summary judgment on the Company’s claims for breach of contract, and (iii) Plaintiffs moved for partial summary judgment on their claim for declaratory relief that the Company breached the terms of a stock option agreement. Trial of the case is currently scheduled for November 2014. We deny all of the Plaintiffs’ claims and intend to contest this matter vigorously.

The Company was a party to a putative stockholder derivative action was filed in the Court of Chancery of the State of Delaware on May 7, 2013 against certain directors and our chief executive officer and against us, as a nominal defendant. On January 8, 2014, in a stipulation and order of dismissal, the action was dismissed with prejudice to plaintiff, with each party bearing its own attorneys' fees and costs.

On May 15, 2013, a former consultant filed suit in Boone County, Kentucky Circuit Court alleging breach of contract and unjust enrichment for unpaid consulting fees and expenses of approximately $55,000. We filed an answer to the complaint on July 22, 2013 and intend to vigorously defend ourselves against the allegations. The trial of the case has been set for September 2014.

- 12 -

Tale of Contents

8. Concentrations

During the three months ended March 31, 2014, two vendors represented 57% and 16% of total inventory purchases. During the three months ended March 31, 2013, two vendors represented 30% and 11% of total inventory purchases, respectively.

9. Related Party Transactions

Between June 2009 and April 2012, an employee who is the son of the managing member of a limited liability company that beneficially owns over 5% of the Company’s Common Stock received advances from the Company in various forms which totaled $391,469 including interest. Principal repayments towards the outstanding advances aggregating $235,000 have been made through March 31, 2014. In April 2012, this employee voluntarily resigned from the Company. The individual agreed to repay the remaining balance with interest based on prime rate on the first business day of the calendar quarter. The amount has been included in Stockholders’ Deficiency as the Company has determined to exercise its rights through a pledge agreement for 42,860 shares as collateral. At March 31, 2014 and December 31, 2013, the Company estimated the value of the collateral at $10,715 and $9,001, respectively.

10. Subsequent Events

The Company evaluates events that have occurred after the balance sheet date but before the financial statements are issued. Based upon the evaluation, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the condensed consolidated financial statements, except as disclosed.

Notes Payable

On April 30, 2014, the Company received an additional $50,000 from a lender, which brought the face value of the Note to $750,000 pursuant to an Amended and Restated Promissory Note (the “April 2014 Note”), effective April 29, 2014, which supersedes the Note with the same Lender. The April 2014 Note contains financial covenants which require the Company to meet certain minimum targets for earnings before interest, taxes and non-cash expenses, including depreciation, amortization and stock-based compensation (“EBITDAS”) for the calendar quarters and years ended between June 30, 2014 and December 31, 2014. The remainder of the material April 2014 Note terms are unchanged from the Note, including the March 1, 2015 maturity date. In consideration of the Lender providing additional funds and entering into the April 2014 Note, the Company granted the Lender a five-year warrant to purchase 75,000 shares of Common Stock at an exercise price of $0.35 per share. The warrant contains customary anti-dilution provisions. The warrant had a relative fair value of $14,900 which was set up as debt discount and will be amortized using the effective interest method over the term of the April 2014 Note. Including the value of warrants issued in connection with the April Note, the Note had an effective interest rate of 40% per annum.

Executive Compensation

On April 28, 2014, the Compensation Committee approved the payment of an annual salary of $150,000 to the Company’s Chief Executive Officer, effective May 1, 2014.

- 13 -

Tale of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operation.

The following discussion and analysis of the results of operations and financial condition of HealthWarehouse.com, Inc. (and including its subsidiaries, the “Company”) as of March 31, 2014 and December 31, 2013 and for the three months ended March 31, 2014 and 2013 should be read in conjunction with our financial statements and the notes to those financial statements that are included elsewhere in this Quarterly Report on Form 10-Q. References in this Management’s Discussion and Analysis of Financial Condition and Results of Operations to “us,” “we,” “our,” and similar terms refer to the Company. This Quarterly Report contains forward-looking statements as that term is defined in the federal securities laws. The events described in forward-looking statements contained in this Quarterly Report may not occur. Generally these statements relate to business plans or strategies, projected or anticipated benefits or other consequences of our plans or strategies, projected or anticipated benefits from acquisitions to be made by us, or projections involving anticipated revenues, earnings or other aspects of our operating results. The words “may,” “will,” “expect,” “believe,” “anticipate,” “project,” “plan,” “intend,” “estimate,” and “continue,” and their opposites and similar expressions, are intended to identify forward-looking statements. We caution you that these statements are not guarantees of future performance or events and are subject to a number of uncertainties, risks and other influences, many of which are beyond our control, which may influence the accuracy of the statements and the projections upon which the statements are based. Factors that may affect our results include, but are not limited to, the risks and uncertainties discussed in Item 7 (“Management’s Discussion and Analysis of Financial Condition and Results of Operations – Factors That May Affect Results and Financial Condition”) of our Annual Report on Form 10-K for the year ended December 31, 2013 filed with the Securities and Exchange Commission (the “SEC”) on April 15, 2014.

Any one or more of these uncertainties, risks and other influences could materially affect our results of operations and whether forward-looking statements made by us ultimately prove to be accurate. Our actual results, performance and achievements could differ materially from those expressed or implied in these forward-looking statements. We undertake no obligation to publicly update or revise any forward-looking statements, whether from new information, future events or otherwise.

Overview

We are a Verified Internet Pharmacy Practice Sites (“VIPPS”) accredited retail mail-order pharmacy and healthcare e-commerce company that sells discounted generic and brand name prescription drugs, as well as, over-the-counter (OTC) medical products and surgical supplies. Our web addresses are http://www.healthwarehouse.com and http://www.hocks.com. At present, we sell:

●	a range of prescription drugs (we are licensed as a mail-order pharmacy for sales to all 50 states and the District of Columbia);

●	diabetic supplies including glucometers, lancets, syringes and test strips;

●	OTC medications covering a range of conditions from allergy and sinus to pain and fever to smoking cessation aids;

●	home medical supplies including incontinence supplies, first aid kits and mobility aids; and

●	diet and nutritional products including supplements, weight loss aids, and vitamins and minerals.

Our objectives are to make the pharmaceutical supply chain more efficient and to pass the savings on to the consumer. We are becoming known by consumers as a convenient, reliable, discount provider of over-the-counter and prescription medications and products. We intend to continue to expand our product line as our business grows.

- 14 -

Tale of Contents

Results of Operations

For The Three Months Ended March 31, 2014 Compared to Three Months Ended March 31, 2013

	For three months ended			% of			For three months ended			% of
	Ended March 31, 2014			Revenue			Ended March 31, 2013			Revenue

Net sales	$	1,716,964			100.0	%	$	2,409,916			100.0	%
Cost of sales		731,408			42.6	%		1,235,156			51.3	%
Gross profit		985,556			57.4	%		1,174,760			48.7	%
Selling, general & administrative		1,217,661			70.9	%		2,389,103			99.0	%
Loss from operations		(232,105	)		(13.5	%)		(1,214,343	)		(50.4	%)
Loss on extinguishment of debt		-			0.0	%		(2,792,900	)		(115.9	%)
Interest expense		(73,536	)		(4.3	%)		(71,123	)		(3.0	%)
Net loss	$	(305,641	)		(17.8	%)	$	(4,078,366	)		(169.2	%)

Net Sales

For three months ended		%			$			For three months ended
March 31, 2014		Change			Change			March 31, 2013

$	1,716,964		-28.8	%	$	(692,952	)	$	2,409,916

Net sales for the three months ended March 31, 2014 declined to $1,716,964 from $2,409,916, a decrease of $692,952, or 28.8% due to the reduction in business to business sales and cash flow constraints. Due to cash flow constraints, we were unable expand our advertising efforts to grow our core online prescription business and we were not able to maintain over-the-counter inventories to satisfy incoming orders. This prompted negative customer reviews that contributed to the decline in sales. Management has taken steps to narrow its product line, particularly on over-the-counter products, and set new stocking levels for these items to improve order fill rates. In addition, customer support personnel are responsible for proactively calling customers after prescription orders are received to obtain the required copies of the prescriptions, in order to process the order and improve the Company’s order conversion rate. Since the implementation of these efforts, customer reviews as surveyed by an independent third party service have been positive relative to the ease of doing business, competitive pricing and responsive customer service.

Cost of Sales and Gross Margin

	For three months ended			%			$			For three months ended
	March 31, 2014			Change			Change			March 31, 2013

Cost of sales	$	731,408			(40.8	%)		(503,747	)	$	1,235,155

Gross margin $	$	985,556			(16.1	%)		(189,205	)	$	1,174,761

Gross margin %		57.4	%		17.9	%		8.7	%		48.7	%

Cost of sales were $731,408 for the three months ended March 31, 2014 as compared to $1,235,155 for the three months ended March 31, 2013, a decrease of $503,747, or 40.8%, primarily as a result of a reduction in order volume and improvement in our costs associated with improved vendor purchasing agreements. Gross margin percentage increased from 48.7% for the three months ended March 31, 2013 to 57.4% for the three months ended March 31, 2014, primarily due to the improved cost discussed above, the elimination of unprofitable business relations and the reduction of lower-margin business to business sales relative to total sales. Management will continue to focus efforts on promoting and offering its higher margin product lines as part of the narrowing of its product offering.

- 15 -

Tale of Contents

Selling, General and Administrative Expenses

	For three months ended March 31, 2014			% Change			$ Change			For three months ended March 31, 2013

S,G&A	$	1,217,661			-49.0	%	$	(1,171,442	)	$	2,389,103

% of sales		70.9	%								99.0	%

Selling, general and administrative expenses totaled $1,217,661 for the three months ended March 31, 2014 compared to $2,389,103 for the three months ended March 31, 2013, a decrease of $1,171,442, or 49.0%. The three months ended March 31, 2014 expense decreases included (a) a decrease in legal expense of $143,083 (primarily due to litigation and the capital raise in 2013); (b) a decrease in warrants expense of $487,200 related to capital raise of 2013; (c) a decrease in stock based compensation of $149,947 (primarily due to employee incentives issued in 2013 and significant forfeitures after the first quarter of 2013); (c) a reduction in salary and contract labor expense of $183,762 (primarily due to a reduction in headcount); (d) a decrease in freight expense of $68,731 (primarily due to the reduction in the order volume); and (e) a decrease in health benefit expense of $41,278 (due to higher employee contributions). We expect that our selling, general and administrative expenses, specifically legal and professional fees, will continue to decrease over time as our outstanding litigation is resolved and our internal controls over financial reporting will reduce our reliance on outside consulting and accounting professionals. We also expect to continue to benefit from the significant reduction in salary and related expense in 2014.

Loss on Extinguishment

During the three months ended March 31, 2013, we recorded a $2,792,900 extinguishment loss which represents the incremental fair value of the equity securities issued as compared to the carrying value of the liabilities that were exchanged.

Other Income and Expense

Interest expense increased from $71,123 in the three months ended March 31, 2013 to $73,536 in the three months ended March 31, 2014, an increase of $2,413, or 3%, primarily due to higher notes payable balances.

Adjusted EBITDAS

We believe Adjusted Earnings Before Interest, Taxes, Depreciation, Amortization and Stock-Based Compensation (“Adjusted EBITDAS”), a non-GAAP financial measure, is useful in evaluating our operating performance compared to that of other companies in our industry, as this metric generally eliminates the effects of certain items that may vary for different companies for reasons unrelated to overall operating performance. We believe that:

Adjusted EBITDAS provides investors and other users of our financial information consistency and comparability with our past financial performance, facilitates period-to-period comparisons of operations and facilitates comparisons with other companies, many of which use similar non-GAAP financial measures to supplement their GAAP results; and

Adjusted EBITDAS is useful because it excludes non-cash charges, such as depreciation and amortization, stock-based compensation and one-time charges, which the amount of such expense in any specific period may not directly correlate to the underlying performance of our business operations and these expenses can vary significantly between periods.

We use Adjusted EBITDAS in conjunction with traditional GAAP measures as part of our overall assessment of our performance, to evaluate the effectiveness of our business strategies and to communicate with our lenders, stockholders and board of directors concerning our financial performance.

Adjusted EBITDAS should not be considered as a substitute for other measures of financial performance reported in accordance with GAAP. There are limitations to using non-GAAP financial measures, including that other companies may calculate these measures differently than we do. We compensate for the inherent limitations associated with using Adjusted EBITDAS through disclosure of these limitations, presentation of our financial statements in accordance with GAAP and reconciliation of Adjusted EBITDAS to the most directly comparable GAAP measure, specifically net loss.

- 16 -

Tale of Contents

The following provides a reconciliation of net loss to Adjusted EBITDAS:

	March 31,
	2014			2013
	(unaudited)

Net loss	$	(305,641	)	$	(4,078,366	)
Non-GAAP adjustments:
Loss on extinguishment of debt		-			2,792,900
Interest expense, net		73,536			71,123
Depreciation and amortization		41,621			35,846
Warrants issued to 2012 investors		-			487,200
Imputed value of contributed services		87,500			87,500
Stock-based compensation		162,499			330,021
Change in fair value of collateral securing
employee advances		(1,714	)		-
Adjusted EBITDAS	$	57,801		$	(273,776	)

Off-Balance Sheet Arrangements

We have not entered into any transactions with unconsolidated entities in which we have financial guarantees, subordinated retained interests, derivative instruments or other contingent arrangements that expose us to material continuing risks, contingent liabilities or any other obligations under a variable interest in an unconsolidated entity that provides us with financing, liquidity, market risk or credit risk support.

Impact of Inflation

We believe that inflation has not had a material impact on our results of operations for the three months ended March 31, 2014 and 2013. We cannot assure you that future inflation will not have an adverse impact on our operating results and financial condition.

Liquidity and Capital Resources

Since inception, we have financed operations primarily through debt and equity financings and advances from stockholders. As of March 31, 2014 we had a working capital deficiency of $4,727,480 and an accumulated deficit of $28,511,039. During the three months ended March 31, 2014 and the year ended December 31, 2013, we incurred net losses of $305,641 and $5,489,892 and used cash in operating activities of $59,918 and $1,024,781, respectively. These conditions raise substantial doubt about our ability to continue as a going concern.

Subsequent to March 31, 2014, we raised an aggregate of $50,000 in debt financing and continue to incur net losses, use cash in operating activities and experience cash and working capital constraints.

On February 13, 2013, we received a Notice of Redemption related to our Series C Redeemable Preferred Stock aggregating $1,000,000. As a result of receiving the Notice of Redemption, we must now apply all of our assets to redemption of the Series C Preferred Stock and to no other corporate purpose, except to the extent prohibited by Delaware law governing distributions to stockholders (we are not permitted to utilize toward the redemption those assets required to pay our debts as they come due and those assets required to continue as a going concern).

We recognize that we will need to raise additional capital in order to fund operations, meet our payment obligations, including the redemption of the Series C Redeemable Preferred Stock, and execute our business plan. There is no assurance that additional financing will be available when needed or that management will be able to obtain financing on terms acceptable to us and whether we will become profitable and generate positive operating cash flow. If we are unable to raise sufficient additional funds, we will have to develop and implement a plan to further extend payables, extend note repayments, extend the preferred stock redemption and reduce overhead until sufficient additional capital is raised to support further operations. There can be no assurance that such a plan will be successful. If we are unable to obtain financing on a timely basis, we could be forced to sell our assets, discontinue our operations and/or seek reorganization under the U.S. bankruptcy code.

- 17 -

Tale of Contents

Accordingly, the accompanying condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate our continuation as a going concern and the realization of assets and the satisfaction of liabilities in the normal course of business. The carrying amounts of assets and liabilities presented in the condensed consolidated financial statements do not necessarily represent realizable or settlement values. The condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

As of March 31, 2014 and December 31, 2013, the Company had cash on hand of $59,800 and $67,744, respectively. Our cash flow from operating, investing and financing activities during these periods were as follows:

For the three months ended March 31, 2014, cash flows included net cash used in operating activities of $59,918. This amount included a decrease in operating cash related to a net loss of $305,641, partially offset by aggregate non-cash adjustments of $302,746, plus aggregate cash used by changes in operating assets and liabilities of $57,024 (primarily a result of a reduction of accounts payable). For the three months ended March 31, 2013, cash flows included net cash used in operating activities of $457,373. This amount included a decrease in operating cash related to a net loss of $4,078,366 partially offset by aggregate non-cash adjustments of $3,746,302 and aggregate cash used by changes in operating assets and liabilities of $125,309 (primarily accrued expenses).

For the three months ended March 31, 2014, net cash utilized by investing activities was $34,866 related to capitalized web development costs. For the three months ended March 31, 2013, net cash provided by investing activities was $699,512 due to due to releasing $725,002 of cash provided by investors from escrow (restricted cash) partially offset by capitalized web development costs of $25,490.

For the three months ended March 31, 2014, net cash provided by financing activities was $86,841 related to the issuance of a notes payable offset by principal payment on equipment leases of $13,159. For the three months ended March 31, 2013, net cash provided by financing activities was $140,214. Cash was provided by $2,526,973 of proceeds from a private placement offering (which excludes $850,002 of cash received during 2012 but closed on during the three months ended March 31, 2013) and $500,000 of proceeds from the issuance of notes payable and $125,000 of private placement deposits, partially offset by repayments of notes payable, convertible notes payable and equipment lease payments of $2,000,000, $1,000,000 and $11,759, respectively.

Critical Accounting Policies and Estimates

There are no material changes from the critical accounting policies set forth in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of our Form 10-K filed on April 15, 2014. Please refer to that document for disclosures regarding the critical accounting policies related to our business.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

Not applicable.

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d–15(e) under the Exchange Act) are designed to provide reasonable assurance that information required to be disclosed in reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the forms and rules of the SEC and that such information is accumulated and communicated to management, including the CEO, in a manner to allow timely decisions regarding required disclosures.

In connection with the preparation of this Form 10–Q, our management, including the CEO, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of March 31, 2014. Management had previously identified material weaknesses in our internal control over financial reporting as of December 31, 2013 (see Form 10-K filed with the SEC on April 15, 2014), which is an integral component of our disclosure controls and procedures. We are working with the third-party financial and operational consultants to continue to develop and implement the appropriate operating procedures to mitigate the weaknesses related to the separation of duties, proper approvals and timely and accurate financial information. The Company is currently evaluating what additional policies and procedures may be necessary, how to most effectively communicate the policies and procedures to its personnel and how to improve the integration of its financial consolidation and reporting system. The directors also plan to pursue the employment of a permanent Chief Financial Officer as the Company’s operations and liquidity position improve.

- 18 -

Tale of Contents

However, certain material weaknesses were not remediated during the three months ended March 31, 2014. As a result, our management has concluded that, as of March 31, 2014, our disclosure controls and procedures were not effective.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting or in other factors during the quarter ended March 31, 2014, that have materially affected, or were reasonably likely to materially affect, our internal control over financial reporting.

Limitations of the Effectiveness of Control

A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Because of the inherent limitations of any control system, no evaluation of controls can provide absolute assurance that all control issues, if any, within a company have been detected.

PART II. OTHER INFORMATION

Item 1. Legal Proceedings.

In the ordinary course of business, we may become subject to lawsuits and other claims and proceedings that might arise from litigation matters or regulatory audits. Such matters are subject to uncertainty and outcomes are often not predictable with assurance. Our management does not presently expect that any such matters will have a material adverse effect on the Company’s consolidated financial condition or consolidated results of operations. We are not currently involved in any pending or threatened material litigation or other material legal proceedings nor have we been made aware of any penalties from regulatory audits, except as described below.

- 19 -

Tale of Contents

Item 1A. Risk Factors.

Not applicable.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

On January 15, 2014, the Company issued 21,289 shares of shares of Common Stock to an employee as part of his compensation related to his service to the Company during 2013. The fair value of the shares was $10,646 based on the closing price on the date of issuance. The issuance of these securities is exempt under Section 4(2) of Securities Act for non-public offering.

Recent Repurchases of Common Stock

There were no repurchases of our Common Stock during the quarter ended March 31, 2014. The Company does not currently have an announced repurchase program.

Item 3. Defaults upon Senior Securities.

Not applicable.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

Not applicable.

Item 6. Exhibits.

The following exhibits are provided:

4.1	Amended and Restated Promissory Note dated April 29, 2014 in the amount of $750,000 payable by the Company to the order of Melrose Capital Advisors, LLC *

4.2	Common Stock Purchase Warrant dated April 29, 2014 for 75,000 common shares *

31.1	Certification of CEO Pursuant to Section 302 of the Sarbanes Oxley Act of 2002.*

31.2	Certification of CFO Pursuant to Section 302 of the Sarbanes Oxley Act of 2002.*

32.1	Certification of CEO Pursuant to Section 906 of the Sarbanes Oxley Act of 2002.*

32.2	Certification of CFO Pursuant to Section 906 of the Sarbanes Oxley Act of 2002.*

101.INS	XBRL Instance Document *

101.SCH	XBRL Schema Document *

101.CAL	XBRL Calculation Linkbase Document *

101.DEF	XBRL Definition Linkbase Dcoument *

101.LAB	XBRL Label Linkbase Document *

101.PRE	XBRL Presentation Linkbase Document *

* Filed herewith.

- 20 -

Tale of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: May 15, 2014

HEALTHWAREHOUSE.COM, INC.

By: /s/ Lalit Dhadphale

Lalit Dhadphale

President and Chief Executive Officer

- 21 -

EX-4.1 2 exhibit41.htm EXHIBIT41 exhibit41.htm

EXHIBIT 4.1

AMENDED AND RESTATED PROMISSORY NOTE

$750,000.00	April 29, 2014
	(“Effective Date”)

FOR VALUE RECEIVED, the undersigned, HEALTHWAREHOUSE.COM, INC., a Delaware corporation, HWAREH.COM, INC., a Delaware corporation, HOCKS.COM, INC., an Ohio corporation, and PAGOSA HEALTH LLC, an Indiana corporation, jointly and severally, (collectively, “Borrower”), with an address at 7107 Industrial Road, Florence, Kentucky 41042, hereby promise to pay to the order of MELROSE CAPITAL ADVISORS, LLC, an Ohio limited liability company (together with its successors and assigns, “Lender”), in lawful money of the United States of America in immediately available funds with an address at c/o Statman, Harris & Eyrich, LLC, 441 Vine Street, 37th Floor, Cincinnati, Ohio 45202, or at such other location as the Lender may designate from time to time, the principal sum of SEVEN HUNDRED FIFTY THOUSAND AND 00/100 DOLLARS ($750,000.00) together with interest accruing from the date hereof at the rate or rates and in the manner hereinafter provided on the principal balance hereof from time to time outstanding, as provided below.

1. Interest. Interest will be charged on the unpaid principal balance of this Note until the full amount of principal has been paid at a floating rate equal to the Prime Rate plus 4.25% per annum. As used herein, “Prime Rate” means the rate publicly announced by PNC Bank, N.A. from time to time as its prime rate. The Prime Rate is determined from time to time by PNC Bank, N.A. as a means of pricing some loans to its borrowers. The Prime Rate is not tied to any external rate of interest or index, and does not necessarily reflect the lowest rate of interest actually charged by PNC Bank, N.A. to any particular class or category of customers. If and when the Prime Rate changes, the rate of interest on this Note will change automatically without notice to the Borrower, effective on the date of any such change. In no event will the rate of interest hereunder exceed the maximum rate allowed by law.

2. Payments. Borrower will make monthly payments of accrued interest on the first day of every month, beginning on May 1, 2014, and continuing on the first day of each month thereafter. On March 1, 2015 (“Maturity Date”), the entire unpaid principal balance of this Note and all accrued and unpaid interest shall be due and payable in full. The entire unpaid principal balance of this Note and all accrued and unpaid interest may be prepaid at any time prior to the Maturity Date by the Borrower.

3. Loan Documents; Restatement. This Note is executed in connection with and is secured by any and all documents and instruments now or in the future given to the Lender to evidence or secure the loans hereunder (collectively, the “Loan Documents”), including but not limited to the following: Security Agreement from HEALTHWAREHOUSE.COM, INC., HWAREH.COM, INC and HOCKS.COM, INC., dated March 28, 2013, and Security Agreement from PAGOSA HEALTH LLC dated September 30, 2013, covering all business assets, including but not limited to accounts, inventory, equipment and general intangibles (the “Collateral”).

This Note amends and restates, and is in substitution for, that certain Amended and Restated Promissory Note dated March 28, 2014 in the principal amount of $700,000.00 payable to the order of the Lender (the "Existing Note"). However, this Note shall in no way extinguish, cancel or satisfy Borrower’s unconditional obligation to repay all indebtedness evidenced by the Existing Note or constitute a novation of the Existing Note. Nothing herein is intended to extinguish, cancel or impair the lien priority or effect of any security agreement with respect to the Borrower’s obligations hereunder and under any other document relating hereto.

Page 1 of 8

4. Representations. In order to induce Lender to extend the credit accommodations provided in this Note, Borrower hereby represents and warrants to Lender the following:

(a) Each Borrower is duly incorporated, validly existing and in good standing under the laws of the State of its incorporation and has the power and authority to own and operate its assets and to conduct its business as now or proposed to be carried on, and is duly qualified, licensed and in good standing to do business in all jurisdictions where its ownership of property or the nature of its business requires such qualification or licensing and failure to be so qualified or licensed could reasonably be expected to materially adversely affect Borrower (on a consolidated basis). Borrower is duly authorized to execute and deliver the Loan Documents, all necessary action to authorize the execution and delivery of the Loan Documents has been properly taken, and the Loan Documents, when executed and delivered by Borrower, will constitute the legal, valid and binding obligations of Borrower enforceable in accordance with their terms except as enforcement may be limited by equitable principles or by bankruptcy, insolvency, reorganization, moratorium, or similar laws relating to or limiting creditors’ rights generally.

(b) There are no actions, suits, arbitrations, investigations, claims, inquiries, or proceedings pending or threatened against or affecting Borrower or its property, and no proceedings before any governmental body are pending or threatened against Borrower or its property, except as set forth on Schedule 4(b). None of such proceedings listed on Schedule 4(b) (if any) are reasonably expected to have a material adverse effect on Borrower (on a consolidated basis).

(c) Borrower is in compliance with all material laws, regulations, rulings, orders, injunctions, decrees, conditions or other requirements applicable to or imposed upon Borrower by any law or by any governmental authority, court or agency with jurisdiction over Borrower. Borrower has filed all required tax returns and reports that are now required to be filed by it in connection with any federal, state and local tax, duty or charge levied, assessed or imposed upon him or his assets, including unemployment, social security, and real estate taxes. Borrower has paid all taxes which are now due and payable except those which currently are being contested in good faith by appropriate proceedings and for which Borrower has set aside adequate reserves or made other adequate provision with respect thereto. No taxing authority has asserted or assessed any additional tax liabilities against Borrower which are outstanding on the Effective Date, and Borrower has not filed for any extension of time for the payment of any tax or the filing of any tax return or report.

(d) All financial information relating to Borrower which has been or may hereafter be delivered by Borrower or on its behalf to Lender is true and correct and Borrower’s financial statements have been prepared in accordance with generally acceptable accounting principles consistently applied (except in the case of unaudited financial statements, for the lack of footnotes and being subject to year-end audit adjustments). Borrower has no material obligations or liabilities of any kind not disclosed in that financial information, and there has been no material adverse change in the financial condition of Borrower nor has Borrower suffered any damage, destruction or loss which has adversely affected its business or assets since the submission of the most recent financial information to Lender.

(e) There does not exist any Event of Default under this Note or any default or violation by Borrower of or under any of the terms, conditions or obligations of: (i) its organizational documents; (ii) any indenture, mortgage, deed of trust, franchise, permit, contract, agreement, or other instrument to which it is a party or by which it is bound that is material to Borrower; or (iii) any law, ordinance, regulation, ruling, order, injunction, decree, condition or other requirement applicable to or imposed upon it by any law, the action of any court or any governmental authority or agency that could reasonably be expected to have a material adverse effect on Borrower (on a consolidated basis); and the consummation of the transactions set forth herein will not result in any such default or violation or Event of Default.

Page 2 of 8

(f) Borrower has good and marketable title to the assets reflected on the most recent financial statements provided to Lender, free and clear of all liens and encumbrances, except for the following (“Permitted Liens”): (i) current taxes and assessments not yet due and payable, (ii) liens to Amerisourcebergen Drug Corporation which are subordinated to the liens to Lender pursuant to a lien subordination agreement acceptable to Lender, (iii) liens to Smart Fill Management Group, Inc. which are junior to the liens to Lender, (iv) liens to Wells Fargo Bank, N.A. on specific equipment, and (v) liens to The Mission Bank on specific equipment.

(g) None of the Loan Documents contains any untrue statement of material fact or omits a material fact necessary in order to make the statements contained in this Note or the Loan Documents not misleading. There is no fact known to Borrower which materially adversely affects or, so far as Borrower can now reasonably foresee, could reasonably be expected to materially adversely affect the business, assets, operations, condition (financial or otherwise) or results of operation of Borrower (on a consolidated basis) and which has not otherwise been fully set forth in this Note.

5. Financial Information. Borrower shall maintain books and records in accordance with generally accepted accounting principles consistently applied (“GAAP”), except in the case of unaudited financial statements, for the lack of footnotes and being subject to year-end audit adjustments, and shall give representatives of the Lender access thereto at all reasonable times, including permission to examine, copy and make abstracts from any of such books and records and such other information as the Lender may from time to time reasonably request, and Borrower will make available to the Lender for examination copies of any reports, statements and returns which Borrower may make to or file with any federal, state or local governmental department, bureau or agency. Borrower shall deliver the following to Lender during the entire time during which any amount is due under this Note:

(a) As soon as practicable after the end of each calendar month in each year, beginning in March 31, 2014, and in any event within forty five (45) days thereafter, an internally prepared balance sheet of Borrower as of the end of such month, and statements of cash flows, shareholders' equity of Borrower for such month and income statements, certified as complete and correct by the principal financial officer of Borrower, subject to changes resulting from year-end adjustments;

(b) As soon as practicable after the end of each calendar quarter beginning March 31, 2014, and in any event within sixty (60) days thereafter, a consolidated balance sheet of Borrower as of the end of such quarter, and consolidated statements of cash flows, shareholders’ equity of Borrower for such quarter, certified as complete and correct by the principal financial officer of Borrower, subject to changes resulting from year-end adjustments; provided, however, that Borrower may deliver its Form 10-Q filed with the SEC at the time required herein to satisfy this requirement.

(c) Within sixty (60) days after the end of each fiscal quarter beginning March 31, 2014, a statement signed by the President or Chief Operating Officer of Borrower setting forth and certifying the calculation of the Financial Covenants (as hereinafter defined);

(d) As soon as practicable after the end of each fiscal year, and in any event within one hundred twenty (120) days thereafter, audited financial statements of Borrower, including, a balance sheet of Borrower as of the end of such year, and statements of cash flows, owners' equity of Borrower for such year, setting forth in each case in comparative form the figures for the previous fiscal year, all in reasonable detail and accompanied by an audit report of independent certified public accountants, selected by Borrower and reasonably satisfactory to Lender, which report and opinion shall be prepared in accordance with generally accepted auditing standards; provided, however, that Borrower may deliver its Form 10-K filed with the SEC at the time required herein to satisfy this requirement.

Page 3 of 8

(e) With reasonable promptness, such other data and information as from time to time may be reasonably requested by Lender.

5. Affirmative Covenants. Borrower agrees that from the date of execution of this Agreement until this Note is repaid in full Borrower will:

(a) Pay and discharge when due all indebtedness and all taxes, assessments, charges, levies and other liabilities imposed upon Borrower, its income, profits, property or business, except those which currently are being contested in good faith by appropriate proceedings and for which Borrower shall have set aside adequate reserves or made other adequate provision with respect thereto acceptable to the Lender in its reasonable discretion.

(b) Do all things necessary to (i) maintain, renew and keep in full force and effect its organizational existence and all rights, permits and franchises necessary to enable it to continue its business as currently conducted; (ii) continue in operation in substantially the same manner as at present; (iii) keep its properties in good operating condition and repair (normal wear and tear excepted); and (iv) make all necessary and proper repairs, renewals, replacements, additions and improvements thereto.

(c) Maintain, with insurers reasonably satisfactory to Lender, insurance with respect to its property and business against such casualties and contingencies, of such types and in such amounts, as is customary for established companies engaged in the same or similar business and similarly situated.

(d) Comply in all material respects with all laws applicable to Borrower and to the operation of its business (including without limitation any statute, ordinance, rule or regulation relating to employment practices, pension benefits or environmental, occupational and health standards and controls).

6. Negative Covenants. Borrower agrees that from the date of execution of this Agreement until this Note is repaid in full Borrower will not, without the Lender’s prior written consent:

(a) Create, incur, assume or suffer to exist any indebtedness for borrowed money other than: (i) this Note; (ii) open account trade debt incurred in the ordinary course of business and not past due; (iii) existing indebtedness secured by the Permitted Liens; and (iv) indebtedness in respect of purchase money financings of equipment in an amount not in excess of $250,000.00 in the aggregate outstanding.

(b) Create, assume, incur or permit to exist any mortgage, pledge, encumbrance, security interest, lien or charge of any kind upon any of its property, now owned or hereafter acquired, or acquire or agree to acquire any kind of property subject to any conditional sales or other title retention agreement, except for Permitted Liens and liens securing purchase money indebtedness permitted pursuant to Section 6(a) above, with the liens limited to the equipment purchased.

(c) Guarantee, endorse or become contingently liable for the obligations of any person, firm, corporation or other entity, except in connection with the endorsement and deposit of checks in the ordinary course of business for collection.

(d) Purchase or hold beneficially any stock, other securities or evidences of indebtedness of, or make or have outstanding, any loans or advances to, or otherwise extend credit to, or make any investment or acquire any interest whatsoever in, any other person, firm, corporation or other entity; provided, however, that Borrower may do so with regards to any Borrower.

Page 4 of 8

(e) Liquidate or dissolve, or merge or consolidate with or into any person, firm, corporation or other entity, or sell, lease, transfer or otherwise dispose of all or any substantial part of its property, assets, operations or business, whether now owned or hereafter acquired.

(f) Make or permit any change (i) in its form of corporate organization and (ii) in the nature of its business as carried on as of the date hereof.

(g) Declare or pay any dividends on or make any distribution with respect to any class of its equity or ownership interest, or purchase, redeem, retire or otherwise acquire any of its equity, provided, however, that if Borrower is a limited liability company with pass through taxation, it may make distributions to its shareholders, partners or members, as the case may be, in an amount equal to the federal and state income tax of such principals of Borrower attributable to the earnings of Borrower as long as no Event of Default exists.

(h) Make acquisitions of all or substantially all of the property or assets of any person, firm, corporation or other entity.

7. Financial Covenants. Borrower agrees that from the date of execution of this Note until this Note is repaid in full, Borrower will comply with the following financial covenants (“Financial Covenants”):

(a) Borrower will not permit its Adjusted EBITDAS at the end of each fiscal quarter to be less than the following:

Fiscal Quarter Ending	Minimum Adjusted EBITDAS

June 30, 2014	$ (50,000)
September 30, 2014	$ (50,000)
December 31, 2014	$ (50,000)

(b) Borrower will not permit its Adjusted EBITDAS at the end of each fiscal year to be less than the following:

Fiscal Year Ending	Minimum Adjusted EBITDAS

December 31, 2014	$ (250,000)

For the purpose of this Section 7, Adjusted EBITDAS shall be defined as Net Income before interest expense, taxes, and non-cash expenses including depreciation and amortization and all stock based compensation expense.

8. Events of Default. The following events shall constitute events of default under this Note (each, an “Event of Default”):

(i) Borrower fails to make any payment of principal and/or interest when and as the same shall become due and payable and such amount remains unpaid five (5) days thereafter;

(ii) any representation or warranty made by Borrower herein or in any of the other Loan Documents is incorrect in any material respect when made or reaffirmed;

(iii) the filing by or against Borrower of any proceeding in bankruptcy, reorganization, debt adjustment or receivership, or any assignment by Borrower for the benefit of creditors; provided, that any involuntary bankruptcy filed against Borrower shall not be an Event of Default unless such involuntary bankruptcy case is not dismissed within 60 days.

Page 5 of 8

(iv) Borrower fails to observe or perform any covenant, undertaking or agreement set forth herein or in any of the other Loan Documents and such failure is not remedied within 10 days;

(v) Borrower defaults under any other debt, liability or obligation to the Lender, or fails to pay or to otherwise observe and perform any obligations imposed upon Borrower under any indebtedness in excess of $100,000.00 (“Material Indebtedness”), if such default shall continue for more than the period of grace, if any, specified therein;

(vi) if any other Event of Default (said term being defined in this Note as it is defined in the Loan Documents) should occur and shall continue for more than the period of grace, if any specified therein;

(vii) any event occurs which could reasonably be expected to have a material adverse effect on the Collateral or on Borrower's financial condition, operations, assets or prospects;

(viii) the entry of any judgment or lien against Borrower by or in favor of any third person in excess of $100,000.00 which judgment or lien is not satisfied, discharged or bonded off within thirty (30) days from the date of entry of said judgment or lien and which is not otherwise stayed or the subject of an appeal filed by Borrower in connection with same; and

(ix) Borrower shall transfer assets to others (excluding any Borrower) for less than fair value or in other than the ordinary course of business, without Lender’s prior written consent.

9. Remedies. Upon the occurrence of an Event of Default, in addition to any other action permitted to be taken by Lender hereunder or under any other of the Loan Documents: (a) at the option of Lender for so long as any Event of Default shall continue to exist, the unpaid principal balance of this Note shall, for the period beginning with the date of the occurrence of the Event of Default and continuing for so long as any Event of Default exists, bear interest at a rate (the “Default Rate”) equal to five percent (5.0%) per annum above the otherwise applicable interest rate; and (b) Lender may, at its option, and regardless of whether Lender shall have exercised the option provided for in clause (a) of this paragraph, declare the entire unpaid principal balance of this Note and all accrued but unpaid interest hereon any other sums then payable in accordance with this Note to be immediately due and payable, whereupon all such sums shall be immediately due and payable and shall thereafter bear interest at the Default Rate and Lender shall have the remedies of a secured party under the laws of the State of Ohio with respect to all property mortgaged or pledged as security for this Note and all of the rights and remedies available under the Loan Documents. No delay or omission on the Lender’s part to exercise any right or power arising hereunder will impair any such right or power or be considered a waiver of any such right or power, nor will the Lender’s action or inaction impair any such right or power. All remedies provided for herein upon any default by Borrower shall be cumulative and not exclusive.

Borrower hereby agrees that: (a) in addition to any other right, after any Event of Default, Borrower will pay to Lender upon demand any and all reasonable costs, expenses and fees, including without limitation reasonable attorneys’ fees incurred before or after suit is commenced in enforcing payment hereof; (b) Borrower waives all setoffs and any and all applicable exemption rights; and (c) the acceptance by Lender of any late payment or other performance which does not strictly comply with the terms of this Note or of any Loan Document shall not be deemed to be a waiver of any rights of Lender arising as a result of such failure to comply.

Page 6 of 8

10. Waivers. Borrower, and any endorsers and guarantors hereof, and all others who may become liable for all or any part of the indebtedness evidenced by this Note, severally waive diligence, presentment for payment, protests, notice of dishonor and of nonpayment and protest, and do hereby consent to any number of forbearances, renewals or extensions of the time of payment hereof, releases or substitutions of all or any part of the security for the payment hereof or release of any party liable for this obligation and waive all defenses based upon suretyship or impairment of collateral. Any such extension or release may be made without notice to any of said parties and without discharging their liability. Borrower hereby waives all relief from any and all appraisement or exemption laws now in force or hereafter enacted.

11. General.

If any provision of this Note is found to be invalid by a court, all the other provisions of this Note will remain in full force and effect. In no event shall the interest rate charged on this Note exceed the maximum rate of interest permitted under applicable state and/or federal usury laws. Any payment of interest that would be deemed unlawful under applicable laws for any reason shall be deemed received on account of, and will automatically be applied to reduce, the principal sum outstanding and any other sums (other than interest) due and payable to Lender under this Note, and the provisions hereof shall be deemed amended to provide for the highest rate of interest permitted under applicable law.

Borrower agrees that there are no conditions or understandings which are not expressed in this Note and the documents referred to herein. No modification, amendment or waiver of, or consent to any departure by Borrower from, any provision of this Note will be effective unless made in a writing signed by the Lender and Borrower and then such waiver or consent shall be effective only in the specific instance and for the purpose for which given.

Any and all references in this Note to any other document or documents shall be references to such other document or documents as the same may from time to time be modified, amended, renewed, consolidated or extended.

The term “Borrower” as used herein shall include the undersigned and its successors and assigns; provided, however, that Borrower may not assign its obligations hereunder and Lender may assign this Note at any time (i) to a person or entity related to Lender; (ii) with the prior written consent of Borrower, as long as no Event of Default exists and (iii) without the consent of Borrower if any Event of Default exists, but with prior written notice to Borrower (unless Lender is prohibited by law from sending such notice). If there is more than one Borrower hereunder, their obligations shall be joint and several.

12. Jurisdiction. This Note shall be governed by Ohio law. Borrower hereby submits to personal jurisdiction in the federal and state courts in Hamilton County, Ohio; waives any and all personal rights under the laws of any state or country to object to jurisdiction within the State of Ohio for the purposes of litigation to enforce this Note, or any other Loan Document; and consents to be sued in the federal and state courts in Hamilton County, Ohio. Nothing contained in this Note, however, shall prevent Lender from bringing any action or exercising any rights under this Note within any other state or country. Borrower agrees that service of process may be made, and personal jurisdiction over Borrower obtained, by serving a copy of the Summons and Complaint upon Borrower at its address set forth in this Note in accordance with the applicable laws of the State of Ohio.

13. WAIVER OF JURY TRIAL. BORROWER HEREBY WAIVES THE RIGHT TO TRIAL BY JURY OF ANY MATTERS ARISING OUT OF THIS NOTE.

Page 7 of 8

14. CONFESSION OF JUDGMENT. Borrower authorizes any attorney to appear in any court of record in or of the State of Ohio, after this Note becomes due and payable, whether by its terms or upon default, to waive service of process and enter judgment by confession against Borrower in favor of the Lender or any holder hereof for the outstanding principal of and accrued but unpaid interest on this Note, plus all costs of collection, including, without limitation, court costs and reasonable attorney’s fees, and thereby to waive and release all errors in the proceedings and judgment, and all rights of appeal from such judgment and stay of execution. Stay of execution and all exemptions are hereby waived. Borrower also agrees that the attorney acting for Borrower as set forth in this paragraph may be compensated by Lender for such services, and Borrower waives any conflict of interest caused by such representation and compensation arrangement. If an obligation is referred to an attorney for collection, and the payment is obtained without the entry of a judgment, the obligors will pay to Lender its attorneys' fees.

WARNING - BY SIGNING THIS PAPER, YOU GIVE UP YOUR RIGHT TO NOTICE AND COURT TRIAL. IF YOU DO NOT PAY ON TIME, A COURT JUDGMENT MAY BE TAKEN AGAINST YOU WITHOUT YOUR PRIOR KNOWLEDGE AND THE POWERS OF A COURT CAN BE USED TO COLLECT FROM YOU REGARDLESS OF ANY CLAIMS YOU MAY HAVE AGAINST THE CREDITOR WHETHER FOR RETURNED GOODS, FAULTY GOODS, FAILURE ON HIS PART TO COMPLY WITH THE AGREEMENT OR ANY OTHER CAUSE.

HEALTHWAREHOUSE.COM, INC.	PAGOSA HEALTH LLC,
a Delaware corporation	an Indiana corporation


By: _/s/ Lalit Dhadphale ________	By: /s/ Lalit Dhadphale ____________
Print Name: Lalit Dhadphale	Print Name: Lalit Dhadphale
Title: President	Title: President

HWAREH.COM, INC.,	HOCKS.COM, INC.,
a Delaware corporation	an Ohio corporation


By: _/s/ Lalit Dhadphale ______	By: /s/ Lalit Dhadphale ______
Print Name: Lalit Dhadphale	Print Name: Lalit Dhadphale
Title: President	Title: President

Page 8 of 8

EX-4.2 3 exhbit42.htm EXHIBIT42 exhbit42.htm

EXHIBIT 4.2

NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL, IN A FORM REASONABLY ACCEPTABLE TO THE COMPANY, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.

----------------

HealthWarehouse.com, Inc.

FORM OF COMMON STOCK PURCHASE WARRANT

Number of shares:	75,000

Holder:	Melrose Capital Advisors, LLC

Grant Date:	April 29, 2014

Expiration Date:	April 29, 2019

Exercise Price Per Share:	$0.35 (Thirty-five cents per share)

HealthWarehouse.com, Inc., a corporation organized and existing under the laws of the State of Delaware (the "Company"), hereby certifies that, for value received, Melrose Capital Advisors, LLC, or its registered assigns or permitted transferees (the "Warrant Holder"), is entitled, subject to the terms set forth below, to purchase from the Company 75,000 shares, as adjusted from time to time as provided in Section 6 hereof, of common stock, $0.001 par value (the "Common Stock"), of the Company (each such share, a "Warrant Share" and all such shares, the "Warrant Shares") at a price of $0.35 (thirty-five cents) per Warrant Share (the "Exercise Price"), at any time and from time to time from and after the date hereof and through and including 5:00 p.m. New York City time on April 29, 2019 (the "Expiration Date"), and subject to the following terms and conditions. This Warrant is being issued to the Warrant Holder pursuant to that certain Subscription Agreement, dated as of April 29, 2014, by and between the Company and the Warrant Holder (the “Subscription Agreement”). All capitalized terms used but not otherwise defined herein have the meanings given to them in the Subscription Agreement.

1. Registration of Warrant. The Company shall register this Warrant upon records to be maintained by the Company for that purpose (the "Warrant Register"), in the name of the record Warrant Holder hereof from time to time. The Company may deem and treat the registered Warrant Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Warrant Holder, and for all other purposes, and the Company shall not be affected by notice to the contrary.

2. Investment Representation. The Warrant Holder by accepting this Warrant represents that the Warrant Holder is acquiring this Warrant for its own account or the account of an accredited investor affiliate for investment purposes and not with the view to any offering or distribution and that the Warrant Holder will not sell or otherwise dispose of this Warrant or the underlying Warrant Shares in violation of applicable securities laws. Subject to Section 10 hereof, the Warrant Holder acknowledges that the certificates representing any Warrant Shares will bear a legend indicating that they have not been registered under the United States Securities Act of 1933, as amended (the "1933 Act") and may not be sold by the Warrant Holder except pursuant to an effective registration statement or pursuant to an exemption from registration requirements of the 1933 Act and in accordance with federal and state securities laws.

3. Validity of Warrant and Issue of Shares. The Company represents and warrants that this Warrant has been duly authorized and validly issued and warrants and agrees that all of Common Stock that may be issued upon the exercise of the rights represented by this Warrant will, when issued upon such exercise, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges with respect to the issue thereof. The Company further warrants and agrees that during the period within which the rights represented by this Warrant may be exercised, the Company will at all times have authorized and reserved a sufficient number of Common Stock to provide for the exercise of the rights represented by this Warrant.

4. Registration of Transfers and Exchange of Warrants.

a. All or any portion of this Warrant shall be assignable or transferable by Warrant Holder to a subsidiary, parent, general partner, limited partner, retired partner, affiliate, member or retired member, or stockholder of a Holder that is a corporation, partnership or limited liability company, subject to such terms and conditions with respect to such assignment or transfer as Warrant Holder shall determine.

Page 1 of 8

b. Subject to compliance with the legend set forth on the face of this Warrant, the Company shall register the transfer of any portion of this Warrant in the Warrant Register, upon surrender of this Warrant with the Form of Assignment attached hereto duly completed and signed, to the Company at the office specified in or pursuant to Section 12. Upon any such registration or transfer, a new warrant to purchase Common Stock, in substantially the form of this Warrant (any such new warrant, a "New Warrant"), evidencing the portion of this Warrant so transferred shall be issued to the transferee and a New Warrant evidencing the remaining portion of this Warrant not so transferred, if any, shall be issued to the transferring Warrant Holder. The acceptance of the New Warrant by the transferee thereof shall be deemed the acceptance of such transferee of all of the rights and obligations of a Warrant Holder of a Warrant.

c. This Warrant is exchangeable, upon the surrender hereof by the Warrant Holder to the office of the Company specified in or pursuant to Section 12 for one or more New Warrants, evidencing in the aggregate the right to purchase the number of Warrant Shares which may then be purchased hereunder. Any such New Warrant will be dated the date of such exchange.

5. Exercise of Warrants.

a. Upon surrender of this Warrant with the Form of Election to Purchase attached hereto duly completed and signed to the Company, at its address set forth in Section 12, and upon payment and delivery of the Exercise Price per Warrant Share multiplied by the number of Warrant Shares that the Warrant Holder intends to purchase hereunder, in lawful money of the United States of America, in cash or by certified or official bank check or checks, to the Company, all as specified by the Warrant Holder in the Form of Election to Purchase, the Company shall promptly (but in no event later than 7 business days after the Date of Exercise (as defined herein)) issue and deliver or cause to be issued and cause to be delivered to or upon the written order of the Warrant Holder and in such name or names as the Warrant Holder may designate (subject to the restrictions on transfer described in the legend set forth on the face of this Warrant), a stock certificate for the number of Warrant Shares issuable upon such exercise, with such restrictive legend as required by the 1933 Act. Any person so designated by the Warrant Holder to receive Warrant Shares shall be deemed to have become holder of record of such Warrant Shares as of the Date of Exercise. In connection with such exercise, the Warrant Holder, or such person so designated by the Warrant Holder in accordance with this paragraph, shall be deemed a stockholder of record with respect to the Warrant Shares purchaser pursuant to such exercise, with all rights of a stockholder, including voting rights and rights to receive dividends.

b. A "Date of Exercise" means the date on which the Company shall have received (i) this Warrant (or any New Warrant, as applicable), with the Form of Election to Purchase attached hereto (or attached to such New Warrant) appropriately completed and duly signed, and (ii) payment of the Exercise Price for the number of Warrant Shares so indicated by the Warrant Holder to be purchased.

c. This Warrant shall be exercisable at any time and from time to time for such number of Warrant Shares as is indicated in the attached Form of Election To Purchase. If less than all of the Warrant Shares which may be purchased under this Warrant are exercised at any time, the Company shall issue or cause to be issued, at its expense, a New Warrant evidencing the right to purchase the remaining number of Warrant Shares for which no exercise has been evidenced by this Warrant.

d. Cashless Exercise. The Warrant Holder may, in its sole discretion, exercise this Warrant in whole or in part and, in lieu of making the cash payment otherwise contemplated to be made to the Company upon such exercise in payment of the aggregate Exercise Price, elect instead to receive upon such exercise the "Net Number" of shares of Common Stock determined according to the following formula (a "Cashless Exercise"):

Net Number = (A x B) -- (A x C)

For purposes of the foregoing formula:

A = the total number of shares with respect to which this Warrant is then being exercised.

B = the closing sale price of the shares of Common Stock (as reported by Bloomberg) on the date immediately preceding the date of the Form of Election to Purchase (the "Closing Price").

C = the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise.

e. Deemed Exercise. If, at the Expiration Date for any Warrant Shares, this Warrant has not theretofore been exercised with respect to such Warrant Shares, and the Closing Price on the business day immediately prior to the Expiration Date is greater than the Exercise Price, then the Warrant Holder shall be deemed to have exercised this Warrant in whole with respect to such Warrant Shares immediately prior to such Expiration Date and shall be deemed to have elected to pay the aggregate Exercise Price pursuant to paragraph d. (Cashless Exercise) of this Section 5, and the Date of Exercise with respect to such deemed exercise shall be the date on which such Expiration Date occurs.

Page 2 of 8

6. Adjustment of the Number of Shares. The character of the shares of stock or other securities at the time issuable upon exercise of this Warrant, are subject to adjustment upon the occurrence of the following events, and all such adjustments shall be cumulative:

a. Adjustment for Stock Splits, Stock Dividends, Recapitalizations, Etc. The Exercise Price and the number of shares of Common Stock or other securities at the time issuable upon exercise of this Warrant shall be appropriately adjusted to reflect any stock dividend, stock split, combination of shares, reclassification, recapitalization or other similar event affecting the number of outstanding shares of stock or securities.

b. Reserved

c. Reserved

d. Distributions of Other Property. If, at any time while this Warrant remains outstanding and unexpired with respect to any Warrant Shares, the Company shall distribute to all holders of Company Common Stock (including any such distribution made in connection with a consolidation or merger in which the Company is the continuing corporation) evidences of its indebtedness or assets (excluding ordinary cash dividends or distributions payable out of consolidated earnings or earned surplus and dividends or distributions referred to in paragraph (a) of this Section 6), then, in lieu of an adjustment to the number of shares Company Common Stock purchasable upon the exercise of this Warrant, the Warrant Holder, upon the exercise hereof at any time after such distribution shall be entitled to receive from the Company the stock or other securities to which the Warrant Holder would have been entitled if the Warrant Holder had exercised this Warrant immediately prior thereto, all subject to further adjustment as provided in this Section 6.

e. Certificate as to Adjustments. In case of any adjustment or readjustment in the number or kind of securities issuable on the exercise of this Warrant, or the Exercise Price, the Company will promptly give written notice thereof (but in no event later than 5 business days thereafter) to the holder of this Warrant in the form of a certificate, certified and confirmed by the Board of Directors of the Company, setting forth such adjustment or readjustment and showing in reasonable detail the facts upon which such adjustment or readjustment is based.

7. Fractional Shares. The Company shall not be required to issue or cause to be issued fractional Warrant Shares on the exercise of this Warrant. The number of full Warrant Shares that shall be issuable upon the exercise of this Warrant shall be computed on the basis of the aggregate number of Warrants Shares purchasable on exercise of this Warrant so presented. If any fraction of a Warrant Share would, except for the provisions of this Section 7, be issuable on the exercise of this Warrant, the Company shall, at its option, (i) pay an amount in cash equal to the Exercise Price multiplied by such fraction or (ii) round the number of Warrant Shares issuable, up to the next whole number.

8. Sale or Merger the Company. The Company will give Warrant Holder 15-day written notice before the event of a sale of all or substantially all of the assets of the Company or the merger or consolidation of the Company in a transaction in which the Company is not the surviving entity (a "Fundamental Transaction"). The Company shall not enter into or be party to such Fundamental Transaction unless the surviving entity assumes in writing all of the obligations of the Company under this Warrant pursuant to written agreements in form and substance satisfactory to the Warrant Holder and approved by the Warrant Holder prior to such Fundamental Transaction, including agreements to deliver to the Warrant Holder in exchange for this Warrant a security of the surviving entity evidenced by a written instrument substantially similar in form and substance to this Warrant, including, without limitation, an adjusted exercise price equal to the value for the shares of Common Stock reflected by the terms of such Fundamental Transaction, and exercisable for a corresponding number of shares of capital stock equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and satisfactory to the Warrant Holder.

9. Issuance of Substitute Warrant. In the event of a merger, consolidation, recapitalization or reorganization of the Company or a reclassification of Company shares of stock, which results in an adjustment to the number of shares subject to this Warrant hereunder, the Company agrees to issue to the Warrant Holder a substitute Warrant reflecting the adjusted number of shares upon the surrender of this Warrant to the Company.

10. Listing of Shares. The Company shall promptly secure the listing of all of the Warrant Shares issuable hereunder upon each national securities exchange and automated quotation system, if any, upon which the Common Stock is then listed (subject to official notice of issuance) and shall maintain, so long as any other shares of Common Stock shall be so listed, such listing of Warrant Shares.

11. Noncircumvention. The Company hereby covenants and agrees that the Company will not, by amendment of its Certificate of Incorporation, Bylaws or through any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale of securities, or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, and will at all times in good faith carry out all the provisions of this Warrant and take all action as may be required to protect the rights of the Warrant Holder. Without limiting the generality of the foregoing, the Company (i) shall not increase the par value of any shares of Common Stock receivable upon the exercise of this Warrant above the Exercise Price then in effect, (ii) shall take all such actions as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable shares of Common Stock upon the exercise of this Warrant, and (iii) shall take all action necessary to reserve and keep available out of its authorized and unissued shares of Common Stock, solely for the purpose of effecting the exercise of the this Warrant, 100% of the number of shares of Common Stock as shall from time to time be necessary to effect the exercise of this Warrant (without regard to any limitations on exercise).

Page 3 of 8

12. Notice. All notices and other communications hereunder shall be in writing and shall be deemed to have been given (i) on the date they are delivered if delivered in person; (ii) on the date initially received if delivered by facsimile transmission followed by registered or certified mail confirmation; (iii) on the date delivered by an overnight courier service; or (iv) on the third business day after it is mailed by registered or certified mail, return receipt requested with postage and other fees prepaid as follows:

If to the Company:

HealthWarehouse.com, Inc.

7107 Industrial Road

Florence, KY 42042

Fax: (866) 821-3784

Attn: Chief Executive Officer

with a copy (for informational purposes only) to:

Mark J. Zummo, Esq.

Kohnen & Patton LLP

800 PNC Center

201 E. Fifth Street

Cincinnati, OH 45202

Telephone: (513) 381-0656

Fax: (513) 381-5823

If to the Warrant Holder:

Melrose Capital

c/o Statman, Harris & Eyrich, LLC

441 Vine Street, 37th Floor

Cincinnati, Ohio 45202

With a copy (for informational purposes only) to:

Statman, Harris & Eyrich, LLC

441 Vine Street, 37th Floor

Cincinnati, Ohio 45202

Attn: Fern Goldman

13. Loss of Warrant. Upon receipt by the Company of satisfactory evidence of loss, theft, destruction or mutilation of this Warrant and of indemnity satisfactory to the Company, and upon surrender and cancellation of this Warrant, if mutilated, the Company shall execute and deliver a new Warrant of like tenor and date and any such lost, stolen or destroyed Warrant shall thereupon become void.

14. Miscellaneous.

a. This Warrant shall be binding on and inure to the benefit of the parties hereto and their respective successors and permitted assigns. This Warrant may be amended only in writing and signed by the Company and the Warrant Holder.

b. Nothing in this Warrant shall be construed to give to any person or corporation other than the Company and the Warrant Holder any legal or equitable right, remedy or cause of action under this Warrant; this Warrant shall be for the sole and exclusive benefit of the Company and the Warrant Holder.

c. This Warrant shall be governed by, construed and enforced in accordance with the internal laws of the State of Delaware without regard to the principles of conflicts of law thereof. Each party irrevocably submits and consent to the exclusive jurisdictions of the United States District Courts of the State of Delaware, or, if such court does not have jurisdiction or will not accept jurisdiction, in any court of general jurisdiction in the State of Delaware, and hereby agrees that such courts shall be the exclusive proper forum for the determination of any dispute arising hereunder.

d. The headings herein are for convenience only, do not constitute a part of this Warrant and shall not be deemed to limit or affect any of the provisions hereof.

e. In case any one or more of the provisions of this Warrant shall be invalid or unenforceable in any respect, the validity and enforceability of the remaining terms and provisions of this Warrant shall not in any way be affected or impaired thereby and the parties will attempt in good faith to agree upon a valid and enforceable provision which shall be a commercially reasonably substitute therefore, and upon so agreeing, shall incorporate such substitute provision in this Warrant.

Page 4 of 8

f. The Warrant Holder shall not, by virtue hereof, be entitled to any voting or other rights of a shareholder of the Company, either at law or equity, and the rights of the Warrant Holder are limited to those expressed in this Warrant.

g. The remedies provided in this Warrant shall be cumulative and in addition to all other remedies available under this Warrant, at law or in equity (including a decree of specific performance and/or other injunctive relief), and nothing herein shall limit the right of the Warrant Holder to pursue actual damages for any failure by the Company to comply with the terms of this Warrant. The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Warrant Holder and that the remedy at law for any such breach may be inadequate. The Company therefore agrees that, in the event of any such breach or threatened breach, the holder of this Warrant shall be entitled, in addition to all other available remedies, to an injunction restraining any breach, without the necessity of showing economic loss and without any bond or other security being required. If any action, suit, or other proceedings is instituted concerning or arising out of this Warrant, the prevailing party shall recover all of such party's costs and reasonable attorney's fees incurred in each such action, suit, or other proceeding, including any and all appeals or petitions from any such action, suit or other proceeding.

h. From and after the date of this Warrant, upon the request of the Warrant Holder or the Company, the Company and the Warrant Holder shall execute and deliver such instruments, documents or other writings as may be reasonably necessary or desirable to confirm and carry out and to effectuate fully the intent and purposes of this Warrant.

[SIGNATURE PAGE FOLLOWS]

Page 5 of 8

IN WITNESS WHEREOF, the Company has caused this Warrant to be duly executed by the authorized officer as of the Grant Date first above stated.

Healthwarehouse.com, Inc.

By: /s/ Lalit Dhadphale _____________________________________

Name: Lalit Dhadphale, President

Page 6 of 8

FORM OF ELECTION TO PURCHASE

(To be executed by the Warrant Holder to exercise the right to purchase shares of Common Stock under the foregoing Warrant)

To: HealthWarehouse.com, Inc.

In accordance with the Warrant enclosed with this Form of Election to Purchase, the undersigned hereby irrevocably elects to purchase ______________________________ shares of Common Stock ("Common Stock"), $0.______ par value, of HealthWarehouse.com, Inc. and encloses one warrant and $___________________ for each Warrant Share being purchased or an aggregate of $_____________ in cash or certified or official bank check or checks, which sum represents the aggregate Exercise Price (as defined in the Warrant) together with any applicable taxes payable by the undersigned pursuant to the Warrant. The undersigned requests that certificates for the shares of Common Stock issuable upon this exercise be issued in the name of:

__________________________________

(Please print name and address)

__________________________________

(Please insert Social Security or Tax Identification

Number)

If the number of shares of Common Stock issuable upon this exercise shall not be all of the shares of Common Stock which the undersigned is entitled to purchase in accordance with the enclosed Warrant, the undersigned requests that a New Warrant (as defined in the Warrant) evidencing the right to purchase the shares of Common Stock not issuable pursuant to the exercise evidenced hereby be issued in the name of and delivered to:

__________________________________

(Please print name and address)

Dated: __________________

Name of Warrant Holder:

(Print) __________________________________

(By:) __________________________________

(Name:) __________________________________

(Title:) __________________________________

Signature must conform in all respects to name of Warrant

Holder as specified on the face of the Warrant

Page 7 of 8

FORM OF ASSIGNMENT PURSUANT TO SECTION 4(a)

(To be executed by the registered holder if such holder desires to transfer the Warrant Certificate.)

FOR VALUE RECEIVED hereby sells, assigns and transfers unto

____________________________________________________________

(Please print name and address of transferee)

this Warrant Certificate, together with all right, title and interest therein, and hereby irrevocably constitutes and appoints _____________________ Attorney, to transfer the within Warrant Certificate on the books of the within-named Company, with full power of substitution.

Dated: ______________

Signature: ________________________________

(Signature must confirm in all respects to name of holder

as specified on the face of the Warrant Certificate.)

__________________________________________________

(Insert Social Security or Other Identifying Number of Assignee).

Page 8 of 8

EX-31.1 4 exhibit311.htm EXHIBIT311 exhibit311.htm

Exhibit 31.1

CERTIFICATION OF C.E.O. PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned, in the capacity and date indicated below, hereby certifies that:

1.	I have reviewed this quarterly report on Form 10-Q of HealthWarehouse.com, Inc.

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(d)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)

designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)

designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)

evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)

disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)

all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)

any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

May 15, 2014	/s/ Lalit Dhadphale
	Lalit Dhadphale
	President and Chief Executive Officer

EX-31.2 5 exhibit312.htm EXHIBIT312 exhibit312.htm

Exhibit 31.2

CERTIFICATION OF C.F.O. PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned, in the capacity and date indicated below, hereby certifies that:

1.	I have reviewed this quarterly report on Form 10-Q of HealthWarehouse.com, Inc.

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

(a)

(b)

(c)

(d)

5.	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)

(b)

any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

May 15, 2014	/s/ Lalit Dhadphale
	Lalit Dhadphale
	Principal Financial Officer

EX-32.1 6 exhibit321.htm EXHIBIT321 exhibit321.htm

Exhibit 32.1

CERTIFICATE PURSUANT TO 18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (Chief Executive Officer)

In connection with the annual report of HealthWarehouse.com, Inc. (the “Company”) on Form 10-Q for the quarterly period ended March 31, 2014 as filed with the Securities and Exchange Commission (the “Report”), I, Lalit Dhadphale, President and Chief Executive Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1.	The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

May 15, 2014	/s/ Lalit Dhadphale
	Lalit Dhadphale
	President and Chief Executive Officer

A signed original of this written statement required by section 906 has been provided to HealthWarehouse.com, Inc. and will be retained by HealthWarehouse.com, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

This certification is being furnished to the SEC with this Report pursuant to Section 906 of the Sarbanes – Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section.

EX-32.1 7 exhibit322.htm EXHIBIT322 exhibit322.htm

Exhibit 32.2

CERTIFICATE PURSUANT TO 18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (Chief Financial Officer)

In connection with the annual report of HealthWarehouse.com, Inc. (the “Company”) on Form 10-Q for the quarterly period ended March 31, 2014 as filed with the Securities and Exchange Commission (the “Report”), I, Lalit Dhadphale, Principal Financial Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1.	The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

May 15, 2014	/s/ Lalit Dhadphale
	Lalit Dhadphale
	Principal Financial Officer

EX-101.INS 8 hewa-20140331.xml HEWA-20140331 0000754813 2014-01-01 2014-03-31 0000754813 2014-03-31 0000754813 2013-12-31 0000754813 2012-12-31 0000754813 us-gaap:SeriesBPreferredStockMember 2013-01-01 2013-12-31 0000754813 2013-01-01 2013-03-31 0000754813 HEWA:StockWarrantsMember 2014-01-01 2014-03-31 0000754813 HEWA:Vendor1Member 2013-01-01 2013-03-31 0000754813 HEWA:Vendor2Member 2013-01-01 2013-03-31 0000754813 HEWA:Vendor1Member 2014-01-01 2014-03-31 0000754813 HEWA:P025to035Member 2014-03-31 0000754813 HEWA:P036to3Member 2014-03-31 0000754813 HEWA:P301to495Member 2014-03-31 0000754813 HEWA:RangeThreeMember 2014-03-31 0000754813 HEWA:RangeOneMember 2014-03-31 0000754813 HEWA:RangeTwoMember 2014-03-31 0000754813 HEWA:Vendor2Member 2014-01-01 2014-03-31 0000754813 us-gaap:SeriesBPreferredStockMember 2014-01-01 2014-03-31 0000754813 2013-03-31 0000754813 2013-01-01 2013-12-31 0000754813 HEWA:RangeFourMember 2014-03-31 0000754813 us-gaap:EmployeeStockOptionMember 2014-03-31 0000754813 us-gaap:EmployeeStockOptionMember 2014-01-01 2014-03-31 0000754813 us-gaap:EmployeeStockOptionMember 2013-01-01 2013-03-31 0000754813 HEWA:StockWarrantsMember 2013-01-01 2013-03-31 0000754813 HEWA:LoanAgreementMember 2014-03-31 0000754813 2014-05-07 0000754813 us-gaap:AffiliatedEntityMember 2012-04-01 2014-03-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure HealthWarehouse.com, Inc. 0000754813 10-Q 2014-03-31 false --12-31 No No Yes Smaller Reporting Company Q1 2014 26550380 212830 625000 625000 451879 422315 451879 422315 4344987 4270257

27729592

27708303

0.30

0.11

0.57

0.16

279380 74730

264

151853

312444

504777

P1Y6M P1Y6M 0.23 1.38 1476372

1122990

1419812

-4191549

-4365107

-28511039

-28130668

3419715

10715 9001

27721737

27166147

27731

27708

452 422

5314539

5784919

165729

539966

94862

109964

5148810

5244953

1000000 1000000

78095

487170

58266

56323

78790

95792

441574 621052

78246

83691

2926669

3310000

1122990

1419812

593116

624634

421330

711398

40612

59143

246151

277300

74767

307211

59800

67744

70867

430002

108544 83780 608109 576590 24745 14643 0.001 0.001 10000 10000 10000 10000 10000 10000 1000000 1000000 29133 269998

0.001

1000000

200000 200000 44443 44443 0 0 0 0

1179212

0.001

50000000

26550380

26529091

26546832 15609892

-0.01

-0.36

-0.10 -0.00 -0.00

-0.01

-0.26

-380371

-5680928

1532722

74730

69840

-305641

-4078366

-5489892

-73536

-2864023

73536

71123

-2792900

-232105

-1214343

1217661

2389103

985556

1174760

731408

1235156

1716964

2409916

40000 3625900 1532722 74730 69840 26000 315300 6934 279380 261084

25523

367978

59800

67744

382353

-7944

382353

86841

140214

-125000

2526973

1000000

2000000

100000

500000

13159

11759

-34866

699512

34866

25490

-725002

-59918

-457373

-1024781

-17002

30441

25172

-340265

-5445

185999

-383331

-91216

18531 10451

31149

85519

273902

-6238

54035

44363

87500 87500 487200

162763

330021

41621

35846

-1714

-41458

-31528

HealthWarehouse.com, Inc., a Delaware company incorporated in 1998, (the Company) is a U.S. licensed virtual retail pharmacy (VRP) and healthcare e-commerce company that sells brand name and generic prescription drugs as well as over-the-counter (OTC) medical products. The Companys objective is to be viewed by individual healthcare product consumers as a low-cost, reliable and hassle-free provider of prescription drugs and OTC medical products. The Company is presently licensed as a mail-order pharmacy in 50 states in the United States and the District of Columbia.   The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) for interim financial information. Accordingly, they do not include all of the information and disclosures required by GAAP for annual financial statements. In the opinion of management, such statements include all adjustments (consisting only of normal recurring items) which are considered necessary for a fair presentation of the condensed consolidated financial statements of the Company as of March 31, 2014 and for the three months ended March 31, 2014 and 2013. The results of operations for the three months ended March 31, 2014 are not necessarily indicative of the operating results for the full year ending December 31, 2014 or any other period. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related disclosures of the Company as of December 31, 2013 and for the year then ended, which were filed with the Securities and Exchange Commission on Form 10-K on April 15, 2014.

Since inception, the Company has financed its operations primarily through debt and equity financings and advances from related parties. As of March 31, 2014, the Company had a working capital deficiency of $4,727,480 and an accumulated deficit of $28,511,039. During the quarter ended March 31, 2014 and the year ended December 31, 2013, the Company incurred net losses of $305,641 and $5,489,892, respectively and used cash in operating activities of $59,918 and $1,024,781, respectively.   These conditions raise substantial doubt about the Companys ability to continue as a going concern.   Subsequent to March 31, 2014, the Company (a) raised an additional $50,000 in debt financing and (b) continues to incur net losses, use cash in operating activities and experience cash and working capital constraints. See Note 10.   On February 13, 2013, the Company received a Notice of Redemption related to its Series C Redeemable Preferred Stock aggregating $1,000,000 (see Note 6). As a result of receiving the Notice of Redemption, the Company must now apply all of its assets to redemption of the Series C Preferred Stock and to no other corporate purpose, except to the extent prohibited by Delaware law governing distributions to stockholders (the Company is not permitted to utilize toward the redemption those assets required to pay its debts as they come due and those assets required to continue as a going concern).   The Company recognizes it will need to raise additional capital in order to fund operations, meet its payment obligations and execute its business plan. There is no assurance that additional financing will be available when needed or that management will be able to obtain financing on terms acceptable to the Company and whether the Company will become profitable and generate positive operating cash flow. If the Company is unable to raise sufficient additional funds, it will have to develop and implement a plan to further extend payables, attempt to extend note repayments, attempt to negotiate the preferred stock redemption and reduce overhead until sufficient additional capital is raised to support further operations. There can be no assurance that such a plan will be successful.  If the Company is unable to obtain financing on a timely basis, the Company could be forced to sell its assets, discontinue its operation and /or seek reorganization under the U.S. bankruptcy code.   Accordingly, the accompanying condensed consolidated financial statements have been prepared in conformity with GAAP, which contemplates continuation of the Company as a going concern and the realization of assets and the satisfaction of liabilities in the normal course of business. The carrying amounts of assets and liabilities presented in the condensed consolidated financial statements do not necessarily represent realizable or settlement values. The condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Principles of Consolidation   The condensed consolidated financial statements include the accounts of HealthWarehouse.com, Inc., Hwareh.com, Inc., Hocks.com, Inc., ION Holding NV, ION Belgium NV and Pagosa, its wholly-owned subsidiaries. ION Holding NV and ION Belgium NV are inactive subsidiaries. All material inter-company balances and transactions have been eliminated in consolidation.   On June 4, 2013, the Company formed a wholly-owned subsidiary called Pagosa Health LLC (Pagosa).  On January 14, 2014, the Company closed Pagosa and decided to focus on its core consumer prescription business. Pagosa had a de minimis impact on the Companys operations or the results for the three months ended March 31, 2014.   Use of Estimates   The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (U.S. GAAP) requires management to make estimates and assumptions that affect the amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.  The Companys significant estimates include reserves related to accounts receivable and inventory, the recoverability and useful lives of long-lived assets, the valuation allowance related to deferred tax assets, the valuation of equity instruments and debt discounts.   Net Loss Per Share of Common Stock   Basic net loss per share is computed by dividing net loss attributable to Common Stockholders by the weighted average number of common shares outstanding during the period.  Diluted net loss per share reflects the potential dilution that could occur if securities or other instruments to issue Common Stock were exercised or converted into Common Stock.  Potentially dilutive securities are excluded from the computation of diluted net loss per share if their inclusion would be anti-dilutive and consist of the following:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">March 31,</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt; text-align: center">2014</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">2013</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 68%">Options</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 13%; text-align: right">2,514,150</td> <td nowrap="nowrap" style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 13%; text-align: right">2,451,483</td> <td nowrap="nowrap" style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Warrants</td> <td> </td> <td> </td> <td style="text-align: right">2,492,846</td> <td nowrap="nowrap"> </td> <td> </td> <td> </td> <td style="text-align: right">6,047,119</td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt">Series B Convertible Preferred Stock</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt; text-align: right">3,714,445</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">3,407,313</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 3pt">Total potentially dilutive shares</td> <td style="padding-bottom: 3pt"> </td> <td style="border-bottom: black 2.25pt double; padding-bottom: 3pt"> </td> <td style="border-bottom: black 2.25pt double; padding-bottom: 3pt; text-align: right">8,721,441</td> <td nowrap="nowrap" style="padding-bottom: 3pt"> </td> <td style="padding-bottom: 3pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">11,905,915</td> <td nowrap="nowrap" style="padding-bottom: 3pt"> </td></tr> </table>   Recently Issued Accounting Pronouncements   The Company has determined there are no new accounting standards that are expected to have a material impact on the Company's condensed consolidated financial statements.

Accrued expenses and other current liabilities consisted of the following:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="text-align: center">March 31,</td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2" style="text-align: center">December 31,</td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt; text-align: center">2014</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">2013</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 68%"> </td> <td style="width: 1%; text-align: right"> </td> <td style="width: 1%"> </td> <td style="width: 13%; text-align: right"> </td> <td nowrap="nowrap" style="width: 1%"> </td> <td style="width: 1%; text-align: right"> </td> <td style="width: 1%"> </td> <td style="width: 13%; text-align: right"> </td> <td nowrap="nowrap" style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Deferred Rent</td> <td style="text-align: right"> </td> <td>$</td> <td style="text-align: right">43,704</td> <td nowrap="nowrap"> </td> <td style="text-align: right"> </td> <td>$</td> <td style="text-align: right">46,254</td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Advertising</td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right">75,000</td> <td nowrap="nowrap"> </td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right">75,000</td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Salaries and Benefits</td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right">178,393</td> <td nowrap="nowrap"> </td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right">132,048</td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Customer Payables</td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right">19,697</td> <td nowrap="nowrap"> </td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right">39,618</td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Dividend Payable</td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right">74,729</td> <td nowrap="nowrap"> </td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right">279,380</td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Accrued Interest</td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right">46,429</td> <td nowrap="nowrap"> </td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right">45,616</td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt">Other</td> <td style="padding-bottom: 1.5pt; text-align: right"> </td> <td style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt; text-align: right">3,622</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: right"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">3,136</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 3pt; text-align: left">Total     </td> <td style="padding-bottom: 3pt; text-align: right"> </td> <td style="border-bottom: black 2.25pt double; padding-bottom: 3pt">$</td> <td style="border-bottom: black 2.25pt double; padding-bottom: 3pt; text-align: right">441,574</td> <td nowrap="nowrap" style="padding-bottom: 3pt"> </td> <td style="padding-bottom: 3pt; text-align: right"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">621,052</td> <td nowrap="nowrap" style="padding-bottom: 3pt"> </td></tr> </table>

The Company is a party to a Loan and Security Agreement (the Loan Agreement) with a lender (the "Lender"). Under the terms of the Loan Agreement, the Company borrowed an aggregate of $700,000 from the Lender (the Loan), including $100,000 during the three months ended March 31, 2014.  The Loan is evidenced by a promissory note (the Note) in the face amount of $700,000 (as amended).  The Note bears interest on the unpaid principal balance of the Note until the full amount of principal has been paid at a floating rate equal to the Prime Rate plus four and one-quarter percent (4.25%) per annum (7.50% as of March 31, 2014).  Under the terms of the Loan Agreement, the Company has agreed to make monthly payments of accrued interest on the first day of every month. The principal amount and all unpaid accrued interest on the Note is payable on March 1, 2015, or earlier in the event of default or a sale or liquidation of the Company. The Loan may be prepaid in whole or in part at any time by the Company without penalty.   The Note contains financial covenants which require the Company to meet certain minimum targets for earnings before interest, taxes and non-cash expenses, including depreciation, amortization and stock-based compensation (EBITDAS).  In connection with the Loan Agreement, the Company granted the Lender five-year warrants to purchase an aggregate of 1,050,000 shares of Common Stock at an exercise price of $0.35 per share, of which 150,000 warrants were issued during the three months ended March 31, 2014.  The warrants contain customary anti-dilution provisions. The warrants had a relative fair value of $392,500, of which $26,000 was established as debt discount during the three months ended March 31, 2014 and will be amortized using the effective interest method over the term of the Note.  The Company amortized $49,435 of the debt discount as interest expense during the three months ended March 31, 2014 and $212,830 remained unamortized as of March 31, 2014.  Including the value of warrants issued in connection with Note and subsequent amendments, the Note had an effective interest rate of 40% per annum.  See Note 10 for subsequent events.   The Company granted the Lender a first, priority security interest in all of the Companys assets, in order to secure the Companys obligation to repay the Loan. The Loan Agreement contains customary negative covenants restricting the Companys ability to take certain actions without the Lenders consent, including incurring additional indebtedness, transferring or encumbering assets, paying dividends or making certain other payments, and acquiring other businesses. Upon the occurrence of an event of default, the Lender has the right to impose interest at a rate equal to five percent (5.0%) per annum above the otherwise applicable interest rate (the Default Rate). The repayment of the Loan may be accelerated prior to the maturity date upon certain specified events of default, including failure to pay, bankruptcy, breach of covenant, and breach of representations and warranties.   The Company recorded amortization of debt discount associated with notes payable of $54,035 and $44,363 for the three months ended March 31, 2014 and 2013, respectively.

Common Stock   On January 15, 2014, the Company issued 21,289 shares of Common Stock to an employee in accordance with an employment agreement.  The fair value of the shares was $10,646 based on the closing price on the date of issuance.   Preferred Stock   As of March 31, 2014 and December 31, 2013, the Company had accrued contractual dividends of $74,730 and $279,380, respectively, related to the Series B Preferred Stock. On January 1, 2014 and 2013, the Company issued 29,564 and 27,630 shares of Series B convertible preferred stock valued at $279,380 and $261,084, respectively, representing approximately $0.66 in value per share of Series B Preferred Stock outstanding on each date, to the Series B convertible preferred stock owners as payment in kind for dividends.   Stock Options   Stock-based compensation expense related to stock options was recorded in the condensed consolidated statements of operations as a component of selling, general and administrative expenses and totaled $151,853 and $312,444 for the three months ended March 31, 2014 and 2013, respectively.   As of March 31, 2014, stock-based compensation expense related to stock options of $1,476,372  remains unamortized, including $584,803 which is being amortized over the weighted average remaining period of 1.5 years.  The remaining $891,569 is related to a performance based option where vesting is currently deemed to be improbable and no amount is being amortized.    Summary   A summary of the stock option activity during the three months ended March 31, 2014 is presented below:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2" style="text-align: center">Weighted</td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2" style="text-align: center">Weighted</td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2" style="text-align: center">Average</td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2" style="text-align: center">Average</td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2" style="text-align: center">Remaining</td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="text-align: center">Number of</td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2" style="text-align: center">Exercise</td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2" style="text-align: center">Life</td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2" style="text-align: center">Intrinsic</td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt; text-align: center">Options</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt; text-align: center">Price</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt; text-align: center">In Years</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Value</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Outstanding, January 1, 2014</td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right">2,543,150</td> <td nowrap="nowrap"> </td> <td style="text-align: right"> </td> <td>$</td> <td style="text-align: right">2.37</td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Granted</td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right">-</td> <td nowrap="nowrap"> </td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right">-</td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Exercised</td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right">-</td> <td nowrap="nowrap"> </td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right">-</td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt">Forfeited</td> <td style="padding-bottom: 1.5pt; text-align: right"> </td> <td style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt; text-align: right">(29,000</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt">)</td> <td style="padding-bottom: 1.5pt; text-align: right"> </td> <td style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt; text-align: right">3.22</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt"> </td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> </td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 36%; padding-bottom: 3pt">Outstanding, March 31, 2014</td> <td style="width: 1%; padding-bottom: 3pt; text-align: right"> </td> <td style="width: 1%; border-bottom: black 2.25pt double; padding-bottom: 3pt"> </td> <td style="width: 13%; border-bottom: black 2.25pt double; padding-bottom: 3pt; text-align: right">2,514,150</td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3pt"> </td> <td style="width: 1%; padding-bottom: 3pt; text-align: right"> </td> <td style="width: 1%; border-bottom: black 2.25pt double; padding-bottom: 3pt">$</td> <td style="width: 13%; border-bottom: black 2.25pt double; padding-bottom: 3pt; text-align: right">2.36</td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3pt"> </td> <td style="width: 1%; padding-bottom: 3pt; text-align: right"> </td> <td style="width: 1%; border-bottom: black 2.25pt double; padding-bottom: 3pt"> </td> <td style="width: 13%; border-bottom: black 2.25pt double; padding-bottom: 3pt; text-align: right">5.7</td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3pt"> </td> <td style="width: 1%; padding-bottom: 3pt; text-align: right"> </td> <td style="width: 1%; border-bottom: black 2.25pt double">$</td> <td style="width: 13%; border-bottom: black 2.25pt double; text-align: right">-</td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td nowrap="nowrap"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td nowrap="nowrap"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td nowrap="nowrap"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 3pt">Exercisable, March 31, 2014</td> <td style="padding-bottom: 3pt; text-align: right"> </td> <td style="border-bottom: black 2.25pt double; padding-bottom: 3pt"> </td> <td style="border-bottom: black 2.25pt double; padding-bottom: 3pt; text-align: right">1,398,475</td> <td nowrap="nowrap" style="padding-bottom: 3pt"> </td> <td style="padding-bottom: 3pt; text-align: right"> </td> <td style="border-bottom: black 2.25pt double; padding-bottom: 3pt">$</td> <td style="border-bottom: black 2.25pt double; padding-bottom: 3pt; text-align: right">2.78</td> <td nowrap="nowrap" style="padding-bottom: 3pt"> </td> <td style="padding-bottom: 3pt; text-align: right"> </td> <td style="border-bottom: black 2.25pt double; padding-bottom: 3pt"> </td> <td style="border-bottom: black 2.25pt double; padding-bottom: 3pt; text-align: right">4.1</td> <td nowrap="nowrap" style="padding-bottom: 3pt"> </td> <td style="padding-bottom: 3pt; text-align: right"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td nowrap="nowrap" style="padding-bottom: 3pt"> </td></tr> </table>   The following table presents information related to stock options at March 31, 2014:   <table cellspacing="0" cellpadding="0" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%"> <tr style="vertical-align: bottom"> <td colspan="2" style="line-height: 115%"> </td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Options Outstanding</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="10" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Options Exercisable</td> <td nowrap="nowrap" style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center; line-height: 115%; border-bottom: Black 1pt solid">Range of Exercise Price</td> <td nowrap="nowrap" style="line-height: 115%; padding-bottom: 1pt"> </td> <td style="line-height: 115%; padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; line-height: 115%; border-bottom: Black 1pt solid">Weighted Average Exercise Price</td> <td nowrap="nowrap" style="line-height: 115%; padding-bottom: 1pt"> </td> <td style="line-height: 115%; padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; line-height: 115%; border-bottom: Black 1pt solid">Outstanding Number of Options</td> <td nowrap="nowrap" style="line-height: 115%; padding-bottom: 1pt"> </td> <td style="line-height: 115%; padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; line-height: 115%; border-bottom: Black 1pt solid">Weighted Average Exercise Price</td> <td nowrap="nowrap" style="line-height: 115%; padding-bottom: 1pt"> </td> <td style="line-height: 115%; padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; line-height: 115%; border-bottom: Black 1pt solid">Weighted Average Remaining Life In Years</td> <td nowrap="nowrap" style="line-height: 115%; padding-bottom: 1pt"> </td> <td style="line-height: 115%; padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; line-height: 115%; border-bottom: Black 1pt solid">Exercisable Number of Options</td> <td nowrap="nowrap" style="line-height: 115%; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="line-height: 115%"> </td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td nowrap="nowrap" style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 18%; text-align: right; line-height: 115%">0.30 - $2.20</td> <td nowrap="nowrap" style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; text-align: right; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 13%; text-align: right; line-height: 115%">1.11</td> <td nowrap="nowrap" style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; text-align: right; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 13%; text-align: right; line-height: 115%">1,339,400</td> <td nowrap="nowrap" style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; text-align: right; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 13%; text-align: right; line-height: 115%">1.58</td> <td nowrap="nowrap" style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; text-align: right; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 13%; text-align: right; line-height: 115%">2.6</td> <td nowrap="nowrap" style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; text-align: right; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 13%; text-align: right; line-height: 115%">573,725</td> <td nowrap="nowrap" style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">2.21 - $3.80</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">3.23</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">757,750</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">2.95</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">3.8</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">507,750</td> <td nowrap="nowrap" style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="border-bottom: black 1.5pt solid; line-height: 115%">$</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">3.81 - $6.99</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">4.79</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">417,000</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">4.66</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">7.5</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">317,000</td> <td nowrap="nowrap" style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">2.36</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">2,514,150</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">2.78</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">4.1</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">1,398,475</td> <td nowrap="nowrap" style="line-height: 115%"> </td></tr> </table>   Warrants   Valuation   In applying the Black-Scholes option pricing model to stock warrants, the Company used the following weighted average assumptions:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td> </td> <td> </td> <td> </td> <td colspan="3" style="border-bottom: black 1.5pt solid; text-align: center">March 31,</td></tr> <tr style="vertical-align: top"> <td style="width: 61%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 18%; border-bottom: black 1.5pt solid; text-align: center">2014</td> <td style="width: 1%"> </td> <td style="width: 18%; border-bottom: black 1.5pt solid; text-align: center">2013</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr style="vertical-align: top; background-color: #CCEEFF"> <td>Risk free interest rate</td> <td> </td> <td> </td> <td style="text-align: center">1.74%</td> <td> </td> <td style="text-align: center">0.88%</td></tr> <tr style="vertical-align: top; background-color: white"> <td>Dividend yield</td> <td> </td> <td> </td> <td style="text-align: center">0.00%</td> <td> </td> <td style="text-align: center">0.00%</td></tr> <tr style="vertical-align: top; background-color: #CCEEFF"> <td>Expected volatility</td> <td> </td> <td> </td> <td style="text-align: center">171.0%</td> <td> </td> <td style="text-align: center">164.3%</td></tr> <tr style="vertical-align: top; background-color: white"> <td>Expected life in years</td> <td> </td> <td> </td> <td style="text-align: center">5.00</td> <td> </td> <td style="text-align: center">5.00</td></tr> </table>   Grants   See Note 5 Notes Payable for details regarding warrants granted in connection with the issuances of notes payable.   The weighted average fair value of the stock warrants granted during the three months ended March 31, 2014 and 2013, was $0.23 and $1.38 per share, respectively.   Stock-based compensation expense related to warrants for the three months ended March 31, 2014 and 2013 was recorded in the condensed consolidated statements of operations as a component of selling, general and administrative expenses and totaled $264 and $504,777, respectively.  As of March 31, 2014, stock-based compensation expense related to warrants of $580,525 remains unamortized, including $3,685 which is being amortized over the weighted average remaining period of 1.5 years.  The remaining $576,840 is related to a performance based warrant where vesting is currently deemed to be improbable and no amount is being amortized.   A summary of the stock warrant activity during the three months ended March 31, 2014 is presented below:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2" style="text-align: center">Weighted</td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2" style="text-align: center">Average</td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2" style="text-align: center">Average</td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2" style="text-align: center">Remaining</td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="text-align: center">Number of</td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2" style="text-align: center">Exercise</td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2" style="text-align: center">Life</td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2" style="text-align: center">Intrinsic</td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt; text-align: center">Warrants</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt; text-align: center">Price</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt; text-align: center">In Years</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Value</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Outstanding, January 1, 2014</td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right">2,342,846</td> <td nowrap="nowrap"> </td> <td style="text-align: right"> </td> <td>$</td> <td style="text-align: right">0.96</td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Granted</td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right">150,000</td> <td nowrap="nowrap"> </td> <td style="text-align: right"> </td> <td>$</td> <td style="text-align: right">0.35</td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Exercised</td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right">-</td> <td nowrap="nowrap"> </td> <td style="text-align: right"> </td> <td>$</td> <td style="text-align: right">-</td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt">Forfeited</td> <td style="padding-bottom: 1.5pt; text-align: right"> </td> <td style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt; text-align: right">-</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: right"> </td> <td style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt; text-align: right">-</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt"> </td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> </td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 36%; padding-bottom: 3pt">Outstanding, March 31, 2014</td> <td style="width: 1%; padding-bottom: 3pt; text-align: right"> </td> <td style="width: 1%; border-bottom: black 2.25pt double; padding-bottom: 3pt"> </td> <td style="width: 13%; border-bottom: black 2.25pt double; padding-bottom: 3pt; text-align: right">2,492,846</td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3pt"> </td> <td style="width: 1%; padding-bottom: 3pt; text-align: right"> </td> <td style="width: 1%; border-bottom: black 2.25pt double; padding-bottom: 3pt">$</td> <td style="width: 13%; border-bottom: black 2.25pt double; padding-bottom: 3pt; text-align: right">0.92</td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3pt"> </td> <td style="width: 1%; padding-bottom: 3pt; text-align: right"> </td> <td style="width: 1%; border-bottom: black 2.25pt double; padding-bottom: 3pt"> </td> <td style="width: 13%; border-bottom: black 2.25pt double; padding-bottom: 3pt; text-align: right">3.7</td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3pt"> </td> <td style="width: 1%; padding-bottom: 3pt; text-align: right"> </td> <td style="width: 1%; border-bottom: black 2.25pt double">$</td> <td style="width: 13%; border-bottom: black 2.25pt double; text-align: right">-</td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td nowrap="nowrap"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td nowrap="nowrap"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td nowrap="nowrap"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 3pt">Exercisable, March 31, 2014</td> <td style="padding-bottom: 3pt; text-align: right"> </td> <td style="border-bottom: black 2.25pt double; padding-bottom: 3pt"> </td> <td style="border-bottom: black 2.25pt double; padding-bottom: 3pt; text-align: right">2,242,846</td> <td nowrap="nowrap" style="padding-bottom: 3pt"> </td> <td style="padding-bottom: 3pt; text-align: right"> </td> <td style="border-bottom: black 2.25pt double; padding-bottom: 3pt">$</td> <td style="border-bottom: black 2.25pt double; padding-bottom: 3pt; text-align: right">0.70</td> <td nowrap="nowrap" style="padding-bottom: 3pt"> </td> <td style="padding-bottom: 3pt; text-align: right"> </td> <td style="border-bottom: black 2.25pt double; padding-bottom: 3pt"> </td> <td style="border-bottom: black 2.25pt double; padding-bottom: 3pt; text-align: right">3.8</td> <td nowrap="nowrap" style="padding-bottom: 3pt"> </td> <td style="padding-bottom: 3pt; text-align: right"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td nowrap="nowrap" style="padding-bottom: 3pt"> </td></tr> </table>   The following table presents information related to stock warrants at March 31, 2014:   <table cellspacing="0" cellpadding="0" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%"> <tr style="vertical-align: bottom"> <td colspan="2" style="line-height: 115%"> </td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Warrants Outstanding</td> <td nowrap="nowrap" style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td colspan="10" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Warrants Exercisable</td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center; line-height: 115%; border-bottom: Black 1pt solid">Range of Exercise Price</td> <td nowrap="nowrap" style="text-align: center; line-height: 115%; padding-bottom: 1pt"> </td> <td style="text-align: center; line-height: 115%; padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; line-height: 115%; border-bottom: Black 1pt solid">Weighted Average Exercise Price</td> <td nowrap="nowrap" style="text-align: center; line-height: 115%; padding-bottom: 1pt"> </td> <td style="text-align: center; line-height: 115%; padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; line-height: 115%; border-bottom: Black 1pt solid">Outstanding Number of Warrants</td> <td nowrap="nowrap" style="text-align: center; line-height: 115%; padding-bottom: 1pt"> </td> <td style="text-align: center; line-height: 115%; padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; line-height: 115%; border-bottom: Black 1pt solid">Weighted Average Exercise Price</td> <td nowrap="nowrap" style="text-align: center; line-height: 115%; padding-bottom: 1pt"> </td> <td style="text-align: center; line-height: 115%; padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; line-height: 115%; border-bottom: Black 1pt solid">Weighted Average Remaining Life In Years</td> <td nowrap="nowrap" style="text-align: center; line-height: 115%; padding-bottom: 1pt"> </td> <td style="text-align: center; line-height: 115%; padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; line-height: 115%; border-bottom: Black 1pt solid">Exercisable Number of Warrants</td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="line-height: 115%"> </td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 19%; text-align: right; line-height: 115%">0.25 - $0.35</td> <td nowrap="nowrap" style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; text-align: right; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 13%; text-align: right; line-height: 115%">0.27</td> <td nowrap="nowrap" style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; text-align: right; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 13%; text-align: right; line-height: 115%">1,900,000</td> <td nowrap="nowrap" style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; text-align: right; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 13%; text-align: right; line-height: 115%">0.27</td> <td nowrap="nowrap" style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; text-align: right; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 13%; text-align: right; line-height: 115%">4.1</td> <td nowrap="nowrap" style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; text-align: right; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 13%; text-align: right; line-height: 115%">1,900,000</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">0.36 - $3.00</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">2.91</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">562,846</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">2.91</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">2.4</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">312,846</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="border-bottom: black 1.5pt solid; line-height: 115%">$</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">3.01 - $4.95</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">4.95</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">30,000</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">4.95</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">3.5</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">30,000</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">0.25 - $4.95</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">0.92</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">2,492,846</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">0.70</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">3.8</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">2,242,846</td></tr> </table> Services Contributed   Effective January 1, 2013, an executive officer of the Company waived payment for services contributed. As a result, the Company imputed the value of the services contributed based on a compensation rate previously approved by the Compensation Committee and recorded salary expense of $87,500 for each of the three month periods ended March 31, 2014 and 2013, with a corresponding credit to stockholders deficiency.

Operating Leases   The Company is a party to a lease agreement for approximately 62,000 square feet of office and storage space with an entity.  The monthly lease rate is $10,671 for years 2014 and 2015 and $11,975 in year 2016.  The Company accounts for rent expense using the straight line method of accounting, deferring the difference between actual rent due and the straight line amount. The lease expires on January 1, 2017. Deferred rent payable of $43,704 and $46,254 as of March 31, 2014 and December 31, 2013, respectively, has been included in accrued expenses and other current liabilities on the condensed consolidated balance sheets.   On June 7, 2013, Pagosa signed a three year lease for $1,000 per month to house an office, pharmacy as well as inventory and is located in Lawrenceburg, IN.  On July 8, 2013, the parties agreed to extend the lease for two additional years, such that the new termination date is now June 7, 2018.  On January 14, 2014, the Company closed Pagosa Health and vacated the Lawrenceburg facility. The Company is currently in discussions with the Landlord regarding termination of the lease related to the building.   The impact of the lease termination was de minimus to the condensed consolidated financial statements as of March 31, 2014.   Future minimum payments, by year and in the aggregate, under operating leases as of March 31, 2014 are as follows:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid">For years ending December 31,</td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Amount</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="text-align: right"> </td> <td colspan="2" style="text-align: right"> </td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 75%">2014</td> <td style="width: 1%; text-align: right"> </td> <td style="width: 1%">$</td> <td style="width: 22%; text-align: right">96,037</td> <td nowrap="nowrap" style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>2015</td> <td style="text-align: right"> </td> <td>$</td> <td style="text-align: right">128,049</td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt">2016</td> <td style="padding-bottom: 1.5pt; text-align: right"> </td> <td style="border-bottom: black 1.5pt solid">$</td> <td style="border-bottom: black 1.5pt solid; text-align: right">143,700</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 3pt">Total future minimum lease payments</td> <td style="padding-bottom: 3pt; text-align: right"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">367,786</td> <td nowrap="nowrap" style="padding-bottom: 3pt"> </td></tr> </table>   During the three months ended March 31, 2014 and 2013, the Company recorded aggregate rent expense of $49,229 and $45,719, respectively.   Litigation   In the ordinary course of business, we may become subject to lawsuits and other claims and proceedings that might arise from litigation matters or regulatory audits. Such matters are subject to uncertainty and outcomes are often not predictable with assurance. Our management does not presently expect that any such matters will have a material adverse effect on the Companys condensed consolidated financial condition or condensed consolidated results of operations. We are not currently involved in any pending or threatened material litigation or other material legal proceedings nor have we been made aware of any penalties from regulatory audits, except as described below.   On February 9, 2012, two of our former stockholders, Rock Castle Holdings, LLC and Jason Smith (collectively Plaintiffs), filed suit against us in the Hamilton County, Ohio Court of Common Pleas, alleging that we had breached the terms of certain incentive options we granted to the Plaintiffs in connection with our now-terminated oral consulting arrangements with the Plaintiffs, by among other things, refusing Plaintiffs purported exercise of options to purchase 233,332 shares of our Common Stock at an exercise price of $2.00 per share in December 2011.  Plaintiffs have requested that, among other things, the court require us to permit the exercise of the 233,332 options.  Plaintiffs have also provided an expert report indicating damages of $2.086 million. Also named as defendants were two individuals, Michael Peppel and Gary Singer, whom Plaintiffs claim acted as agents for us in connection with our purchase of shares of our Common Stock from Plaintiffs in September 2011.  On July 19, 2012, the Company and Mr. Peppel filed an answer and counterclaim for breach of contract, alleging that Plaintiffs breached consulting agreements with the Company and undertook a series of actions that damaged and hurt the Company.  On July 24, 2012, the Company filed a complaint against Dennis Smith for breach of contract in the Hamilton County, Ohio Court of Common Pleas, which action was consolidated with the earlier case.  Plaintiffs filed an answer in response to the counterclaim, and Dennis Smith filed an answer in response to the Companys complaint.  On April 26, 2013, Plaintiffs dismissed Mr. Singer from the lawsuit.    On March 24, 2014, all parties filed motions for summary judgment: (i) the Company and Mr. Peppel moved for summary judgment on all claims asserted by Plaintiffs, (ii) Dennis B. Smith and Counterclaim Defendants and Plaintiffs moved for summary judgment on the Companys claims for breach of contract, and (iii) Plaintiffs moved for partial summary judgment on their claim for declaratory relief that the Company breached the terms of a stock option agreement. Trial of the case is currently scheduled for November  2014.  We deny all of the Plaintiffs claims and intend to contest this matter vigorously.             The Company was a party to a putative stockholder derivative action was filed in the Court of Chancery of the State of Delaware on May 7, 2013 against certain directors and our chief executive officer and against us, as a nominal defendant.   On January 8, 2014, in a stipulation and order of dismissal, the action was dismissed with prejudice to plaintiff, with each party bearing its own attorneys' fees and costs.   On May 15, 2013, a former consultant filed suit in Boone County, Kentucky Circuit Court alleging breach of contract and unjust enrichment for unpaid consulting fees and expenses of approximately $55,000.  We filed an answer to the complaint on July 22, 2013 and intend to vigorously defend ourselves against the allegations.  The trial of the case has been set for September 2014.

During the three months ended March 31, 2014, two vendors represented 57% and 16% of total inventory purchases. During the three months ended March 31, 2013, two vendors represented 30% and 11% of total inventory purchases, respectively.

Between June 2009 and April 2012, an employee who is the son of the managing member of a limited liability company that beneficially owns over 5% of the Companys Common Stock received advances from the Company in various forms which totaled $391,469 including interest.  Principal repayments towards the outstanding advances aggregating $235,000 have been made through March 31, 2014.  In April 2012, this employee voluntarily resigned from the Company. The individual agreed to repay the remaining balance with interest based on prime rate on the first business day of the calendar quarter. The amount has been included in Stockholders Deficiency as the Company has determined to exercise its rights through a pledge agreement for 42,860 shares as collateral.  At March 31, 2014 and December 31, 2013, the Company estimated the value of the collateral at $10,715 and $9,001, respectively.

The Company evaluates events that have occurred after the balance sheet date but before the financial statements are issued. Based upon the evaluation, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the condensed consolidated financial statements, except as disclosed.   Notes Payable   On April 30, 2014, the Company received an additional $50,000 from a lender, which brought the face value of the Note to $750,000 pursuant to an Amended and Restated Promissory Note (the April 2014 Note), effective April 29, 2014, which supersedes the Note with the same Lender. The April 2014 Note contains financial covenants which require the Company to meet certain minimum targets for earnings before interest, taxes and non-cash expenses, including depreciation, amortization and stock-based compensation (EBITDAS) for the calendar quarters and years ended between June 30, 2014 and December 31, 2014. The remainder of the material April 2014 Note terms are unchanged from the Note, including the March 1, 2015 maturity date.  In consideration of the Lender providing additional funds and entering into the April 2014 Note, the Company granted the Lender a five-year warrant to purchase 75,000 shares of Common Stock at an exercise price of $0.35 per share. The warrant contains customary anti-dilution provisions. The warrant had a relative fair value of $14,900 which was set up as debt discount and will be amortized using the effective interest method over the term of the April 2014 Note.  Including the value of warrants issued in connection with the April Note, the Note had an effective interest rate of 40% per annum. Executive Compensation   On April 28, 2014, the Compensation Committee approved the payment of an annual salary of $150,000 to the Companys Chief Executive Officer, effective May 1, 2014.

The condensed consolidated financial statements include the accounts of HealthWarehouse.com, Inc., Hwareh.com, Inc., Hocks.com, Inc., ION Holding NV, ION Belgium NV and Pagosa, its wholly-owned subsidiaries. ION Holding NV and ION Belgium NV are inactive subsidiaries. All material inter-company balances and transactions have been eliminated in consolidation.   On June 4, 2013, the Company formed a wholly-owned subsidiary called Pagosa Health LLC (Pagosa).  On January 14, 2014, the Company closed Pagosa and decided to focus on its core consumer prescription business. Pagosa had a de minimis impact on the Companys operations or the results for the three months ended March 31, 2014.

The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (U.S. GAAP) requires management to make estimates and assumptions that affect the amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.  The Companys significant estimates include reserves related to accounts receivable and inventory, the recoverability and useful lives of long-lived assets, the valuation allowance related to deferred tax assets, the valuation of equity instruments and debt discounts.

Basic net loss per share is computed by dividing net loss attributable to Common Stockholders by the weighted average number of common shares outstanding during the period.  Diluted net loss per share reflects the potential dilution that could occur if securities or other instruments to issue Common Stock were exercised or converted into Common Stock.  Potentially dilutive securities are excluded from the computation of diluted net loss per share if their inclusion would be anti-dilutive and consist of the following:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">March 31,</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt; text-align: center">2014</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">2013</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 68%">Options</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 13%; text-align: right">2,514,150</td> <td nowrap="nowrap" style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 13%; text-align: right">2,451,483</td> <td nowrap="nowrap" style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Warrants</td> <td> </td> <td> </td> <td style="text-align: right">2,492,846</td> <td nowrap="nowrap"> </td> <td> </td> <td> </td> <td style="text-align: right">6,047,119</td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt">Series B Convertible Preferred Stock</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt; text-align: right">3,714,445</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">3,407,313</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 3pt">Total potentially dilutive shares</td> <td style="padding-bottom: 3pt"> </td> <td style="border-bottom: black 2.25pt double; padding-bottom: 3pt"> </td> <td style="border-bottom: black 2.25pt double; padding-bottom: 3pt; text-align: right">8,721,441</td> <td nowrap="nowrap" style="padding-bottom: 3pt"> </td> <td style="padding-bottom: 3pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">11,905,915</td> <td nowrap="nowrap" style="padding-bottom: 3pt"> </td></tr> </table>

The Company has determined there are no new accounting standards that are expected to have a material impact on the Company's condensed consolidated financial statements.

Potentially dilutive securities are excluded from the computation of diluted net loss per share if their inclusion would be anti-dilutive and consist of the following:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">March 31,</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt; text-align: center">2014</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">2013</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 68%">Options</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 13%; text-align: right">2,514,150</td> <td nowrap="nowrap" style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 13%; text-align: right">2,451,483</td> <td nowrap="nowrap" style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Warrants</td> <td> </td> <td> </td> <td style="text-align: right">2,492,846</td> <td nowrap="nowrap"> </td> <td> </td> <td> </td> <td style="text-align: right">6,047,119</td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt">Series B Convertible Preferred Stock</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt; text-align: right">3,714,445</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">3,407,313</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 3pt">Total potentially dilutive shares</td> <td style="padding-bottom: 3pt"> </td> <td style="border-bottom: black 2.25pt double; padding-bottom: 3pt"> </td> <td style="border-bottom: black 2.25pt double; padding-bottom: 3pt; text-align: right">8,721,441</td> <td nowrap="nowrap" style="padding-bottom: 3pt"> </td> <td style="padding-bottom: 3pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">11,905,915</td> <td nowrap="nowrap" style="padding-bottom: 3pt"> </td></tr> </table>

Accrued expenses and other current liabilities consisted of the following:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="text-align: center">March 31,</td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2" style="text-align: center">December 31,</td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt; text-align: center">2014</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">2013</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 68%"> </td> <td style="width: 1%; text-align: right"> </td> <td style="width: 1%"> </td> <td style="width: 13%; text-align: right"> </td> <td nowrap="nowrap" style="width: 1%"> </td> <td style="width: 1%; text-align: right"> </td> <td style="width: 1%"> </td> <td style="width: 13%; text-align: right"> </td> <td nowrap="nowrap" style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Deferred Rent</td> <td style="text-align: right"> </td> <td>$</td> <td style="text-align: right">43,704</td> <td nowrap="nowrap"> </td> <td style="text-align: right"> </td> <td>$</td> <td style="text-align: right">46,254</td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Advertising</td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right">75,000</td> <td nowrap="nowrap"> </td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right">75,000</td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Salaries and Benefits</td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right">178,393</td> <td nowrap="nowrap"> </td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right">132,048</td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Customer Payables</td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right">19,697</td> <td nowrap="nowrap"> </td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right">39,618</td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Dividend Payable</td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right">74,729</td> <td nowrap="nowrap"> </td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right">279,380</td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Accrued Interest</td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right">46,429</td> <td nowrap="nowrap"> </td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right">45,616</td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt">Other</td> <td style="padding-bottom: 1.5pt; text-align: right"> </td> <td style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt; text-align: right">3,622</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: right"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">3,136</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 3pt; text-align: right"> Total     </td> <td style="padding-bottom: 3pt; text-align: right"> </td> <td style="border-bottom: black 2.25pt double; padding-bottom: 3pt">$</td> <td style="border-bottom: black 2.25pt double; padding-bottom: 3pt; text-align: right">441,574</td> <td nowrap="nowrap" style="padding-bottom: 3pt"> </td> <td style="padding-bottom: 3pt; text-align: right"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">621,052</td> <td nowrap="nowrap" style="padding-bottom: 3pt"> </td></tr> </table>

Future minimum payments, by year and in the aggregate, under operating leases as of March 31, 2014 are as follows:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid">For years ending December 31,</td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Amount</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="text-align: right"> </td> <td colspan="2" style="text-align: right"> </td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 75%">2014</td> <td style="width: 1%; text-align: right"> </td> <td style="width: 1%">$</td> <td style="width: 22%; text-align: right">96,037</td> <td nowrap="nowrap" style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>2015</td> <td style="text-align: right"> </td> <td>$</td> <td style="text-align: right">128,049</td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt">2016</td> <td style="padding-bottom: 1.5pt; text-align: right"> </td> <td style="border-bottom: black 1.5pt solid">$</td> <td style="border-bottom: black 1.5pt solid; text-align: right">143,700</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 3pt">Total future minimum lease payments</td> <td style="padding-bottom: 3pt; text-align: right"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">367,786</td> <td nowrap="nowrap" style="padding-bottom: 3pt"> </td></tr> </table>

A summary of the stock option activity during the three months ended March 31, 2014 is presented below:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2" style="text-align: center">Weighted</td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2" style="text-align: center">Weighted</td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2" style="text-align: center">Average</td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2" style="text-align: center">Average</td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2" style="text-align: center">Remaining</td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="text-align: center">Number of</td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2" style="text-align: center">Exercise</td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2" style="text-align: center">Life</td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2" style="text-align: center">Intrinsic</td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt; text-align: center">Options</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt; text-align: center">Price</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt; text-align: center">In Years</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Value</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Outstanding, January 1, 2014</td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right">2,543,150</td> <td nowrap="nowrap"> </td> <td style="text-align: right"> </td> <td>$</td> <td style="text-align: right">2.37</td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Granted</td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right">-</td> <td nowrap="nowrap"> </td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right">-</td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Exercised</td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right">-</td> <td nowrap="nowrap"> </td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right">-</td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt">Forfeited</td> <td style="padding-bottom: 1.5pt; text-align: right"> </td> <td style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt; text-align: right">(29,000</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt">)</td> <td style="padding-bottom: 1.5pt; text-align: right"> </td> <td style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt; text-align: right">3.22</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt"> </td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> </td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 36%; padding-bottom: 3pt">Outstanding, March 31, 2014</td> <td style="width: 1%; padding-bottom: 3pt; text-align: right"> </td> <td style="width: 1%; border-bottom: black 2.25pt double; padding-bottom: 3pt"> </td> <td style="width: 13%; border-bottom: black 2.25pt double; padding-bottom: 3pt; text-align: right">2,514,150</td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3pt"> </td> <td style="width: 1%; padding-bottom: 3pt; text-align: right"> </td> <td style="width: 1%; border-bottom: black 2.25pt double; padding-bottom: 3pt">$</td> <td style="width: 13%; border-bottom: black 2.25pt double; padding-bottom: 3pt; text-align: right">2.36</td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3pt"> </td> <td style="width: 1%; padding-bottom: 3pt; text-align: right"> </td> <td style="width: 1%; border-bottom: black 2.25pt double; padding-bottom: 3pt"> </td> <td style="width: 13%; border-bottom: black 2.25pt double; padding-bottom: 3pt; text-align: right">5.7</td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3pt"> </td> <td style="width: 1%; padding-bottom: 3pt; text-align: right"> </td> <td style="width: 1%; border-bottom: black 2.25pt double">$</td> <td style="width: 13%; border-bottom: black 2.25pt double; text-align: right">-</td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td nowrap="nowrap"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td nowrap="nowrap"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td nowrap="nowrap"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 3pt">Exercisable, March 31, 2014</td> <td style="padding-bottom: 3pt; text-align: right"> </td> <td style="border-bottom: black 2.25pt double; padding-bottom: 3pt"> </td> <td style="border-bottom: black 2.25pt double; padding-bottom: 3pt; text-align: right">1,398,475</td> <td nowrap="nowrap" style="padding-bottom: 3pt"> </td> <td style="padding-bottom: 3pt; text-align: right"> </td> <td style="border-bottom: black 2.25pt double; padding-bottom: 3pt">$</td> <td style="border-bottom: black 2.25pt double; padding-bottom: 3pt; text-align: right">2.78</td> <td nowrap="nowrap" style="padding-bottom: 3pt"> </td> <td style="padding-bottom: 3pt; text-align: right"> </td> <td style="border-bottom: black 2.25pt double; padding-bottom: 3pt"> </td> <td style="border-bottom: black 2.25pt double; padding-bottom: 3pt; text-align: right">4.1</td> <td nowrap="nowrap" style="padding-bottom: 3pt"> </td> <td style="padding-bottom: 3pt; text-align: right"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td nowrap="nowrap" style="padding-bottom: 3pt"> </td></tr> </table>

In applying the Black-Scholes option pricing model to stock warrants, the Company used the following weighted average assumptions:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td> </td> <td> </td> <td> </td> <td colspan="3" style="border-bottom: black 1.5pt solid; text-align: center">March 31,</td></tr> <tr style="vertical-align: top"> <td style="width: 61%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 18%; border-bottom: black 1.5pt solid; text-align: center">2014</td> <td style="width: 1%"> </td> <td style="width: 18%; border-bottom: black 1.5pt solid; text-align: center">2013</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr style="vertical-align: top; background-color: #CCEEFF"> <td>Risk free interest rate</td> <td> </td> <td> </td> <td style="text-align: center">1.74%</td> <td> </td> <td style="text-align: center">0.88%</td></tr> <tr style="vertical-align: top; background-color: white"> <td>Dividend yield</td> <td> </td> <td> </td> <td style="text-align: center">0.00%</td> <td> </td> <td style="text-align: center">0.00%</td></tr> <tr style="vertical-align: top; background-color: #CCEEFF"> <td>Expected volatility</td> <td> </td> <td> </td> <td style="text-align: center">171.0%</td> <td> </td> <td style="text-align: center">164.3%</td></tr> <tr style="vertical-align: top; background-color: white"> <td>Expected life in years</td> <td> </td> <td> </td> <td style="text-align: center">5.00</td> <td> </td> <td style="text-align: center">5.00</td></tr> </table>

A summary of the stock warrant activity during the three months ended March 31, 2014 is presented below:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2" style="text-align: center">Weighted</td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2" style="text-align: center">Average</td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2" style="text-align: center">Average</td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2" style="text-align: center">Remaining</td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="text-align: center">Number of</td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2" style="text-align: center">Exercise</td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2" style="text-align: center">Life</td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2" style="text-align: center">Intrinsic</td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt; text-align: center">Warrants</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt; text-align: center">Price</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt; text-align: center">In Years</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Value</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Outstanding, January 1, 2014</td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right">2,342,846</td> <td nowrap="nowrap"> </td> <td style="text-align: right"> </td> <td>$</td> <td style="text-align: right">0.96</td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Granted</td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right">150,000</td> <td nowrap="nowrap"> </td> <td style="text-align: right"> </td> <td>$</td> <td style="text-align: right">0.35</td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Exercised</td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right">-</td> <td nowrap="nowrap"> </td> <td style="text-align: right"> </td> <td>$</td> <td style="text-align: right">-</td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td> <td> </td> <td colspan="2"> </td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt">Forfeited</td> <td style="padding-bottom: 1.5pt; text-align: right"> </td> <td style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt; text-align: right">-</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: right"> </td> <td style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt; text-align: right">-</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt"> </td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> </td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 36%; padding-bottom: 3pt">Outstanding, March 31, 2014</td> <td style="width: 1%; padding-bottom: 3pt; text-align: right"> </td> <td style="width: 1%; border-bottom: black 2.25pt double; padding-bottom: 3pt"> </td> <td style="width: 13%; border-bottom: black 2.25pt double; padding-bottom: 3pt; text-align: right">2,492,846</td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3pt"> </td> <td style="width: 1%; padding-bottom: 3pt; text-align: right"> </td> <td style="width: 1%; border-bottom: black 2.25pt double; padding-bottom: 3pt">$</td> <td style="width: 13%; border-bottom: black 2.25pt double; padding-bottom: 3pt; text-align: right">0.92</td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3pt"> </td> <td style="width: 1%; padding-bottom: 3pt; text-align: right"> </td> <td style="width: 1%; border-bottom: black 2.25pt double; padding-bottom: 3pt"> </td> <td style="width: 13%; border-bottom: black 2.25pt double; padding-bottom: 3pt; text-align: right">3.7</td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3pt"> </td> <td style="width: 1%; padding-bottom: 3pt; text-align: right"> </td> <td style="width: 1%; border-bottom: black 2.25pt double">$</td> <td style="width: 13%; border-bottom: black 2.25pt double; text-align: right">-</td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td nowrap="nowrap"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td nowrap="nowrap"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td nowrap="nowrap"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 3pt">Exercisable, March 31, 2014</td> <td style="padding-bottom: 3pt; text-align: right"> </td> <td style="border-bottom: black 2.25pt double; padding-bottom: 3pt"> </td> <td style="border-bottom: black 2.25pt double; padding-bottom: 3pt; text-align: right">2,242,846</td> <td nowrap="nowrap" style="padding-bottom: 3pt"> </td> <td style="padding-bottom: 3pt; text-align: right"> </td> <td style="border-bottom: black 2.25pt double; padding-bottom: 3pt">$</td> <td style="border-bottom: black 2.25pt double; padding-bottom: 3pt; text-align: right">0.70</td> <td nowrap="nowrap" style="padding-bottom: 3pt"> </td> <td style="padding-bottom: 3pt; text-align: right"> </td> <td style="border-bottom: black 2.25pt double; padding-bottom: 3pt"> </td> <td style="border-bottom: black 2.25pt double; padding-bottom: 3pt; text-align: right">3.8</td> <td nowrap="nowrap" style="padding-bottom: 3pt"> </td> <td style="padding-bottom: 3pt; text-align: right"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td nowrap="nowrap" style="padding-bottom: 3pt"> </td></tr> </table>

4727480 50000 2514150 2451483 2492846 6047119 3714445 3407313 8721441 11905915

441574

621052

3622

3136

46429

45616

74729

279380

19697

39618

178393

132048

75000

43704

46254

96037

143700

367786

128049

49229

45719

43704 46254 10671 10671 11975 2017-01-01 10715 9001

2514150

2543150

417000

1339400

757750

-29000

2.36

2.37

4.79

1.11

3.23

3.22

P5Y8M12D

P4Y1M6D

1398475 2.78

1398475

317000

573725

507750

2.78 4.66 1.58 2.95 P4Y1M6D P7Y6M P2Y7M6D P3Y9M18D P5Y P5Y

1.710

1.643

0.0000 0.0000

0.0174

0.0088

150000 2242846 0.35 0.70 P3Y8M12D P3Y9M18D

1900000

562846

30000

2492846

0.27 2.91 4.95 0.92 0.27 2.91 4.95 0.70 1900000 312846 30000 2242846 P4Y1M6D P2Y4M24D P3Y6M P3Y9M18D

87500

576840 891569 580525 700000 100000 0.0750 150000 392500 26000 49435 The following table presents information related to stock options at March 31, 2014:   <table cellspacing="0" cellpadding="0" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%"> <tr style="vertical-align: bottom"> <td colspan="2" style="line-height: 115%"> </td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Options Outstanding</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="10" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Options Exercisable</td> <td nowrap="nowrap" style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center; line-height: 115%; border-bottom: Black 1pt solid">Range of Exercise Price</td> <td nowrap="nowrap" style="line-height: 115%; padding-bottom: 1pt"> </td> <td style="line-height: 115%; padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; line-height: 115%; border-bottom: Black 1pt solid">Weighted Average Exercise Price</td> <td nowrap="nowrap" style="line-height: 115%; padding-bottom: 1pt"> </td> <td style="line-height: 115%; padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; line-height: 115%; border-bottom: Black 1pt solid">Outstanding Number of Options</td> <td nowrap="nowrap" style="line-height: 115%; padding-bottom: 1pt"> </td> <td style="line-height: 115%; padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; line-height: 115%; border-bottom: Black 1pt solid">Weighted Average Exercise Price</td> <td nowrap="nowrap" style="line-height: 115%; padding-bottom: 1pt"> </td> <td style="line-height: 115%; padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; line-height: 115%; border-bottom: Black 1pt solid">Weighted Average Remaining Life In Years</td> <td nowrap="nowrap" style="line-height: 115%; padding-bottom: 1pt"> </td> <td style="line-height: 115%; padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; line-height: 115%; border-bottom: Black 1pt solid">Exercisable Number of Options</td> <td nowrap="nowrap" style="line-height: 115%; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="line-height: 115%"> </td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td nowrap="nowrap" style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 18%; text-align: right; line-height: 115%">0.30 - $2.20</td> <td nowrap="nowrap" style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; text-align: right; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 13%; text-align: right; line-height: 115%">1.11</td> <td nowrap="nowrap" style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; text-align: right; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 13%; text-align: right; line-height: 115%">1,339,400</td> <td nowrap="nowrap" style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; text-align: right; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 13%; text-align: right; line-height: 115%">1.58</td> <td nowrap="nowrap" style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; text-align: right; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 13%; text-align: right; line-height: 115%">2.6</td> <td nowrap="nowrap" style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; text-align: right; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 13%; text-align: right; line-height: 115%">573,725</td> <td nowrap="nowrap" style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">2.21 - $3.80</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">3.23</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">757,750</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">2.95</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">3.8</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">507,750</td> <td nowrap="nowrap" style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="border-bottom: black 1.5pt solid; line-height: 115%">$</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">3.81 - $6.99</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">4.79</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">417,000</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">4.66</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">7.5</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">317,000</td> <td nowrap="nowrap" style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">2.36</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">2,514,150</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">2.78</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">4.1</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">1,398,475</td> <td nowrap="nowrap" style="line-height: 115%"> </td></tr> </table>   The following table presents information related to stock warrants at March 31, 2014:   <table cellspacing="0" cellpadding="0" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%"> <tr style="vertical-align: bottom"> <td colspan="2" style="line-height: 115%"> </td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Warrants Outstanding</td> <td nowrap="nowrap" style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td colspan="10" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Warrants Exercisable</td> <td nowrap="nowrap" style="text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center; line-height: 115%; border-bottom: Black 1pt solid">Range of Exercise Price</td> <td nowrap="nowrap" style="text-align: center; line-height: 115%; padding-bottom: 1pt"> </td> <td style="text-align: center; line-height: 115%; padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; line-height: 115%; border-bottom: Black 1pt solid">Weighted Average Exercise Price</td> <td nowrap="nowrap" style="text-align: center; line-height: 115%; padding-bottom: 1pt"> </td> <td style="text-align: center; line-height: 115%; padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; line-height: 115%; border-bottom: Black 1pt solid">Outstanding Number of Warrants</td> <td nowrap="nowrap" style="text-align: center; line-height: 115%; padding-bottom: 1pt"> </td> <td style="text-align: center; line-height: 115%; padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; line-height: 115%; border-bottom: Black 1pt solid">Weighted Average Exercise Price</td> <td nowrap="nowrap" style="text-align: center; line-height: 115%; padding-bottom: 1pt"> </td> <td style="text-align: center; line-height: 115%; padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; line-height: 115%; border-bottom: Black 1pt solid">Weighted Average Remaining Life In Years</td> <td nowrap="nowrap" style="text-align: center; line-height: 115%; padding-bottom: 1pt"> </td> <td style="text-align: center; line-height: 115%; padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; line-height: 115%; border-bottom: Black 1pt solid">Exercisable Number of Warrants</td> <td nowrap="nowrap" style="line-height: 115%; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="line-height: 115%"> </td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td nowrap="nowrap" style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 18%; text-align: right; line-height: 115%">0.25 - $0.35</td> <td nowrap="nowrap" style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; text-align: right; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 13%; text-align: right; line-height: 115%">0.27</td> <td nowrap="nowrap" style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; text-align: right; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 13%; text-align: right; line-height: 115%">1,900,000</td> <td nowrap="nowrap" style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; text-align: right; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 13%; text-align: right; line-height: 115%">0.27</td> <td nowrap="nowrap" style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; text-align: right; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 13%; text-align: right; line-height: 115%">4.1</td> <td nowrap="nowrap" style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; text-align: right; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 13%; text-align: right; line-height: 115%">1,900,000</td> <td nowrap="nowrap" style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">0.36 - $3.00</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">2.91</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">562,846</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">2.91</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">2.4</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">312,846</td> <td nowrap="nowrap" style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="border-bottom: black 1.5pt solid; line-height: 115%">$</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">3.01 - $4.95</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">4.95</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">30,000</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">4.95</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">3.5</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">30,000</td> <td nowrap="nowrap" style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">0.25 - $4.95</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">0.92</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">2,492,846</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">0.70</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">3.8</td> <td nowrap="nowrap" style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">2,242,846</td> <td nowrap="nowrap" style="line-height: 115%"> </td></tr> </table> 1050000 0.35 2342846 0.96 212830 3685 584803 235000

EX-101.SCH 9 hewa-20140331.xsd HEWA-20140331 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Disclosure - Organization and Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Going Concern and Management's Liquidity Plans link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Accrued Expenses and Other Current Liabilities link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Notes Payable link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Stockholders' Deficiency link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Commitments and Contingent Liabilities link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Concentrations link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Stockholders' Deficiency (Tables) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Commitments and Contingent Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Going Concern and Management's Liquidity Plans (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Accrued Expenses and Other Current Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Notes Payable (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Stockholders' Deficiency (Details) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Stockholders' Deficiency (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Stockholders' Deficiency (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Stockholders' Deficiency (Details 3) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Stockholders' Deficiency (Details 4) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Stockholders' Deficiency (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Commitments and Contingent Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Commitments and Contingent Liabilities (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Concentrations (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Related Party Transactions (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 10 hewa-20140331_cal.xml HEWA-20140331_CAL EX-101.DEF 11 hewa-20140331_def.xml HEWA-20140331_DEF EX-101.LAB 12 hewa-20140331_lab.xml HEWA-20140331_LAB Series B Preferred Stock [Member] Equity Components [Axis] Employee Advances Accumulated Deficit Stock Warrants [Member] Award Type [Axis] Vendor 1 [Member] Concentration Risk Type [Axis] Vendor 2 [Member] Customer 2 [Member] Customer 1 [Member] $0.25 - $0.35 [Member] ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRange [Axis] $0.36 - $3.00 [Member] $3.01 - $4.95 [Member] 3.81 - $6.99 [Member] 0.30 - $2.20 [Member] 2.21 - $3.80 [Member] Minimum [Member] Range [Axis] Maximum [Member] Series C Preferred Stock [Member] Convertible Series B Preferred Stock Vendor 3 [Member] 0.25 - $4.95 [Member] Stock Option [Member] Option Indexed to Issuer's Equity, Type [Axis] Loan Agreement [Member] Receivable Type [Axis] Related Party Outstanding [Member] Related Party [Axis] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Is Entity a Well-known Seasoned Issuer Is Entity a Voluntary Filer? Is Entity's Reporting Status Current Entity Filer Category Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] Assets Current assets: Cash Accounts receivable, net of allowance of $59,534 and $250,828 as of March 31, 2014 and December 31, 2013 Inventories - finished goods, net Prepaid expenses and other current assets Total current assets Property and equipment, net of accumulated depreciation of $608,109 and $576,590 as of March 31, 2014 and December 31, 2013 Web development costs, net of accumulated amortization of $24,745 and $14,643 as of March 31, 2014 and December 31, 2013 Total assets Liabilities and Stockholders' Deficiency Current liabilities: Accounts payable - trade Accounts payable - related parties Accrued expenses and other current liabilities Deferred revenue Current portion of equipment lease payable Notes payable and other advances, net of debt discount of $212,830 as of March 31, 2014 Note payable and other advances - related parties Redeemable preferred stock - Series C; par value $0.001 per share; 10,000 designated Series C: 10,000 issued and outstanding as of March 31, 2014 and December 31, 2013 (aggregate liquidation preference of $1,000,000) Total current liabilities Long term liabilities: Notes payable, net of debt discount of $29,133 as of March 31, 2014 and $269,998 as of December 31, 2013 Long term portion of equipment lease payable Total long term liabilities Total liabilities Commitments and contingencies Stockholders' deficiency: Preferred stock - par value $0.001 per share; authorized 1,000,000 shares; issued and outstanding as of March 31, 2014 and December 31, 2013 as follows: Convertible preferred stock - Series A - 200,000 shares designated Series A; 44,443 shares available to be issued; no shares issued and outstanding Convertible preferred stock - Series B - 625,000 shares designated Series B; 451,879 and 422,315 shares issued and outstanding as of March 31, 2014 and December 31, 2013, respectively (aggregate liquidation preference of $4,344,987 and $4,270,257 as of March 31, 2014 and December 31, 2013, respectively) Common stock - par value $0.001 per share; authorized 50,000,000 shares; 27,729,592 and 27,708,303 shares issued and 26,550,380 and 26,529,091 shares outstanding as of March 31, 2014 and December 31, 2013, respectively Additional paid-in capital Employee advances Treasury stock, at cost, 1,179,212 shares as of March 31, 2014 and December 31, 2013 Accumulated deficit Total stockholders' deficiency Total liabilities and stockholders' deficiency Property and equipment, net of accumulated depreciation Web development costs, net of accumulated amortization Current Portion Notes payable and other advances, net of debt discount Redeemable preferred stock Series C, par value Redeemable preferred stock Series C, shares designated Redeemable preferred stock Series C, shares issued Redeemable preferred stock Series C, shares outstanding Redeemable preferred stock Series C, aggregate liquidation preference Current Portion Notes payable, net of debt discount Preferred stock, par value Preferred stock, authorized Preferred stock, shares issued Preferred stock, shares outstanding Series A Convertible preferred stock, shares designated Series A Convertible preferred stock, shares available to be issued Series A Convertible preferred stock, shares issued Series A Convertible preferred stock, shares outstanding Series B Convertible preferred stock, shares designated Series B Convertible preferred stock, shares issued Series B Convertible preferred stock, shares outstanding Series B Convertible preferred stock, aggregate liquidation preference Common stock, par value Common stock, authorized Common stock, shares issued Common stock, shares outstanding Treasury stock, shares Condensed Consolidated Statements Of Operations Net sales Cost of sales Gross profit Operating expenses: Selling, general and administrative expenses Loss from operations Other income (expense): Loss on extinguishment of debt Interest expense Total other expense Net loss Preferred stock: Series B convertible contractual dividends Series B convertible deemed dividends Loss attributable to common stockholders Per share data: Net loss - basic and diluted Series B convertible contractual dividends Series B convertible deemed dividends Net loss attributable to common stockholders - basic and diluted Weighted average number of common shares outstanding - basic and diluted Statement of Cash Flows [Abstract] Cash flows from operating activities Net loss Adjustments to reconcile net loss to net cash used in operating activities: Provision for doubtful accounts Provision for employee advance reserve Depreciation and amortization Stock-based compensation Warrants issued to 2012 private placement investors Loss on extinguishment of notes and accounts payable Imputed value of services contributed Amortization of debt discount Changes in operating assets and liabilities: Accounts receivable Inventories - finished goods Prepaid expenses and other current assets Accounts payable - trade Accounts payable - related parties Accrued expenses and other current liabilities Deferred revenue Net cash used in operating activities Cash flows from investing activities Change in restricted cash Website development costs Net cash (used in) and provided by investing activities Cash flows from financing activities Principal payments on equipment leases payable Proceeds from issuance of notes payable Repayment of notes payable Repayment of convertible notes payable Proceeds from the sale of common stock Proceeds from offering prior to reaching minimum offering amount Net cash provided by financing activities (Net decrease) net increase in cash Cash - beginning of period Cash - end of period Cash paid for: Interest Non-cash investing and financing activities: Issuance of Series B preferred stock for settlement of accrued dividends Cashless exercise of warrants into common stock Warrants issued as debt discount in connection with notes payable Accrual of contractual dividends on Series B convertible preferred stock Deemed dividends on Series B convertible preferred stock Common stock and warrants issued in exchange of notes and accounts payable Conversion of accounts payable to notes payable Organization And Basis Of Presentation Note 1 - Organization and Basis of Presentation Going Concern And Managements Liquidity Plans Note 2 - Going Concern and Management's Liquidity Plans Summary Of Significant Accounting Policies Note 3 - Summary of Significant Accounting Policies Accrued Expenses And Other Current Liabilities Note 4 - Accrued Expenses and Other Current Liabilities Notes Payable Note 5 - Notes Payable Stockholders Deficiency Note 6 - Stockholders' Deficiency Commitments And Contingent Liabilities Note 7 - Commitments and Contingent Liabilities Concentrations EX-101.PRE 13 hewa-20140331_pre.xml HEWA-20140331_PRE EXCEL 14 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0`:,QE5V@$``#$6```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,F%UKPC`4AN\'^P\EM\/& MI)MSP^K%/BXW8>X'9,W1%MLD)-'IOU]:/QC2.63"SHU%FYSW,90'^@Y&JZJ, MEF!=H55*6-PE$:A,RT+-4O(^>>[T2>2\4%*46D%*UN#(:'AY,9BL#;@H[%8N M);GWYIY2E^50"1=K`RK[?9HII4'Y3N^GD&&@T>8 MBD7IHZ=5^'E#8J%T)'K8+*RS4B*,*8M,^$!*ETH>I'2V"7'8V:QQ>6'<5<`@ MM#6AOO-SP';?:S@:6TB(QL+Z%U$%#+HJZ:>V\P^MY_'Q(2V4>CHM,I`Z6U3A M!&)G+`CI<@!?E7%SC2M1J!WWD?QFL:/-A9T9I/Y_S>`3.3@2C@0)QS42CALD M'#TD'+=(./I(..Z0<+`N%A`L1F58E,JP.)5AD2K#8E6&1:L,BU<9%K$R+&;E M6,S*L9B58S$KQV)6CL6L'(M9.1:S*TG?'A$%@?0'[%K.M#=PGAGKT],"#.A+J`E:";,FF3>$[ M_`(``/__`P!02P,$%``&``@````A`+55,"/U````3`(```L`"`)?]=J>*V?5@^@8B)G:13'&HX<85?=WFQ?>*24FV+7^ZBRBXL:NI3\ M(V(T'4\4"_'L)MI< M3_3_MCAQ(DN)T$C@\SS?BG-`Z^N!+I]HJ?B]SCSBIX3A363X8<'%#U1?```` M__\#`%!+`P04``8`"````"$`_GO?E-(!```<%0``&@`(`7AL+U]R96QS+W=O M_%[)K?BL"EJL2UI0]@)88@((EL]X>W MKX40%*F=7J*]1+*C.*/)>KYX9XNOPS[[<#YLFSI7U.NKS-5%4V[K3:[>5L\/ M$Y6%:.O2[IO:Y>KH@EK,[^]F+VYO8WHH5-LV9&F5.N2JBK%]U#H4E3O8T&M: M5Z<[Z\8?;$Q#O]&M+79VXS3W^R/M?ZZAYC=K9LLR5WY9DE'9ZMBF5_^_>+-> M;POWU!3O!U?'7]ZA/QN_"Y5S,2UJ_<;%7%VF@C[=(=-+FI7^0T[R0U;.!,GA MD;`<'D$Y)"V'D!PS$)9C!DC.6%C-&(DA%E9##.5(FT/0'1X*N\-#Y(Z1#D$# M0U"Z='#E2$<@X0A,!!4%!/=1Y?!46LX4R9'F`\2#=.'`NB%Q:Z`W+(U.AN@T MTI%C8.:83FD5*NM=^1I]^ND.:;N>?TQOIM&FDF851!5)JR$HAZ7)R9B"'XJD MK2'H#4O#DB$LN5-87MHUUYRY3)T[.`R/=D8ZA/EWA MUI:F$H92TB_9\+L`6]_T-.??````__\#`%!+`P04``8`"````"$`E8#6&FT# M```\"P``#P```'AL+W=OFWX'A?<,_39-, M-&/4MIE)U*DV>P;88%[V'WNMRO7-_LLM5ZI M5$SP@>V=N;9%>21BQC<#^]?JVY<+VU*:\)BD@M.!?:#*OAE^_G2]$_+E68@7 M"P2X&MB)UMLKQU%10C.BSL268J&6*]91"QDS3>&#W(10[6KL@\^UMSE*X>QFX@>T,JR(7THKIFN2I7D%Y1W7PR^_Y M_KEYTECQR.A.O2\RH;5_8CP6._,H6'NHH@`2V!6WGEBL$[CONFYU[0=EFT0? M+X*\@_0+!^$]Q='B17E'1T+8J7#*-=.'\(Z7[C,!6VA'Q+5%,A6(=+B1T!"H) MRQ1DX)J^"^BK<"QX1"4O=!X()QM`BFL58IESE,W79C;+/,N(/)C7+]F&,^@) MPG4XBB*17#9E9D+# MV@4YD.>4XE67:)7G-I$I'&T*KAA$(-#";/`0GTH&.JUWIM6D66,5U: M9[`'6S78"U:&]XQ@G1KT;5[-=G`MRR&"UV',O1:@/\W<`?L61$*WK23ABD3% M(,(:F'&OA>Z$--6*K"&9&F'UYQ0AA'OTWR MO]OY31'K8!K]-M:=.C6K,8WEOS">M1]!5)98P[A:J[1G&T3\9ZS(C ML/=]\VLXMKCNS@C\K83Z>(0&+:Z[&P1[%&"N(6A0U"V$/0HPUQ"TA/`P;O*( M*@LPUA`T=#X>SD83Z?1KA158.X5]\(45D32"3S]S,-].A7W.\<-W^!<``/__ M`P!02P,$%``&``@````A`#?M>S7'!```TA$``!@```!X;"]W;W)KENOHUZ,SJ9W9OL33:;_7A&;)4, MT`9PG/GW6TWQU8UR]65&\'#Z]*GJ*LKEM\\L-3YX428B7YET3DR#Y['8)_EQ M9?[S]]LL,(VRBO)]E(J>%997Q MB6=1.1=GGL,W!U%D4067Q=$JSP6/]O5#66HQ0CPKBY+<1(9%\0B'.!R2F+^* M^)+QO$*2@J=1!?K+4W(N6[8L?H0NBXKWRWD6B^P,%+LD3:JOFM0TLGCQ_9B+ M(MJEL.]/ZD1QRUU?C.BS)"Y$*0[5'.@L%#K>7(\51!N%W8D-[;8?[WR,@9'@6;.7,D4BQ0$P%\C M2V1J@"/19_W_FNRKT\JTO;GK$YL"W-CQLGI+)*5IQ)>R$ME_"*(-%9*PAL0& M]U!&M]5[.X4M2I(7 MR;(R(=OA\1+"\[$.G:7U`8[<SAE`5L6T1,A"@KI,(^QY*O.UYJT2"I1(9 M`REM@S>`NY/&M'7'B-#M((H2,&BHI#5K6I%\:&4Z`P&AU]&C1H1`)G0:-?>V M4PA%(JPSE#@M38(AWH-U0U^3AI"PCBGUJ1=ZNK0A@CDD#&F_/44:[.]Q:1*L M20LT:0CQ:VF^31VB`;9#`&6V2]T[RKQGE$FPIBS4E"$$E86!ZP[6K0.^'0(H M]1W?(QV%XIG_C#()5C.-DIX74PTQX,S=5)M"*-ID<[M1.J933CZDND>)5@@V MB$'[**.^YVF([1#![""DQ+[M7ZAJG-8FP;HVK5AL$(/:9LQFE/2U`F.K($"^ M8SMWQ%$HM$,'I]75:#V\/3.&MP%-Q7<2H@28RHH\B/!/]&']'E832K1BL:DI M5Z:BKS^4:&"#:3WV0Q8.TEA5^%1OH%CI585:^#8-J%G=MUU[I`]I6@2%TG([ M^:BLVH_[)]%Z^FEK;VK*E=FN?4L=TK3N!9Y#[NI[JEG0<;>@1&\7#:A9W2:N MY^AG5X4XQ`]LK]^F&EY9P0<&/M9PY8O9R$BM-VP:4&NDX]M:I=RJ""\,G!ZA MJGRJ?=!Q_Z!$;R`-:/J8#)O(C+HV\UE?K52%6AMYT$?L!,IQH;T'3<%!$+X@ MS.R`V/XHX`K$]0(2LCXZJ?T!L-A?8A:@Q$$%1E^=H$W.]'6X;FA[![AP7IO63Q$^5)QCCW52VJTKDD_)`U(B6SO#(:VP?3>]>FARM,:R8/6W6@HM&\& MC74(ZB6,`LQTQ*#EJ"JUAO*@RAN-A>J-&:9G632Q'C+/=;S`UE)53M@]!EZF M21B$/0:5X@B-(V;&BR/?\C0MC5A@)',?,J#`F1PO*G&N!]N=J&"6KC^>X+<3#N,@F0/X M($357LAAL_LU9OT_````__\#`%!+`P04``8`"````"$`@,M$:`+JN#-$==EVL)C?5*:2XW20U>I+!1= M59=*F>:53!56]2,:^'C,,^3C[*U$54M%:E2D+<3?G/-+,ZB5V2-R95J_OEV^ M9;B\@,0^+_+VLQ.5I3);):<*U^F^@'Y_:&::#=K=PYU\F6'''I`;)=J=-S(+]HJT719V:X[@W[EZ-J,_I>:,[Y&=7[XD5<( MW(9Q(B.PQ_B5H,F!%$%EY:YVV(W`W[5T0,?TK6C_P=<8Y:=S"\-M08](QU:' M3Q\U&3@*,@O=(DH9+B``^)7*G$P-<"3]Z/Y>\T-[WLC&BHKHO8@!T??O]:=%S%X$FNU%='.A.Y9F+9$9=FKV#<5 M0U^8NF4[SW0(5D?GBGM3T?6'8U&HQ=V(^6F;;M^-1QKK;S#),EZQKMG-);8#029$436 MYPL"OB#D"R):`+^W2#1MR;83#Y5&#$LD`T%F.1AU9.9.%A$$3>T<@N^IP1H4,.^UA<%-LE#8 M0B0D8B&1S!&,Q_"I''M,/D<&G#_F-UI2B?>:^[9XE($X?CNAA81/";>S6E]R M"R(8O[54T[:Y?2$4-A`)B7C1YHTDEWFCN MP^%19LYH(>$+B4!(A$(B$A(Q)>CNHYGVTK"YWB9S&HS?Y&[#G;/$$YM4XOWF M!MRCS)S?0L*G!.VGL>1/;H%0(!02D9"(QT%8CNFH7$^3.0G&:SC'/N\UJ<1[ M_;5VNO.H1YDYKX6$3PGJM>6HELX=\`*A1"@D(B$1"XEDCF#LAH\/X_?\9MW1 MO-&7CLF=>P)Q.Z$8B<1(S(3BN'!KY\ZYR:P( MZS>YS#SN-[WZL'YS9R\/V5,ZHG0CP>V!FQ`(Q$HJ12(S$8H0D MG4B'I\.E;M.D$DU1E*@^H1TJBD;*\!M)&%EP]KJ5WI)9+P:Y8W/EGK:"[,!] M>4R27Q/EGK[RIG1V^@JNDR01<&L`0I>K^/4-6$D%J0UT`?,2X'1Y(`[<\Y_9_````__\#`%!+`P04 M``8`"````"$`S%18Z>(#``"<#P``&0```'AL+W=OWEVP$FL`D;8;=J_ MW[%-`>-<2/O0).V9,S-GQB=X>?M:Y,X+J3EEY\)$0XPE'SE[H6H%K[/TSTI,/=814KX MSY;5!1;PL=[YO*H)SE10D?LH"&9^@6GI:H9%/8:#;;JYN4%150;&A.Q9LB=9TB77S;E:S&FQSZ?@TG.'WG M5A\L^H*F->-L*SR@\W6A=L^)G_C`M%YF%#J0LCLUV:[68*C0=7J9XY9757>O,2!LBYFT"",ST(S/+,%F M9C0+6UZ=66/F2I$P">1/BS`R3\S,XU27068%T3QI^74%&M/O/9K.6HQ1`X#Z MW8^K008-:I@.:]"8,%`RP(GH-L/(/S/SGY^[!)MYT:R;JNY=8T:H/SD4-IJC7 M'GG)J1*N\KO0-CQ[\1N0G@)\IYR>PL#Q1D[!MCY[]4,-NMS^P/K.+W]XQ//B M[GM$G[H&U%^`$^LOO[/'GSR%-K?//@`-J-'^M..'`[L;*;WM>T<.@`;U^X_B MZ+CIAQ_R/A5E*A'9!\!POXF73$^4<)7]A;;_'3D`&G1Y"`/_&SD$VPB/[+\& M-?M_NGLT,,+S^Z_0`^'C;KGU_C>@_OP[B&%_:&!_%Y+;MF?OOZ)H\'I@8?\D!TQ`.M$]"`FAT(O*1S*K.$JSP0 MV1YHGX`&U(P!3"!(\<@HP9CL!Y_Y&4&0&W_PP<_?;_2UX\*[\@/7.]H MR9V<;.%1/?#F$%_KVY7^(%BEKAD;)N!6I-[NX19,X`X2>`#>,B;>/\C[6WNO M7O\'``#__P,`4$L#!!0`!@`(````(0#6PS9?NP,``$4-```9````>&PO=V]R M:W-H965TU"J7OJ^3`^LI-+C-:O@FQT7)55P*_:^K`6C6;.H+/PH".9^2?/*18:EF,+! M=[L\9<\\/9:L4D@B6$$5Q"\/>2W/;&4ZA:ZDXO58WZ6\K(%BFQ>Y^FA(7:=, ME]_V%1=T6X#O]W!&TS-WU[X"Q^8-JLL!P7$]YI@YKE\R].`E("'!GRZ1ZR36EZZ1'J7CY&T%A2X4D44L" MUY8D(MXLBI/["2P^1M08?*:*;E:"GQSH&M"4-=4]&"Z!^>P,XS!>+UD%CYKD M4;.L76AW<"&A/F\;D@0K_PURFK:8)\3`N\&$!N%#-"8D"*,?TN=)/BMKL%;6 M2=>A/.&#ODSTN0RY14:#U^ZL%SQ)NO!1&3%04&-P]KDRT/0-ZIP3Z,GK1O4B MP/78R>S>\&,$B$F:`D1D%MW/Y@9AI1B"[$=P75F#;>4H2@PO*B,&E<,X@)"B\,+PHC!@KZ1<\)[=(:_!`FG264!HQ4Z3U[T!ODUU/MP8/I;M& M0FG$M(6.KA1Z82M/:S6]:-CLW2;""!!CF3>5L2H>0F?WS4\+H5EE9X'$PPW7 M@N"B)T[@+2Y4/M2C9W+^&[0M/>[W%F2D27S!_4W#+,3AU=_D433L^!9DI?Z2 M<3V2IAO'`6:ICYH^1-`D]<&I7=]]&<#"-`D.7?0.P@!K-N8A#CH4?B41#CJ4>2#F2',9A[$\,8#T`2=SW> M5F,\`H.VQP]).F:TWH(LZQT&$X^G63SLE4SLV1=6%-))^5&?5$.8 MF>:I.44_1LTYV'P!A]B:[MEW*O9Y)9V"[6!IX"4@+/`8C#>*U\U1&ULE%5=;]HP M%'V?M/\0^9U\D@00H2JTW2IUTC3MX]DX3F(UCB/;E/;?[SJ&C(2Q41X@MH_/ M/??TM(&30DB.-2QEZ:E64IQWEWCM MA;Z?>!RS!EF&A;R&0Q0%(_1.D!VGC;8DDM98@WY5L58=V3BYAHYC^;QK)T3P M%BBVK&;ZK2-%#B>+Q[(1$F]KR/LUF&)RY.X69_2<$2F4*+0+=)X5>I[SW)M[ MP+1:Y@PR,+8[DA89N@T6FQ1YJV7GST]&]^KDV5&5V'^2+']B#06SH4RF`%LA MG@WT,3=;<-D[N_W0%>"K='):X%VMOXG]9\K*2D.U8TC(Y+7(W^ZH(F`HT+AA M;)B(J$$`?#NA&Z=^%$#0_Y!X5E&7X!W6>+648N]`TT!(U6+3@L$"B(^9 M61E]KI=2A1P-R:UAR1!T.R2AH#POJRA)E]X+>$H.F/4Y)A@B-D>$*07(ZS5" MXJ<:_^[Z48H!&RFF"D;;VFX`=Z\M',4]1\SC'C)0`@Y=K\2`,S0]"1PELY[7 MBK,8*%\O;CI$;/Z%&&B#0-=K,V#HPI.XX72LS6+2M*MGX*;1?/"YGXQ]'%R8 MN3-_\(GO)U&?VT`YI'^]<@,>*Y_WO-95BSDH]X>'FPN'`T7)>Q09\$A1/`JZ MMI@_7HY;?W2>3"]8E;Y'F`&/A8T"KRT&/.D;,$I&=L)D-3R7,-8X.SOM:.%4 MEG1#ZUHY1.S,7`RAA_K=?F3?AN9?.MI?PRCOYI[7'\`H;7%)OV!9LD8Y-2V` MTG?-Z)1V&-N%%FTWT+9"PPSM'BMX9U*8`KX+X$((?5R8&=._A5>_`0``__\# M`%!+`P04``8`"````"$`+P6E]70$``"S$@``&0```'AL+W=O[,1[M"G9 MMFKV*_^_?^^_S'ROZXMF6QQ90U?^*^W\K^O??UN>6?O8'2CM/G M11AVY8'611>P$VW@FQUKZZ*'RW8?=J>6%EL15!]#'$5I6!=5X\L,B]8E!]OM MJI+>L?*IIDTOD[3T6/3`OSM4I^XM6UVZI*N+]O'I]*5D]0E2/%3'JG\527VO M+A??]PUKBX\SR<_:;4_]%#N!%;$%[;8OM[1K@1%(4V`$YZI M9$<@`*]>7?'6`$6*%_%^KK;]8>63-$BRB""`>P^TZ^\KGM+WRJ>N9_4O"4(J ME4R"51)X5TDP"6*<9+./9"$J"[RK+`@'>):@)'V?2RC7)62Z*_IBO6S9V8/> M`^;=J>"=C!:0F>M#0.5I?4`8'O.-!XE00'=0U.\O;:+Q@V6.5;Q=80[6>>'8:*Z-Q,@*(S*?Q5DR*".8YQ(!KX.^5[1+ M=6YN%>9!.D>2&CVVD9A!N\SH@%Q^[\`PTQG>5H^#369(UV8C,=-WENK=0FB5 MY4XZVF!N<^-@G9L]NQ+S5EDRCR-#UUPBIMEKW.8Z-[?*\B"=HSV[$C-F0%*C M0W,;,_HRUR!1^OZQIGPU=NEQU)*X#= M;)A%>Z(52!8^R4B&S8E6"!=ZAJ,X2FI;BSW42((&2W>>'23- M8"PB28DQV`HT?7,YV3*;)M)_9PBY0K7Q8Y2[+,,F:%F%Z!3@\P M8_D(SO13%H,F/":Q)EPS&1)@HR-R ME66\E&LL/V0SR/:9B9F6(#73T52YG8T&&4[C6&[;H;#.);;=AI[IN'4@6_A@XAVJ27@ M%DMY["!_3Y^*/?U1M/NJZ;PCW,=8_W;!CS6&XZ;U_P```/__`P!02P,$%``&``@````A`.L.6]*T M`P``S0P``!D```!X;"]W;W)K&ULE%==CYLZ$'V_ M4O\#XGWYL"'91$FJW:ZVK70K554_GAUP$K2`$78VN_^^8X88#)LM>4D".3YS MSLQX,*N/+T7N//-:9J)'/K.E*Q,F6Y*/G:?>72 M_;CY\-_J).HG>>!<."E0I*:YTR!?GG(*GEF*Y(I=`6K MGX[532**"BBV69ZIUX;4=8ID^75?BIIM<_#]$D8L.7,W%R/Z(DMJ(<5.>4#G MH]"QYX6_\(%ILTHS<*#3[M1\MW;OPN5]N'#]S:I)T.^,GV3OMR,/XO2YSM+_ MLY)#MJ%.N@);(9XT]&NJ;\%B?[3ZL:G`]]I)^8X=<_5#G+[P;']04.X8'&EC MR_3U@YLN52/ MF:9TG>0HE2C^("ALJ9"$M"3PW9(0ZD4DGM].8/%146/P@2FV6=7BY$#70$Q9 M,=V#X1*8S\Y0A_%ZR2IXU"1WFF7M0KN#"PGU>=[0:+;RGR&G28NY1PQ\&DQH M$#ZH,9)`1E_2VTD^1]9@'5DG74NYQQO],.3M,/2:,!J\=J.>>!K-#2]&1@P4 MU!B,#,(R"#1]@SKG%'KR?:-Z$>!Z[#2Z-?RH`#'SI@`DCF@8!P9A*0"1?07O M1]9@.S(A0^^(L;QW];="SZX)K<'#T`MC"4TC9DKH^36A-7@0FG;9Q-"(P7S? MD$40=`#+LWX.]#;9^^G68#LPC8:>$7,N=!A=+/3BFL@:;$%>BCU$O!^ZS7H00>08>^U MH$G1!Y/N']''(XZ,MER(H#;MU",7IKM^//>-3ZR\7F4G@,9=A+;R".HJ?RGW M5XVZ\(U9-]I]+05;Y#<06,1A[ M$T6\,?_BD0@$]470N!M5MHS!#)PH8SP,:=R-NC87"+)E#+L!3Y5XZ"IXO>>? M>)Y+)Q%'?6(,87R8N^8T>T>:\ZCY`PZ3%=OS;ZS>9Z5T&PO=V]R:W-H965TF\<*6%K)=NZ`6NP^M<%J+>+=V?/Y[N M[EU'&U87K)0U7[IO7+N?5G_^L3A*]:SWG!L''&J]=/?&-'/?U_F>5TQ[LN$U MC&REJIB!2[7S=:,X*]J'JM*/@F#J5TS4+CG,U1@/N=V*G#_*_%#QVI")XB4S MP*_WHM$GMRH?8U+W=Y`NB>P(ES8O'A[Y#J'B(*-%TW0*95G%<;+P7R"D M>:?)+C7A4+$^*3`3@-+K'DO%>FDEPQ( M($+C25`,B3Z;.(RFO2_!D29M0S9)@OA]WG9\?3Z>)/$T[I\?<"6W<*%XR!7; M\V:D@;W9!\U*Y_HCQ8`-3,;'#,4VFQTSTLS:F,T"_/1!H:"1`+ZOP`_0IK>@ MH=A&FPUGSDA#:.$U-!*,0)O=@H9B&^W>0B/-K`N;EZ2#S^RO._NMH`=&H.(A M=U9"/GX]46RCIA8J:4Y1G%S),"E&L*6WL*'88DNLO961)@S:W1=X]HNSIO$1 M9&!Q0]A:M-_O!Z!):]B.?V5J M)VKME'P+EH$W@[`I:O/HPLBF[94VTD![UO[=0SO.H<$(/!!OI32G"YR@;_!7 M_P$``/__`P!02P,$%``&``@````A`/CB";5P`@``_P4``!D```!X;"]W;W)K M&ULE%1;;]HP&'V?M/]@^;UQ+I``(E2MJFZ5-FF: M=GDVCD.LQG%DF]N_WV<;`I2IHB\DYCO?.>>[.//[G6S1AFLC5%?B)(HQXAU3 ME>A6)?[]Z_EN@I&QM*MHJSI>XCTW^'[Q^=-\J_2K:3BW"!@Z4^+&VGY&B&$- ME]1$JN<=1&JE);5PU"MB>LUIY9-D2](XSHFDHL.!8:9OX5!U+1A_4FPM>6<# MB>8MM>#?-*(W1S;);J&35+^N^SNF9`\42]$*N_>D&$DV>UEU2M-E"W7ODA%E M1VY_N**7@FEE5&TCH"/!Z'7-4S(EP+285P(J<&U'FM2!)TEM)2##DZWNBEB[F6FT1 M[`Q(FIZZ#4QF0.P*RZ`]_R\,*G(Y#R[)IP+:P#`VBVPZG9,-=)`=,(_7F'1` M$!`?'(#JQQVXI!*/,!HG49QH0F=N%W3 M@<\T\S>:(7S0'&7%6?,O-/./:#JPTSP-#*IY(QPPH;]97A23D[,@'.YPV/&> MKOAWJE>B,ZCE->Q!'!5@78<;'`Y6]7Z7E\K"S?.O#7QH.2QZ'`&X5LH>#^X; M,7RZ%_\```#__P,`4$L#!!0`!@`(````(0#[9W?N.`,``$P*```9````>&PO M=V]R:W-H965T?W[E@L[A[KDKGB4G%11T3 M?^01A]6IR'B]C(@\ MYRE+1+JK6*W11+*2:N!7!6_4T:U*/V)74?FX:VY2435@L>$EUR^M*7&J=/YM M6PM)-R7D_>Q/:'KT;B\N["N>2J%$KD=@YR+H9O21,I5!0L!D%4^.4BA(`X-.IN)D, M*`A];K_W/--%3,:ST33TQC[(G0U3^H$;2^*D.Z5%]0]%_L$*38*#R1CH#_'@ M:I/)P02^3R;![=2?SMY'<3&MMDH)U72YD&+OP.0!N&JHF6-_#L['\F`R7<'> MJA<4RIC<&Y>8P",#I5#0XZ?EQ/,7[A,T)CUH5I<:2[$^*DP7C&V""VTM7>#M MH*&>Y]"O]_+(9L2&[>BZP@7P[F"#/NKZ4A%-^Y+D4A)$G:0'"TT_AS45'L,8 M#T.;FV("#>D8)YY%N4(-3.%)TQ&T]5N_JTB&%+TL`.4\BV%Z(X8LS\F\<9]M MA9JH'1;?FX7V,&!$+MD2-%C!Y./LQNQS3ZQV%$3OLF.8(!Q;\37&A]B' M%#UV<_R?[8O#\V[$-GMHL:,&ZSX9AYXU4VN,#['W'&#//SGTR*-KR(W8)K^U MR%^HD"L[V.=QE>O%IZ)_V0=S%,?YZ9DB.IS>>2Q636[9F9:F<5.S,R1Q` MO[O5[J7A/C`[NK6^\N=PBL"ZVP7@,&_HEOV@2,0YT+HXX7Y@^X]&PO=V]R:W-H965TV3K-`CUT:H.L51$&+$:Z8R41KCA^51Z;TI.;<(&&J3XM+:9D&(8267U`2JX36LY$I+:F&H"V(: MS6G6;I(5B<-P0B05-?8,"WT-A\ISP?B=8@?):^M)-*^H!?VF%(TYLTEV#9VD M>G]H;IB2#5#L1"7L#"WHIF%9&Y38`.N*% M7GJ>DSD!IM4R$^#`Q8XTSU.\CA;;"2:K99O/+\&/YM5_9$IU_*1%]D74',*& M,KD"[)3:.^A#YJ9@,[G8?=\6X)M&&<_IH;+?U?$S%T5IH=H)&'*^%MGS'3<, M`@6:($X<$U,5"(!O)(6[&1`(?6I_CR*S98I'43!+DO%D-@6:'3?V7CA.C-C! M6"5_>U1TXO(L\8EE!/)/ZW&03,-1!(?^AX1X1:W!.VKI:JG5$<&E@2--0]T5 MC!9`?';F971>_V45/#J2M6-),=QV,&&@/(^K<3A?DD?(E)TPFTM,U$=LSPA7 M"I#7:03CKS7^/?6S%`=V4EP5G+:-GP#N3EL\./<2,4\Z2$$)'2]$@>&2K\Z M>!R%':\7YS%0OD[*AR4+R-Q[R5X%N(GK;)>[0Y\%#;,$&/Z1*,)ETF/K+A M^LM^K\LW)/^\2JX+ON5591!3!]=L8BA,-]OUP77LKOY@?@/]L6TFI%N`_M30 M@G^ENA"U017/@3(,7#_2OL/Y@55-VR5VRD)C:O^6\"+B\&C!G<`H5\J>!^[! M[5YMJS\```#__P,`4$L#!!0`!@`(````(0!6,1^20`8```D:```8````>&PO M=V]R:W-H965T&ULG)G;;MLX$(;O%]AW,'0?6R0E2@KB%)6* M[BZP"RP6>[A6;#D6:EN&I#3MV^]0PYBY'$]<_1QYGA_++\\.';?C?[ M6K5=W1R6@9B'P:PZK)IU?7A>!O_\_?DN#69=7Q[6Y:XY5,O@>]4%'QY__NGA MM6F_=-NJZF<0X=`M@VW?'^\7BVZUK?9E-V^.U0'>V33MONSA9?N\Z(YM5:Z' M1?O=0H:A7NS+^A!@A/OVEAC-9E.OJD_-ZF5?'7H,TE:[L@?^;EL?N[=H^]4M MX?9E^^7E>+=J]D<(\53OZO[[$#28[5?WOST?FK9\VL&^OXFH7+W%'EZ,PN_K M5=MTS::?0[@%@H[WG"VR!41Z?%C7L`.3]EE;;9;!1W%?*!TL'A^&!/U;5Z^= M]_>LVS:OO[3U^O?Z4$&VH4ZF`D]-\\5(?UN;_X+%B]'JST,%_FQGZVI3ONSZ MOYK77ZOZ>=M#N6/8D=G8_?K[IZI;048AS%S&)M*JV0$`_)SM:],:D)'RV_#[ MM5[WVV6@]#Q.0B5`/GNJNOYS;4(&L]5+US?[_U`D;"@,(FT0^&V#"/GN(,H& M@=\NB$QC$>OK*`OL,6@_`NV-I&EG<0V23'@5)GDX/Y,6L M^6@6#4M!W4%-OS[*]&'Q%N$<)=F0TSA+0X9>^._K M)(D<.,&"[?M8IJK1V:9_JZI9Q/`DPT-),N`E4:(3^G[AOZ_"1`JW/\('+#[? MY8H:,>-2]+HY2I!+1EK$[KI#R0LB2!+E)9:`:0IVVW$PBQB@JPNV'$H0,`JU M8(DM_/?C3$1N@P0OH7B7\V;$#"MF>4.)Q9)"\:-2^()$")6Y,PGKN#A M;(=I<)JPRLUVBX<:.)@GC2N=Q;LDH7COL@B!X]T?Q!%+36XUF#V92:TUVT%! M)$J)$/Z=VI?BF;'M'8\KV<,A3_#8/,L%:A`O2:'Q3U>VN?,%J=*9BT#1S,CV MT&Z;>`('/4%D(RVW&D2,(A$GH_KZ=J&E"&,7@T*:\>U!7LD?#GL"Y^:I[3[? M$)(T&1\-7Y#%278.[8<<0XPM@P^.W&HP?W$*'Z4NWU0S`D/N>%6=&PB$9_1PC<)F,`9VT=Q M04`1)UPDNVIS8FPCT6A8^S8Q3!)OEMA47I(03/DN+QG4U$LB-NIRJ[&]**(T M%;S25"*C*(O/]*-\EY<,:GI#'[-KYU9#NHP=EHL2FCWF);<=%SGV%'X3FEL- M9C$)T]'M,Q%$<),:GIDZTDQW;R#>-K6'5;32WL3%P6@UR)A%J78$V(9$(,(L MTVZLTSPR9[D\M.784;S^L6R^7P@=)Y+U:6&CV#Y5`'=FV)A/S'X"K\"A&?B. M$KM=6SC4O%U:1#&_Y2F&BRX#*TG2*!-N`S1WS%6NX(W=)&8C+I>H(4?$Y<:6 M]J*&`DYXRO4;?HEN`&4\N4',('*K(:#\+$^8RDE",2<\Y0;,L:?$W%,D:@@F MVTIQ64-!)YQ%*(A^I?)C:XFYM4C4Q,.']H@?^(*^+=UQ)WS&B/WS8@;.=><; M5K&!XSH>SXW5X*&0\-'7./%`5X6ATVT"64*9" MA5J?:T0XMOY9N5)GHV8YY-YB!@%H[-4AA2+FMV@%TR@=0S],3T5XWDX`;[M[ M&%8Q4-9NN=7@\TLQ^##?'Q,?2R?JS_*]KD^=+-=M8&Q$\X32$>+ MC_+Q1=\`(:-/^^QTS;L!#XB;)1=/4KZ>/9^QYB1??WLN]]9;732&JI6-_6_W\T^(HZI=FE^>M!1&J9FGOVO8P M=YPFV^5EVDS$(:]@9"/J,FWA8[UUFD.=I^MN4KEWN.O.G#(M*ALCS.MK8HC- MILCR1Y&]EGG58I`ZWZ[XM!\1BNS:\*5:?WR>GC(1'F`$,_%OF@_NJ"V M56;S']M*U.GS'M;]SJ9I]AF[^S`*7Q99+1JQ:2<0SD'0\9HC)W(@TFJQ+F`% M,NU6G6^6]G)'2 M'VOY)YCLC&8_=17XL[;6^29]W;=_B>-O>;'=M5!N'U8D%S9??SSF3089A3`3 M[LM(F=@#`/RTRD)N#DS;=+6HQ=&"K0?@ MS2&5&YG-(;),CP=)/I\>R(N<\UU.ZJ:"NH&:OJUFLX7S!F7(E"0>2[BN2,XH MHI/$`;P3(Z1MR&AFD^*E/;6M$YOGGL)V^#%*H'PGR517)":%A@8I&Z)=ESXY M"=(\^/^S0`>(41)A;MV0N7UJNC4D0X$?S/RH7Z0&"(FX'5!.(H`A`41)T`'R M:3#U]?%D.,ZFLZEW&M?PH`A#/'-II9B4EJ0E1HFIM":%AC;3T:XKK9Q$,D<1 M4:(RQWA(MV>"`FT-_>G2$(-[$.4D'3'H]PX>$)3X77'9+P]][7#O71S6X*2# MWMQ9Y"0"QTX[!^%0@OEC+KST\>3RN(87W8,G)Q$\TM9BE%S&NSRNX3%HPK>G MKYM%`$GU8J6Y3&@0Z(CW>0?V_6'W"TC[C1EJ!HBC*ALE.N9-]L'&_N&3'18K MC79"R28T2G0\V60G)+I@%D51W^5U1N(BYC;- ML/?#SY._!GT#PT.L-,848ICS$AT/-,,4?H$GU>2,4/N53XB@@9,@'V[.M$"# M0$-VGT^ M"P/2BA)=P;G'^H7JD,0_KH0<^TA(?41^,0.$E)'X:C! M+YM3;SJ-Z#H27<(#E_O]4O5*XT"G/F^ZU'/3JB&1^Y@H3H@<1)S!N'>D3X)1OW*L<1* M@X",!1%G-(%&">+A]21>O!W2;?Y'6F^+JK'V^0:>D=U)`%V@QLM)_-"*0W?! M]BQ:N%3L?MW!)7(.MV_N!,0;(=K/#_+Z\W0MO?H?``#__P,`4$L#!!0`!@`( M````(0!$_>0>>3,``$JG```4````>&PO?7?_]O7=3TMF#NJ?__L9CJ]^^U77]6]F^JVK#?&=]6(;Z[&D]MRRI^3ZZ_J MNTE5]NN;JIK>#K_:VMS<^^JV'(R>%;WQ;#1EWVYW_UDQ&PW^,JN.W4<[?/+J MZWKPZNOIJS?CWNRV&DT+X"C>CJ:#Z7WQ?N0V`.ZOOYJ^^OHK#77#MXOOQJ/I M3?CGF_R M/_N[.P?=[?RK>*2+^[LV)-W-]7]=.N.LF@S&PGB_>%-.6Y./H$G?Z/)N6%[G MJSR_*H=U:\[Q;#+A,,6[0=WC0'^JRLG2]9^OKW>WUK>[^S]UBO,;.*LN3F=3$UT`S:&(3.'IX"G]#D%K0?S\ M7UL4R*<;&1=/7B1EQZG+]]4_"O\],/[]\<7?#'ZZ,/1R?';XOS;]^^ MO3@O7GQ__J98>]D"O>I%^6TQ>V"OLJZK:?W;?.YQ6=_DGQWU3`G5Q:3J58-/ MY>6PZA2C:EJ,KPJ(,/YSL;N^8$EK;VMWL'&P=%&6MK]`IO9NH M5&S$&U:[O82$7M6T0'T_^E2-IN/)`$JM%U>#T0#]V"^NQ^-^;0#D@)Y-JKMR MT"^JGU&P-;.D#:ERQ\XG7HRGB-KJ,6<3U/8$O:I%J[_,!G<2[`81 M/33P;`B[]HM^A3;O#U?`8=#VV*4!CX;#LK+ MP7`PA8@M9HN,=5?>BZN@,DJ\WU*)"\9-*H?JNY+SM74(,R8S*+&"$Q+`%/E*]\,I["EN&X#7N6_4\2HH:( M_>IR6O0Q`;+UQD-;W:W.P?9BMLFW>?[+WW_Y>_ZA]EZQ-1;44*G//L80<[?AW;#$I/I7#656L;6YL;G8+Q*:HI7!_5W0W.YAAF+<> M7(],5L*\WX;O!K)-?2>ZC7I^`I<6+\KKZTEUS?+%$']IT'?L[V#&=W.ZJBM( M])^6_IS7!BOXY,,8`S>M)K?LLYS+YV@>]<4"`A]VNMLKQ'%M:^^PD;"=%V-9>#:JNMXC'%"]:P4AB/D`E?>6-X$H%[` M^4>_*W9V.CLH8C^D_%0.AB9ETW%Q6?ES_*X8C<.(Q2=KX_T1(+X&Q+VMW=4@ MO@;$W6[G8-]9L)VMKM,!)NW^D>*[T]D&;8<'^\Z6 M[72V]C<[6[O\^6A_8W[?EAKP'F-0<(_D0[P>KUW=\/Q?545P6#E`RX(8^L9,8*AK5.44_-..LAG=_^P@Q$+ M!WD\G?(],.Z)JW4UZ`VF^1"GE`R&F_&P3_3^'-'34-1.*T1HJ3##_6-G/])7 M/\,`$G-7TP%AWIGY^;_,0\Q7"7[.F9Q(_)R3+_)>\E57N!'!&>@T M3L07S6XIVU^SBI/.7[-"(K-?M,Q#_DR^Z$JZ+?9`\B7.Y=8M$)V6#Y\9[!64 M:XULK'>^>VNH)^AB4BP;O0+MGM&.BA5VO!,T5>.MYG`^:9G%=OU7+;D8'T^" MZF$DO?Z/0=+CEEEYHLWMR<5Z]%\!/R!RVU=TY6E2"F4Q#'`-C0/(:R?ZLD M%3D,N;)QXW+$"5Z` M#18F[/I_GM4^24#82_IT3'Z`3-/(,US!I_IW3XM3$>H71"E>?N96;A$5E_K3 M0-4[@OE)T1_/+J=7,P369[5SNLX/K[*`!\CJ:O*IE1)\DZ9\%;FEF==\"W.N MUN$P3@%ME:PV+9"/H_RE"ED=4AF@@&+!%EJ+++R2><.2%#I1!;CXA%R/)RWI M6JX@1N;,&Z@AO[\D:?G^]DX"X)-Z4JA@8$"V4L+N1+`M'D=9YGDNWY4?]/BF M)"'$.>=(:A4*$\%5Z;68'&ZJ$_GRJPH)^5B)]8,\ED_*.=Z1`XV\@N/=F75D MJ>3)H"<4:^=\<6*Y&N.*1L\R_OG`"/H++Q\O#7G8.*G>?G%Y[_GD`<`R\:7P M0FYZ]9RS":9J<&<)A'MGLV650I7$)<5CXCL'')'K557?JPNY@*&B-$HCSGP: M1<;2-I.1?_S(U$*MG#4/%@;9/`EM%A2R@J0:&9_:JGC$SUTI0G1+*_Q'6+6,WX&-M' M<7XT$HR<%1>%$G<.E1^)05\^)K@;^=R3\6A=NZ?I[HY'3KER"%0]E8/6NI0Z#RXD#6N437I#:C@,.MSU+^4(5<2/=?4)+?F M%)XA?#P:*3&]62"W]XV__"WK<,>H??_O?+_$6F/_] MQOD&9:F>"ZP^#2;FA4^J*<6%X@Y/\K;LD6MGZ@\?SVR:X+ZQMIN>]JW6I>40 MA@:$Z0WIW)K(IRXN<4SZQ8C6':.^14'XRW!?W9L,[HS+^Y/9-:#4Q6>F6%X> MSW8=@%D9FN**:_O3BV/;'G]?F5&%9/U9C[:HXH*CQ7/].S2\_+,K$NB$""2U MD4^#ZG.P;";;DIGD$'XQ.2KUC,,8."41S&=@J*G>4_*DGE#VLUJ\F M)+B]MIV8>EMP*DX/Y,5*J`6G,`+74=>(Q``C94%WUW!]/"$UW5`#JNYNJIE, M16+^$&V_'RFP=L$P\]A6G[Y1E(G+(.B.ZKG&&M/DLQ.G" MAP^YA9D8^.3IR/"E-/A"K#&Z#?0"X0=/9ME$<&2#L M.[SO"#?WN/A2-XSJ#6=]4`#SL;[0EDPT5*K`3C0[@T9P`MZ*#H>;I/TM6BA' M(W'4(KQLT&MFBX[O,.2H8_:X+4=$;D(;R<,9#2\)&E-PRB3:>2$*0$XSMR,P MQ3HC=08.`:E'VXJ^@`=NZY?%YYL!BSJMP"28!W@Q*A@N]64)6V5Q50[@*<=V MINS"Z9]"=(\P+W[+BVK:4IB=WDAH"+_558A7`%P+6GZ(7K:=7`/>;(A:9Y\F M"6('>.1J:"@1.1Q^`.(&(VD0(DPSWEJGB0_#?@%>(L!A<:_>.H`5AO-R^DXA M9*)W73K$>4$&.[[!4S!9T\`XA*LJR%D:^S/[S[-1X@D(5''!:CF4[(<.C91Q M%Y(J/\ZV\7LXO1V<7;'1(E7',]9G^`E>'T(\DVG!=2X>M)#=5G@;;#J<<8NG M;HP_*M[!L#1PK/]1_L01ONZPZ.ZZ!M*66OIF+'P?$]]7$_0(I_HNB@VM@Q^L M94,-K&?#PM#/;\*D^%X1Q9EC*11@,!IG:"I2IN4.]. M7X#&@5@\)OF0RL%M"7+N)2_CV?6-\Q*UO[0/9XY.L-/UH,(K2.[[F7)IRSRNL-G#KH+/; MI=-B^W"C>`-;L*1XY"\S`,*0+95[#0K"!E9:S#D/,XA5MYXTFTLVHIT%YO;F M+@UK76.9M5W@/>P<'&[-E[;M2PM_?801T`^H3?;)EJ-9\;!+-PW(7^-,ZHP[ MH.D931%[$39^H8_JE[]?W&##3>BM3(ZM*!4AU+-+]#LV#U5M::6BO"0Y9RA) M_1;7&@3-%4/(1-(:93[`M4D"GTD26G)RSO)P!<9$,U<1^47YTH$$K2%>4\U? M<]T(L*ICM,A==NH7ER\C0.90&>(3K'>4:'/9$%9HE&F"2&-=VBUI_I),&-+U M66"/4HO@ MX8J:'^E-NW5N9Y`2D";Q\U'2L0WQ[6MG,6"T5%P1*CYB:/&"[]EY40=`]UZ: ML)7B#NR6=G1@!!%8!,D\V+?D-S%9GXOR[D[^D/-*!*%KH!218?IP"G;0H2/T M+9!!,C-H"O(-KB$X*.YFA`DU+;K$7R@HC=)*E`C$2OBU-X-+\REQ=&*40;!! M8RW^N87]F!>7UT.[&6>D.747\N_8;C:EX_.O.`6T!D_X MA-V3D]&R!5?Y0T>OBVEDQ!EA&Y*!W#27DB3D%]2AC,U`*G=DW@46V%`J!,T(LF!O"[L2,!HI-G#Q+)K2 M\F<9=1V`(YAK1L36>*7N?)J@D`?HQY?$@R3&8XH/\XTFOP7]YJ^'<2)AH+B) M-WTL:JM./_?`&+W@,NIJ,;!R13+.#&.B0N6@.:-H-HE,D*H%.-2.Y\-&X(&( MQ4,:5.Z5LUS35,V)!G4GTL\"%@[G$Z;&.`/R^"X;5!JN=?BKV<0.89+1%[VT M&0M1T9$8:HS_#A87#WN2S@\9<4$!&\``8>,NJA:3F93QA3CD8":-A:01IO8Y M(+*")5ETK,ANWN`84]:S.Y(`TPA\PWJ!?7K8`$B,9LA8R"(2?_S`.7RFZ`%W MV&S=*@HLXI6RF`YNU;2G-#YO7B=/2=1RAT8WSOI[[@.9V\2)0_Q M-$:TK^!@5/!/8(T[4DU:!W)[WK,LQV4Y^FDRNYN2S^!>5M42]SQ"M-@U!L5H MCE\9"K,"1T3]W3NW^1NBQ^!22R^IAF0AO5=2#)K42V7U1Q(>3$&2"YL6R!+5C+(/1GDSN92%+GPX4V)F@DT)X9])3T[O6[QU/KO%H[>@_9R6 M]@':27?:Q'(2;9!Z1E2WJ-,YS#R]*IXX$U^C*K:)8L(2`/K$)7R]1BD:)A_' MV!,>^CJ[*_A4O`>$"Y,8$:'!-EF1[?Q6B#RB@G/Q@HG)67H_K4F:`C".M:\/[=2Z]P:KRTP?]`8&78J;Y ME6QFOIAL\,B<7.?D-Y./T%_6OF$1(KN%!T41XE\RP.&D M<+@O/GPXMO2:^U195U/ZVJDDSR6/V^W&?XM\03R0F:E%JRU9)0,1O1JM;DJ0ZL_69G('#Y*]A:= M2!'(.Z+XKG9$)YI"?U1Y-I'O(P&:HW,2)E!K,+ZW3/#GX/(K*[8>-Q4/`:RJ M'.(,;>/N54':5H4_)KIRICFU]$Y+3__HB_3Y<)\Y>0U>FH[$LQB=6>(GG^,: M(",9YQ!GS7?YA(_47JRXI[X$T)3Z?9/Q".?'-6BUH+YH-(IEC/N5PFYR`6@+ M`FM<)_Y#"#>J2!@USJ3RC7UR*D%W&PF5KM2\L?,T5%L,'LHBBTJ._0GZMR7M M'-%:*=ZFEZQ/!72XY$\*/]Z&S!'6FGT$;SQZ]HD\WQT\W]8R8K%'+Q-F1XNA MV4X.+?.,+4L-F&==4/P@\Z:9[?SH\5;Q1U@F_W(M_^"H+]FF;[']-,$YGJ9= MMA78K^D_)M728K#C&?D'2JJX@"ZMD6_PQC?DA@'Y]P%)[^7E8N3R[PW;V8=Z M[^2W-5X<[Z#<>3/X[)5)EQ"\)6C4F'"@I#BH!YA M^?82PT0Z1(CRA:S[XHC+P2X5%)HG;$S\V!PJ5].F;\U2#3;PV0?[XQFIX.]C M`D)2:V89`7![Q77F?>C+\60R5J^"P(GWDV&HM7V?;8XJV.T36SL$G6`BLC$' M0_9PK>LG)?;J81?8US(V@G\\(D$?$`+Y3#P&O`GKC`0G0Q"EY2:%5'@^.DX.'/1O9:@_>%":A\ M"!7$S*;.L"1#9S)4LFVV;::IXN;Z$_3X@UQ:Y1,Q82!*[3)R:U@=_:@#$?J2 M4/ZHS^^&1"Y79$6,07@993U4LK!R4NS%BYV-K=W?O#0/1;T`M\6+_8W=S=_@ M0@G*:*OLJ1QWZ"_@#1V@%%>:$C>GW2KIV)^0<=1NI=>\.1ZO!A,,:Y_L.8-H M$H5^-MWE3!H\>=Q)&%1]\.A?MJIA'R;Q:5$1S1W7/0Q$=1?G!;H.!R@9SQEZ M+L%,/.YF:742-2347,[0X/0R/I"*&/@L=P3/#E(3PUN.<>DC+ZC)P@IQ;3[_ MEF`;A0FXE7D,OIY?Q_)O*L'=55QF)5WCM$[D0S2Y\CBA0"M/3?XV_:UX<*ZY MPD=2*73B',OJ^S10[-SD,9QK'E&QM@4PH=*).)&@3PD$Q^QH@?)G%)RP/@J- MC\'PI"*=/AI""CIMG]9"9B>[<)`F`L6B^MTZ7K%XS[FQ-LSC$YB";,>[SJ MBRMY5N#1%]E)Y3X2GQ5>M_XO.;6U8\XXT:4M++220VW=-NZY"QUEFX+T+KJY M.0//-MCM^L\(.6:4#*=[QH8_5>AR*7"TW)/.8^P45]`>JB:YDGQE4;T` M#(P("Q/:XL.@((R[9;H$ICA#PFZ<(U$)PM2LN[9SV-F!1G[T/-P<).[A&?OI M9UD+SYM,*-&:&TSIQ\F`;.8";>L97?%+.'0D0R269Q4T!_2>DP=3;R9839G= MC)>%O4XV;(S1&[9M(]1L"RC9P1XH+#(#86`E!6Y3#LI`^E*^JN)V]5.:34NJ>1)Z*E*T*>@!&Q;FGS7QY'6%CLZ_V5W M8W/.?:%#A:^UIAWAL_I8U)!`V4*EE[BPK1D<0"(7L^9RFLS&6#'&F$/2$E@N MM=]X%17/LS&!PJIX-KA?Q*;H;1C8\H$SX24@57TW9-68X81$ZWI'(J4R&G\#=W;9JPN5![Y>4/T(^E#) M._V*@11$C=&OB1F$D=G=HH=HUIEGC$9/MO6W3$J+* M@Y;,9JF/,NM4R@&W_(;/B#VGSR,T?*T:MV+8B0*"/=6Y/"U<:EYV/I7 M-'3SMEOH]YZ+;#4A%MUF>ZIL0TDOOJJ$2,*][^(J%2&S+:BU>8N)'L@Z'2VP M;D;F-)N@"`.:"\C`CV:9?$P@-=RZ:BLY6-NGKTW/AJ&AUK9X@H6G9>991W\- MC5VE@5G_''4(Q[[6W0>I2HYO5-\H4L*Y[LZ$'5/0`@%Y]69OQXW9[^P!1N,: MQET`'9=D\5-*9M$1N&F$W1]D#V_S@#(5LAR[]?37G1-NT0BU-AG_;,4=`BF< MS+T]])N_Q=BD,<%1!"4[L"K!EG$SI0XS2;>(VM`A0]6J0Z@*Z6X>>(,A,#`G M9%W1B]',M-C&D,[%=VL=RF7(OEP4#P07+"%J;6^TC=U"W&I29<*K,B`1W0!_ M41,$AZ=[`9$Q#DVJ<"Q1,@EK-/(&0*T=H.E1%^*-AE.]N0AKK77UM-3NMB/L M-J_<[>SL_,?KPT5"1I.^,/-%6)1H=3L[O.6XO;^E,-,YKM:R%/S6U&JM[<*N M!YO;/K(AL+ZLC$O#X,8Q;Q4NW-(:#=OJO5DV[V[L6DMM';59,VKMX+"+X!VJ MG)*P`1F>:J**I&E(K]>,*0!*.6?=(=8N3/-Y4&7`W8TQ&/X2_^`6F;HT5T$* M13U&+@_4/D_&SA,]4QP>)>0/_=\9_S7XBD>)_RJIY)'CS6?\U1L/Y2[P5#)9 MQ*X^F;Q#N[DA%P3]=7%"5OPC4=M(WUZ5M^JH=BOH@Z]LX>DKWQ[A)(>MD@>0 MCV@*B(T;$H!41+`CN*_FH^"J@`\->-@P@X([IWW@ZDL>Y_S#W_(!RM=17UW7AR5:FA-9_Q M0B^G;6[F'[<>>IN#=CZEE\_U0$@`.EGV+Q]Z`=/$*A>1C=QKSQ\*F$T.K428 M2&C*A6C8:;9%BY^\;5CUCG$8DD">0_I1E^^E4P**E2-M^]K6QE9+"/A,%U?7MC<.6M_QF7VWMW%XF/.*Q-V*P_D7 M0&V-[4%?ON9MBI_6SWM*WN(].#,CMUD#;FG3',J'<@P?TC7S[BV-#U8,3:2H M91F)M4(W2TLX/@[JGZAKT$_%]7F@+$=;#[035LZ9"W5#FMNOIIC(^LAXQ; MKP?&(4/85*Z=4J8M/6EJKO5I3!3M4FCYM_DJE_,.[<*NS/@U95_A+B"K"&DB M=L1]FTMNR6"%:,1?I*JJJ%V@7!D;F1K?V?DH=UH8!%,A9C;6YL M><>ON[%]8%DTBQ#F'?L6P.=/<-LBO'*V'V?)Y=HHW/HOYRIO^6"*>SU$=?O[ M&9KDAOYZ/ST['+O=KNS=[#[G^+;ZOGT@YW-1_BV_B#_ M"<[M]-42AS*`\$_S*+__%)&R4>#&!@U9P38W@!(Y M?9`(\B4Q`OB+*M7.$\C\3&6&\27;P1:?F2^YLW&X8)Y;<]%WI.0^$8/4)#N7 M/C'V-I;D8OMZZ)578OAG7;-3,80'EEC*7O*0_0_IT\\E7]JU+TL/RSVHPZXX M5*[/M%++L))=1/8T-,Q[J&1#K%-5JY)^X(XB)E-_+%JG222[S%EX],VUJ!`9 M?AKP2TI]2R@*?A$7GU8IQ!4]@^FLHT?/.E'%8A^^3*<_?M-3B#WL]J>>X7 M"2>1^9GK.7,_`1+K#4:#^6STWI;U!-3J-R)-H"NCT,PQJE&6P,@>@;1F.D\! M>!IT^:X6[1^:A-Q^5K(#%"M<['=M5PM%K#DI>-Z^[,0M_L/]W1"M:,1>3"2" ML#O=:%$Y9:;_*X!VI0WW=%B;6=/7XS@'];D#2?^C&$+:C`2`8("=$=>G`F M]I[YYG_K6`HM55XYG%VG@L(33O&^ M@IT);AN.>7*%C8A"/Y2?K;)].9M0!WA_8@QE\*'5>*NJJ6"IC4LEIJ;IS=^S ME89JH)Q^)K_HU6@[0Z672M2@WW5HP#+MVT3Q!S$($I'W_3 MR5^;$O4^E>Z8VC(])_T_/%,JH4R?JYK/H(,:O=EGCAGB_17P=].[]&\(:V3"G'NNQQ9^2+_U-T#N)H_BD-IZ/G( MI[QY2JE`.&BD(>C;:,TC7N:UKBDO?D-CZ]"$;VUGM[/?/L7P1Q8NJT`GT)H&9GK&6DV=2#;B^(U M;X7H&:TP1,8R`4*W*_S%7-MV["[N`@/CQE=[>,8%K>3GJ$D$Q24E;O?CU&N#5;1;]`$@:\&S^YW)K0L>[>$\ MM!V;?QI:!SR50^_2:JF36-I;,\+*$AEU'JD)2%.9W>#W'NWX.D13Q$-MCX?R M*9$\'8+^6!,-5I=]0(/+6'`JZHL(?4(=1CC+U7R)MK)G^B*)N5_NKI[`+M:( M?5NB:=SSA3"MWY"&7.E\(W^+T/&U$M-2>D/P$H"LBM92,9B4^$0,[(\@\0B0 M;`5[J9D;`Z>+#Y9;]GYIAW(A/U/&*Y\\"OK+W[]U-XGKCEV)%VMI%%$X'JL6=[7]7\KOG,+J:A@D1>%#@(>3(B;K*-'U0^3=,U8 M-G`YEE6_-V5OPW9)?+?H4$*IM*.>"K!'`D5N`2T$H@[Y.D(#B?5W.(8_XL*M M^?57U@BO,UO(RHK:Y$XO?(3G[,!QO[RE/&QLH$,>[-&"3KL%M\:+(RVB=SCQ M]63@KY!LU\ZNBKZD0NMPT0,/&_I\QP.");67L^KNCO\GUO]&RO\<\E43O5K! M/<`$1STI=3GH;GV@"`&!X_A%O!5I"2Z:?I\6&4T1)%M!KG,]$6FOWD=Z(>Q_ MF*&&9>B\I(->KTP-_N_XM6)_'">88)(F3UK%[6L(IPY9=Q#YODTO(,!;TU0N MAPE04193X0@7B!+12`$R7V8Z'O^$]TTF0$H/3"@%C(#!'4BZ(R@D`_\W8BSQ MC%\C>JHZ-J^2+3BV/R=,J:=%T$U1#[VI>+B91Z],D2T^K>1"VSU)4?F7)^T, M5A81/N)[A=&EI?)E]T%X!\SUDR>HS(D#&"Z?@*GT>BNE%40!.?/GL:<)&_(N M6,'CT%M9CYV`4?]Y54@$5Q4"-TF?Y[UKY7^^&WQ8O`R);H=-N'D6]IT77]8/E7^ MA#8SAI:'#(M).O&OF_/P,/"`#3SV7G,B8PAA%$O4R(.B9*\O]%VS`+F%50`D M[.I0[7R_Q0SG*`E`0+1P!\,;!FC14=F)*\:-]/8K_DVJ0SXBG1.#2OH6B4H@ M6F)`$<:D#\[%GJ(%D9LY/5YSBW7GXS?];'M_IEXUG>\$Q$A%B0]02#O&%#A= M_4HIDZ8!OSFI#&"@%DA6-9K_!\M+_V![@!V1=2XE+QKS<]>6"&SY/=HQ_]^+ M1F^86,[EH=Q%;C*@B2L$G/;K$7(@G$JR>8YEO6:`15!)X..8][OQ.^QBF1!\ MKGY`?1'?C8,9OR-`\-F'J(:"L](G/].#5CY.P)+S]CTD:R=GQ7Z-,P7+,`4O M10X*KRL&-MTHN$$JD^"C>)=50/R`7/0=W"E^4!Y`Z[G+#H#KI;LGQDDF>=. M:[_*W"(BP`MA_G74;0X:_%5O83#>7/80MYF#R<%>C^FR='*+._E'6';6^^F^ M.!Y,>G)!';6B)]DV;X:+&6_.PFK5"&_)_4B0F-G?`4R,6P0_)J_`WWSR2]+`'$&J`26Y,R/$#`":OQWI]4VZ`*>L\1CY1$OG`DLBKACTE M^'>A"K<^^A*+V+$,O7?W?V.HZ>[]QHYD/TK>)-R"6T50_(3]X#`Y@8OVV][T M^W57[_=`AN&C3TV=F61<$%B'EX\68O,0;#Y^RFN?(K94'K^EZU(?WI!;X">_ M&4ZS7R7%>Y7J%C/4<)WG"XOO):VWSK<40Q/B8A%!>KCHK_R'2WN;.;FT:_5< MX^`9*4DX8DY07^PZ3+%^ZFCP;\5T+CI!X5566)I_NU)YS/A)NCO1_Y=Y^"$@^>(=Y(+ M.!4<"60!IDL]Q_OL_M@N0]I$(T`4KCS;.8QL31-SR'N;7@[G;XIH1'UDI*SF M`>J%77<-.CPSA8L=S5:/1G,]FQ$>*G:0N'H"4:"_/9YF\(V424T+/\G7M&28 M4EIJ>OIXAYZ,](&IC(/=W-(,AUC,,YK]&F468@C343O\M/M>O!S!BLI`*!E3 MNF<9C_).4-,3,;C==E>R)>H)E\$N=OD!5X-/Y^J3S?)VM8*;+OO\GK-,YII: M9O-7D',Y/F^N,[Y%L;0?GS"UV57SX8-#+U*(!23'ULL$6A;`\>R,1_V].7P$ MTGJNCRLPB!5&7-Z?'X/#-&/8L-_&$?;+15B(-(O-E^YZRH9^&P058)?0-+YR M^^,^S&.RST7T$?DT_8`=:2#0:U&&?BZ)YA:B?IU3[S1(\C87 M@>3!SA^VT5^X-4WQ)3PE;5*-^D2@7+Y`OTAP:=SMG'`*(AFW&3?@%:SM^^O< M6#+=E&*\7>'BEQ]8#$S`?Q_A6CB`4*1YC,+FA[N(4?7O6+>D2\@UEW/]URY9 MP,F<9N715&5D^W"64&H+QIBU)GGBK[P[Q9!M(;S_W_YJ@&DAX[9,53I7-I93 M($PHVII%#BRT4!_M.'0ZE0ZW-/88$9;?EB.:CU5`0$#)[-M/!Q%RA8>I1+3T M0HV@=7;*/TBA"&H6KY8&HR6AT0]EN*C`>P3^>JW+O1!VX)27 MKY]_TGX9P/."$_IQ-=!OH&O;V1L*%EC,_!,*^\X*-TFR.4\"W2?G)IB3)L\Y M_UZ"PS+67Q3_=79-^&UL M-I*S$[IU\E%1\_(["IGF#5/D(^*86H//G4B%Q`G*<'-0OJN"6_M9&M_UPV=< MHMNTCA+/J-[ELMS,L47<#82GKAT*8Q'[IRPB=2"US,5Y]2_!@JW0DY`KC-8)DB:[`Q]A&!9@/#&GOM# M:OPC4Z1\\ZGI\/@PGG_$P5HAT'K_!5_C.WK2:V_%BR68;RUSA)HXA;$I[?!D M`XA,&\"*A=A?W,M+\X/BY)`7\S=UFC;'U)-/[\$O!36=0)XK^OT+80IW#,40 M+OQS]ZWTS*A=("CC#D^`TVFRAYK]EM(AG2YN.5[8*[B855*R+&E(6=)QDB/[:3\45+QXX^_K MG(@D,J1+?Q)]?F6=\+O8A]#Z(2,8$1>4W]V+Z^:`_NA_XN>XO..'%X8)Y^8C MPW.M;1VE;RB1WQ3?*]P@_FB:(#T_+U!L'_5;.`IC7,,"6_?UK%'\28E\^Y09 MDV=TT1"^83!:@(C-I3@,:YT^;!,\`G-H6HI)PK=<,07Z+H6HM9X(NWR])5"I M+(-65&=8^ZG(\_3Y1Y>G:D?@QR1[[?E'W_G8LD=O_+6W^#+),LR$U$O^O:G= M_,,3C&)\S#'2K^':I7B;?YJL^!_?6:KN?^;KOYM_>G#(JT3YD&!/F@<7XTN% MBX8+8DOG)Z]8*:N4+WL4WVQL?I<]:L7W]OIK/B5^[=(-0:?;$X0+KM<&)>Y& MYXN]TZ_ZN22.^>CR"\>4;MS#;$\;W?+:\^EOYAXFP]L/3("+(N^60(SL&3V< M?VW?NG[$W.1IKWSGU/K.FVLO*DLYJ+EC['LN>(.MR8/F^R1VC%Z6]N\=4S\= M^>:%EALY-Y?4A8P_^04]S+!JENO644^=>IJE,MVM_RS"^R)(^\H74DX`#`?U M4X%^>($'[F?;T2U/\'+5=?3G_M4*BBK6>%P7_)X]J=J6?GK"=BM\I><[OA6T MZ[;C":-%FSW(=45W*=^M`/1/N@@L[I#O$E[G:2ZS-TYJ:PU_)*\J5B'TH:DK MD)/>#U^J<9]O>0SN!X(M1F%ZH7SY8MM^L<.P&#_`MX@@Z17TY:OM^]5HAP+! M-RT>>IBL6RTY2>+K10DQ7;2WFJT65!P:]49L'0/%FW M/`_T>$@:&^OW7A>C]&I(\<.BES^6#ES%P\LGK>#>A_&[LQ2_7&-KKK,MY:^6 M:#4O4J0"?4'6,B>^[LG%.W%+-XBRM1/$86MGH3CH:EV\1K=\N4#-9?(03JT+ M=TM7>1BO,099BE];HPALN7PKC";NXNOB;/ZAL>43K(''A]C+?,1\L916T>O- M"=:BM?E;"UG\/+QT]0TU8O7-RL4_ZM.IHE]-=-G3M_YQ_'P;0\RZ*SLI1Q?3 M?GZ"R[\ZWZY.NI5JW9!8ZG(]M.H*;\U-=6]!]5*`O*,7/GG=-=6..%VMN9E'%HW!/+6GNH2K_1%6^GL5$\?YC_FV:2E!\MR25\&!P MEZXCHB]99TE0E\Y^!!2/")K2%1^&IUDPQ\]WLIZ4[MT-%T4_"OY5&GSTR-;E MWJ5K[N5K?M#]2@46=I>OOR#VF@N'E0I?E!;[J"2B%Z-\"PB5-/DLBDOS&3_@ MUU..[2Y517-+TG]L[ZTN>,/++[2U=*'EO3"+X"Q>?'_^IEAKN2WSJR01RM)] MOZB+)$?3V]ACX$)3?-VFMZ`9_%5=3U_]'P$```#__P,`4$L#!!0`!@`(```` M(0`W<\)-/`P``/-R```-````>&PO]IHO[UT;@8 MJ-5'?K(WZW>VO?W6S"=\?+/R`]<,X6/PU-FL`\M<;K"1ZW2T;O>JXYJVIT82KMV%B!#7#%ZV MZXN%[Z[-T)[;CAV^,5FJXBZN/SQY?F#.'8#ZVM/-12*;?=@3[]J+P-_XJ_`2 MQ'7\U6/LHQYUQ!R3=WGA;UW##C;+PMUXX4;7TD!)]\V$Y4:]4)3)YYB\! MQ.]^WOKAM[^)_KS[P[MWW7]]\^T_?K"6__SQ]_O?_?B-VDG4$)G@@W*9E]U2 ML?!U)+D36W![L_(]8D@?:$*VKE\\_XMGX'<0#&`>_NSV9O.+\METX$@/X2U\ MQP^4$+P,]K$CGNE:T2]FIF//`QM_MC)=VWF+#FMX@`5&_#O7!C?AP4ZDX;1Z MYH@FL6F$,#B;^GB$VN2"228>++?)_"G')D[7H%I7$_XX7G8S.]I4561>GX5/U`.QP[;)H0];"^*#_XKNDAL7108[_FQF3./^V+Y^+Z..*/;$$: MO)7H#RV.F#\VX"C;<=+BLS_`\@R.W-Y`'1Q:@6?`!R5^__BVAN+,@Y(=/=R) M?E?QZZ?`?.MIK$01:[#Q'7N)*)YFK"2,A^39U;TQNV=Z"3)1%`5"#6,V/(+0 M^^EXUC[2V7C)0@D>778<@8>2OZ8#;SM) MB^1O24LX0P4GHR9J^&PO7D`9MP`2<1.I.):&-.OI.)O0AWIWJ`^TJVC"UI)J MUUK:6W??NE1W;EP"C&$0R]5$H=#M@C702_$[A-LP5S-/"W8`&(B"0G! M%FW8F"U(B]I(6HC92!H(VDA:B-H(72>O/TA*D1M2*'6W#$$0P_`!!PU7"4WAG(SH#<(R.J%$_\74!O7`U!<;6P'.<3ECM_ M7Z45%BQ:WMZ\KLB.$=C&@ULJ<$,*OH4S`_';J)J*/H"NHD9:82/%7*^=MX>M M.[<"@^WM82K843P#D7V:LC(P^_S>L9\\UV++KFHDYOO`#ZU%R/8>L=,G17A@ M@TJN$;U8D`B>)OKU`OW`DS`?3?3#LEZN_<"+5/T07,+ZVXP'W&45!S6X@`9U M&9XV$<#B38(`G"`#`>X*BSF`\)2!`";%"0((T`P!P"F)BB;]H$>R&<1`IA+T M'TLEY)C$2D[E$:TL2K^@O\1*@TN_C6@F^18"/:,9/I0`:*2R*,7*2C'$[=#3 M,@K@0PD%!HRZ[0QYO:*<+XT0DG0!0\8(I($R1MJ+2I)S06<&H)R1:8MU"`D* M3$6R(0`<*1"((WJ2QE]854S3*3T M"A*0W(AQ0AH(!%D9DD2#)BM%4@RR5"ZF]HDD3^#UI'LV>HIDC^(+-IMGL,EXA%L?(+[,F6$^+'(BK M7MK>X;:0S8PY6(-7E4K:B')QU@3Y:8`%8<5+@?"62^U\D!4246DY#1AA=?GQ MJN9 M,)`2H5XJF#`D("HY9=B5W-?.;<7`7YFA2;3W2*CU=Z=^_(C`QUIT M"B$9V`O[0B46DJAK8,E/U01&!)1^$(V9T3RW1..98S=4XY MZ/S8$74.UW-PO5_<.]/XI,.)NM(^N/KN$H;<9M_BW`?W%SDKBBO`G2_%N/": M.QSNQPG?0PZ*@60:6CDJD!&J&"&L!)1ULY,AI&D:@,]9AXYW494!/'S0)/04 M*L=3767:A>FIXZRB:(+C/)9V;/_?K^5H!CV_N82,>JFB^*6$-87'9?6]$.;S MH6`]_!7!PTWJ]6KAPE1=P5UA,J!L'3)VT.38Y[Q9-;SQ[CQ*KCPY.,IFTZ[! M%[QG5HU5@#O?:HP+B0HKRM*/<+P>+20J>CS?O0K[?YW2@^..Z^OGA.4,\@YN M,L@M^0MY*ID%UQ=6,7[7<3E5WO;:2V/9%78V['G'AG>P&P[I>8+QQ8_@A=$: M$2^88=ITPR&F5T1)'3=P"9`?/&IQ=:K!HSB$SRQ)\G$G:^D)?+B*3]51YN#P M_*0+#H5%?@_BGY_D\R7*07%U2-5?C!#V=)T'PJ(A&+<*M(+PT,312C@U.#U7 M[+N*'-8HNAH`+LZZ%8`%!ZBZT#!W)GFB!K;Z5D+2J^'.D34GH165,B7E M_!;*ZZ^ETMP-O#6O\2A!25JN%37HO;Q-2575NO#(7`=-(3VMG?:B?(FNEM*Q MH8@N.,Y7>/DC0^'PFL<2V[0,VY3)31_X6SZDFYH5O,$W/)"D^UOE0GF_P$!( M%V]Q:]1\:SMP8SX\>XD;SA>P?(MPF:STE*R&$U`B"P;'NK)`0D24 MAADD`FZLS5\PRB,IF;_X^-8%XSN2DGD*Y!&+=/A"W*+41WV>75V0W:FY3$86 M/F!PG!&!`4]G6&P=>*28CP\D8U?VX*(@,0@K;"%)S];B19G!C9I207Q_P&%4 M1-#]Z]HQ/3/T@S<%K^9)Q?%.'PB*^Z/OIQSQ$C3X*`+H3_#X-G@RG`*\Q(,X M1Q"N<]41D_8%GAZ\M+^.&&@=H>'C#XO).F*@=22&3ZI8/XF(^>"MMZF'^%R* M0[>(B(^V]V(M^WBN5P:>(Z&$GR;W( MXOKS`>[FE9"(UPN1OH,UM`CPOVQ#0B.V(D)P>BDBY-$.X1Z722?F1"`L(1$^ M7&&7BMC)*((R_F8&'O86KNONQ&B!1=GUBE#]+U^S6[TQWD-\P"&["5PZ'P"B MEM;*W#KA8_KE1,W>_YG=/1:"*?[5]_9G/V0B)FKV_B/>EA=Z,C[G1TH?>MP<5X,+V[&.BSZ=V=,>YJW=E_@#)\ M&N0U/$ZPP=,6V5,AX8K%GGZ]<>"9C$%L;`S^4W9LHI(/$7QV+TZ`#6L5B1&= M3?JTRMO_`@``__\#`%!+`P04``8`"````"$`^V*E;90&``"G&P``$P```'AL M+W1H96UE+W1H96UE,2YX;6SL64]OVS84OP_8=R!T;VTGMAL'=8K8L9NM31O$ M;H<>:9F66%.B0-))?1O:XX`!P[IAEP&[[3!L*]`"NW2?)EN'K0/Z%?9(2K(8 MRTO2!AO6U8=$(G]\_]_C(W7UVH.(H4,B).5QVZM=KGJ(Q#X?TSAH>W>&_4L; M'I(*QV/,>$S:WIQ([]K6^^]=Q9LJ)!%!L#Z6F[CMA4HEFY6*]&$8R\L\(3', M3;B(L()7$53&`A\!W8A5UJK59B7"-/90C",@>WLRH3Y!0TW2V\J(]QB\QDKJ M`9^)@29-G!4&.Y[6-$+.99<)=(A9VP,^8WXT)`^4AQB6"B;:7M7\O,K6U0K> M3!`6#? M!TVM+$6:]?Y&K9/1+(#LXS+M;K51K;OX`OWU)9E;G4ZGT4IEL40-R#[6E_`; MU69]>\W!&Y#%-Y;P]?O/R\1?E>%G$__K#)[_\_'DY M$#)H(=&++Y_\]NS)BZ\^_?V[QR7P;8%'1?B01D2B6^0('?`(=#.&<24G(W&^ M%<,04V<%#H%V">F>"AW@K3EF9;@.<8UW5T#Q*`->G]UW9!V$8J9H"><;8>0` M]SAG'2Y*#7!#\RI8>#B+@W+F8E;$'6!\6,:[BV/'M;U9`E4S"TK']MV0.&+N M,QPK')"8**3G^)20$NWN4>K8=8_Z@DL^4>@>11U,2TTRI",GD!:+=FD$?IF7 MZ0RN=FRS=Q=U."O3>H<],9&R;,UM`?H6G'X#0[TJ=?L>FT1.[P M:3?$45*&'=`X+&(_D%,(48SVN2J#[W$W0_0[^`''*]U]EQ+'W:<7@CLT<$1: M!(B>F8D27UXGW(G?P9Q-,#%5!DJZ4ZDC&O]=V684ZK;E\*YLM[UMV,3*DF?W M1+%>A?L/EN@=/(OW"63%\A;UKD*_J]#>6U^A5^7RQ=?E12F&*JT;$MMKF\X[ M6MEX3RAC`S5GY*8TO;>$#6C\S210*:D`XD2+N&\:(9+:6L\]/[*GC8;^AQB*X?$:H^/[?"Z'LZ. M&SD9(U5@SK09HW5-X*S,UJ^D1$&WUV%6TT*=F5O-B&:*HL,M5UF;V)S+P>2Y M:C"86Q,Z&P3]$%BY"<=^S1K..YB1L;:[]5'F%N.%BW21#/&8I#[2>B_[J&:< ME,7*DB):#QL,^NQXBM4*W%J:[!MP.XN3BNSJ*]AEWGL3+V41O/`24#N9CBPN M)B>+T5';:S76&A[R<=+V)G!4ALZ%8JNU'N M_*J8E+\@58IA_#]31>\G<`6Q/M8>\.%V6&"D,Z7M<:%"#E4H":G?%]`XF-H! MT0)7O#`-005WU.:_((?ZO\TY2\.D-9PDU0$-D*"P'ZE0$+(/9 M94FRE)")J(*X,K%BC\@A84-=`YMZ;_=0"*%NJDE:!@SN9/RY[VD&C0+=Y!3S MS:ED^=YK<^"?[GQL,H-2;ATV#4UF_US$O#U8[*IVO5F>[;U%1?3$HLVJ9UD! MS`I;02M-^]<4X9Q;K:U82QJO-3+AP(O+&L-@WA`E<)&$]!_8_ZCPF?W@H3?4 M(3^`VHK@^X4F!F$#47W)-AY(%T@[.(+&R0[:8-*DK&G3UDE;+=NL+[C3S?F> M,+:6["S^/J>Q\^;,9>?DXD4:.[6P8VL[MM+4X-F3*0I#D^P@8QQCOI05/V;Q MT7UP]`Y\-I@Q)4TPP:&PO=V]R:W-H965T&/.1-BBD:H.Z3=JD:=K'LV,,6,48V4[3_OM=XX22 MI.O:%XPOQ\?GW'MMEM>/L@T>N#9"=3DBLQ`%O&.J%%V=HU\_[RZN4&`L[4K: MJH[GZ(D;=+WZ^&&Y4_K>-)S;`!@ZDZ/&VC[#V+"&2VIFJN<=?*F4EM3"5-?8 M])K3'-@D>PN= MI/I^VU\P)7N@V(A6V*>!%`6295_J3FFZ:<'W(TDH.W`/DS-Z*9A61E5V!G38 M"SWWO,`+#$RK92G`@4M[H'F5HQN2%0G"J^60G]^"[\SD/3"-VGW2HOPJ.@[) MAC*Y`FR4NG?0+Z4+P6)\MOIN*,!W'92\HMO6_E"[SUS4C85JIV#(^"4>)`K8U M5LD_'D3V5)XDVI/`N"FI^XPD`R(#SGV&1FS_J^D0[8=R8UCR1&<.\BG@49Y6"4D M7N('J"[;8V[/,=$Q8OT"8G$,*3P$GN-&SR08+(V^H%Y37R_WS$&^`SOYKH>< MG]O3P/HT4/C`5$A"DE'LD12H^E2*2W$,A^%U26X1X"9&$Y*._%ZEQT`OC\EX M5C`@UO]%%!ZQ&&H6Q6D8AN,F1R:@-Z8F7A?OP*?BYR.O%^\Q?F,27IZ:6T^_ M+\*0'"^'>\=M\;)W+]S?*[[9)=N`D?DLR M:(CS^)IDT!<0Q^,"N'YZ6O-O5->B,T'+*]@JG%V"3NTO,#^QJA^.WD99N'B& MUP;^,QQZ+YP!N%+*'B9N@_'/M?H+``#__P,`4$L#!!0`!@`(````(0"M>EC> MN0,``(X-```8````>&PO=V]R:W-H965T&ULE)==DZHX$(;O MMVK_`\7]$8**,Y9Z:F!J=D_5;M76?EY'B)H:(&P2QYE_?[H)(@DZ!V]4X.7M M)YUTTJZ^OI>%]\:DXJ):^V02^AZK,I'S:K_V__G[YMZ&00J.["2JHFH605/=D*65,.EW`>JEHSF MS4ME$41A&`W,AMC5U+Y M>JR_9**LP6++"ZX_&E/?*[/EMWTE)-T6,.YW,J/9V;NY&-B7/)-"B9V>@%U@ M0(=C?@P>`W#:K'(.(\"T>Y+MUOX36:8D]H/-JDG0OYR=5.^WIP[B](OD^6^\ M8I!MF"=-MW^Q@F6:Y3!SOHC"]'^? M0[XTT_:']'*VH\="_RE.OS*^/VB(-(UNF]`M'2]_+CDJ+\C\C(JV5,8E:$_@^ MF>?1_2;3U@2^6Q,23L@LC'\,$IA!-?EZIIIN5E*E(@ M&ZA]0O':AVJ"\2J8F;=-N`K>(/=9JTB,`CX[!;$5Z5F!TP<,'0AD9CP(BA$$ M9PO)$G.C'S=RXAI%U%#/R"*.N^<6!N1@/`:*U_ZL-]IIYVJXC`+629>/F:U( M/U-89!!F/!F*8:'VXL[MN(E1],DN&6G8TZ'BPFZ1@)D<3G]1TY[*EY MWF>_`8:'Y>@=`<4.F%-XB9'T`Q.G2M*AY`;;XSUL*';8+K:F/(W$8G/J)!U* M+B96%1`XSL8GKE$[=$X!)JW&PG.*);VBN<6'.^_HB25FG^[O(,0IPZ35?,YG M?/J:6WQWG0#$[.<6G[/DDU;3CQVY]7I%69D,].`G-6M))%L_U$\7P>3A\NJ;;K!,9[ M1QY1[>3QD@!3Q=C-@<;*HUO&5S07&YOOKD,#VMT!WZ".AX="-*CCH<;E,]VN MZ=Y*)O.MWUR]P`:VYKNV>]4[GFEO(+MX-5PLH#< M2=,:FPLMZJ8WW`H-+6WS\P#_>QCT6N$$Q#LA]/D".[GNG]3F.P```/__`P!0 M2P,$%``&``@````A`(D'B*<;`P``?@D``!D```!X;"]W;W)K&ULE)9=;YLP%(;O)^T_(.X;,.8C1$FJDJI;I4V:IGU<.V""5<#( M=IOVW^\8TQ"3MDMN`L2O7QZ_Q_')\OJYJ9TG*B3C[?B05:4*@<<6KER*Z6ZA>?)O*(-D3/> MT19&2BX:HN!1[#S9"4J*?E)3>X'OQUY#6.L:AX4XQX.7).RNX?3NP;E@LN>:EF8.<9T-,UIU[J@=-Z63!8@8[=$;1%_@HF>R>S[_H*_!!.04OR6*N? M?/^5LEVEH-P1K$@O;%&\W%*90Z)@,PLB[93S&@#@TVF8WAJ0"'GNKWM6J&KE MXG@6)3Y&('>V5*H[IBU=)W^4BC=_C0@-5L8D&$S@.IB@X&(3/)C`=30)YA&* MXO^C>&99?4JW1)'U4O"]`UL/P&5']$9&"W#6\6`(^>UX(!<]YT9/ZJ>"6D)- MG]8XB)?>$]0A'S39J2:P%9LW%.E!X@'?`1)RNQQ23UJYH>L<028'_WXAF=%` M(0^:T%9L/E)8C!#>,>/'`6HQ!'WT7AS,[3=G1I/V\88X\:=DUCAL@7'D.%)(IG1#&1IG$YVX>9X'*H.MK\11LNL6,QH"%<7@"9HU',1K/ M'HLKO81+BVTN-"U49C2&"\?!!'MC#2/\#A5TNPOBZM4V%\:3G9T-HN&L"%&4 MC(=!_^/0+58OSRCB`/G1"&\R,QW4](:.[.AW(G:LE4Y-2S@<_5D"/Q]A^J=Y M4+SK>\"6*^A[_6T%_W,H-`A_!N*2<_7ZH#OTX9_3^A\```#__P,`4$L#!!0` M!@`(````(0`J&Q(+3`,``*P)```9````>&PO=V]R:W-H965T3MPRCO!M45Z9C68%9(]+H2F'%;M&@14$RG-+L6.-&*!&&*R3`/R])RWNU M.KM%KD;LZ=C>9;1N06)/*B)>.U%=J[/5ET-#&=I7$/>+[:&LU^YNKN1KDC'* M:2$,D#.5T>N88S,V06FSS@E$(-.N,5PD^H.]2B/=W*R[_/PF^,1'OS5>TM,G M1O*OI,&0;"B3+,">TB>)?LGE(QAL7HU^[`KPG6DY+M"Q$C_HZ3,FAU)`M7T( M2,:URE]3S#-(*,@8CB^5,EJ!`;AJ-9&=`0E!+]WWB>2B3'0W,/S0@#70=:V@V&0"2$,<4"*QW'\N[R]70E+ MN_U$6_5@/)$S3--9V5T3L3]%TFO$B0=D8A;Z8&RV3_JR:3DHT:%&0S)<^Z+? MN=PJ!AIS8+S!@8KCOT2Z1$RB`"OC*);=2QA::^3,=:RIMZUBXJY_O-`)O6A& M[!2Q$%^Z1$S<@\CM[B4\=1^X,_,*"3OS3N3;MN7.JK-3"%S?JDXZ%;%=*P@N MRVAB/WB/?0E/[;O.;/%M%:/\NY8?>#-@-P8\*XS,.`=MR/-A4A_I.K,N_!:/] MM6#5^Z6F62*4=W4ZJGV_QNR`=[BJN);1HSSY M'.C9X>EP*#\X,@`N*!7]C9Q@^)^U^0L``/__`P!02P,$%``& M``@````A`-"U^[?-(P``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`)81O"+H1]"(A>"U$3A.]%C)^A::G"EWN8T/0"GS7RXV,4*=Q8?KVQF\:\U,F M+;:`1)`8DD!22`;)(06DA%20&K*$-)`6LH*L(1O(%K*#["&'H7CU+N?X9]1[ ME]NO]UYFL].YPARR@$20&))`4D@&R2$%I(14D!JRA#20%K*"K"$;R!:R@^PA MAZ%XE2Q78V=4I)*'G?LVZ-RG3*?.#8D@,22!I)`,DD,*2`FI(#5D M"6D@+60%64,VD"UD!]E##D/QZEVNY"1 M7_O=%-!PTN_I$_9N^COH]X[\H_KD;=#Q+=>IYY,B4DQ*2"DI(^6D@E22*E)- M6I(:4DM:D=:D#6E+VI'VI(-'?H/H)H?.:!#]7)).0WB&ZFYXP&T4\,>0W"S14-+NTE.1@A%J2(%),24DK*2#FI M()6DBE23EJ2&U))6I#5I0]J2=J0]Z>"17_O=?,\9M=]/#TD\[<+ONAO(_<%@ M<,T_F89G!Z=<6G!A!94B4DQ*2"DI(^6D@E22*E)-6I(:4DM:D=:D#6E+VI'V MI(-'?H/HYH;.:!#]5)+7((:S2\<[N_/N`0'_A&%!BD@Q*2&EI(R4DPI22:I( M-6E):D@M:45:DS:D+6E'VI,.'OFUW\T0G5'[_8225_NG.:;A<#`+AX-3+NW[ MB^Y)$+^-1*28E)!24D;*206I)%6DFK0D-:26M"*M21O2EK0C[4D'C_P&T^;7?S2F=4?O]%)17^VY62D[][7;?)'P0H'L<2VK_QLX@%Z2( M%),24DK*2#FI()6DBE23EJ2&U))6I#5I0]J2=J0]Z>"1UR"ZA^#.:!#'[/Y4 MHJ/AW`%I08I(,2DAI:2,E),*4DFJ2#5I26I(+6E%6I,VI"UI1]J3#A[YM7_> M5.*44XF.@JG$X-&AN>4ZG1V0(E),2D@I*2/EI()4DBI235J2&E)+6I'6I`UI M2]J1]J2#1WZ#.&\JL7MR5H;YX?'!T?3N=$$Y)RU($2DF):24E)%R4D$J216I M)BU)#:DEK4AKTH:T)>U(>]+!([_VN_F\EY\==,\^A[7OZ/AB27]NJ+F,%HX& M;20BQ5K0SB$2)8N5LF!&RK6@Q2J4+%;I:";GJ8-SF^`IM\IRZ6!6:RP+OU2R M\(VCP6:WI)46/,;RJ^>\B;WN>?"P>AS92LTUE]'"T6`](U*L!6V;$R6+E3IZ M>I=FEDMW::ZQ+'RA9.%+*SBLL>#AL\IR:?A:8UGXI9*%;QP-]D1+6FG!D1H[ M;S*N>T$HK#%'ME)SS66T<#18SX@4:T';YD3)8J6.@AH+=FEFN727YAK+PA=* M%KZT@L,:"YXHJBR7AJ\UEH5?*EGXQM%@3[2DE18R'Z?]E)9WON/(5G^NN8P6CKH_IR/+Y`;5W<>2 M7+I%L<:R'98H6?C44??G%'XZ#>;H,LNEX7.-9>$+)0M?6L%A^.":O[)<&K[6 M6!9^J63A&RLX#!]<0[262\.O--9(=7=334]5]^;Q]W]7W3(XG.J[G['RZMN1 MK?]\"EHXFAW?D3VVG8@4:T';/8F2A4]9,"/E6M!B%4H6JV3!BE1K08NU5+)8 M#0NVI)46'*FC\^:B9$C'P=&1W^R#\[6Y*SCKWS(^OIBFL:RC14JW_>MO5Y>S MR54P7L::QZYM$@9/-==PK29WP>"86<'CZW87L^`(FVL86UBA9*M=.KJT^W<5 MJ=:"%FNI9+$:%FQ)*RUXC.6=GTIK]SO=R%@ZZ%S'[/[%HZ-NPF(PC@5[9NYR MS:PM+JR@#@Z1Y1K&"DXT8BUHCS`D5E!CI9K+NG-FN9X(GVM!"U\H6:S2T:6U MT(I4:T&+M52R6`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`D3X8?ES.;W5V^ M#4:KDL$KC63;56ND)_?DTN62/=EOUU4PL#=<6,N%K91L2]9^Y.E%<+*P8>"M M1K&MV"E9X+TCMXNN;F8WT^#2Y^#%]L>G;J;SC!;:90^.ASUY4^LC+;3/U5T% M#EIH,)>SN.QS7=F$5:1D]W1C);O83QQ)^*[:9(8\:/NIEK'(F9)%SI4LVXV]T6G]G*G"FW03>9* M\SFUKI$VV.>Z\D?)8)\O7'AOE'0%K1_&+M>5]PN3>%(GM?KVN#EY$:&6O\]MI*Q*PUDL6LE6^NEH]-:7P?C4L/(K8:QR"LE MB[SV(]]R.@Q?;;X/=[.1PP/OSUPANOM-Z MR3NY(]XUT2NCN9)UKX62=<)(R7+%CIX>7Q.7ZS24A+>+4HUL"\N4;&&YDIT6 M%8[D$;6N\4VO1FY\E5K,@E=*%KS62,-+&_32I*;O)Z.&P] M/_`9QWB2YS`*@0?0D=TUT'F/N<@UH08I(,2DAI:2, ME),*4DFJ2#5I26I(+6E%6I,VI"UI1]J3#A[YM1].DC\S''`V7,YONP;1/:%S M.F6>7@8G?W/+I6UD08I(,2DAI:2,E),*4DFJ2#5I26I(+6E%6I,VI"UI1]J3 M#AYY#4)F<,XY/ARS^\<'1X.^/R^0WBO(EGF7!#@^AI>+'@<@UH08I( M,2DAI:2,E),*4DFJ2#5I26I(+6E%6I,VI"UI1]J3#A[YM=]-HPXO%OZC6^A7 M_63L\&Z$HVN[))Z3%J1(:7C3=!)>V<>62X>7Q"-_([M).6SDGWF"6*9KT`MZ M\C88M'`%![DB)??\W]OP2S.Q9K!=F2B=RM@DMK_EHU-8\B"ON/?P]-,GA=T\ M:'"-Z&BP(7/2@A218E+BD;])X:3',ZO.R8VKGJZE=@;GL\&\]]QR:0M;D"(E MO0ET,_,>L;R+_A+<$XZUA,TV)4I]D-N+V^']L;=OKZ*__+OJ/>]2_XJ7^HZN M99<,]D5P%WYNN6Q?]+&DH%*DN6Z.TW_!=$&LJ58@40H+^/5]WM6K/+.#IMJ3 M7]_AK9FY*RBY=(,6I$CI5-_![MZE6O=<2=@K>_*K M\RI8Q[DK.*B[!2E2ZN^G!E/RL:8.J],M/"S@;6/WM(HW%C_=?8_9_:L/1X-S MBSEI08I(,2DAI:2,E),*4DFJ2#5I26I(+6E%6I,VI"UI1]J3#A[YM7_>U8<\ MR1*V<$?^9,15,,C.+=>I,Y,B4DQ*2"DI(^6D@E22*E)-6I(:4DM:D=:D#6E+ MVI'VI(-'?H,X[^I#3C?0('H:3D:X7`-:D")23$I(*2DCY:2"5)(J4DU:DAI2 M2UJ1UJ0-:4O:D?:D@T=^[8=7'\\<#'B9<=V3/QEQ9:=+_0>:+)<-!Z>"2A%S MQ:2$E)(R4DXJ2"6I(M6D):DAM:05:4W:D+:D'6E/.GCD-XCNBFEXI?9,@^@O ML(;7G=U97C=9/;A505J0(E),2D@I*2/EI()4DBI235J2&E)+6I'6I`UI2]J1 M]J2#1W[MAU>KS]0^KTJO>PJ&@^#9L;GETKZ_($6DF)204E)&RDD%J215I)JT M)#6DEK0BK4D;TI:T(^U)!X_\!G'>M7YWV1-<$#GRAH,^UX`6S!618E)"2DD9 M*2<5I))4D6K2DM206M**M"9M2%O2CK0G'3SR:S^CF)J=7W8O_9_[X^S4G M/AP%(T5PE3NW7#92]+$&S2=BKIB4D%)21LI)!:DD5:2:M"0UI):T(JU)&]*6 MM"/M20>/_+9RWBS1-6>)'`WJ=4Y:D")23$I(*2DCY:2"5)(J4DU:DAI22UJ1 MUJ0-:4O:D?:D@T=^[9\W<7;-B3-'P7`0/N-@N6PXZ&,-FDW$7#$I(:6DC)23 M"E))JD@U:4EJ2"UI15J3-J0M:4?:DPX>>0WBYKQ9QF-V?Y;1T7"6D;0@1:28 ME)!24D;*206I)%6DFK0D-:26M"*M21O2EK0C[4D'C_S:/V^6\8:SC$HVNSTG M+1P-VDA$BK6@79$F2A8^==2][&PW8B;!`)19+AV`RLEP:OM98%GZI9.$; M1X,]T9)66G"DQLZ;NI.?24&-.;*5FFLNHX6C8"\'-R@CRZ6[(=98MAL2)0N? M6L'!7L97A"V7AL\UEH4OE"Q\:06'X8/[<97ETO"UQK+P2R4+WUC!8?C@9DAK MN33\2F.-U&LX`_72\+7&LO!+)0O?6,%A^.": MM;5<&GZEL4:J.YQR"ZO[95]-ZYXG"0=D1[;^<\UEM'`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`R\Z/CV&"MM'/.LD8H%4\=[D&M"!%C@;#0JRY MK,LD2A8^)66,E6LNBU4H6:R25#%6K;DLUE+)8C6DEK%6FFND*X>31V$=O6B8 MON6V]P9&F9N`E`S<:YZF2J[=GAWC.Q_-I2T($6DF)204E)&RDD%J215I)JT)#6D MEK0BK4D;TI:T(^U)!X_\,3VU(>]+!([]!A)-@SS0(3G;=]C2839^3 M%J2(%),24DK*2#FI()6DBE23EJ2&U))6I#5I0]J2=J0]Z>"17_OA]%IXD'C9 MZ0-GW6Y[DM=_M/_/20M'\OD.S14YDAN<2K$C;UY\&GYQ,+%<6C`E9:2<5)!* M1W(;3\-72K:JM16T\Y/I57#'9FFY-%9#:DDKTIJT(6U).]+>([^=R&D@3R;^ MU!5C%S&X*NBI>[OJ='(WG07G6//;4R[=>0M'@[J)E*QN8D?="SH6_CIX52^Q M7!H^U5A6]9F2A<^MX#!\<+NKL%P:OM18%KY2LO"U%1R&#ZY+EY9+PS<:R\*W M2A9^906'X8.;0VO+I>$W&LO";Y4L_,X*#L,'5Q-[RR7A_?;738,-3V:?.4JY MF<'A26M/\C:.KOK\%K1PY`U(?2[YR(P6C%DP(:6,E2E9K)P%"U*I!6V@K)0L M5LV"2U*C!2U6JV2Q5BRX)FVTH,7:*EFL'0ON/?*KNINM.Z.J^\F]X0V"6TLTBYL(P+ MRY6L)1>.]/._=\=WJ(-/7S)XI9%L2VJ-].2^6[I\!GD7SI8^/?8E#<;I,LE1@X/11HM8X*V2 M!=XI6>"]([<[9A-O=_@MZ[D)UA>=?=_UDZG#$=#1=#AW--+@^H+=YR9.X^3T M.KB27[A8PQ'0T7`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`B1?9;?^T:IES)?NLO89$B^T`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`O=^6YI?)+L_?=[\@RY=WEY+[[ M?5>FR(^WWG>_ULH4^2G6^^ZW5YDB/ZQZW_V2*E/D9U+ON]]%98K\Z*FLVUA* M.9-](!,-+--(2CN:\FYV=]_]S#;+R&]HWW>_:LT4^VRG+&QMY44K+1E%)2JM&41E+:T93%5$;EZ=@XFDI*-II22DHUFM)( M2CN:LIA>RW+&QMY44K+1E%)2JM&41E+:T93%5$9RN74U5C\RDH^FE%*F&DUI M)*4=35E,9227NR9CRY&1?#2EE#+5:$HC*6V?\N;4%+_^\-WO[W]YJ-Y_^>7C MYZ^O?GOX6:Y*WQZ_0/_EXR_=[9?^/[X]_BY7JZ]?_?7QV[?'3\=__OKP_J>' M+UT&F;OZ^?'QF_Z'K.Z;/QZ__.UXY?O#_PL```#__P,`4$L#!!0`!@`(```` M(0"%2D13LP(``&,'```9````>&PO=V]R:W-H965T8T#B)*1,MU(=LJIS^^WYY=4F(=:PO6Z%;D M]$E8>K5Y_VY]T.;>UD(X`@RMS6GM7)>%H>6U4,P&NA,M_%-JHYB#1U.%MC." M%?TAU81)%)V'BLF6>H;,G,*ARU)R<:/Y7HG6>1(C&N8@?UO+SCZS*7X*G6+F M?M^=<:TZH-C)1KJGGI02Q;.[JM6&[1KP_1@O&7_F[A^.Z)7D1EM=N@#H0I_H ML>0`'P2)7$RH"#LL?\^R,+5.4WB8'41+6*`DYVP[E8B)25\;YU6 MOSPH'J@\23*0P/=`LC@_E23T"?7^;IACF[71!P(S`Y*V8SB!<0;$KQL")XC= M(CBG,-.0JX4F/&SB-%V'#U`Y/F"N/08^_V!&1`BBHS*HG:Z,8%3&TF(JUSXP ME4E>EUG\CPR"<[J<)G]DT&.@;:/!Y>O*0'.Z001##Z;2<,5'8F_:@TZ0!LA4 M&L=U&:7!^5L-QG-]%F.=APB4>[2;1/&8UZRC0#]5_?%E<`U'J/C+MWV6;^,+[-MOV/#\0_8 M<1VKQ!=F*ME:TH@2**/>B_%;TC\XW4'FL.FT@^W6_ZSA92;@)DX^YQP?[XEU^?6W.VO>J MZ^OVLM*MF:EKU:5L]_7EN-+_^I9\F>M:/Q27?7%N+]5*?ZMZ_>OZUU^6+VWW MU)^J:M"`X=*O]-,P7$/#Z,M3U13]K+U6%[AS:+NF&.!G=S3Z:U<5^S&I.1NV M:?I&4]07G3*$W4QAF0&?0 M!\4U+XR%`4SKY;Z&"HCL6E<=5OJ#%>96H!OKY2C0WW7UT@M_:_VI?=EU]?ZW M^E*!VC!/9`8>V_:)A&9[`D&R@;*3<0;^Z+1]=2B>S\.?[4M:UP!.\,RK< M'1\=KBS1_U@B>'],A"M+M&>N[07SL>9W1ERP1+BR1/@+QQM4XW'*HF(HULNN M?='@/0`5^VM!WBHKM&"J^611BFGZ?C1[,&V$Y8'0K'1X>IB8'BSW?6W-O:7Q M'6Q2LIC-G1@Y8LLCB"<(;:0"L0HD*K!3@50%,A7(!<``629MP#L_0QM"0[3A M56TXZH3$.S,`4Y,HAVRED$@,A,4(2A.P0DB(D0T@N(I(F4-?/,`>A@7=/ M5BF0)=C0H'=5FD(FE1`2(R1!R`XA*4(RA.0B(JD$"Z&DTON.(=&C&+R(#44< MF(7)']9\+LNSG8)X6H20&"$)0G8(21&2(207$:EV_U.UDVBY=HK8BVGAV"(D M0DB,D`0A.X2D",D0DHN(5"ALK)^89!(M%\H0_U8H0B**.-(.$RA&B*<@;H2$ M$3D3]0Y1IU.6Z+&%[+%L"N+4N4@MR0'/*,E!M]09:1V&4UT^;5KP,JQX=]X% M![9.NJ$2$EDEA@@J(22BB!V,.[!M6LI:&D_W>14)XQ`$0JSIE$7V=6!U%&VF M^YPU%UDE;:`Y>5>;;^WU1]I`\\?%(2RR.`P1Q*&(XTXS'Z&8&,4D+$:0`\6D MB"=#,;G((PE`>BQ)@3LN$"H=P^52.03^NZV)"U.>DRV+-1;#3?]I31H6>*:I3$G"(^SI`7:8 M.N51XS?6N!9D'/HA==,=*I)D41?I?39)%6U)).P;) M#E->GRU+E!S&VMO;UA^S*-L=EW3'MY6=(>'CBVL5I1&84TYS8\XXQ)@M!RG' MRKAC+Z@,*P<'9*R[Y!W4QUM-TA`H[12#'%E%9:78\BAQ8Z1LI,DO/0\943G$K/-^EA65-U MQVI;G<^]5K;/Y.P2MI+UK&"^%K$%X]%?=#^'C">!2$\,F"\30(X7L# MX]$\A`X>X^D\S.[A<-#[,!:D/@\Y`+[#L[%#.`+"_!LGA',0C#^XX0,(AV]L MW!".!``WII'A@/=:'*O?B^Y87WKM7!U`1'/\*.KH$3'],;`/@,=V@*-=T!F. M).$HOX+30)-X_-"V`_]!!IC^=4D;GNS MV3S#H<27G!$UTWG,LFI`'B[EX_!85=?->%SNC]DY+4?% M-;O0R$MQ.Z<5_7I['9?76Y8>ZDGGT]B=3!;CGO/I5.QT.SOM- M_'HI;NGSB>+^ZKP>DZ>GAT-.$;#L M@UOV\CC\YFP2=STWZHCH_#Z6(T7TZF#ID/GK.R"G)V.1SLW\JJ M./]+&3F-*^7$;9S0SQXG'TR<-A-G[41W,EHZD_5T25?_8"*-UK=-/YLK.LO1 M:CZ?+5:?S%PT,VD!-#._>,EU,Y%^ZDNNOW2O#B55:'6_$^H(5$:2BO*2]+9\-N=;:54FW^_U/Z*>_LY1N[>1R2`I39DFKVQY.S M6#V,?U"=[1N;;8^-M-AI"RXJ=NO9P+=!8(/0!I$-8ALD!AB3+*TV5'S_#VW8 M#6NCH]IJT(GE6D)H"SW%LX%O@\`&H0TB&\0V2`P@A*!%!4),J5CZMP1=$SSK M<4@+T:B)M0QTJVRFE('6:"9-=JU)*P80'T@`)`02`8F!)"81FE!$!](`"0$$@&)@20F$8$NK4#Y&>+.1R3,G8N!'4D-%"$-S/S;NV5KU.8? MB`\D`!("B8#$0!*3"%FX(38?K1_7/EO+V!4Q\P_$`^(#"8"$0"(@,9#$)")0 MZE]$H/]U_MF1U$`1*_]3:_VW1FW^@?A``B`AD`A(#"0QB9"%VRFAR\<%4)O+ MZ!MDE@`B#Y&/*$`4(HH0Q8@2@63,W$M]O>@=U7K1XT^G;ML@:\NWFX+.2D_T M$/F(`D0AH@A1C"@12,K`G=0=,JC&2\B@D$@](,\!Y",*$(6((D0QHD0@&3.W M2F;,O`W,*<%W/@0#"3GUKI2=ZW42-?$0!HA!1A"A&E`@D9>#6Z0X95*.<`\A#YB`)$(:((48PH$4C&S'V1&3-O!],5GQG=O2.H%DOHT79=9EDL M[;)HK70->`X@'U&`*$04(8H1)0))B;BC,B7Z9$=0#9B002%U'-B4!2#/`>0C M"A"%B")$,:)$(!DSMTMFS%P6SGS$9VS5,=]_WQ8,>L\6IG2PU!PWJ:9+2-&@ M1;MW[!Q`7H-- M.'\4UUJY1=I4:&4HB\!KFK^C3/G3A6"^9W!JU(VDWW@`HUZBX6=1/Y MG)`\6_U\W!EHSXEVTR.9W7':!:4U^WAQN=B):M3=^@Z1UR`Z#M,WZR,*]$13 MF>:*G?L()\:($N%+E@^W@^;B^B1FU3V:J\AMD%P?UJG=KK/2,7N(?(V:"IH[ M,V=NG6P%VJ;^>T:]MD.-EJV@$:)8H\;YC+ROK#I*M$WM7`IE]ZJ?"(4MJ:L0 MUV6WD:RL\':=52=4.U$C7ULY:JG-UNYJ9G4X@;9Q6U5"C;K*BQ#%&BGGB\EL MZ3A6/A-M4SN70G$S:5:4O;J^M%V[JB45A=8@46@K^V1/3^QJP6L0W7*GG_)% M([RA3)?.;#:S7@X"[CL MT=K0%;)JT3XEX\:+)I*5#M?32/T9C__BXFNTJ+5<+5T2T\I*H&W,6@3GD;;J MG,<:*>=4AY/YVK$RE6BCGF*TVVB[&+^XU6-[[4(OO4/D(?(1!8A"1!&B&%$B MD"PL[F/-POID!V-SJVH4DF]6]AZZXTY)O7]U50/(1ZL`48@H0A0C2@22,G!K M>X<,JA,6&Y%"QAOTCGJ>.N9NB_$0^8@"1"&B"%&,*!%(QFRWT)^D'GME>E]H M`C0?7E:#M^NLNM2W$S7RT2I`%"**$,6(^$N'+A=*!O7E@OHK]CF[O6:[['0J M!_OBC;]*H`E/#RU6GTQLW;7^9L(><18;?HFE<&!D22/U@P=&5C12_SW7'G') M&ZW9'F\N>:,R[ALA;Y3LGA%G0M>IMVO[.@Y]`T*GCWUS7!JIMTZ8,Z61NJ1A M9$8C]9D+C,QII-[`[1&:TCN#)O3:DS"]NI`LO:J0*+V:4"+K1[AU/_1BM^%7 M+52$7F0V_*Z"(_0BLN%W#1RAII[F].E++3K-Z1NASW*^]>M.$O9<8TN)ZK6G M-/5EZ=N,_*M.MHV=/KNYIJ_97]/;:WXI!Z?LA18`?>Y"#^.;^G!'_5(UKXW/ M144?W-1OD$?ZP"JC!_Z$WRU?BJ+2OY`:X_:3K:=_`P``__\#`%!+`P04``8` M"````"$`3SV1;?D"``#L"```&````'AL+W=O5K?/=>4],:FX:%(2^2'Q6).)G#>[E/SY_7#SB7A*TR:G ME6A82EZ8(K?KCQ]6!R$?5Y M"U0K&7LH`;WGBK%X8OD M^7?>,*@V]`D[L!7B$:'?<@S!XN!L]8/IP$_IY:R@^TK_$H>OC.]*#>V>@R,T MMLQ?[IG*H*)`XT_FR)2)"A*`JU=SW!I0$?JGI=#A>E9#8T$4<]O\W`8J`EO=%9CW",`LUX MHPB&)KG2K]:LM`6-D`;(4-JT/5G@OGNG`+C0I-$7O(M`W7N_43R][#AV9:_7 M&L&N5!>9F!T]W#*)RXMVDF2$&USG2G01U\T;_<.#>?#M7'>#8%>JBYR[6;B\ MXYN#"UV-+N+:F5]N3@2[?[P?@W;%CJ%S1Q%^_(-2V8\M]I-W]YM9>2+3G22N MJ?@-4X`:*E]O4H3H$[4N=,'4A1,D&O41P90YD^E"KJGDQ)2=+?8`KYG.-\BI6`&=H>B3M MM+(/6K10(I@X0L.4,;6A@(``%$&```8````>&PO=V]R:W-H965T&ULE%5=;]L@%'V?M/^`>*^)DSANK#A5NJI;I56:IGT\$XQM5&,L($W[ M[W>!A,5MM68OEKD^G'//O1>\NGJ2'7KDV@C5ESA-)ACQGJE*]$V)?_ZXO;C$ MR%C:5[13/2_Q,S?X:OWQPVJO](-I.;<(&'I3XM;:H2#$L)9+:A(U\!Z^U$I+ M:F&I&V(&S6GE-\F.3">3!9%4]#@P%/H<#E77@O$;Q7:2]S:0:-Y1"_F;5@SF MR";9.722ZH?=<,&4'(!B*SIAGSTI1I(5=TVO--UVX/LIG5-VY/:+5_12,*V, MJFT"="0D^MKSDBP),*U7E0`'KNQ(\[K$F[2XSC%9KWQ]?@F^-R?OR+1J_UF+ MZJOH.10;VN0:L%7JP4'O*A>"S>35[EO?@&\:5;RFN\Y^5_LO7#2MA6YG8,CY M*JKG&VX8%!1HDFGFF)CJ(`%X(BG<9$!!Z%.)IR`L*MN6>+9(LGPR2P&.MMS8 M6^$H,6([8Y7\'4"I3RIP^=1NJ*7KE59[!.T&M!FH&YZT`.*WU\90=VRJXJ+I7K$#B5F;XM M,_L?&08-RP$#%H\%Y1(P,`LWY!AT8>C"6SB-QD`Z@,Z0!>#(L!R$7:0NT0%'T<"U+M"U$$@61CI.W[RQG17.&:VKM7#BV]'$X_\X, M_Q7%VT_?][O9M^K4;.O#7JVP^:]K58;/:U8=J M.?]1-?-/=S__=/M2G[XV3U75SB#"H5G.G]KV>+-8-.NG:K]JKNMC=8!W'NK3 M?M7"GZ?'17,\5:M-=]!^MY!1E"SVJ^UACA%N3B$QZH>'[;HR]?IY7QU:#'*J M=JL6\F^>ML?F'&V_#@FW7YV^/A^OUO7^""'NM[MM^Z,+.I_MUS>_/1[JT^I^ M![J_"[U:GV-W?XS"[[?K4]W4#^TUA%M@HF/-^2)?0*2[V\T6%-AEGYVJA^7\ ML[@Q.IDO[FZ[!?IW6[TT@]]GS5/]\LMIN_E]>ZA@M:%.M@+W=?W5HK]M[$MP M\&)T])>N`G^>9IOJ8?6\:_^J7WZMMH]/+90[!D56V,WFAZF:-:PHA+F6L8VT MKG>0`/R<[;>V-6!%5M^[_U^VF_9I.5?)=9Q&2@`^NZ^:]LO6AIS/UL]-6^__ M0TBX4!A$NB`*LG?ORW<'T2X(_'\.DEQK&:=90"H+E-6MDEFUJ[O;4_TR@]:# MQ)OCRC:RN('(=GD4+#**Z1?LK?6"A;)!/MLHRSG,#!S>0)&_W0D1WRZ^06'6 MCBD\#"7*,V&K8,,:?`%^#L(F_4$+D-#K@"4>ZO"7]YRNA6VZYQ,5^,+P1+(_ M39=*.29R)M",$9GW44BRT`?AR5IX.8?:#!8A[>-VV17(0$/VC*9$>9$P4P3) M'E()S]["T%*#S$3$LT,/8A7(:-9%LA,5>$B8:8(HB*A*J:SMS"K@GCM3>PA9%*L@A8Z M9O)*`B@12P88!/SZ2>XIS3VL`O8@ID%&K`+(.`TB%7P*\'V2(>\C#]*?A(BP M.X3!E7.Z`!;FR;,F+Y#!Y+5()'N_'+ZOXDSSS/%](LZ?>?Z>S"W,,W\=+&P= M9#!S2#Q-5'_B#BB'@%)1Q+49!`)R%V!.PV4/ZYWN**Z")5DXB"3!UKATC"M2 MEL)NCDHUOB@]0AI(6'L;=%"@%#1%8R'VM!A(1Y M0XLUOX&6Z6D0:)54`[/3PD&87Y;&/+OR$F`<$)*^-;_P]"W-NXEU2B$0PO1C M'2FFKR2`UHH/C7%`2/K6_`;I!W826B;\['<-0G)O%@CYD\#AOHR8280.!9QI M*.5"(UF:5X+94F&W^P"=&UWE$;M^E82X2J1B(8P#_*M`\[!`$B M'3/`."!$A;7"@8H+14#C'&:OV56]$$/SO5*94N/\"9(+*=@EP;@@(0*L'X8+ M0/QUJ/+T1"`^N0Y:S/C0@2D+S]DTMU1=)@UF]3",6Z68Y$R MH"3`E=*13)A2XY`0'*:3'E-G%IG0, M5BJ5L'UB48PO2J^22H#%>D<5+$WG6"C6`X6]>]:;,LQIQC_0EY20L'P? M6DB$_"=W\W`1,9-1:"V8.0?68FS20K&>+R2Q8`'W*)B'E8P0*2>,(_S+084P MDPX4,C9KH?BN6Q(SCNR_?C)=288$#/>(,"Y&@!![PS=\O#N:CS=S@<)!Y.2L M6J5CW.3`)VF/"%^0U7A# M!S#O&'A+LQD9;6P50J[_TURSSW\E`50F56Q<9Y>X2#, M/TE3#I0.(-FQN3'3#&VE=QFY0@.FT\`^UQ0.0@EQGO%&+PG@+P&>Q[<*-'OF MX1<*X/%N?O>Z4$/OEG$L67N4!%!)FJ?,=(PC2(G>&(`/6;="SR7;*1)-CLEHYQK9_S?;[QQ?`WE_Z0>7='L8K$;+T+![F*)",O M*PD`^U_XKJ5/$MW.$60M>H06Q#KGX"948&>AWY*"\%MYA48(=:0ZY?<92@(D M><:W,<8!(3(^9-K:8]HQ^]Q6.(@D,>JKH;%#060J61CC"_-&2>!4O"0:7IN^ M_EJ"&SAWW\)!TUHP$)9-)3(>?V7D"_.&%F;B@>WE,?.8770*>*#("I[6@@P^ M=:`]'SU\09@2?.H(GZ?95Z?'JJQVNV:VKI_M$T42ODKO7^V?=OHL[6,G[/5" MW,#3+_#ZHG\#'D(ZKAZK/U:GQ^VAF>VJ!P@97:<@ZH2/,>$?;7WLGN*YKUMX M_*C[]0D>-ZO@^9GH&N"'NF[/?]@3]`^PW?T/``#__P,`4$L#!!0`!@`(```` M(0`#[635L`(``"<'```9````>&PO=V]R:W-H965TOWO,>8^>US7:$G)A4738J)XV'$FDSDO-FF^-?/^YL)1DK3)J>5:%B* M7YC"MXO/G^8'(7>J9$PC4&A4BDNMVYGKJJQD-56.:%D#_Q1"UE3#4&Y=U4I& M\VY27;F^Y\5N37F#K<),7J,ABH)G;"VR?SAVTC)-U44/"[1#DKZ+[2/\3A*^/;4D.W(RC(U#7+7]9, M91`HR#A^9)0R48$!^$4U-SL#`J'/W?7`H_%B)'*2OB'T7@>A0A_H=%@J,(7$\B_B0B4?Q_*ZXMJTMI335=S*4X(-AY M8%RUU.QC,@-E$T\`(;\=#^1BYMR92=U4H!6T]&D1^.'\3`(X1W[O']``T, M09^M2Y)3[=:;9:9=O'Y$0A)Y0_>K`1$",@EZ8N`-0KC>FX%'WB:CE9>62:RW M<.I/PKA?N7._.B=B+TP(.=4W\`;A7^_-P&-O9+CRTC+66Y"0,`Q'75\-B-!+ M`O*/W.*/>#/PV-MHRR\M8WLZ27PP-W(/1Z%1L01DYD53:-0Q0K8QIZ30'W2GG1VH$7;O:T;H>&$ZFY+^"`Q>)4]!^!""/TZ,&=I M_XE;_`4``/__`P!02P,$%``&``@````A`%5O,]PI!P``GQX``!D```!X;"]W M;W)K&ULK%G?CZ,V$'ZOU/\AXOV6`/FM)*<-X+92 M*U75M7UF"4G0AA`!>WOWWW?&-N#Q<-GLJB_+YO-XF&]F[!GL]>=OQ7GT-:OJ MO+QL'.]A[(RR2UKN\\MQX_S]17Q:.*.Z22[[Y%Q>LHWS/:N=S]N??UJ_EM5S M?6Z=7K*BJ1^**_9!48.954D#?RLCFY]K;)D+R<59]071VE85??H*`^'/,VB,GTILDNCE%39.6G`_OJ47^M66Y'>HZY(JN>7 MZZ>T+*Z@XBD_Y\UWJ=09%>GJM^.EK)*G,_#^YDV2M-4M?S#U19Y695T>F@=0 MYRI#.>>ENW1!TW:]SX$!NGU498>-\^BM1.`Y[G8M'?1/GKW6QO^C^E2^_E+E M^]_S2P;>ACAA!)[*\AE%?]LC!)-=-EO("/Q9C?;9(7DY-W^5K[]F^?'40+BG MP`B)K?;?HZQ.P:.@YL&?HJ:T/(,!\'=4Y)@:X)'DFWR^YOOFM'&"V<-T/@X\ M$!\]974C`XHN3$QT!/AJ2?Z8.=BZDUG^/H; M,R=Z)CSU3/COACQHDSSAJ>6]2<_SQL29G@C/^TQTE8=EP**D2;;KJGP=P2H` M'];7!->4MP)M;:34N[O8_2AT$#-4\HA:-@XL7XA*#?GV=>O/O;7[%7(DU3([ M+F-)A*T$)@2JC6P@M@%A`"XPZFA!T/\'6J@%:;4&[5K`X$E9AJU$.R6R@=@& MA`$0#I!_-H<`EN+P(FHC@9,V#J2=$0F?VKA3,K`!]$(3*A)V(AT/AL0,$29" MJ(`]-A7<#]Z99:@%\I22"ZCE.R5TDUPGTI%C2,P082*$'!`QR=V.#PI+#NV[ M=PH)(`N,D-GQZ(3::1%#8H8($R$FPTJ_WV04IB8K)`BZA1$R)&)(S!!A(L2^ M.;4/=Z4Y5(!W9PSJH:8K!$PWO3VE.11V0IVW&1(S1)@(88-MC;''WDX0%*8F M*\3T-D,BAL0,$29"[%M2^S[L;=1#35>(Y>V9Y>U.J/,V0V*&"!,A;#S8(^]W MMY2F1FO(=#B'(@[%'!($HF9BZ;H[*SQ5Z&#O:YVTTY#EW+GEW%ZJG1AQ*.:0 M(!"U'`O6_9:K\D8L5Y"_[,B$'H,B#L4<$@2B9F(U,LQ4K@5)/7VWL[#]KB?..HZ1IR`?]@ECIU_2B7$OU09, M:`@>`%&.6)1N&:BJ[.7T8O*75B\:M MYH74O)R-`VMEB59"9C&-"M:U^VFI*DAH*<@?M[3L`N7IRMD[/M(0S+E)2VOV MI&;/7XPG5@**5I'/LPTKG,'K8RM*E4E"5T-=%.T*`?&5J6=&44$^K*EN,0U$ M44M-%-U),!^/Z7H36K8W>(>J+!,N)0S"%!($() M#Q_O][R4I@550X9-(8MYJJ,)>JMMQ M.!1S"&]D\(W*/8J2NF%1!_9%5AVS,#N?ZU%:ON#M"81JN^Y@=;6S"[J['7O$ MGZYP5P.KV,@,1F1SR4;F,#(?G+.`$7DTSN8L842VT_9(,(9[)WEU9(]X,`=: MN2';8`YT3T,CP!1:D*$1'T9DM;7?XPO']"T M0S<.X>#$H3<_3E:/D,3+Q5#9P,2@//TYP$9S!1\88F^I#63;M#S#4[:Z6 MM_\!``#__P,`4$L#!!0`!@`(````(0`+-<.U>@(``"`&```9````>&PO=V]R M:W-H965TNG1;]F(;?#CGGOO!\OI)=>01C)6Z+VF6I)1` M+W0E^Z:DW[[>7]T#R5]!DNO5V_?+'?:/-@6P!%DZ&U)6^>&@C$K M6E#<)GJ`'O_4VBCN<&D:9@<#O`J'5,?R-)TQQ65/(T-ASN'0=2T%W&JQ5="[ M2&*@XP[CMZT<[(%-B7/H%#<$6#)E6RTJB`Y]V8J`NZ3HK;F:4K98A/]\E M[.S1-[&MWKTWLOHH>\!D8YE\`39:/WCH?>6W\#`[.7T7"O#9D`IJONW<%[W[ M`+)I'59[BH:\KZ)ZO@4K,*%(D^13SR1TAP'@DRCI.P,3PI_">R;,"Z.^DY*1%;Z[3Z$5'9GBNRY'L6?!]89LGT*KT\@X3%B(+!6^[X M:FGTCF#3H*0=N&_!K$#BUQVA%8]=>W!)L:DQ5HM5>%SEBW3)'C%U8H^YB1A\ MCIAL1#`4'951[7QE#_;*/K<^E)NX<2R3ORYS^3\R'ES2R5'PIP8C!LLV&IR\ MKHPTYQOT8*S!2^E?F8NF(^@,:80<2_M^S>>9;\Y_5-@?#&&,B=[O8+Y'O_GB M#[F>O93]>S-Y\$NI_4X>9C&T2IS(V+`*3`/OH.LL$7KKIRW'%AQWQXM@'<[_ MOC\IUN&"8.,/'-"!-_")FT;VEG10(V6:7*%A$T<\+IP>,$R<4NUP,L-GBSF"8)KK=UAX2^1\6Y?_00``/__`P!02P,$%``&``@````A`(6Y":V!!``` MZ0X``!D```!X;"]W;W)K&ULK%?;CJ,X$'U?:?\! M\3[AFI"@)*-`PNY(L])J-3OS3(B3H`8<8=+I_OLMWP#;&=0C[4O3G%0=ZE25 MR_;Z\UM=6:^H)25N-K8W^_K1^X?2%7A#H+&!JRL:]==XL=AQ175.=DAF^H@5_.N*WS#E[;BT-N++V(QSX?"X+M,?%O49-QTE:5.4=Q$^NY8U(MKKX"%V= MMR_WVZ<"US>@.)95V;TS4MNJB_C+I<%M?JQ`]YL7YH7D9B\&?5T6+2;XW,V` MSN&!FII7SLH!INWZ5(("FG:K1>>-O?/BS/-M9[MF"?I>H@<9_6^1*W[\T9:G MKV6#(-M0)UJ!(\8OU/3+B4+@[!C>&:O`WZUU0N?\7G7_X,>?J+Q<.RCW'!11 M8?'I?8](`1D%FID_ITP%KB``^&O5)6T-R$C^QIZ/\M1=-W:PF,TC-_#`W#HB MTF4EI;2MXDXZ7/_@1IZ@XB2^(('G$Y()QT`XPE,X>N$L\MQ5$,'7)QQ#X0A/ M^<5)>V!C,N$I/^0.,B<^M!".\)2.DQ$Z/+^L7/N\R[?K%C\L6`.007++Z8KR M8B"3=>*?[BOWL\)!Q2C)CK)L;%B\4!,"W?:Z#;SYVGF%#BF$36+:>*I%*BUH M.U#:O0X<="`;`0XHZF5!R?\'692%RI(!)1(8=/J:!FDA7?8Z<-"!;`0H&J#[ M=`T!+,3G2TA6@CIM;.B_4246:HP)MPD@=[U1J)JDO4FOPT`.!I*-$44*Q*-+ MH=/@%[N,LD"?JN(B-?*$&TV*ZTUZ<09R,)!LC"CB0(@NSI_/?ET>Y6'R9%@) M1P)(:U\H/]($I[V1=-L;R,%`LC&BJ($A,%8SW6W46`V9(_ZJ7S.I@>P-Y&`@ MV1A1XHO4^/C`FM&YW%W+XB7!D"KH["=Q!S"8^+BB'&K8'&$LX[X\!@5:*6Z'7HC6:!,$`642!%'CS_&-![$?<.WGXF#;5&JHR2J.H$, M@:<<"<)!"D>BP>9@()G@,>->J7$_2?XH/FJLQB>0B.TH\A\=Y*VT\.PFC):%<+-]"63B8,6+,J=?!@SHX+,2V(6:N*!.2[4I*V&Z;" M(!CRO1]\ID1)*X\Q>_[2#;6&RZ0).]^INNA^.=%@'UH]'M]T80[+ADXDU%=0 MVW)283`NH8#\\70S:RBM0BXW#"+75==7)C_^I(QT:]7EPCE2S`JYG#X^..#( MK/>N@*#20]6@*&J,J;!2RLVYZ'FV'QY/]`NK!=,?+*)HJ>66GN-I4/ZHW/Q< MS@]Z-6HO*$551:P"W^F9&_ICN^YA?B'81S$,*BBHCB]C&`0F#A>('?N@9I_0 MB\43^\2/X:!C\B1!#,<&$]^%\0Z$F3\D80Q;\1-\'L.F]@1?Q+"9`.[TD<)% MXY9?T%]Y>RD;8E7H#$EQV9AM^56%OW1BW!YQ!U<,R!N!H"J=TVSIC MW,D7^H'^DKK]#P``__\#`%!+`P04``8`"````"$`XN%RO$8<``!MD@``&0`` M`'AL+W=O-+QUN,HB6OB.&5[-KO_?ALDF@W@111[9O9BG7G0_>(,`LV# MWO[K/_=?3_Y]>'RZ>_CV[G1P=G%Z;=?3;F].3I^>;;Q]O MOCY\.[P[_>_AZ?1?[____][^>'C\X^G+X?!\0@K?GMZ=?GE^_CXY/W^Z_7*X MOWDZ>_A^^$8IGQX>[V^>Z3\?/Y\_?7\\W'QLG>Z_G@<7%Y?G]S=WWTX[A/GVZNSW,'V[_O#]\>^Y$'@]?;YZI_$]?[KX_L=K][4OD[F\>__CS^V^W M#_??2>+WNZ]WS_]M14]/[F\GB\_?'AYO?O]*]?[/8'1SR]KM?X#\_=WMX\/3 MPZ?G,Y([[PJ*=;X^OSXGI?=O/]Y1#52SGSP>/KT[_3"8["\O3\_?OVT;:'MW M^/%D_/ODZ'/Y3IXJ-"Y'P.WE';`]7CRG6VI1DCD+QDKI]N$K%8#^_^3^ M3@T-:I&;_[1_?]Q]?/[R[G1X>3:^NA@.R/SD]\/3GZXWW5& M`RW5B01:A/YJD6!X-@K&5V]>HS+4*O17JUR?!6_&@_'E*XI"A6[K0W^UR-79 MF_%X=/GFZN7UN=0B]%>+C*5-CK3#E?:CO]P.U"1''&@6MJ6EO^Q@M-L1QVOM M2'_[$DHUCS@.:(1U':Z&FN[,D=%$QWS[P4+_8-_@A;[!C(@##GQ;'R M\L@8&$/C98-PP&-#_8.K2IU])+>@G\`R@PR[KL^]7M9XL;K6I*Y8.2>7=* M[4;KUA.MR/]^/[QX\_;\W[2*WFJ;*=H,;(L96Z@E4\G.71"Z(')![(+$!0L7 MI"[(7)"[8.F"P@6E"RH7U"YH7+!RP=H%&Q=L7;!SP=X`YS0(^I%`P_"?&`E* M1HT$[L,I`QD:@=/M;,$N$+HA<$+L@<<'"!:D+,A?D+EBZH'!!Z8+*!;4+ M&A>L7+!VP<8%6Q?L7+`W@-7MM(3\$]VN9-Z=T@)B+`#7=C]/.YLA#<#>:&2; MS'J3?BP`"8%$0&(@"9`%D!1(!B0'L@12`"F!5$!J(`V0%9`UD`V0+9`=D+U) MK`%"??I/#!`E0Q<9:X0,+NSNGW9&1T=(;]*/$"`AD`A(#"0!L@"2`LF`Y$"6 M0`H@)9`*2`VD`;("L@:R`;(%L@.R-XDU0FA[9XT0_SF(MPK*NAT(W('3C@QI M!/;K0C`8VT-CUANQVQQ(""0"$@-)@"R`I$`R(#F0)9`"2`FD`E(#:8"L@*R! M;(!L@>R`[$UB]3MMS5_1[\K:[O>.!-?]7F$&9`XD!!(!B8$D0!9`4B`9D!S( M$D@!I`12`:F!-$!60-9`-D"V0'9`]B:Q.IF.4:_H9&5M=[(F;3BFW=3/@,P[ M8@R$$$BDO8;]8(E!)P&O!9`4=#+0R3LR-(\SP>#27I"6O1$O2`5(ER!==<2H M:@VD,76LOJ`"O:(OE+7=%YH8?0%DWA&C@"&02'L9?0$Z24>.M^&B-^(V3$$Z M`^F\]S*O%U=.]_1&+%V`=`G254>,VM=`&E/'ZAXZ^[^B>Y2UW3V:&-T#9-X1 MHX`AD$A[&=T#.DE'G.YQVG#1&W$;IB"=@73>>YG=XP0#EKT12Q<@78)TU1&C M]C60QM2QND>%X5[1/ZVYW4&,C!Y"--?(:5OG,!2*%;=`Q%I&QS&2'!-Q--HW M<';2"[%B^92U1#YC)/*Y.)KR3J1F*58L7["6R)>,1+X21U/>B0C48L7R#6NU M\G:_JH@&QK#.5/#Y^L)0T6,Y(<$Y]\$`SMU6XA5BR?LI;(9XQ$/A=' M*7T0.,?RI5BQ?,%:(E\R$OE*'$UY9V]?BQ7+-ZSEZ6X5R3C6W>N'[S_K;KJI MT?=W%Q"Q^ELC*?]L`&BNT;"]1]2.G1!1Q([2/#$CD4_0<8$H94?1RAB)5HZ. M2T0%.XI6R4BT*G2L$37LZ.DC%4TP^\@S]2R%VHK"^BHP'8Q'P\'862\CMI'#2(SB"5N9I1I<.XOC0AS; M_,Z&SG4U91G)+&,DZT.NT4A6I"6B@AU%JV0D6A4ZUH@:=FRU[#56'?Y?T:%= MK,#JT`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`V2L&A(ZGR65CJAX[59M`V5;/$,T1A8@B M1#&B!-$"48HH0Y0C6B(J$)6(*D0UH@;1"M$:T0;1%M$.T=Y"=N^KT)G9^W\I M?*">%'97B0Z-Y`&8L5 MRR>L)0-WP4CD4W$T2C]R8FB96+%\SEHBOV0D\H4X&O)#I_2E6+%\Q5HB7S,2 M^48<#?F1LSM,1'XKCJ:\$Z?;B17+[UFKE;>'I(JZF4/R%YN; M+DAG1CV##EU*&&N&:*Z1-;@ZQY%4,$+'&%&"6@M&HI6B8X8H9T=I^"4CT2K0 ML414L:-HU8Q$JT''%:(U.XK6AI%H;=%QAVC/CI[>5_&_5_2^#CV:.QF-S/`) M!"IFZCI$5SNZGV$.7"=&.M=6(UF30HW&$DF*-%+AO'Y]@QQCR5%%-@=G@\&% M^3]G2B:8]0*S3AG)4,\THL!5F\]P>#VZ<%:K',67K"3U*ECI:+U*;44MV=5K M["SL%6968V8-(ZG)RE8.SIP8SQJ%-ZPBM=@R$N&=1KJ)QE?#J\`Y^NPM;7M] M1P@8B33)!9YU6W# M,_?QDX1]1'G!2)131J*<:43'5Z5\-;ZZ,1+EA),HK6WEXYHSB-;N(\(:1"&\9B?!.(]TQV:E%)-Z:#7GO?,F":L63-M-;972:?-Y]K*6B4[>6N5U$CF M8:P=]=(Q.G.?L$I0><%%DAF>,I(;?)E&M/%5XV0TN**EUGZ\*D?M)0N)=L%( M2EUJU)?ZTEF7*E2N64:4&T:BO+*5K\Z$5M&.9<EB$Z8R33:\Y()F'(2*PBC53H]H/Y(N MCT^\[/Z*BHT[`1"-:&[PP66&:(XH1!0ABA$EB!:(4D09HAS1$E&!J$14(:H1 M-8A6B-:(-HBVB':(]A:R1X4;)/^+K\$/^^BYK";T50_[:C+55JHX_9KC[-5F M8L.C:8XH1!0ABA$EB!:(4D09HAS1$E&!J$14(:H1-8A6B-:(-HBVB':(]A:R MA\[KPNGJ+HJ[<'3(OK\R[9-5>A0*@Y/2"H3KWJ M7:,7;A^[B*)5W0Y9U04T'P(*$46(8@O957I=C$J]UN8.S0Y=TAK5C[!@Y`1% M9MJ1K'B$S1&%C#A">#6T'MVZ#G]S=E,1>XANS*@3>7/VQ@R>7ER,P]]^UKTJ M[F!V[R_6[BY,875CA^CS2MH"4,A65^W9T(E)1)PJ1_>8D>M@ M];=Z*/L5=6S-[?.W1G9_NW&[F5CU=404,NK[VXEM1VQ@="\C]KD<_:0[U0.( MKZDJ'NI:!5J$K.X<.V6$W&J.,2,7`>[._^AHPL] MM:WGM0SPO90^=U1Y<1'ETT4IMA6?G'3HQS)E8R(/#H@E81 MHAA1@FB!*$64(T"\[NA"+S^Y M6P&-C'/*#-$<48@H0A0C2A`M$*6(,D0YHB6B`E&)J$)4(VH0K1"M$6T0;1'M M$.TM9/>^>W0YOOFA5QJA]S62:]B,K03--3+&2(@H8D>)=\2,1"O12&WX9`%R M/]6R$"M>@%+6$OF,D4,$47L*'6.&8E\HI'38TZ3+L2*FS1E+9'/ M&(E\+HYFCSEGD:58L7S!6B)?,A+Y2B.C)6I$#3MZ>DR=WU[18]UQS^HQC:10 M,WHLJ9V)@N8:.:WL'$-"L>)FB%A+FB%F)/*).!JM#-\@$2N63UE+Y#-&(I^+ MHRGO[+J78L7R!6N)?,E(Y"MQ-.6=L)?(E(Y&OQ-&4=\Y?M5BQ?,-:GNY6AW5S&KO=_;(P$#T% M`?VMD91_QE:"YAK1;4XN;(@H8D=IGIB1:"7HN$"4LJ-H98Q$*T?'):*"'46K M9"1:%3K6B!IVQ#ZBYTGL/CJ^G6G-[3@'(W-6X3=(M!5%2[DOYN+(*&2DOT$R M'`5O1LXY*6(;N8,(-HU< MDR6B@AU%JV0D6A4ZUH@:=FRUK-W.^'71G-;&HK8Q(@SHW;"5D>?VUB(8]>?[OM7*S8:MG]Z4:N?C%!^P`5%WU*3S*VZZ)9R-8\0YRDB/Q9&U$K8RR^69HETAU&V6_J(-+_ZGK"4Y9HQD M;N4:6?.TDS=0P8ZB53(2K0JU:D0-.WKFJ1M6O1$E'!CE+4 MDI%H5>A8(VK8T3-GW0A1V[=_Y\X?/<7G[H$8F=,G@&^2:"MK6G=:%#?GJ1AJ M*PJ"ML_7C:Y]UUU=!.F_&,435J)K2#]B/)-:%Z&[D4C77>=8D6J9[M7_-JB> M86:Y9,8U63+JE(?P31(4+E&X8I6CM:C9BN9-7U=8FAHK1WMI=T-)[A+PLOVQ M>I;8N=>HD7$EGB&:(PHU,I:%B*UDRL2,9,HDB!:HE;*5:&6,1"M'M$2M@JU$ MJV0D6A6B&K4:MO),93=XY/;1RY9IC"F--;*GKW.V9OCH_GKY.7"KENDE>&58DE[QD]EK"\,I`@<(E M"E0/2#<0-DO!@0&Q-2;X#0@C(C[#-$<48@H0A0C2A`M M$*6(,D0YHB6B`E&)J$)4(VH0K1"M$6T0;1'M$.TM9/6^>LW^Z(7D15N,5L4. MY&A$XXXG^PS17".*VK-5J-&5[*,BC:S8>>"^F!J+%6LEB!:(4D09HERC*SFY M+!E)40MQE"MJ,';NZI1BQ46M$-6(&D0K1&M$&T1;1#M$>XVZ:MM#1X7J(,+^ M=PZ:](J_>YC02`W@?D\8#)V8STRLN#WG&AG=%3*2[HHT4I44^4OGKDPL5BR? ML):,A@4CD4_%T91W[I)E8L7R.6N)_)*1R!?B:,H[Q]E2K%B^8BV1KQF)?".. MIKSSO-E*K%A^S5HBOV$D\EMQ-.6=0\A.K%A^KU&W:-A#4@74S"%Y_%I&3_+" M>.L09<'9S;25@>8:6A>A8XPH0:T%(]%*T3%#E+.C+*=+1J)5H&.) MJ&)'T:H9B5:#CBM$:W84K0TCT=JBXP[1GAU;+;OW50SQ%;W?A1S-._>7&IGG M8CB!SK25'16^=.Y6SK45W?WBD11J1/=/&$4ORC&6'+M;"^Y'V1/,;(&9I8QD M<&<:\>LCQCM+-2 M+TT8%S;G#N-<:]&-`AZ0(2.Y\QLQDD+$&I%\&[,]EVWN,<1[V2'U#;M^='G&8&>EXIN] M57#I!`KF6LM:)[6C3,1(6]&M2AZIL49Z*1G!QT,25%ZPC"BGC.3>3:81?U\! M[QOG*+UD'9$N&$FA2XU^6N@*E6N6$>6&D2BO;&7Z$7E[%5^C\(951'C+2%IC MI]'/6V-O2=LC4$4PS>7N;]^,4N]Y="%+'@A3C7ZU(G:.SHKHG"3F6LM:$3M' MNN/&.48ORC'65GJYP1M-"6:V8"29I8QD\Y1IQ)^D\-TRR]E-EIPE(Q$O6.GH MU:345GU-G#E MW8R%\_SIR^'P/+]YOGG_]O[P^/DP.WS]^G1R^_#G-UK"!O1-,(.?/!X^O3O] M,`HF'RB>3X.C]^A2Z%6-4E3$ MUY?RAE+:+;:C-AU?4TJ[-W52/@2#R0>*]7O4*$5]QMB70C6E[]GZ4JBF=)WP MI`Q)S9O/AR&U:'>+R2D;?9>!?+SY#"D?"DG[\J$6I;>!,>4#5=2K107SUY*J MXM&9JJP]_,.(]-NUU:V&ZF./PW1,?>+CEQ/Z]5>LP#2XH!)Y<[@,)NK@BCYT M*IVH8RBFT!ESH@Z5F$(GQHDZ(F(*G?\FZL"'*72:FZCC&Z9,+R^H;+Y24Z"/ M2N!+H;@:J?E2II<#4O-U%P5WJ*:^%(K+4#Z^%`JI4$U]*10-H9KZ4BB0067S MI="S7!/U\!:V`3V9-5&/8F$*/2=$/KYVHZ=^R,>70L^?D(]O"-+3).3C2Z$' M5"?JB50L`3UN.E'/EV(*/3PZ44^+8@H]"CI1SWYB"CV?2&7S]1P];4AE\Z70 ML_%4-M^"1H^U4]E\*?1$.I7-ET(/DU/9?"GT4#;EXUL>Z7EJRL>70H]"4SZ^ M%'J*F?+QI=`+_A/UKCZV#KUI0R7PI=![,U0"7PJ]\D(E\*70VRI4`E\*O1]" M^?C6$'K;@_+QI="+&I2/+X7>L:!\?"GT!=F)^CXLUG0:7$[4=ULQA3[*.E%? M8<44^L3J1'U3%5/H@ZD3]8543*'/GT[4]TXQA3YF2F7SI=!O2DW4CTBA#_U" MU$3])!2F3(,1U<>WBM.WL:G4OA3Z%#65P)!+H9_.(Q]??>B'\,C'ET*_ MU$8^OA+0[ZZ1CR^%?L!U$M+/C6+KT&^O3A;>%/K95,K'YT._>$KY^%+HAT,I M']\*2S\#2OGX4NA'/2D?7PK]1"?EXTN9T]+K6RL36GA]/*=EU\?#\N;Q\]VWIY.OAT^TO[]H M/Q+R>/=9G5*[_WC6OU3[^\/S\\,]'0%.3[X<;CX>Z,?4+M3/O'UZ>'CF_Z#A M>?[CX?&/]@SQ_G\"````__\#`%!+`P04``8`"````"$`\MO:R6L"``#'!0`` M&0```'AL+W=O*;:RE>YU(*5$B?RQ M[K3AVQ;C?DG'7+QQ#XLS>B6%T597+D$Z%HR>QWS/[ADR+>:EQ`A\VHF!JJ#+ M-%]-*%O,A_S\DG"P)]_$-OKPV-4)KLL<_L_,AYEYDOYK_[XWPY M#!"+/W".>E[#$S>U["QIH4+*43)%8R9,8E@XW0_=O-4.!VCX;/#"!&R648+@ M2FOWMD!A%J_@Q1\```#__P,`4$L#!!0`!@`(````(0#EUU+J7@8``&`8```9 M````>&PO=V]R:W-H965T6XTO_ZDGR:ZUH_%)=]<6XOU4K_7O7ZY_6O MORS?VNZE/U75H`'#I5_IIV&XAH;1EZ>J*?I9>ZTN<.?0=DTQP,_N:/37KBKV M8U)S-FS3](VFJ"\Z90B[]W"TAT-=5E%;OC;59:`D774N!GC^_E1?>\[6E.^A M:XKNY?7ZJ6R;*U`\U^=Z^#Z2ZEI3AMGQTG;%\QGJ_F:Y1W>C^<5KKCS[S` M="P(UYZK?DAJ0JEKY6L_M,T_-,AB5)3$9B1P9210\GN3798,5YX\FWN>Z\\# M>(('H\+=\='ARA+]]R6"]\=$N+)$>^;:7C`?:WXPXH(EPI4EPE\XWJ`:CU,6 M%4.Q7G;MFP;O`:C87POR5EFA!5/-)XM23-/WH]F#:2,L3X1FI(+01BH0JT"B`CL52%4@4X%<``R09=(&O/,S MM"$T1!M>U88#-[%L10@>P5,B%8A5(%&!G0JD*I"I0"X`DA#.'2$<,,O]-YI[ M@F2M='B'!$_X/=$E5S%#1L:\U"D*602"2$Q0A*$[!"2(B1#2"XBDDBP#DHB/38,B1ZU MX$5L*.+`)$SVL.9SQ2!3$$^+$!(C)$'(#B$I0C*$Y"(BU>Y_J'82+==.$7LQ MK1M;A$0(B1&2(&2'D!0A&4)R$9$*A7WU`Y-,HN5"&>+?"D5(1!%'W&"L0#%" M/`5Q(R2,R)FH=X@ZG;)$CRUDCV53$*?.16I)#GA&20ZZH\Y(YS"+K/JT@8AR`08DVG++*M M`ZNC:#/=YZRYR"II`[W)0VV^M-'L,CB,$00AR*..\U\A&)B%).P M&$$.%),BG@S%Y"*/)`!IL20%[KA`J'0,ETOE$/COMB8N3'E.MBS*H?TU[:7( MT,`E)RHM6,SIYZ.'7"CA:QJ/8:+[M*:/E/&(<39:2 MM&UBZ_H?4M(N#W9:;M.-12$;A!&D5';?+8MR;N:*;HF<*^:0->H6>*:I3$G" M(^SI`7:8.N51XR?6N!9D'/HA=9V;--5]H><9]WQ$FGS/B`3 M[0HEF2BD>$EQ\]:B49*7IL2;3`RB$VXM_$4@O]X)X[%%+R'JE$>)7I*HG85O M(9%8Q!TOD3;O`R+1KE`2B4&REY3OQ"UDD(5*\M*4>!.)0=1+@1O8RIZ=,![) M2H@ZY5&BE21J.U@X<^5ESGG6'2N1AO`#*M'^$?AX91MR5@+U*U92OIRV+$JR MTI3(N6+.1:WD^BY6B26)5J*00)UR'M%*+)%1>[ZE/&+.D^Y8B323HDC_JTFR M:$LJ:<<@V6'*Z[-EB9+#6'M[V_IC%F6[XY+N^+:R,R1\?'&MHC0"<\II;LP9 MAQBSY2#E6!EW[`658>7@?(QUE[R#>G^K21H"I9UB$!C@MC$Z)E*1)@HVB5@B M.:<3=E348]!$VZ<]AFMY@;)0)IQ(="4:+N51#X?+>!0=SK7L)6LEQ-,SU4W7@A?@_#JJ;@?PL<3QJ,@ MA$\6C*=!"-\;&(_F(73P&$_G878/AW/>I[$@]7G(^>\=GHT=P@D0YM\X(1R# M8/S)#9]`.'QCXX9P)`"X,8T,Y[O7XEC]7G3'^M)KY^H`(IKC1U%'3XCICX%] M`#RW`YSL@LYP(@DG^14V'?@/,L#T?P/K?P$``/__`P!02P,$%``& M``@````A`)53-B00!P``)!X``!D```!X;"]W;W)K&ULK)EMCZ,V$,??5^IWB'A_`0-Y0IL]A?"L5JJJ:_N:)62#-H0(V-N[;]\Q MQ@9[:&ZSO3>7VQ_CP?[/V![CA\_?RO/L:UXW1779:F1N:+/\DE6'XO*\U?[Z M$GQ::[.F32^']%Q=\JWV/6^TSX^__O+P5M4OS2G/VQEXN#1;[=2V5T?7F^R4 MEVDSKZ[Y!9X=9-PUCJ95I<-.;!J=_CHSH>BRSW MJNRUS"\MGXMIP;V7V'G=E6K^\7C]E57D%%T_%N6B_=TZU69DY M\?.EJM.G,XS[&['3C/ON_D#NRR*KJZ8ZMG-PI[..XC%O](T.GAX?#@6,@,H^ MJ_/C5ML1)S&)IC\^=`+]7>1OS>C_L^94O85U"/>G;(C^GKN?VS>HORXOG40K@7,"(Z,.?PW]IJUG*^6!D6`?/94]ZT04%=:K/LM6FK\A]F MU(U(.#%[)_`[X>1&0ZMO:(N&IC%?$6-CK>#M-QK"TZ[;\-N_D:SFZ\7"7JY_ MT'+9MX0)T+=\YRLW?4/XY:_=M3-5@,%(+(-Y.S71W.S>="_0IYE MO8V+;8ALL><6-*FH6T\%O@H"%80JB%00JR`9`1UD$=I`\OT,;:@;J@T?EV$BQ$#$1R1`)$0D0B1&)!D321,8%]*$+I-W3ASJ!N;> M6"6R4N:%RXQNJB1,A$J(^(@$B(2(1(C$B"1C(JD$@B"5S,7\?IVHHTXG/CZ7 M$0L")%*'K$PE>801;^8AXB,2(!(B$B$2(Y*,B20+;!F2++R!HPH\;>4^`LC+I2'B(]( M@$B(2(1(C$@R)I(LM%;^";LN=8,6#V7]=)G1S<5#F`B5$/$1"1`)$8D0B1%) MQD12">HBI-("MHH[EUCJ1DX=1I3462BI(XR$*(CXB`2(A(A$B,2()&,BB4*+ M-*3*!S:>S@]*GJ4L@MM;WP48HA9&/48!1B%&$48Q1(B%9,%K>J9/-6M/# MR[V91%BE"+LU'ZG;(R675K*,^\&*-_0P\C$*,`HQBC"*,4HD)$M$"[^Q1+?W M(\+J1$D&ALR-4&;?6XV0AY&/48!1B%&$48Q1(B%YS+2R&X^9G7SF]+#7GHKL MQ:U@KX*`3VAAP0FG/_>P^E"2HD?+D10(>80A$[:(4?FREO/&'ZQXW@08A1A% M&,48)3V"'W`OJT,K.J0.G.-[<;Y4UTZ<.Y1B-:*D5(_&2B'D00NZ?IMK=JPT MB++!^8/!(%+O9BB0PMZ*#"^+AH;=@=4@2O40#P;<<\+=3$A&JSTDV6)(**[9 M1$+!6B0RBKJ1MRNZNE,T='V/D=RK0[_:P5L6U;*2L#[FF<:,AY MQ#T-SF..>N>VL;+4!2N1G,OZT8(2Z?>_%G16HDI:,J3DHGHF)\)JT+)'['LR M_?3G0\XE:#\Y@CYASRT%ALB!*IA!OA9*0#Q&+> MO=1W;KJE?IQZRN+A]E8W2_#!1DB*D8]1@%&(4811C%$B(2GY3+4$O[T==.;R M%M@CN*Y7`?K`:9&`E.S3DR,=6`48A1A%&,4;T;H;N7.R-3`9VU\*^NY=Y M_9SO\_.YF675*[U'Z98+@?DEC^'L(`&AT\H3EQ@./>U,/8&;(2CRIYZ8\*3+ M8\7;SH3W0(\GVL`3&M*I)^(&2O'FV@Y\"IQHL7#@6]@$7SKPZ6B"KQSX=H+Y M;NWL)C59._`5`=N[&P<.TIA#]>W0>GCJB>W0@A(_@6H1VDP]@JA=LYF(9P*02WL3DLR@:M_X]5U?(_X,6Z MN-]]_!<``/__`P!02P,$%``&``@````A`$Q)3ND,`P``4PD``!D```!X;"]W M;W)K&ULE%9=;]HP%'V?M/\0^;T)#@0((E1T5;=* MFS1-^W@VB4.L)G%DF]+^^]UKAXP`9>D+D,OQ.3[WVO=F>?M2E=XS5UK(.B'4 M'Q&/UZG,1+U-R*^?#S=SXFG#ZHR5LN8)>>6:W*X^?ECNI7K2!>?&`X9:)Z0P MIED$@4X+7C'MRX;7\$\N5<4,/*IMH!O%66875640CD;3H&*B)HYAH89PR#P7 M*;^7Z:[BM7$DBI?,P/YU(1I]8*O2(7054T^[YB:550,4&U$*\VI)B5>EB\=M M+17;E.#[A4Y8>N"V#V?TE4B5U#(W/M`%;J/GGN,@#H!IMXKG"5G3 MQ1V=D&"UM`GZ+?A>'_WV="'WGY7(OHJ:0[:A3EB!C91/"'W,,`2+@[/5#[8" MWY67\9SM2O-#[K]PL2T,E#L"1VALD;W>19/I?`8T&Z[-@T!.XJ4[;63UQZ%HR^58PI8%OEN6\=2/ M9J,Q!='_D`1N1];@/3-LM51R[\&I`4G=,#R#=`'$EQV!%<2N$9P0.-6P5PUE M>%Z%\7@9/$/JTA9SYS#PV6%HAPA`M%,&M>'*"$9ES"UNY6XCD.[.;AA'EPU/^ZK7I1#!/=YVP@XZ2S0.+YL M`3OVX.N`X+Y4&SFW$/=YL2"3T=S'VW\]3;BPK]%&^A697K9#H=4-]V/1?;%# MR':BWO6E>-$'I\JB3ZC;3G%O6$$[_MPM;8[V)'@K@YM0^>EH2<=`FL3 MT0&EL0M//+GF@&+=60OC^1N>WM4@L#6?QB>+M1NI0?./3M$?:@7$IS>,"QV[T.K?X"``#__P,`4$L#!!0`!@`( M````(0!A-OK*;P4``/(3```9````>&PO=V]R:W-H965TWG6WDC=%-5EI5L34]?():_VQ>6XTO_X%GWQ M=*UIL\L^.U<7LM(_2*-_7?_\T_)6U2_-B9!6`X5+L])/;7OU#:/)3Z3,FDEU M)1?XY5#59=;"U_IH-->:9/LNJ3P;MFG.C#(K+CI3\.O/:%2'0Y&3H,I?2W)I MF4A-SED+]]^?B7+0?G:BNE;F?'"]5G3V? MH>YWR\URH=U]0?)ED==54QW:"<@9[$9QS0MC88#2>KDOH`)JNU:3PTI_LOS4 MP,^K,@MV;TO]:S^WOU2TFQ?'4PG!/H2):F+__"$B3@Z,@,[&G5"FOSG`#\%BGU[6NG.;#*=FXX%X=HS:=JHH)*ZEK\V;57^Q8(L+L5$;"X"GW=$ M'B0Z/-'M$RUKXMK3N===_D$FW%QWW_#)+[F8>-.I._/F@!XDSG@B3`">^-E+ M+G@F?/:9#R]EP6@R<^FPUV>PX>E&.\C:;+VLJYL&4P@&H+EF=$):/M45 MX\PJ[4?^[P8>1IRJ/%&9E0ZUPY@VT*UO:\>TEL8;=%C.8S8X1HG8B@C:3E0V M4$&H@D@%.Q7$*DA4D(Z``;;TWD#;_1_>4!GJC:AJ(\!@EBU;M141(B500:B" M2`4[%<0J2%20CH!D!$PG9(0#S7+_82!Z@F:M=)B"HYY0"MVP&`=&H`]R%2_Z MD-X,1$)$(D1VB,2()(BD8R)Y`G4A3^@#\@[Y,@6;%C00Y?ZD-XE M1$)$(D1VB,2()(BD8R*Y!(9(+CWN&!K=F2&*V##BP"CT_>&8:H?T02(M0"1$ M)$)DATB,2()(.B92[;`B_$#M-%JNG1%[T3\XMH@$B(2(1(CL$(D121!)QT0J M=*X4RM:0"5TPVU.1OVPJ&#R8XG<&WX&U@JT@5$2NGY/94#\B`2,V?/3]8?J$?9#HCPB1'2(Q(@DB*2-L'R990K?!:%F%#1!WY%MU[1SYO#U44+:'DY$] MB`2,V%ZW(MNFIJZ5A5\@GV M/-BGZ=`ZPJ@[K0/[2-$[5$4VAY.1.8@$C,`Z)FXS1"3B62,[D$Z,LA)$TK&. M9`#=4IY MVR%*)`88A0)9;&:Y"]MS9ZI1_'IV?PL[D3;T7(Q1(A`3GYGNW+*4\4Q%3"OH\:_&/('F91R.5MM_//F5NNZTY5_[C2 MN-&0>"R4!O%$("[NFG-'?4:EHKX[C4:W?,B___+LAO5!?3YQI/2BLCO>#E&# METR+OW/3EZ101,TZ+[VY#68JHQ*)F'$OA#<[JPE)&B!Q&T M0'O4C.Q@@;UJEJ0^DBTYGQLMKU[IH0$DK)<]9B<:&]>'?204JO*I#WNL.WSF MPY8$\V#NPTI]AWL^K'>8QYX/*Q;FP<*'!0'S>.'#`QYS.)%YZ@Q0[Y^>U-R) MW]@^O'!AG8WCPUL'YD^N_P2^P0]&?P4X<;EF1_)K5A^+2Z.=R0',-;OELV9G M-NQ+R_<;SU4+9RW@/[SHP]D:@?8QZ:;D4%6M^$(OT)_6K;\#``#__P,`4$L# M!!0`!@`(````(0`--K(/,@$``$`"```1``@!9&]C4')O<',O8V]R92YX;6P@ MH@0!**```0`````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````````````````"ZY*)I=#RX-%.O M>\E6\A0.[7W00[%MVZ(==QK)G^+U\N&I&S77]K@K"8@?]U.+$)=IE1L-ZO;` M]V^^SD+8E?AW5BK9V3'I041067J/G>S.R&UL(*($`2B@``$````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M````````````````````````````````G%;?;]HP$'Z?M/\!Y;T-+6R:JI"* M`ELG44!+VCU:KG.`U<3.;`>1_O4[)T!#9S*5E\CQ_?KNNSO;P>TV2SL;4)I+ M,?"N+KM>!P23"1>K@?<8?[_XYG6TH2*AJ10P\$K0WFWX^5.P4#('93CH#KH0 M>N"MCK7'FXTYUVDBF<6GG^(R1\!A,,SSE#-J,,OP@3,EM5R:SF3+(`W\IC!` M=!&P0G%3AMW`;_X&$:,IC-!QN*2IAL!_VPCN@5K2%I0K'08;<[,!9J3J:/Z* MM%U[G6>JP<(9>!NJ.!4&85FU^J=:I[DV*OPMU8M>`Q@=^*A0;U;+IFYSS?MA MKU]IX.I8TWJHD:#@&&/,30IZOEQ091R0>_TFY@I%C;@&M*\BP=X@$V&0+_)3 MU-7FLHG\D,-H/AM/9M%D3'`5S:<_Q\,8?^Z&T^%L-#G#Y.HC-E&,T1X^%&9G MX@XS5RLJ^&O54Q4)=U1S3>22+!0Y`P`^)'4)&4C!0HK)YH(*NP$Z#)LYD MHB++J"JMVXBO!,45AN] M[L*WE^3:F5][34[$<5-.8ELD=SKMS+O#M#>EVZ:=@MX9%+AI.^I+;#M#>:K) MC"K;*!MGF!.-NC,^P^0$`R>*4V-T9],.S]&,>RS&>(OO[^W@SB-94 M08(WVU[^MA'&PO M7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"+0`4``8`"````"$`E8#6&FT# M```\"P``#P````````````````!+"@``>&PO=V]R:V)O;VLN>&UL4$L!`BT` M%``&``@````A`#?M>S7'!```TA$``!@`````````````````Y0T``'AL+W=O M&UL M4$L!`BT`%``&``@````A`,Q46.GB`P``G`\``!D`````````````````XQ<` M`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@` M```A`"\%I?5T!```LQ(``!D`````````````````_"(``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`%8Q'Y)`!@``"1H``!@````````` M````````3#@``'AL+W=O&PO&PO&UL4$L!`BT`%``&``@````A`!_/%T&] M`@``_@8``!D`````````````````U8H``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A M`(D'B*<;`P``?@D``!D`````````````````N)$``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`(5*1%.S`@``8P<` M`!D`````````````````D;P``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`")<`'Q" M"```]R4``!@`````````````````"\8``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`%2JWY48"```!2<``!@````````` M````````;M0``'AL+W=O&UL4$L!`BT`%``&``@````A`%5O,]PI!P``GQX``!D` M````````````````H]\``'AL+W=O&PO M=V]R:W-H965T&UL4$L!`BT`%``&``@````A`.+A&PO=V]R:W-H965T&UL4$L!`BT`%``& M``@````A`)53-B00!P``)!X``!D`````````````````(!0!`'AL+W=OConcentration Percentage 57.00% 30.00%
Vendor 2 [Member]
Concentration Percentage 16.00% 11.00%

X

- Definition

For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 21

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13537-108611

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6404-108592

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13531-108611

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 18

-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6351-108592

+ Details

Name: us-gaap_ConcentrationRiskPercentage1

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

XML 16 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 17 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8

Stockholders' Deficiency (Details) (USD $)
3 Months Ended

Mar. 31, 2014

Number of options, outstanding

Outstanding, beginning of period (in shares) 2,543,150

Granted

Exercised

Forfeited (29,000)

Outstanding, end of period (in shares) 2,514,150

Exercisable, March 31, 2014 1,398,475

Options, weighted average exercise price

Outstanding, beginning of period (in dollars per share) $ 2.37

Granted

Exercised

Forfeited $ 3.22

Outstanding, end of period (in dollars per share) $ 2.36

Exercisable, March 31, 2014 $ 2.78

Weighted Average Remaining Life In Years

Weighted Average Remaining Life (in years) Outstanding 5 years 8 months 12 days

Weighted Average Remaining Life (in years) Exercisable 4 years 1 month 6 days

X

- Definition

Exercisable.

+ References

No definition available.

+ Details

Name: HEWA_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber1

Namespace Prefix: HEWA_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Share based compensation arrangement by share based payment award options exercisable weighted average exercise price1.

+ References

No definition available.

+ Details

Name: HEWA_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice1

Namespace Prefix: HEWA_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Details

Name: HEWA_WeightedAverageRemainingLifeInYears

Namespace Prefix: HEWA_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition

Weighted average price of options that were either forfeited or expired.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iv)(3)-(4)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iv)(3)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Gross number of share options (or share units) granted during the period.

+ References

No definition available.

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Number of options outstanding, including both vested and non-vested options.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(i)-(ii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(i)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (e)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition

Weighted average price at which option holders acquired shares when converting their stock options into shares.

+ References

No definition available.

+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.

+ References

No definition available.

+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

Number of share options (or share units) exercised during the current period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28,29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iv)(2)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30

-Article 5

+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 18 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8

Accrued Expenses and Other Current Liabilities
3 Months Ended

Mar. 31, 2014

Accrued Expenses And Other Current Liabilities

Note 4 - Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities consisted of the following:

March 31, December 31,

2014 2013

Deferred Rent $ 43,704 $ 46,254

Advertising 75,000 75,000

Salaries and Benefits 178,393 132,048

Customer Payables 19,697 39,618

Dividend Payable 74,729 279,380

Accrued Interest 46,429 45,616

Other 3,622 3,136

Total $ 441,574 $ 621,052

X

- Details

Name: HEWA_AccruedExpensesAndOtherCurrentLiabilitiesAbstract

Namespace Prefix: HEWA_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.

+ References

No definition available.

+ Details

Name: us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

EXCEL 19 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\T9F,S,&,U.5\T,65D7S1F9C%?.6,S9E]C9F4S M8S0X86-C8F$B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-/3D1%3E-%1%]#3TY33TQ)1$%4141?4U1!5$5- M13$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7 M;W)K#I7;W)K#I7;W)K#I7;W)K#I%>&-E;%=O#I7;W)K#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E)E;&%T961?4&%R='E?5')A;G-A8W1I;VYS/"]X.DYA M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I7;W)K#I%>&-E;%=O5]O9E]3:6=N:69I8V%N M=%]!8V-O=6YT,CPO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/D%C8W)U961?17AP96YS97-?86YD7T]T:&5R7T-U#I7;W)K5]486)L97,\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-U;6UA#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/E-T;V-K:&]L9&5R#I7;W)K5]$971A:6PS/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I% M>&-E;%=O#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-T;V-K:&]L9&5R#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I.86UE/D-O;F-E;G1R871I;VYS7T1E=&%I;'-?3F%R#I.86UE/@T*("`@(#QX.E=O#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I!8W1I=F53:&5E M=#X-"B`@/'@Z4')O=&5C=%-T#I0#I0#I0&UL/CPA6V5N9&EF M72TM/@T*/"]H96%D/@T*("`\8F]D>3X-"B`@(#QP/E1H:7,@<&%G92!S:&]U M;&0@8F4@;W!E;F5D('=I=&@@36EC'1087)T M7S1F8S,P8S4Y7S0Q961?-&9F,5\Y8S-F7V-F93-C-#AA8V-B80T*0V]N=&5N M="U,;V-A=&EO;CH@9FEL93HO+R]#.B\T9F,S,&,U.5\T,65D7S1F9C%?.6,S M9E]C9F4S8S0X86-C8F$O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!#96YT3PO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^)S`P,#`W-30X,3,\'0^36%R M(#,Q+`T*"0DR,#$T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!A(%9O;'5N=&%R>2!&:6QE2=S(%)E<&]R=&EN9R!3=&%T=7,@0W5R M'0^)UEE2!&:6QE3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)U-M86QL97(@4F5P;W)T:6YG($-O;7!A;GD\'0^)S(P,30\3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%\T9F,S,&,U.5\T,65D7S1F9C%?.6,S9E]C M9F4S8S0X86-C8F$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-&9C M,S!C-3E?-#%E9%\T9F8Q7SEC,V9?8V9E,V,T.&%C8V)A+U=O'0O:'1M;#L@8VAA'!E;G-EF%T:6]N(&]F("0R-"PW-#4@86YD("0Q M-"PV-#,@87,@;V8@36%R8V@@,S$L(#(P,30@86YD($1E8V5M8F5R(#,Q+"`R M,#$S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,#@L-30T/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S6%B M;&4\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)R9N8G-P M.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N M8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N M8G-P.SQS<&%N/CPO2`H86=G2D\+W1D/@T*("`@("`@("`\=&0@8VQA3PO=&0^#0H@("`@("`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`@ M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB'!E;G-E/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@W,RPU,S8I/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\T9F,S,&,U M.5\T,65D7S1F9C%?.6,S9E]C9F4S8S0X86-C8F$-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO-&9C,S!C-3E?-#%E9%\T9F8Q7SEC,V9?8V9E,V,T M.&%C8V)A+U=O'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N M8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF%T:6]N(&]F(&1E M8G0@9&ES8V]U;G0\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO6%B;&4@+2!R96QA=&5D('!A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6UE;G1S(&]N(&5Q M=6EP;65N="!L96%S97,@<&%Y86)L93PO=&0^#0H@("`@("`@(#QT9"!C;&%S M6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO2!F:6YA;F-I;F<@ M86-T:79I=&EE'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&5R8VES92!O9B!W87)R86YT'0^)R9N8G-P.R9N8G-P.SQS M<&%N/CPO'0^)SQS<&%N/CPO6%B;&4\+W1D/@T*("`@("`@("`\=&0@ M8VQA'0^)SQS<&%N/CPO6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA6%B;&4@=&\@;F]T97,@<&%Y86)L93PO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS M<&%N/CPO7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^ M)SQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M2`H)B,Q-#<[5E)0)B,Q-#@[*2!A;F0@:&5A M;'1H8V%R90T*92UC;VUM97)C92!C;VUP86YY('1H870@28C,30V.W,@;V)J96-T:79E(&ES('1O M(&)E('9I97=E9"!B>2!I;F1I=FED=6%L(&AE86QT:&-A2!I6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M:6YD96YT.B`P+C5I;CL@=&5X="UA;&EG;CH@:G5S=&EF>2<^5&AE(&%C M8V]M<&%N>6EN9R!U;F%U9&ET960@8V]N9&5N2!'04%0(&9O2!O9B!N;W)M M86P@2!O=&AE2!A'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!0;&%N2!0;&%N'0^)SQS<&%N/CPO2!0;&%N'0^)SQP('-T>6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2!I;F-U6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P M/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E'0M:6YD96YT.B`P+C5I;CL@ M=&5X="UA;&EG;CH@:G5S=&EF>2<^/&9O;G0@2`H82D@'!E'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU6QE/3-$)V)A8VMG0T*,3,L(#(P,3,L('1H92!# M;VUP86YY(')E8V5I=F5D(&$@3F]T:6-E(&]F(%)E9&5M<'1I;VX@2!M=7-T(&YO=R!A<'!L>2!A;&P@;V8@:71S(&%S'1E;G0@<')O:&EB:71E9"!B>2!$96QA=V%R92!L87<@9V]V97)N M:6YG(&1I6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6UE;G0@ M;V)L:6=A=&EO;G,@86YD(&5X96-U=&4@:71S(&)U6%B;&5S+`T*871T96UP="!T;R!E M>'1E;F0@;F]T92!R97!A>6UE;G1S+"!A='1E;7!T('1O(&YE9V]T:6%T92!T M:&4@<')E9F5R2!I2!B87-IF%T:6]N('5N9&5R('1H92!5+E,N(&)A;FMR=7!T8WD@8V]D92X\+V9O M;G0^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU M'0M86QI9VXZ(&IU2!A7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE2<^/&D^4')I;F-I<&QE6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE2<^ M)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E'0M:6YD96YT M.B`P+C5I;CL@=&5X="UA;&EG;CH@:G5S=&EF>2<^3VX@2G5N92`T+"`R,#$S M+"!T:&4@0V]M<&%N>2!F;W)M960@82!W:&]L;'DM;W=N960-"G-U8G-I9&EA M6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\ M<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-E'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU M2!A8V-E<'1E9"!I;B!T M:&4@56YI=&5D(%-T871E2P@=&AE(')E8V]V97)A8FEL:71Y(&%N M9"!U"!A6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU'0M86QI M9VXZ(&IU2!D:79I9&EN9PT*;F5T(&QO'0M:6YD M96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\=&%B;&4@8V5L;'-P86-I;F<] M,T0P(&-E;&QP861D:6YG/3-$,"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/CQB/DUA6QE M/3-$)W!A9&1I;F6QE/3-$)W9E6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/CQB/C(P,30\+V(^/"]F;VYT/CPO=&0^#0H@("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,2XU M<'0G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E6QE M/3-$)W9EF4Z(#$P<'0G/D]P=&EO;G,\+V9O;G0^/"]T M9#X-"B`@("`\=&0@6QE/3-$)W=I9'1H.B`Q,R4[('1E>'0M86QI9VXZ(')I9VAT)SX\ M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C(L-3$T+#$U,#PO9F]N M=#X\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@6QE/3-$)W=I9'1H.B`Q)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0M M6QE/3-$)V9O;G0MF4Z(#$P<'0G/E-E6QE/3-$)V)O6QE M/3-$)V)O'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL M93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C,L-S$T+#0T-3PO9F]N=#X\+W1D/@T* M("`@(#QT9"!N;W=R87`],T1N;W=R87`@6QE M/3-$)V)O6QE/3-$ M)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W!A M9&1I;F6QE M/3-$)V)O6QE/3-$ M)V)O'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS M1"=F;VYT+7-I>F4Z(#$P<'0G/C@L-S(Q+#0T,3PO9F]N=#X\+W1D/@T*("`@ M(#QT9"!N;W=R87`],T1N;W=R87`@6QE/3-$)V9O M;G0M6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE2!H87,@ M9&5T97)M:6YE9"!T:&5R92!A'!E8W1E9"!T;R!H879E(&$@;6%T97)I86P@:6UP M86-T(&]N('1H92!#;VUP86YY)W,@8V]N9&5N3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%\T9F,S,&,U.5\T,65D7S1F9C%?.6,S9E]C M9F4S8S0X86-C8F$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-&9C M,S!C-3E?-#%E9%\T9F8Q7SEC,V9?8V9E,V,T.&%C8V)A+U=O'0O:'1M;#L@8VAA'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UEF4Z(#$P<'0G M/CQB/DUA6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E M6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$ M)W!A9&1I;FF4Z(#$P<'0G/CQB/C(P,3,\+V(^/"]F;VYT/CPO M=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=P861D:6YG M+6)O='1O;3H@,2XU<'0G/B8C,38P.SPO=&0^/"]T6QE/3-$)W=I9'1H M.B`Q)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W=I9'1H.B`Q)2<^ M)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9EF4Z(#$P<'0G/D1E9F5R6QE/3-$)V9O M;G0M6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9#X\9F]N="!S='EL93TS M1"=F;VYT+7-I>F4Z(#$P<'0G/B0\+V9O;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0M MF4Z(#$P<'0G/D%D M=F5R=&ES:6YG/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@ M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N M.B!R:6=H="<^/&9O;G0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL M93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C$W."PS.3,\+V9O;G0^/"]T9#X-"B`@ M("`\=&0@;F]W6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT M9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R M:6=H="<^/&9O;G0@6%B;&5S/"]F M;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M)SXF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O M;G0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@F4Z M(#$P<'0G/D%C8W)U960@26YT97)E6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C0V+#0R M.3PO9F]N=#X\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I M>F4Z(#$P<'0G/C0U+#8Q-CPO9F]N=#X\+W1D/@T*("`@(#QT9"!N;W=R87`] M,T1N;W=R87`^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$ M)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)V)OF4Z(#$P M<'0G/E1O=&%L)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[(#PO9F]N=#X\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,W!T.R!T97AT M+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V)O6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F'0M M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B M;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE)SX\9F]N="!S='EL M93TS1"=F;VYT+7-I>F4Z(#$P<'0G/B0\+V9O;G0^/"]T9#X-"B`@("`\=&0@ M6QE/3-$)V9O;G0M'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6%B;&4\+W-T6%B M;&4\+W1D/@T*("`@("`@("`\=&0@8VQA'0M:6YD96YT.B`P+C5I;CL@=&5X="UA;&EG;CH@:G5S M=&EF>2<^5&AE($-O;7!A;GD@:7,@82!P87)T>2!T;R!A($QO86X@86YD(%-E M8W5R:71Y#0I!9W)E96UE;G0@*'1H92`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`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M:6YD96YT.B`P+C5I;CL@=&5X="UA;&EG;CH@:G5S=&EF>2<^07,@;V8@ M36%R8V@@,S$L(#(P,30@86YD($1E8V5M8F5R(#,Q+"`R,#$S+`T*=&AE($-O M;7!A;GD@:&%D(&%C8W)U960@8V]N=')A8W1U86P@9&EV:61E;F1S(&]F("0W M-"PW,S`@86YD("0R-SDL,S@P+"!R97-P96-T:79E;'DL(')E;&%T960@=&\@ M=&AE(%-E2P@&EM871E;'D@)#`N-C8@ M:6X@=F%L=64@<&5R('-H87)E(&]F(%-E6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M'0M86QI9VXZ(&IU6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M'!E;G-E(')E;&%T960@=&\@F5D M+CPO<#X-"@T*/'`@'0M86QI9VXZ(&IU6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2!D=7)I;F<-"G1H92!T:')E92!M;VYT:',@96YD960@36%R8V@@,S$L(#(P M,30@:7,@<')E6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(&-E M;G1E6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E6QE/3-$)V9O;G0MF4Z(#$P<'0G/CQB/D5X97)C:7-E/"]B M/CPO9F]N=#X\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@8V]LF4Z(#$P<'0G/CQB/DQI9F4\+V(^/"]F;VYT/CPO=&0^#0H@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF M(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=T97AT M+6%L:6=N.B!C96YT97(G/CQF;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)W9E M6QE M/3-$)W!A9&1I;FF4Z(#$P<'0G/CQB M/D]P=&EO;G,\+V(^/"]F;VYT/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,2XU<'0G/B8C,38P.SPO M=&0^#0H@("`@/'1D('-T>6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/CQB/E!R:6-E/"]B/CPO9F]N=#X\+W1D/@T*("`@ M(#QT9"!N;W=R87`],T1N;W=R87`@6QE/3-$)V)O'0M86QI9VXZ(&-E;G1E6QE M/3-$)W!A9&1I;FF4Z(#$P<'0G/CQB/E9A;'5E/"]B/CPO9F]N M=#X\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C(N,S<\ M+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@6QE/3-$)V9O M;G0M6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@ M6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$ M)W!A9&1I;F6QE/3-$)V)O6QE/3-$)V)O'0M86QI M9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/B@R M.2PP,#`\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;F6QE M/3-$)W!A9&1I;F6QE/3-$)V)O6QE/3-$)V)O'0M M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G M/C,N,C(\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;F6QE/3-$)V)O6QE/3-$)W=I9'1H.B`S-B4[('!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W=I M9'1H.B`Q)3L@<&%D9&EN9RUB;W1T;VTZ(#-P=#L@=&5X="UA;&EG;CH@6QE/3-$)W=I9'1H.B`Q)3L@ M8F]R9&5R+6)O='1O;3H@8FQA8VL@,BXR-7!T(&1O=6)L93L@<&%D9&EN9RUB M;W1T;VTZ(#-P="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q)3L@<&%D9&EN9RUB;W1T;VTZ(#-P=#L@=&5X M="UA;&EG;CH@6QE/3-$ M)W=I9'1H.B`Q)3L@8F]R9&5R+6)O='1O;3H@8FQA8VL@,BXR-7!T(&1O=6)L M93L@<&%D9&EN9RUB;W1T;VTZ(#-P="<^/&9O;G0@6QE/3-$)W=I M9'1H.B`Q,R4[(&)O'0M86QI9VXZ(')I9VAT)SX\9F]N M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C(N,S8\+V9O;G0^/"]T9#X- M"B`@("`\=&0@;F]W6QE/3-$)W=I9'1H.B`Q)3L@ M<&%D9&EN9RUB;W1T;VTZ(#-P="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W=I9'1H M.B`Q)3L@<&%D9&EN9RUB;W1T;VTZ(#-P="<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@F4Z(#$P<'0G/B0\+V9O;G0^ M/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0M6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`] M,T1N;W=R87`^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@&5R8VES86)L92P@36%R8V@@,S$L(#(P,30\+V9O M;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$)V)O6QE M/3-$)V)O'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL M93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C$L,SDX+#0W-3PO9F]N=#X\+W1D/@T* M("`@(#QT9"!N;W=R87`],T1N;W=R87`@6QE/3-$)V)O6QE/3-$)V9O;G0M6QE/3-$)V)O6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T* M#0H\=&%B;&4@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!S='EL M93TS1"=F;VYT.B`Q,'!T($-A;&EB6QE/3-$)W9E6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@8V]L'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE&5R M8VES86)L93PO8CX\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO M='(^#0H\='(@6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E M6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E&5R8VES M92!06QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E.R!P861D:6YG+6)O='1O M;3H@,7!T)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE M:6=H=#H@,3$U)3L@<&%D9&EN9RUB;W1T;VTZ(#%P="<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@8V]L6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E.R!P861D:6YG+6)O M='1O;3H@,7!T)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE M+6AE:6=H=#H@,3$U)3L@<&%D9&EN9RUB;W1T;VTZ(#%P="<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@8V]L6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E.R!P861D:6YG+6)O='1O;3H@,7!T)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=T97AT+6%L M:6=N.B!C96YT97([(&QI;F4M:&5I9VAT.B`Q,34E.R!B;W)D97(M8F]T=&]M M.B!";&%C:R`Q<'0@6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E.R!P861D M:6YG+6)O='1O;3H@,7!T)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N M/3-$,B!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([(&QI;F4M:&5I9VAT M.B`Q,34E.R!B;W)D97(M8F]T=&]M.B!";&%C:R`Q<'0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M8V]L6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$ M,B!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@;F]W6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G M/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)W=I9'1H.B`Q)3L@;&EN M92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@6QE/3-$)W=I9'1H.B`Q,R4[('1E>'0M86QI9VXZ(')I M9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$ M)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@ M("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q,R4[('1E>'0M86QI9VXZ(')I9VAT M.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@'0M86QI9VXZ(')I9VAT.R!L M:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P M.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG M;CH@6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P M.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q,R4[('1E>'0M86QI M9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)W9E6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^ M#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN M92UH96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@ M("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH M96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@ M("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH M96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N M.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@ M/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG M:'0Z(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@ M,3$U)2<^/&9O;G0@6QE/3-$)V)O6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@ M,3$U)2<^/&9O;G0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO M=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O M;G0@6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C M,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=L M:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z M(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C M,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE2<^ M)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E'0M:6YD96YT M.B`P+C5I;CL@=&5X="UA;&EG;CH@:G5S=&EF>2<^26X@87!P;'EI;F<@=&AE M($)L86-K+5-C:&]L97,@;W!T:6]N('!R:6-I;F<-"FUO9&5L('1O('-T;V-K M('=A2!U6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M M86QI9VXZ(&-E;G1E6QE/3-$)W=I9'1H.B`Q."4[ M(&)O6QE/3-$)V9O;G0MF4Z(#$P<'0G/CQB M/C(P,3,\+V(^/"]F;VYT/CPO=&0^/"]T6QE/3-$)W9EF4Z(#$P<'0G/E)I6QE/3-$)W1E>'0M86QI9VXZ M(&-E;G1E6QE/3-$)V9O M;G0M6QE/3-$)W9E6QE/3-$)V9O;G0MF4Z(#$P<'0G/C`N,#`E/"]F;VYT/CPO=&0^ M/"]T6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0G/D5X<&5C M=&5D(&QI9F4@:6X@>65AF4Z M(#$P<'0G/C4N,#`\+V9O;G0^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M:6YD96YT.B`P+C5I;CL@=&5X="UA;&EG;CH@:G5S=&EF>2<^ M4V5E($YO=&4@-2`F(S$U,#L@3F]T97,@4&%Y86)L92!F;W(@9&5T86EL6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P M/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E'0M:6YD96YT.B`P+C5I;CL@ M=&5X="UA;&EG;CH@:G5S=&EF>2<^5&AE('=E:6=H=&5D(&%V97)A9V4@9F%I M'0M86QI9VXZ(&IU M'0M86QI9VXZ(&IU'!E;G-E(')E;&%T960@=&\-"G=AF5D+CPO<#X-"@T*/'`@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI M9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ M(&-E;G1EF4Z(#$P<'0G/CQB/E)E;6%I;FEN9SPO8CX\ M+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&-E M;G1E6QE/3-$)V9O;G0M6QE/3-$)V9O M;G0M6QE/3-$)W1E>'0M86QI M9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/CQB/E!R:6-E/"]B/CPO9F]N=#X\+W1D/@T*("`@(#QT M9"!N;W=R87`],T1N;W=R87`@6QE/3-$)V)O'0M86QI9VXZ(&-E;G1E6QE/3-$ M)W!A9&1I;FF4Z(#$P<'0G/CQB/E9A;'5E/"]B/CPO9F]N=#X\ M+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C`N.38\+V9O M;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!R:6=H="<^/&9O;G0@6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z M(#$P<'0G/C`N,S4\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W9EF4Z(#$P<'0G/D5X97)C M:7-E9#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N M.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@6QE M/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q+C5P M="!S;VQI9#L@<&%D9&EN9RUB;W1T;VTZ(#$N-7!T)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q+C5P="!S M;VQI9#L@<&%D9&EN9RUB;W1T;VTZ(#$N-7!T.R!T97AT+6%L:6=N.B!R:6=H M="<^/&9O;G0@6QE/3-$ M)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W9EF4Z(#$P<'0G/D]U='-T86YD:6YG+"!-87)C:"`S,2P@,C`Q-#PO M9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[('!A9&1I M;F'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[(&)O6QE/3-$)W=I9'1H.B`Q,R4[(&)O'0M86QI9VXZ(')I9VAT M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[(&)O M6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q M)3L@<&%D9&EN9RUB;W1T;VTZ(#-P=#L@=&5X="UA;&EG;CH@6QE/3-$)W=I9'1H.B`Q)3L@8F]R9&5R M+6)O='1O;3H@8FQA8VL@,BXR-7!T(&1O=6)L93L@<&%D9&EN9RUB;W1T;VTZ M(#-P="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE M/3-$)V9O;G0M6QE/3-$)W=I M9'1H.B`Q)3L@<&%D9&EN9RUB;W1T;VTZ(#-P=#L@=&5X="UA;&EG;CH@6QE/3-$)W=I9'1H.B`Q)3L@ M8F]R9&5R+6)O='1O;3H@8FQA8VL@,BXR-7!T(&1O=6)L92<^/&9O;G0@6QE/3-$)W=I9'1H.B`Q,R4[(&)O6QE/3-$)W=I9'1H.B`Q)3L@<&%D9&EN9RUB;W1T M;VTZ(#-P="<^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^)B,Q-C`[/"]T9#X- M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F'0M86QI9VXZ M(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!P861D:6YG+6)O='1O;3H@ M,W!T)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T M=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!P861D:6YG+6)O='1O;3H@,W!T M.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!P861D M:6YG+6)O='1O;3H@,W!T)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P M<'0G/B0\+V9O;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0M6QE/3-$ M)V)O6QE/3-$)V)O M'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F M;VYT+7-I>F4Z(#$P<'0G/C,N.#PO9F]N=#X\+W1D/@T*("`@(#QT9"!N;W=R M87`],T1N;W=R87`@6QE/3-$)V)O6QE/3-$)V9O;G0M'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^ M)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E'0M:6YD96YT M.B`P+C5I;B<^/"]P/@T*#0H\=&%B;&4@8V5L;'-P86-I;F<],T0P(&-E;&QP M861D:6YG/3-$,"!S='EL93TS1"=F;VYT.B`Q,'!T($-A;&EB6QE/3-$ M)W9E6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N M.B!C96YT97([(&QI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!C;VQS<&%N/3-$-B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C M:R`Q+C5P="!S;VQI9#L@=&5X="UA;&EG;CH@8V5N=&5R.R!L:6YE+6AE:6=H M=#H@,3$U)2<^/&9O;G0@'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)W1E>'0M M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ M(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ M(&-E;G1E6QE/3-$ M)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE M/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE M/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`] M,T1N;W=R87`@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=L:6YE+6AE M:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@8V]L6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!C;VQS<&%N/3-$,B!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@8V]L M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z M(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U M)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W=I9'1H.B`Q)3L@;&EN M92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@6QE/3-$)W=I9'1H.B`Q,R4[('1E>'0M86QI9VXZ(')I M9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$ M)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@ M("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q,R4[('1E>'0M86QI9VXZ(')I9VAT M.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE M:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W9E6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO M=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@ M;&EN92UH96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^ M#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN M92UH96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^ M#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN M92UH96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@ M("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH M96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H M=#H@,3$U)2<^/&9O;G0@6QE/3-$)V)O6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z M(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q M-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H M=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@ M;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE M/3-$)V)O'0M86QI9VXZ(')I M9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX\9F]N="!S='EL93TS1"=F;VYT M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L M:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z M(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C M,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI M9VXZ(&IU'0M:6YD96YT.B`T,'!T)SY%9F9E8W1I=F4@2F%N M=6%R>2`Q+"`R,#$S+"!A;B!E>&5C=71I=F4@;V9F:6-E2!W86EV960-"G!A>6UE;G0@9F]R('-E2!E>'!E;G-E M(&]F("0X-RPU,#`@9F]R(&5A8V@@;V8@=&AE('1H7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE2<^/&D^3W!E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P M/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E'0M:6YD96YT.B`P+C5I;CL@ M=&5X="UA;&EG;CH@:G5S=&EF>2<^5&AE($-O;7!A;GD@:7,@82!P87)T>2!T M;R!A(&QE87-E(&%G&EM871E;'D@-C(L,#`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`@(#QT9"!N;W=R87`],T1N;W=R87`^)B,Q-C`[/"]T9#X\ M+W1R/@T*/'1R('-T>6QE/3-$)W9EF4Z(#$P<'0G/C(P M,30\+V9O;G0^/"]T9#X-"B`@("`\=&0@F4Z(#$P<'0G M/B0\+V9O;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL M93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C$R."PP-#D\+V9O;G0^/"]T9#X-"B`@ M("`\=&0@;F]WF4Z(#$P<'0G/C(P M,38\+V9O;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0M6QE/3-$ M)V9O;G0MF4Z(#$P<'0G/E1O=&%L(&9U='5R92!M:6YI;75M(&QE M87-E('!A>6UE;G1S/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W!A M9&1I;F'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R M+C(U<'0@9&]U8FQE)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G M/B0\+V9O;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\ M<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-E'0M:6YD96YT.B`P+C5I;CL@=&5X="UA M;&EG;CH@:G5S=&EF>2<^26X@=&AE(&]R9&EN87)Y(&-O=7)S92!O9B!B=7-I M;F5S2!S=6-H(&UA='1E2!P96YD:6YG(&]R M('1H2!P96YA;'1I97,@9G)O;2!R96=U;&%T;W)Y(&%U9&ET M6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T* M#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E'0M:6YD96YT.B`P+C5I;CL@=&5X M="UA;&EG;CH@:G5S=&EF>2<^3VX@1F5B2P-"D]H:6\@0V]U&5R8VES92!O9B!T:&4@ M,C,S+#,S,@T*;W!T:6]N'!E2`Q.2P@ M,C`Q,BP@=&AE($-O;7!A;GD@86YD($UR+B!097!P96P@9FEL960-"F%N(&%N M2XF(S$V,#LF(S$V,#M/;B!*=6QY(#(T+"`R,#$R+"!T:&4@0V]M M<&%N>2!F:6QE9"!A(&-O;7!L86EN="!A9V%I;G-T#0I$96YN:7,@4VUI=&@@ M9F]R(&)R96%C:"!O9B!C;VYT2!J=61G;65N=#H@ M*&DI('1H92!#;VUP86YY(&%N9"!-2!J M=61G;65N="!O;B!T:&4-"D-O;7!A;GDF(S$T-CMS(&-L86EM0T*'0M86QI9VXZ(&IU2!W87,@82!P87)T>2!T;R!A('!U M=&%T:79E('-T;V-K:&]L9&5R(&1E2!B96%R:6YG#0II M=',@;W=N(&%T=&]R;F5Y'0M86QI9VXZ(&IU2<^3VX@36%Y(#$U+"`R,#$S+"!A(&9O2P@2V5N M='5C:WD@0VER8W5I="!#;W5R="!A;&QE9VEN9R!B'!E;G-E2`D-34L,#`P M+B8C,38P.R8C,38P.U=E(&9I;&5D(&%N(&%N'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M'0^)SQS<&%N/CPO'0M:6YD96YT.B`P+C5I;CL@=&5X="UA M;&EG;CH@:G5S=&EF>2<^1'5R:6YG('1H92!T:')E92!M;VYT:',@96YD960@ M36%R8V@@,S$L(#(P,30L#0IT=V\@=F5N9&]R2!P=7)C:&%S97,L(')E2X\+W`^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\T9F,S,&,U.5\T,65D7S1F M9C%?.6,S9E]C9F4S8S0X86-C8F$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z M+R\O0SHO-&9C,S!C-3E?-#%E9%\T9F8Q7SEC,V9?8V9E,V,T.&%C8V)A+U=O M'0O:'1M M;#L@8VAA2!4'0M M86QI9VXZ(&IU65E#0IV;VQU;G1A2!R97-I9VYE9"!F2!O9B!T:&4@8V%L96YD87(@ M<75A2!A2!H87,- M"F1E=&5R;6EN960@=&\@97AE'0M:6YD M96YT.B`P+C5I;CL@=&5X="UA;&EG;CH@:G5S=&EF>2<^)B,Q-C`[/"]P/CQS M<&%N/CPO7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0M:6YD96YT.B`P+C5I;CL@=&5X="UA;&EG;CH@:G5S=&EF>2<^ M5&AE($-O;7!A;GD@979A;'5A=&5S(&5V96YT0T*86YY(')E8V]G;FEZ960@;W(@;F]N+7)E8V]G;FEZ960@'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE&5S(&%N9`T*;F]N+6-A65A2!D871E+B8C,38P.R8C,38P.TEN(&-O;G-I9&5R871I;VX@ M;V8@=&AE($QE;F1EF5D('5S:6YG('1H92!E9F9E8W1I=F4@:6YT97)E M'0M M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M'0M:6YD96YT M.B`P+C5I;CL@=&5X="UA;&EG;CH@:G5S=&EF>2<^)B,Q-C`[/"]P/CQS<&%N M/CPO7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA2!/9B!3 M:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S(%!O;&EC:65S/"]S=')O M;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0M:6YD96YT.B`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`Q)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W=I9'1H.B`Q)2<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE/3-$)W=I9'1H.B`Q,R4[('1E>'0M86QI9VXZ(')I9VAT M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C(L-#4Q+#0X,SPO M9F]N=#X\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@F4Z(#$P<'0G/E=A M6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C(L-#DR M+#@T-CPO9F]N=#X\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^)B,Q M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0M6QE/3-$)W!A M9&1I;F6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P M<'0G/C,L-#`W+#,Q,SPO9F]N=#X\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N M;W=R87`@F4Z(#$P<'0G/E1O=&%L('!O=&5N=&EA;&QY(&1I;'5T:79E('-H87)E6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)V)O6QE M/3-$)V)O'0M M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G M/C$Q+#DP-2PY,34\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;F2!)'0^ M)SQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M2!H87,@9&5T97)M:6YE9"!T M:&5R92!A'!E8W1E9"!T;R!H879E(&$@;6%T97)I86P@:6UP86-T(&]N('1H92!# M;VUP86YY)W,@8V]N9&5N3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%\T9F,S,&,U.5\T,65D7S1F9C%?.6,S9E]C9F4S8S0X86-C8F$- M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-&9C,S!C-3E?-#%E9%\T M9F8Q7SEC,V9?8V9E,V,T.&%C8V)A+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0M:6YD96YT.B`P+C5I;CL@=&5X="UA;&EG;CH@:G5S M=&EF>2<^4&]T96YT:6%L;'D@9&EL=71I=F4@'0M:6YD96YT.B`P+C5I;B<^)B,Q M-C`[/"]P/@T*#0H\=&%B;&4@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG M/3-$,"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/CQB/DUA6QE/3-$)W!A9&1I;F6QE/3-$)W9E M6QE M/3-$)W!A9&1I;FF4Z(#$P<'0G/CQB M/C(P,30\+V(^/"]F;VYT/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A M<"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,2XU<'0G/B8C,38P.SPO=&0^ M#0H@("`@/'1D('-T>6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E M6QE/3-$)W9EF4Z(#$P<'0G/D]P=&EO;G,\+V9O;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$)W=I M9'1H.B`Q,R4[('1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F M;VYT+7-I>F4Z(#$P<'0G/C(L-3$T+#$U,#PO9F]N=#X\+W1D/@T*("`@(#QT M9"!N;W=R87`],T1N;W=R87`@6QE/3-$)W=I9'1H.B`Q)2<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)V9O;G0MF4Z M(#$P<'0G/E-E6QE/3-$)V)O6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z M(#$P<'0G/C,L-S$T+#0T-3PO9F]N=#X\+W1D/@T*("`@(#QT9"!N;W=R87`] M,T1N;W=R87`@6QE/3-$)V)O6QE/3-$)V9O;G0M6QE/3-$ M)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V9O;G0M'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'!E;G-E'0M86QI9VXZ(&IU6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UEF4Z(#$P<'0G/CQB M/DUA6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W!A M9&1I;FF4Z(#$P<'0G/CQB/C(P,3,\+V(^/"]F;VYT/CPO=&0^ M#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=P861D:6YG+6)O M='1O;3H@,2XU<'0G/B8C,38P.SPO=&0^/"]T6QE/3-$)W=I9'1H.B`Q M)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W=I9'1H.B`Q)2<^)B,Q M-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9EF4Z(#$P<'0G/D1E9F5R6QE/3-$)V9O;G0M M6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9#X\9F]N="!S='EL93TS1"=F M;VYT+7-I>F4Z(#$P<'0G/B0\+V9O;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0MF4Z(#$P<'0G/D%D=F5R M=&ES:6YG/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT M9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R M:6=H="<^/&9O;G0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS M1"=F;VYT+7-I>F4Z(#$P<'0G/C$W."PS.3,\+V9O;G0^/"]T9#X-"B`@("`\ M=&0@;F]W6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9#XF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H M="<^/&9O;G0@F4Z(#$P<'0G/D-U6%B;&5S/"]F;VYT M/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@ M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!R:6=H="<^/&9O;G0@6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@F4Z(#$P M<'0G/D%C8W)U960@26YT97)E6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C0V+#0R.3PO M9F]N=#X\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z M(#$P<'0G/C0U+#8Q-CPO9F]N=#X\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N M;W=R87`^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)V9O M;G0M6QE/3-$)W!A9&1I;F6QE/3-$)V)O6QE M/3-$)V)O6QE/3-$)V9O;G0M6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I M>F4Z(#$P<'0G/C8R,2PP-3(\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;F3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%\T9F,S,&,U.5\T,65D7S1F9C%?.6,S9E]C9F4S M8S0X86-C8F$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-&9C,S!C M-3E?-#%E9%\T9F8Q7SEC,V9?8V9E,V,T.&%C8V)A+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQP M('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2!D=7)I;F<-"G1H92!T:')E92!M;VYT:',@96YD960@36%R8V@@ M,S$L(#(P,30@:7,@<')E6QE/3-$)W9E6QE/3-$)W1E>'0M86QI M9VXZ(&-E;G1E6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&-E M;G1E6QE/3-$)W9E6QE/3-$)V9O;G0MF4Z(#$P<'0G/CQB/D5X97)C M:7-E/"]B/CPO9F]N=#X\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@8V]L M6QE/3-$)V9O;G0M6QE M/3-$)W9E6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/CQB/E!R:6-E/"]B/CPO9F]N=#X\+W1D M/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@6QE/3-$)V)O'0M86QI9VXZ(&-E M;G1E6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/CQB/E9A;'5E/"]B M/CPO9F]N=#X\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G M/C(N,S<\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@6QE M/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^ M/&9O;G0@6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M M6QE/3-$)W!A9&1I;F6QE/3-$)V)O6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P M<'0G/B@R.2PP,#`\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)V)O6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z M(#$P<'0G/C,N,C(\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;F6QE/3-$)V)O6QE/3-$)W=I9'1H.B`S-B4[('!A9&1I;F6QE/3-$)V9O;G0M6QE M/3-$)W=I9'1H.B`Q)3L@<&%D9&EN9RUB;W1T;VTZ(#-P=#L@=&5X="UA;&EG M;CH@6QE/3-$)W=I9'1H M.B`Q)3L@8F]R9&5R+6)O='1O;3H@8FQA8VL@,BXR-7!T(&1O=6)L93L@<&%D M9&EN9RUB;W1T;VTZ(#-P="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q)3L@<&%D9&EN9RUB;W1T;VTZ(#-P M=#L@=&5X="UA;&EG;CH@6QE/3-$)W=I9'1H.B`Q)3L@8F]R9&5R+6)O='1O;3H@8FQA8VL@,BXR-7!T M(&1O=6)L93L@<&%D9&EN9RUB;W1T;VTZ(#-P="<^/&9O;G0@6QE M/3-$)W=I9'1H.B`Q,R4[(&)O'0M86QI9VXZ(')I9VAT M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C(N,S8\+V9O;G0^ M/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W=I9'1H M.B`Q)3L@<&%D9&EN9RUB;W1T;VTZ(#-P="<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@6QE/3-$ M)W=I9'1H.B`Q)3L@<&%D9&EN9RUB;W1T;VTZ(#-P="<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@F4Z(#$P<'0G/B0\ M+V9O;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0M6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!N M;W=R87`],T1N;W=R87`^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V)O6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SX\9F]N M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C$L,SDX+#0W-3PO9F]N=#X\ M+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@6QE/3-$)V)O6QE/3-$)V9O;G0M6QE/3-$)V)O6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0Z(#$P<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E'0M:6YD96YT.B`P+C5I;B<^ M)B,Q-C`[/"]P/@T*#0H\=&%B;&4@8V5L;'-P86-I;F<],T0P(&-E;&QP861D M:6YG/3-$,"!S='EL93TS1"=F;VYT.B`Q,'!T($-A;&EB6QE/3-$)W9E M6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@8V]L'0M86QI M9VXZ(&-E;G1E6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE&5R8VES86)L93PO8CX\+V9O;G0^/"]T9#X-"B`@("`\=&0@ M;F]W6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)W1E>'0M M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI M9VXZ(&-E;G1E&5R8VES92!06QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E.R!P M861D:6YG+6)O='1O;3H@,7!T)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=L:6YE+6AE:6=H=#H@,3$U)3L@<&%D9&EN9RUB;W1T;VTZ(#%P="<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@8V]L6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M.R!P861D:6YG+6)O='1O;3H@,7!T)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)3L@<&%D9&EN9RUB;W1T;VTZ(#%P M="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@8V]L6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E.R!P861D:6YG+6)O='1O M;3H@,7!T)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL M93TS1"=T97AT+6%L:6=N.B!C96YT97([(&QI;F4M:&5I9VAT.B`Q,34E.R!B M;W)D97(M8F]T=&]M.B!";&%C:R`Q<'0@6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E.R!P861D:6YG+6)O='1O;3H@,7!T)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([ M(&QI;F4M:&5I9VAT.B`Q,34E.R!B;W)D97(M8F]T=&]M.B!";&%C:R`Q<'0@ M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`] M,T1N;W=R87`@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=L:6YE+6AE M:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@8V]L6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!C;VQS<&%N/3-$,B!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH M96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I M9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@ M/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@6QE/3-$)W=I9'1H.B`Q,R4[('1E M>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C M,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q,R4[('1E>'0M M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@'0M86QI M9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z M(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q M)3L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z M(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q M,R4[('1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O M;G0@6QE/3-$)W9E6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G M/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N M.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C M,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R M:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C M,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R M:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P M.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H M=#L@;&EN92UH96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L M:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)V)O6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L M:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q M-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H M=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG M:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A M<"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@ M;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE M/3-$)V)O6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U M)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG M:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M:6YD96YT.B`P+C5I;CL@=&5X="UA;&EG;CH@:G5S M=&EF>2<^26X@87!P;'EI;F<@=&AE($)L86-K+5-C:&]L97,@;W!T:6]N('!R M:6-I;F<-"FUO9&5L('1O('-T;V-K('=A2!U M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE'0M86QI9VXZ(&-E;G1E6QE/3-$)W=I9'1H.B`Q."4[(&)O6QE/3-$ M)V9O;G0MF4Z(#$P<'0G/CQB/C(P,3,\+V(^/"]F;VYT/CPO=&0^/"]T M6QE M/3-$)W9EF4Z(#$P M<'0G/E)I6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)V9O;G0M'!E M8W1E9"!V;VQA=&EL:71Y/"]F;VYT/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E M>'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0G/D5X<&5C=&5D(&QI9F4@:6X@>65AF4Z(#$P<'0G/C4N,#`\+V9O;G0^/"]T9#X- M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@F4Z(#$P<'0G M/C4N,#`\+V9O;G0^/"]T9#X\+W1R/@T*/"]T86)L93X\'0^)SQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE M/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI M9VXZ(&-E;G1E6QE/3-$ M)W1E>'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0G/CQB/E)E M;6%I;FEN9SPO8CX\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W1E M>'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE M/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE M/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)V)O'0M86QI9VXZ M(&-E;G1E6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/CQB/E9A;'5E M/"]B/CPO9F]N=#X\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P M<'0G/C`N.38\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M)SXF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS M1"=F;VYT+7-I>F4Z(#$P<'0G/C`N,S4\+V9O;G0^/"]T9#X-"B`@("`\=&0@ M;F]W6QE M/3-$)W9EF4Z M(#$P<'0G/D5X97)C:7-E9#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M'0M86QI9VXZ(')I9VAT M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M M.B!B;&%C:R`Q+C5P="!S;VQI9#L@<&%D9&EN9RUB;W1T;VTZ(#$N-7!T)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B M;&%C:R`Q+C5P="!S;VQI9#L@<&%D9&EN9RUB;W1T;VTZ(#$N-7!T.R!T97AT M+6%L:6=N.B!R:6=H="<^/&9O;G0@6QE/3-$)W!A9&1I;F6QE/3-$ M)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W9EF4Z(#$P<'0G/D]U='-T86YD:6YG+"!-87)C M:"`S,2P@,C`Q-#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T M:#H@,24[('!A9&1I;F'0M86QI9VXZ(')I9VAT M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[(&)O M6QE/3-$)W=I9'1H M.B`Q,R4[(&)O'0M86QI9VXZ(')I9VAT)SX\9F]N="!S M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C(L-#DR+#@T-CPO9F]N=#X\+W1D M/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@'0M M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W M:61T:#H@,24[(&)O6QE/3-$)V9O;G0M6QE M/3-$)W=I9'1H.B`Q)3L@<&%D9&EN9RUB;W1T;VTZ(#-P=#L@=&5X="UA;&EG M;CH@6QE/3-$)W=I9'1H M.B`Q)3L@8F]R9&5R+6)O='1O;3H@8FQA8VL@,BXR-7!T(&1O=6)L93L@<&%D M9&EN9RUB;W1T;VTZ(#-P="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q)3L@<&%D9&EN9RUB;W1T;VTZ(#-P=#L@=&5X M="UA;&EG;CH@6QE/3-$ M)W=I9'1H.B`Q)3L@8F]R9&5R+6)O='1O;3H@8FQA8VL@,BXR-7!T(&1O=6)L M92<^/&9O;G0@6QE/3-$)W=I9'1H.B`Q,R4[(&)O6QE/3-$)W=I9'1H.B`Q)3L@ M<&%D9&EN9RUB;W1T;VTZ(#-P="<^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T M>6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@6QE M/3-$)W!A9&1I;F6QE/3-$)V9O;G0M M6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!P861D M:6YG+6)O='1O;3H@,W!T)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!P861D:6YG M+6)O='1O;3H@,W!T.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@ M9&]U8FQE.R!P861D:6YG+6)O='1O;3H@,W!T)SX\9F]N="!S='EL93TS1"=F M;VYT+7-I>F4Z(#$P<'0G/B0\+V9O;G0^/"]T9#X-"B`@("`\=&0@6QE M/3-$)V9O;G0M6QE/3-$)V)O6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SX\9F]N M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C,N.#PO9F]N=#X\+W1D/@T* M("`@(#QT9"!N;W=R87`],T1N;W=R87`@6QE/3-$)V)O2!O9B!3 M=&]C:R!787)R86YT'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V)O&5R8VES M86)L93PO8CX\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E&5R8VES92!06QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI M9VXZ(&-E;G1E6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE&5R8VES86)L92!.=6UB97(@;V8@5V%R6QE/3-$)W9E6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@8V]L6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@ M6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U M)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@8V]L6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I M9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(')I M9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO M=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@ M6QE/3-$)W=I9'1H M.B`Q,R4[('1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^ M/&9O;G0@6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z M(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q M,R4[('1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O M;G0@'0M M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G M/B8C,38P.SPO=&0^/"]T6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX\9F]N="!S='EL93TS1"=F M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^ M#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN M92UH96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)V)O6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^ M#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN M92UH96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@ M("`@/'1D('-T>6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G M/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@ M,3$U)2<^/&9O;G0@6QE/3-$)W9E6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C M,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@ M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H M=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V)O6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q M-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V)O'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0^)SQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE2<^1G5T=7)E(&UI;FEM=6T@<&%Y;65N=',L(&)Y('EE87(@ M86YD(&EN('1H92!A9V=R96=A=&4L('5N9&5R(&]P97)A=&EN9PT*;&5A6QE/3-$)W9E65AF4Z(#$P M<'0G/CQB/D%M;W5N=#PO8CX\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;F6QE/3-$)W9E6QE/3-$)W=I9'1H M.B`W-24G/CQF;VYT('-T>6QE/3-$)V9O;G0M'0M M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W M:61T:#H@,24G/CQF;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q)2<^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T M>6QE/3-$)W9E6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9#X\9F]N="!S M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/B0\+V9O;G0^/"]T9#X-"B`@("`\ M=&0@6QE/3-$ M)V9O;G0M6QE M/3-$)W9E6QE/3-$)V9O;G0M'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q+C5P="!S;VQI9"<^ M/&9O;G0@6QE/3-$)V)O6QE/3-$)W!A9&1I;F6QE/3-$ M)V9O;G0M6QE/3-$)V)O7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA2!0;&%N'0^)SQS<&%N/CPO M3PO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M2!/9B!3:6=N M:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S($1E=&%I;',\+W-T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA2`H1&5T86EL'0^)SQS<&%N/CPO M'0^)R9N8G-P.R9N8G-P.SQS M<&%N/CPO'0^)R9N8G-P.R9N8G-P M.SQS<&%N/CPO&5R8VES86)L92P@36%R8V@@,S$L(#(P,30\ M+W1D/@T*("`@("`@("`\=&0@8VQA7,\&5R8VES86)L93PO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^)S0@>65A7,\'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO&5R8VES92!0&5R8VES86)L M92!.=6UB97(@;V8@3W!T:6]N'0^)SQS<&%N/CPO&5R8VES92!0 M&5R8VES86)L93PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO&5R8VES92!0&5R8VES86)L M93PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&5R8VES92!0'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&5R8VES92!0'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\T9F,S M,&,U.5\T,65D7S1F9C%?.6,S9E]C9F4S8S0X86-C8F$-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO-&9C,S!C-3E?-#%E9%\T9F8Q7SEC,V9?8V9E M,V,T.&%C8V)A+U=O'0O:'1M;#L@8VAA2!$971A:6QS(#(\+W-T6EE M;&0\+W1D/@T*("`@("`@("`\=&0@8VQA'!E8W1E9"!L:69E(&EN('EE87)S M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG-2!Y96%R3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\T M9F,S,&,U.5\T,65D7S1F9C%?.6,S9E]C9F4S8S0X86-C8F$-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-&9C,S!C-3E?-#%E9%\T9F8Q7SEC,V9? M8V9E,V,T.&%C8V)A+U=O'0O:'1M;#L@8VAA&5R8VES960\+W1D/@T*("`@("`@("`\=&0@ M8VQA'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO M&5R8VES960\+W1D/@T* M("`@("`@("`\=&0@8VQA'0^)R9N8G-P.R9N M8G-P.SQS<&%N/CPO7,\&5R8VES86)L93PO=&0^#0H@("`@("`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`@("`@("`@/'1D(&-L87-S/3-$=&5X M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'!E;G-E('=A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S$@>65A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!L96%S92!R871E(&EN(#(P,34\ M+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'0^2F%N(#$L#0H)"3(P,3<\'0^)SQS<&%N M/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\T9F,S,&,U.5\T,65D M7S1F9C%?.6,S9E]C9F4S8S0X86-C8F$-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO-&9C,S!C-3E?-#%E9%\T9F8Q7SEC,V9?8V9E,V,T.&%C8V)A M+U=O'0O M:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M2!/=71S=&%N9&EN9R!;365M8F5R73QB'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\>&UL('AM;&YS.F\],T0B=7)N.G-C:&5M87,M;6EC XML 20 R29.htm IDEA: XBRL DOCUMENT v2.4.0.8

Stockholders' Deficiency (Details 4) (USD $)

Mar. 31, 2014

$0.25 - $0.35 [Member]

Outstanding Number of Warrants 1,900,000

Weighted Average Remaining Contractual Term 4 years 1 month 6 days

Weighted Average Exercise Price Outstanding $ 0.27

Exercisable Number of Warrants 1,900,000

Weighted Average Exercise Price Exercisable $ 0.27

$0.36 - $3.00 [Member]

Outstanding Number of Warrants 562,846

Weighted Average Remaining Contractual Term 2 years 4 months 24 days

Weighted Average Exercise Price Outstanding $ 2.91

Exercisable Number of Warrants 312,846

Weighted Average Exercise Price Exercisable $ 2.91

$3.01 - $4.95 [Member]

Outstanding Number of Warrants 30,000

Weighted Average Remaining Contractual Term 3 years 6 months

Weighted Average Exercise Price Outstanding $ 4.95

Exercisable Number of Warrants 30,000

Weighted Average Exercise Price Exercisable $ 4.95

0.25 - $4.95 [Member]

Outstanding Number of Warrants 2,492,846

Weighted Average Remaining Contractual Term 3 years 9 months 18 days

Weighted Average Exercise Price Outstanding $ 0.92

Exercisable Number of Warrants 2,242,846

Weighted Average Exercise Price Exercisable $ 0.70

X

- Definition

Number Exercisable.

+ References

No definition available.

+ Details

Name: HEWA_ClassOfWarrantOrRightExercisable

Namespace Prefix: HEWA_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Weighted average exercise price exercisable.

+ References

No definition available.

+ Details

Name: HEWA_WarrantExercisableWeightedAverageExercisePrice

Namespace Prefix: HEWA_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

WarrantsOutstandingWeightedAverageExercisePrice

+ References

No definition available.

+ Details

Name: HEWA_WarrantsOutstandingWeightedAverageExercisePrice

Namespace Prefix: HEWA_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

Weighted average remaining contractual term.

+ References

No definition available.

+ Details

Name: HEWA_WeightedAverageRemainingContractualTerm

Namespace Prefix: HEWA_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: instant

X

- Definition

Number of warrants or rights outstanding.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(i))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph i

-Article 4

+ Details

Name: us-gaap_ClassOfWarrantOrRightOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

XML 21 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8

Stockholders' Deficiency (Details 3) (USD $)
3 Months Ended

Mar. 31, 2014

Number of warrants, outstanding

Outstanding, beginning of period (in shares) 2,342,846

Granted 150,000

Exercised

Forfeited

Exercisable, March 31, 2014 2,242,846

Warrants, weighted average exercise price

Outstanding, beginning of period (in dollars per share) $ 0.96

Granted $ 0.35

Exercised

Forfeited

Exercisable, March 31, 2014 $ 0.70

Weighted Average Remaining Life In Years

Weighted Average Remaining Life (in years) Outstanding 3 years 8 months 12 days

Weighted Average Remaining Life (in years) Exercisable 3 years 9 months 18 days

Aggregate Intrinsic Value

Aggregate Intrinsic Value Outstanding

Aggregate Intrinsic Value Exercisable

X

- Details

Name: HEWA_AggregateIntrinsicValue

Namespace Prefix: HEWA_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Aggregate intrinsic value exercisable.

+ References

No definition available.

+ Details

Name: HEWA_AggregateIntrinsicValueExercisable

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Aggregate intrinsic value outstanding.

+ References

No definition available.

+ Details

Name: HEWA_AggregateIntrinsicValueOutstanding

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: HEWA_NumberOfWarrantsOutstanding

Namespace Prefix: HEWA_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber2

+ References

No definition available.

+ Details

Name: HEWA_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber2

Namespace Prefix: HEWA_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice2

+ References

No definition available.

+ Details

Name: HEWA_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice2

Namespace Prefix: HEWA_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

Share based compensation arrangement by share based payment award options forfeitures and expirations in period weighted average exercise price1.

+ References

No definition available.

+ Details

Name: HEWA_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice1

Namespace Prefix: HEWA_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

Forfeited.

+ References

No definition available.

+ Details

Name: HEWA_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod1

Namespace Prefix: HEWA_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Granted.

+ References

No definition available.

+ Details

Name: HEWA_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross1

Namespace Prefix: HEWA_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Outstanding.

+ References

No definition available.

+ Details

Name: HEWA_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber1

Namespace Prefix: HEWA_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Outstanding.

+ References

No definition available.

+ Details

Name: HEWA_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1

Namespace Prefix: HEWA_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

Share based compensation arrangements by share based payment award options exercises in period weighted average exercise price1.

+ References

No definition available.

+ Details

Name: HEWA_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice1

Namespace Prefix: HEWA_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

Granted.

+ References

No definition available.

+ Details

Name: HEWA_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice1

Namespace Prefix: HEWA_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

Exercised.

+ References

No definition available.

+ Details

Name: HEWA_StockIssuedDuringPeriodSharesStockOptionsExercised1

Namespace Prefix: HEWA_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: HEWA_WarrantsWeightedAverageExercisePrice

Namespace Prefix: HEWA_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: HEWA_WeightedAverageRemainingLifeInYears

Namespace Prefix: HEWA_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Weighted average remaining life in years exercisable.

+ References

No definition available.

+ Details

Name: HEWA_WeightedAverageRemainingLifeInYearsExercisable

Namespace Prefix: HEWA_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition

Weighted average remaining life in years outstanding.

+ References

No definition available.

+ Details

Name: HEWA_WeightedAverageRemainingLifeInYearsOutstanding

Namespace Prefix: HEWA_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

XML 22 R30.htm IDEA: XBRL DOCUMENT v2.4.0.8

Stockholders' Deficiency (Details Narrative) (USD $)
3 Months Ended 12 Months Ended 3 Months Ended

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2014

Stock Warrants [Member]

Mar. 31, 2013

Stock Warrants [Member]

Mar. 31, 2014

Series B Preferred Stock [Member]

Dec. 31, 2013

Series B Preferred Stock [Member]

Mar. 31, 2014

Stock Option [Member]

Mar. 31, 2013

Stock Option [Member]

Preferred Stock Contractual Dividends 74,730 279,380

Weighted Average Fair Value $ 0.23 $ 1.38

Selling, General And Administrative Expenses $ 264 $ 504,777 $ 151,853 $ 312,444

Stock-Based Compensation Expense related to stock options, unamortized 1,476,372

Stock-Based Compensation Expense, amortized 3,685 584,803

Stock-based compensation expense warrants. unamortized 580,525

Weighted Average Remaining Period 1 year 6 months 1 year 6 months

Performance based option vesting 576,840 891,569

Salary expense $ 87,500 $ 87,500

X

- Definition

custom:PerformanceBasedOptionVesting

+ References

No definition available.

+ Details

Name: HEWA_PerformanceBasedOptionVesting

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Preferred Stock Contractual Dividends.

+ References

No definition available.

+ Details

Name: HEWA_PreferredStockContractualDividends

Namespace Prefix: HEWA_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Stock Based Compensation Expense.

+ References

No definition available.

+ Details

Name: HEWA_StockbasedCompensationExpense

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Stockbased compensation expense amortized.

+ References

No definition available.

+ Details

Name: HEWA_StockbasedCompensationExpenseAmortized

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

custom:StockbasedCompensationExpenseWarrants

+ References

No definition available.

+ Details

Name: HEWA_StockbasedCompensationExpenseWarrants

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Weighted Average Fair Value per share.

+ References

No definition available.

+ Details

Name: HEWA_WeightedAverageFairValueOfOptionGrantedPerShare

Namespace Prefix: HEWA_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

custom:Weighted Average Remaining Period

+ References

No definition available.

+ Details

Name: HEWA_WeightedAverageRemainingPeriod

Namespace Prefix: HEWA_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition

Other generally recurring costs associated with normal operations excluding those directly related to the marketing or selling of products and services not otherwise defined.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.4)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_OtherSellingGeneralAndAdministrativeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Expenditures for salaries other than officers. Does not include allocated share-based compensation, pension and post-retirement benefit expense or other labor-related non-salary expense. For commercial and industrial companies, excludes any direct and overhead labor that is included in cost of goods sold.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.4)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_SalariesAndWages

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 23 R31.htm IDEA: XBRL DOCUMENT v2.4.0.8

Commitments and Contingent Liabilities (Details) (USD $)

Mar. 31, 2014

Commitments And Contingent Liabilities Details

2014 $ 96,037

2015 128,049

2016 143,700

Total future minimum lease payments $ 367,786

X

- Details

Name: HEWA_CommitmentsAndContingentLiabilitiesDetails

Namespace Prefix: HEWA_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 10

-Section 55

-Paragraph 40

-Subparagraph (Note 3)

-URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 20

-Section 50

-Paragraph 2

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717

+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount of required minimum rental payments maturing in the next fiscal year following the latest fiscal year for operating leases having an initial or remaining non-cancelable letter-terms in excess of one year.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 10

-Section 55

-Paragraph 40

-Subparagraph (Note 3)

-URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 20

-Section 50

-Paragraph 2

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717

+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount of required minimum rental payments maturing in the third fiscal year following the latest fiscal year for operating leases having an initial or remaining non-cancelable letter-terms in excess of one year.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 10

-Section 55

-Paragraph 40

-Subparagraph (Note 3)

-URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 20

-Section 50

-Paragraph 2

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717

+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount of required minimum rental payments maturing in the second fiscal year following the latest fiscal year for operating leases having an initial or remaining non-cancelable letter-terms in excess of one year.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 10

-Section 55

-Paragraph 40

-Subparagraph (Note 3)

-URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 20

-Section 50

-Paragraph 2

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717

+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 24 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8

Summary of Significant Accounting Policies
3 Months Ended

Mar. 31, 2014

Summary Of Significant Accounting Policies

Note 3 - Summary of Significant Accounting Policies
Principles of Consolidation

The condensed consolidated financial statements include the accounts of HealthWarehouse.com, Inc., Hwareh.com, Inc., Hocks.com, Inc., ION Holding NV, ION Belgium NV and Pagosa, its wholly-owned subsidiaries. ION Holding NV and ION Belgium NV are inactive subsidiaries. All material inter-company balances and transactions have been eliminated in consolidation.

On June 4, 2013, the Company formed a wholly-owned subsidiary called Pagosa Health LLC (“Pagosa”). On January 14, 2014, the Company closed Pagosa and decided to focus on its core consumer prescription business. Pagosa had a de minimis impact on the Company’s operations or the results for the three months ended March 31, 2014.

Use of Estimates

The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company’s significant estimates include reserves related to accounts receivable and inventory, the recoverability and useful lives of long-lived assets, the valuation allowance related to deferred tax assets, the valuation of equity instruments and debt discounts.

Net Loss Per Share of Common Stock

Basic net loss per share is computed by dividing net loss attributable to Common Stockholders by the weighted average number of common shares outstanding during the period. Diluted net loss per share reflects the potential dilution that could occur if securities or other instruments to issue Common Stock were exercised or converted into Common Stock. Potentially dilutive securities are excluded from the computation of diluted net loss per share if their inclusion would be anti-dilutive and consist of the following:

March 31,

2014 2013

Options 2,514,150 2,451,483

Warrants 2,492,846 6,047,119

Series B Convertible Preferred Stock 3,714,445 3,407,313

Total potentially dilutive shares 8,721,441 11,905,915

Recently Issued Accounting Pronouncements

The Company has determined there are no new accounting standards that are expected to have a material impact on the Company's condensed consolidated financial statements.

X

- Details

Name: HEWA_SummaryOfSignificantAccountingPoliciesAbstract

Namespace Prefix: HEWA_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for all significant accounting policies of the reporting entity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18726-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18861-107790

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18743-107790

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18854-107790

+ Details

Name: us-gaap_SignificantAccountingPoliciesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 25 R32.htm IDEA: XBRL DOCUMENT v2.4.0.8

Commitments and Contingent Liabilities (Details Narrative) (USD $)
3 Months Ended

Mar. 31, 2014

Mar. 31, 2013

Dec. 31, 2013

Commitments And Contingent Liabilities Details Narrative

Monthly lease rate in 2014 $ 10,671

Monthly lease rate in 2015 10,671

Monthly lease rate in 2016 11,975

Lease expires date Jan. 01, 2017

Deferred rent payable 43,704 46,254

Rent Expense $ 49,229 $ 45,719

X

- Details

Name: HEWA_CommitmentsAndContingentLiabilitiesDetailsNarrativeAbstract

Namespace Prefix: HEWA_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

custom:DeferredRentPayable

+ References

No definition available.

+ Details

Name: HEWA_DeferredRentPayable

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

custom:LeaseExpiresDate

+ References

No definition available.

+ Details

Name: HEWA_LeaseExpiresDate

Namespace Prefix: HEWA_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition

custom:MonthlyLeaseRateIn2014

+ References

No definition available.

+ Details

Name: HEWA_MonthlyLeaseRateIn2014

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

custom:MonthlyLeaseRateIn2015

+ References

No definition available.

+ Details

Name: HEWA_MonthlyLeaseRateIn2015

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

custom:MonthlyLeaseRateIn2016

+ References

No definition available.

+ Details

Name: HEWA_MonthlyLeaseRateIn2016

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.

+ References

No definition available.

+ Details

Name: us-gaap_LeaseAndRentalExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 26 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)

Mar. 31, 2014

Dec. 31, 2013

Current assets:

Cash $ 59,800 $ 67,744

Accounts receivable, net of allowance of $59,534 and $250,828 as of March 31, 2014 and December 31, 2013 74,767 307,211

Inventories - finished goods, net 246,151 277,300

Prepaid expenses and other current assets 40,612 59,143

Total current assets 421,330 711,398

Property and equipment, net of accumulated depreciation of $608,109 and $576,590 as of March 31, 2014 and December 31, 2013 593,116 624,634

Web development costs, net of accumulated amortization of $24,745 and $14,643 as of March 31, 2014 and December 31, 2013 108,544 83,780

Total assets 1,122,990 1,419,812

Current liabilities:

Accounts payable - trade 2,926,669 3,310,000

Accounts payable - related parties 78,246 83,691

Accrued expenses and other current liabilities 441,574 621,052

Deferred revenue 78,790 95,792

Current portion of equipment lease payable 58,266 56,323

Notes payable and other advances, net of debt discount of $212,830 as of March 31, 2014 487,170

Note payable and other advances - related parties 78,095 78,095

Redeemable preferred stock - Series C; par value $0.001 per share; 10,000 designated Series C: 10,000 issued and outstanding as of March 31, 2014 and December 31, 2013 (aggregate liquidation preference of $1,000,000) 1,000,000 1,000,000

Total current liabilities 5,148,810 5,244,953

Long term liabilities:

Notes payable, net of debt discount of $29,133 as of March 31, 2014 and $269,998 as of December 31, 2013 70,867 430,002

Long term portion of equipment lease payable 94,862 109,964

Total long term liabilities 165,729 539,966

Total liabilities 5,314,539 5,784,919

Commitments and contingencies

Preferred stock - par value $0.001 per share; authorized 1,000,000 shares; issued and outstanding as of March 31, 2014 and December 31, 2013 as follows:

Convertible preferred stock - Series A - 200,000 shares designated Series A; 44,443 shares available to be issued; no shares issued and outstanding

Convertible preferred stock - Series B - 625,000 shares designated Series B; 451,879 and 422,315 shares issued and outstanding as of March 31, 2014 and December 31, 2013, respectively (aggregate liquidation preference of $4,344,987 and $4,270,257 as of March 31, 2014 and December 31, 2013, respectively) 452 422

Common stock - par value $0.001 per share; authorized 50,000,000 shares; 27,729,592 and 27,708,303 shares issued and 26,550,380 and 26,529,091 shares outstanding as of March 31, 2014 and December 31, 2013, respectively 27,731 27,708

Additional paid-in capital 27,721,737 27,166,147

Employee advances (10,715) (9,001)

Treasury stock, at cost, 1,179,212 shares as of March 31, 2014 and December 31, 2013 (3,419,715) (3,419,715)

Accumulated deficit (28,511,039) (28,130,668)

Total stockholders' deficiency (4,191,549) (4,365,107)

Total liabilities and stockholders' deficiency $ 1,122,990 $ 1,419,812

X

- Definition

Accrued expenses and other current liabilities

+ References

No definition available.

+ Details

Name: HEWA_AccruedExpensesAndOtherCurrentLiabilities

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

EmployeeAdvancesCollateralizedShares

+ References

No definition available.

+ Details

Name: HEWA_EmployeeAdvancesCollateralizedShares

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Convertible preferred stock - Series A &#8211; 200,000 shares designated Series A; 44,443 shares available to be issued; no shares issued and outstanding

+ References

No definition available.

+ Details

Name: HEWA_PreferredStockAdditionalSeriesAValue

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Convertible preferred stock - Series B &#8211; 625,000 shares designated Series B; 394,685 and 368,862 shares issued and outstanding as of December 31, 2012 and 2011, respectively (aggregate liquidation preference of $3,990,877 and $3,729,973 as of December 31, 2012 and 2011, respectively)

+ References

No definition available.

+ Details

Name: HEWA_PreferredStockAdditionalSeriesBValue

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Redeemable preferred stock - Series C (see below)

+ References

No definition available.

+ Details

Name: HEWA_RedeemablePreferredStockSeriesCCurrentLiability

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

custom:WebDevelopmentCostsNetOfAccumulatedAmortization

+ References

No definition available.

+ Details

Name: HEWA_WebDevelopmentCostsNetOfAccumulatedAmortization

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount due from customers, clients, or other third-parties, or arising from transactions not separately disclosed, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.

+ References

No definition available.

+ Details

Name: us-gaap_AccountsAndOtherReceivablesNetCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount for accounts payable to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k)(1))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39622-107864

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph k

-Subparagraph 1

-Article 4

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19

-Subparagraph a

-Article 5

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

+ Details

Name: us-gaap_AccountsPayableRelatedPartiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19

-Subparagraph a

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Current Liabilities

-URI http://asc.fasb.org/extlink&oid=6509677

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccountsPayableTradeCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.30(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AdditionalPaidInCapital

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.18)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 12

-Article 7

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 18

-Article 5

+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.9)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6801-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 9

-Article 5

+ Details

Name: us-gaap_AssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_AssetsCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of capital lease obligation due within one year or the normal operating cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 30

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6455398&loc=d3e45280-112737

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6455314&loc=d3e45023-112735

+ Details

Name: us-gaap_CapitalLeaseObligationsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal, through the balance sheet date and due to be paid more than one year (or one operating cycle, if longer) after the balance sheet date.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 22

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 30

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6455398&loc=d3e45280-112737

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6455314&loc=d3e45023-112735

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CapitalLeaseObligationsNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 1

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_Cash

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 450

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14326-108349

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.25)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 25

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 7

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 17

-Article 9

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.17)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.(a),19)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

+ Details

Name: us-gaap_CommitmentsAndContingencies

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

The carrying amount of consideration received or receivable as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year or the normal operating cycle, if longer, including sales, license fees, and royalties, but excluding interest income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 13.A.4(a).Q1)

-URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 8

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 13

-Section A

+ Details

Name: us-gaap_DeferredRevenueCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k)(1))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (d)

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph k

-Subparagraph 1

-Article 4

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19

-Subparagraph a

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DueToRelatedPartiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 5

-Section BB

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 5.BB)

-URI http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 6

-Article 5

+ Details

Name: us-gaap_InventoryFinishedGoodsNetOfReserves

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19-26)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_Liabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.32)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 25

-Article 7

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 32

-Article 5

+ Details

Name: us-gaap_LiabilitiesAndStockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.21)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 21

-Article 5

+ Details

Name: us-gaap_LiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_LiabilitiesCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of obligation due after one year or beyond the normal operating cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22-26)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 22, 23, 24, 25, 26, 27

-Article 5

+ Details

Name: us-gaap_LiabilitiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_LiabilitiesNoncurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of long-term debt, after unamortized discount or premium, scheduled to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19,20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19

-Article 5

+ Details

Name: us-gaap_LongTermDebtCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.16)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19, 20, 22

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.16)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 13, 16

-Article 9

+ Details

Name: us-gaap_NotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 8

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

+ Details

Name: us-gaap_PrepaidExpenseAndOtherAssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.13)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 13

-Subparagraph a

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 8

-Article 7

+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

The cumulative amount of the reporting entity's undistributed earnings or deficit.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.31(a)(3))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 30

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656

+ Details

Name: us-gaap_TreasuryStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 27 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8

Organization and Basis of Presentation
3 Months Ended

Mar. 31, 2014

Organization And Basis Of Presentation

Note 1 - Organization and Basis of Presentation
HealthWarehouse.com, Inc., a Delaware company incorporated in 1998, (the “Company”) is a U.S. licensed virtual retail pharmacy (“VRP”) and healthcare e-commerce company that sells brand name and generic prescription drugs as well as over-the-counter (“OTC”) medical products. The Company’s objective is to be viewed by individual healthcare product consumers as a low-cost, reliable and hassle-free provider of prescription drugs and OTC medical products. The Company is presently licensed as a mail-order pharmacy in 50 states in the United States and the District of Columbia.

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information. Accordingly, they do not include all of the information and disclosures required by GAAP for annual financial statements. In the opinion of management, such statements include all adjustments (consisting only of normal recurring items) which are considered necessary for a fair presentation of the condensed consolidated financial statements of the Company as of March 31, 2014 and for the three months ended March 31, 2014 and 2013. The results of operations for the three months ended March 31, 2014 are not necessarily indicative of the operating results for the full year ending December 31, 2014 or any other period. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related disclosures of the Company as of December 31, 2013 and for the year then ended, which were filed with the Securities and Exchange Commission on Form 10-K on April 15, 2014.

X

- Details

Name: HEWA_OrganizationAndBasisOfPresentationAbstract

Namespace Prefix: HEWA_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 720

-SubTopic 15

-URI http://asc.fasb.org/subtopic&trid=2122524

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=28200181&loc=SL6228881-111685

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=7668296&loc=d3e288-107754

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2197480

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=18733093&loc=d3e5614-111684

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 915

-SubTopic 235

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6472506&loc=d3e38932-110933

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 852

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2209116

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 272

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2134480

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2122150

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755

+ Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 28 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8

Summary of Significant Accounting Policies (Details) (USD $)

Mar. 31, 2014

Dec. 31, 2013

Summary Of Significant Accounting Policies Details

Options $ 2,514,150 $ 2,451,483

Warrants 2,492,846 6,047,119

Series B Convertible Preferred Stock 3,714,445 3,407,313

Total potentially dilutive shares $ 8,721,441 $ 11,905,915

X

- Definition

Options

+ References

No definition available.

+ Details

Name: HEWA_DilutiveOptions

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Series B Convertible Preferred Stock

+ References

No definition available.

+ Details

Name: HEWA_DilutiveSeriesBConvertiblePreferredStock

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

DilutiveWarrants

+ References

No definition available.

+ Details

Name: HEWA_DilutiveWarrants

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

custom:Potentially Dilutive Securities

+ References

No definition available.

+ Details

Name: HEWA_PotentiallyDilutiveSecurities

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: HEWA_SummaryOfSignificantAccountingPoliciesDetailsAbstract

Namespace Prefix: HEWA_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 29 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8

Notes Payable (Details Narrative) (USD $)
3 Months Ended

Mar. 31, 2014

Mar. 31, 2013

Amortization of debt discount $ 54,035 $ 44,363

Loan Agreement [Member]

Face amount of loan 700,000

Current borrowed amount of loan 100,000

Note bears interest rate 7.50%

Aggregate number of Warrants Issued 1,050,000

Warrants issued Exercise Price $ 0.35

Warrants issued 150,000

Fair value related to warrants 392,500

Fair value related to warrants as debt discount 26,000

Debt discount as interest expense, amortized 49,435

Debt discount as interest expense, unamortized $ 212,830

X

- Definition

Warrants issued exercise price.

+ References

No definition available.

+ Details

Name: HEWA_AggregateNumberOfWarrantsIssued

Namespace Prefix: HEWA_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

custom:CurrentBorrowedAmountOfLoan

+ References

No definition available.

+ Details

Name: HEWA_CurrentBorrowedAmountOfLoan

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

custom:DebtDiscountAsInterestExpenseAmortized

+ References

No definition available.

+ Details

Name: HEWA_DebtDiscountAsInterestExpenseAmortized

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Debt discount as interest expense unamortized.

+ References

No definition available.

+ Details

Name: HEWA_DebtDiscountAsInterestExpenseUnamortized

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

custom:FaceAmountOfLoan

+ References

No definition available.

+ Details

Name: HEWA_FaceAmountOfLoan

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

custom:FairValueRelatedToWarrants

+ References

No definition available.

+ Details

Name: HEWA_FairValueRelatedToWarrants

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

custom:FairValueRelatedToWarrantsAsDebtDiscount

+ References

No definition available.

+ Details

Name: HEWA_FairValueRelatedToWarrantsAsDebtDiscount

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

custom:NoteBearsInterestRate

+ References

No definition available.

+ Details

Name: HEWA_NoteBearsInterestRate

Namespace Prefix: HEWA_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition

custom:WarrantsIssued

+ References

No definition available.

+ Details

Name: HEWA_WarrantsIssued

Namespace Prefix: HEWA_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Warrants issued ixercise price.

+ References

No definition available.

+ Details

Name: HEWA_WarrantsIssuedExercisePrice

Namespace Prefix: HEWA_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28541-108399

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.8)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 8

-Article 5

+ Details

Name: us-gaap_AmortizationOfDebtDiscountPremium

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 30 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 31 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8

Going Concern and Management's Liquidity Plans
3 Months Ended

Mar. 31, 2014

Going Concern And Managements Liquidity Plans

Note 2 - Going Concern and Management's Liquidity Plans
Since inception, the Company has financed its operations primarily through debt and equity financings and advances from related parties. As of March 31, 2014, the Company had a working capital deficiency of $4,727,480 and an accumulated deficit of $28,511,039. During the quarter ended March 31, 2014 and the year ended December 31, 2013, the Company incurred net losses of $305,641 and $5,489,892, respectively and used cash in operating activities of $59,918 and $1,024,781, respectively. These conditions raise substantial doubt about the Company’s ability to continue as a going concern.

Subsequent to March 31, 2014, the Company (a) raised an additional $50,000 in debt financing and (b) continues to incur net losses, use cash in operating activities and experience cash and working capital constraints. See Note 10.

On February 13, 2013, the Company received a Notice of Redemption related to its Series C Redeemable Preferred Stock aggregating $1,000,000 (see Note 6). As a result of receiving the Notice of Redemption, the Company must now apply all of its assets to redemption of the Series C Preferred Stock and to no other corporate purpose, except to the extent prohibited by Delaware law governing distributions to stockholders (the Company is not permitted to utilize toward the redemption those assets required to pay its debts as they come due and those assets required to continue as a going concern).

The Company recognizes it will need to raise additional capital in order to fund operations, meet its payment obligations and execute its business plan. There is no assurance that additional financing will be available when needed or that management will be able to obtain financing on terms acceptable to the Company and whether the Company will become profitable and generate positive operating cash flow. If the Company is unable to raise sufficient additional funds, it will have to develop and implement a plan to further extend payables, attempt to extend note repayments, attempt to negotiate the preferred stock redemption and reduce overhead until sufficient additional capital is raised to support further operations. There can be no assurance that such a plan will be successful. If the Company is unable to obtain financing on a timely basis, the Company could be forced to sell its assets, discontinue its operation and /or seek reorganization under the U.S. bankruptcy code.

Accordingly, the accompanying condensed consolidated financial statements have been prepared in conformity with GAAP, which contemplates continuation of the Company as a going concern and the realization of assets and the satisfaction of liabilities in the normal course of business. The carrying amounts of assets and liabilities presented in the condensed consolidated financial statements do not necessarily represent realizable or settlement values. The condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

X

- Details

Name: HEWA_GoingConcernAndManagementsLiquidityPlansAbstract

Namespace Prefix: HEWA_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Going Concern and Management's Liquidity Plans

+ References

No definition available.

+ Details

Name: HEWA_GoingConcernAndManagementsLiquidityPlansTextBlock

Namespace Prefix: HEWA_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 32 R3.htm IDEA: XBRL DOCUMENT v2.4.0.8

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)

Mar. 31, 2014

Dec. 31, 2013

Current assets:

Property and equipment, net of accumulated depreciation $ 608,109 $ 576,590

Web development costs, net of accumulated amortization 24,745 14,643

Current liabilities:

Current Portion Notes payable and other advances, net of debt discount 212,830

Redeemable preferred stock Series C, par value 0.001 0.001

Redeemable preferred stock Series C, shares designated 10,000 10,000

Redeemable preferred stock Series C, shares issued 10,000 10,000

Redeemable preferred stock Series C, shares outstanding 10,000 10,000

Redeemable preferred stock Series C, aggregate liquidation preference 1,000,000 1,000,000

Long term liabilities:

Current Portion Notes payable, net of debt discount 29,133 269,998

Stockholders' deficiency:

Preferred stock, par value $ 0.001 $ 0.001

Preferred stock, authorized 1,000,000 1,000,000

Preferred stock, shares issued 1,000,000 1,000,000

Preferred stock, shares outstanding 1,000,000 1,000,000

Series A Convertible preferred stock, shares designated 200,000 200,000

Series A Convertible preferred stock, shares available to be issued 44,443 44,443

Series A Convertible preferred stock, shares issued 0 0

Series A Convertible preferred stock, shares outstanding 0 0

Series B Convertible preferred stock, shares designated 625,000 625,000

Series B Convertible preferred stock, shares issued 451,879 422,315

Series B Convertible preferred stock, shares outstanding 451,879 422,315

Series B Convertible preferred stock, aggregate liquidation preference $ 4,344,987 $ 4,270,257

Common stock, par value $ 0.001 $ 0.001

Common stock, authorized 50,000,000 50,000,000

Common stock, shares issued 27,729,592 27,708,303

Common stock, shares outstanding 26,550,380 26,529,091

Treasury stock, shares 1,179,212 1,179,212

X

- Definition

custom:CurrentPortionNotesPayableNetOfDebtDiscount1

+ References

No definition available.

+ Details

Name: HEWA_CurrentPortionNotesPayableNetOfDebtDiscount1

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Current Portion Notes Payable, deferred debt discount

+ References

No definition available.

+ Details

Name: HEWA_DebtInstrumentCurrentUnamortizedDiscount

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Series B Convertible preferred stock, aggregate liquidation preference

+ References

No definition available.

+ Details

Name: HEWA_PreferredStockAggregateLiquidationPreference

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Series A Convertible preferred stock, shares designated

+ References

No definition available.

+ Details

Name: HEWA_PreferredStockSeriesASharesDesignated

Namespace Prefix: HEWA_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Series A Convertible preferred stock, shares issued

+ References

No definition available.

+ Details

Name: HEWA_PreferredStockSeriesASharesIssued

Namespace Prefix: HEWA_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Series A Convertible preferred stock, shares outstanding

+ References

No definition available.

+ Details

Name: HEWA_PreferredStockSeriesASharesOutstanding

Namespace Prefix: HEWA_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Series B Convertible preferred stock, shares designated

+ References

No definition available.

+ Details

Name: HEWA_PreferredStockSeriesBSharesDesignated

Namespace Prefix: HEWA_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Series B Convertible preferred stock, shares issued

+ References

No definition available.

+ Details

Name: HEWA_PreferredStockSeriesBSharesIssued

Namespace Prefix: HEWA_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Series B Convertible preferred stock, shares outstanding

+ References

No definition available.

+ Details

Name: HEWA_PreferredStockSeriesBSharesOutstanding

Namespace Prefix: HEWA_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

custom:PropertyAndEquipmentNetOfAccumulatedDepreciation1

+ References

No definition available.

+ Details

Name: HEWA_PropertyAndEquipmentNetOfAccumulatedDepreciation1

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

custom:Redeemable Preferred Stock Series C Aggregate Liquidation Preference

+ References

No definition available.

+ Details

Name: HEWA_RedeemablePreferredStockSeriesCAggregateLiquidationPreference

Namespace Prefix: HEWA_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

custom:Redeemable Preferred Stock Series C Par Value

+ References

No definition available.

+ Details

Name: HEWA_RedeemablePreferredStockSeriesCParValue

Namespace Prefix: HEWA_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

custom:Redeemable Preferred Stock Series C Shares Designated

+ References

No definition available.

+ Details

Name: HEWA_RedeemablePreferredStockSeriesCSharesDesignated

Namespace Prefix: HEWA_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

custom:Redeemable Preferred Stock Series C Shares Issued

+ References

No definition available.

+ Details

Name: HEWA_RedeemablePreferredStockSeriesCSharesIssued

Namespace Prefix: HEWA_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

custom:Redeemable Preferred Stock Series C Shares Outstanding

+ References

No definition available.

+ Details

Name: HEWA_RedeemablePreferredStockSeriesCSharesOutstanding

Namespace Prefix: HEWA_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Series A Convertible preferred stock, shares available to be issued.

+ References

No definition available.

+ Details

Name: HEWA_SeriesConvertiblePreferredStockSharesAvailableToBeIssued

Namespace Prefix: HEWA_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

custom:WebDevelopmentCostsNetOfAccumulatedAmortization1

+ References

No definition available.

+ Details

Name: HEWA_WebDevelopmentCostsNetOfAccumulatedAmortization1

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_AssetsCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Face amount or stated value per share of common stock.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

The maximum number of common shares permitted to be issued by an entity's charter and bylaws.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_LiabilitiesCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_LiabilitiesNoncurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_StockholdersEquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28,29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30

-Article 5

+ Details

Name: us-gaap_TreasuryStockShares

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

XML 33 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8

Summary of Significant Accounting Policies (Tables)
3 Months Ended

Mar. 31, 2014

Summary Of Significant Accounting Policies Tables

Schedule of Potentially Dilutive Securities
Potentially dilutive securities are excluded from the computation of diluted net loss per share if their inclusion would be anti-dilutive and consist of the following:

March 31,

2014 2013

Options 2,514,150 2,451,483

Warrants 2,492,846 6,047,119

Series B Convertible Preferred Stock 3,714,445 3,407,313

Total potentially dilutive shares 8,721,441 11,905,915

X

- Details

Name: HEWA_SummaryOfSignificantAccountingPoliciesTablesAbstract

Namespace Prefix: HEWA_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details

Name: us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 34 R1.htm IDEA: XBRL DOCUMENT v2.4.0.8

Document and Entity Information
3 Months Ended

Mar. 31, 2014

May 07, 2014

Document And Entity Information

Entity Registrant Name HealthWarehouse.com, Inc.

Entity Central Index Key 0000754813

Document Type 10-Q

Document Period End Date Mar. 31, 2014

Amendment Flag false

Current Fiscal Year End Date --12-31

Is Entity a Well-known Seasoned Issuer No

Is Entity a Voluntary Filer? No

Is Entity's Reporting Status Current Yes

Entity Filer Category Smaller Reporting Company

Entity Common Stock, Shares Outstanding 26,550,380

Document Fiscal Period Focus Q1

Document Fiscal Year Focus 2014

X

- Definition

If the value is true, then the document is an amendment to previously-filed/accepted document.

+ References

No definition available.

+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition

End date of current fiscal year in the format --MM-DD.

+ References

No definition available.

+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition

This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.

+ References

No definition available.

+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition

This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.

+ References

No definition available.

+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition

The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.

+ References

No definition available.

+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".

+ References

No definition available.

+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition

Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.

+ References

No definition available.

+ Details

Name: dei_EntityCommonStockSharesOutstanding

Namespace Prefix: dei_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.

+ References

No definition available.

+ Details

Name: dei_EntityCurrentReportingStatus

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition

Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.

+ References

No definition available.

+ Details

Name: dei_EntityFilerCategory

Namespace Prefix: dei_

Data Type: dei:filerCategoryItemType

Balance Type: na

Period Type: duration

X

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition

Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.

+ References

No definition available.

+ Details

Name: dei_EntityVoluntaryFilers

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition

Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.

+ References

No definition available.

+ Details

Name: dei_EntityWellKnownSeasonedIssuer

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Details

Name: HEWA_DocumentAndEntityInformationAbstract

Namespace Prefix: HEWA_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 35 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8

Accrued Expenses and Other Current Liabilities (Tables)
3 Months Ended

Mar. 31, 2014

Accrued Expenses And Other Current Liabilities Tables

Accrued expenses and other current liabilities
Accrued expenses and other current liabilities consisted of the following:

March 31, December 31,

2014 2013

Deferred Rent $ 43,704 $ 46,254

Advertising 75,000 75,000

Salaries and Benefits 178,393 132,048

Customer Payables 19,697 39,618

Dividend Payable 74,729 279,380

Accrued Interest 46,429 45,616

Other 3,622 3,136

Total $ 441,574 $ 621,052

X

- Details

Name: HEWA_AccruedExpensesAndOtherCurrentLiabilitiesTablesAbstract

Namespace Prefix: HEWA_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.

+ References

No definition available.

+ Details

Name: us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 36 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (USD $)
3 Months Ended

Mar. 31, 2014

Mar. 31, 2013

Condensed Consolidated Statements Of Operations

Net sales $ 1,716,964 $ 2,409,916

Cost of sales 731,408 1,235,156

Gross profit 985,556 1,174,760

Operating expenses:

Selling, general and administrative expenses 1,217,661 2,389,103

Loss from operations (232,105) (1,214,343)

Other income (expense):

Loss on extinguishment of debt (2,792,900)

Interest expense (73,536) (71,123)

Total other expense (73,536) (2,864,023)

Net loss (305,641) (4,078,366)

Series B convertible contractual dividends (74,730) (69,840)

Series B convertible deemed dividends (1,532,722)

Loss attributable to common stockholders $ (380,371) $ (5,680,928)

Per share data:

Net loss - basic and diluted $ (0.01) $ (0.26)

Series B convertible contractual dividends $ 0.00 $ 0.00

Series B convertible deemed dividends $ (0.10)

Net loss attributable to common stockholders - basic and diluted $ (0.01) $ (0.36)

Weighted average number of common shares outstanding - basic and diluted 26,546,832 15,609,892

X

- Details

Name: HEWA_CondensedConsolidatedStatementsOfOperationsUnauditedAbstract

Namespace Prefix: HEWA_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

custom:Series B Convertible Contractual Dividends

+ References

No definition available.

+ Details

Name: HEWA_SeriesBConvertibleContractualDividends

Namespace Prefix: HEWA_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

custom:Series B Convertible Deemed Dividend

+ References

No definition available.

+ Details

Name: HEWA_SeriesBConvertibleDeemedDividend

Namespace Prefix: HEWA_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

custom:Series B Convertible Deemed Dividends

+ References

No definition available.

+ Details

Name: HEWA_SeriesBConvertibleDeemedDividends

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Weighted average number of common shares outstanding - basic and diluted

+ References

No definition available.

+ Details

Name: HEWA_WeightedAverageNumberBasicDilutedSharesOutstanding

Namespace Prefix: HEWA_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 2

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.2(a),(d))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_CostOfGoodsAndServicesSold

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References

No definition available.

+ Details

Name: us-gaap_EarningsPerShareBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 50

-Section 40

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6850294&loc=d3e12317-112629

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 50

-Section 40

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6850294&loc=d3e12355-112629

+ Details

Name: us-gaap_GainsLossesOnExtinguishmentOfDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1,2)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_GrossProfit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The amount of net income (loss) before extraordinary items per each basic and diluted share of common stock or unit when the per share amount is the same for both basic and diluted shares.

+ References

No definition available.

+ Details

Name: us-gaap_IncomeLossFromOperationsBeforeExtraordinaryItemsPerBasicAndDilutedShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of the cost of borrowed funds accounted for as interest expense.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-04.9)

-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 9

-Article 9

+ Details

Name: us-gaap_InterestExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=6519514

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=6518256

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e565-108580

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1377-109256

+ Details

Name: us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.7)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 7

-Article 5

+ Details

Name: us-gaap_NonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_NonoperatingIncomeExpenseAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_OperatingExpensesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The net result for the period of deducting operating expenses from operating revenues.

+ References

No definition available.

+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.

+ References

No definition available.

+ Details

Name: us-gaap_PreferredStockDividendsIncomeStatementImpact

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 1

-Article 5

+ Details

Name: us-gaap_SalesRevenueNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.4)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 4

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section 30

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6386349&loc=d3e3636-108311

+ Details

Name: us-gaap_SellingGeneralAndAdministrativeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 37 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8

Commitments and Contingent Liabilities
3 Months Ended

Mar. 31, 2014

Commitments And Contingent Liabilities

Note 7 - Commitments and Contingent Liabilities
Operating Leases

The Company is a party to a lease agreement for approximately 62,000 square feet of office and storage space with an entity. The monthly lease rate is $10,671 for years 2014 and 2015 and $11,975 in year 2016. The Company accounts for rent expense using the straight line method of accounting, deferring the difference between actual rent due and the straight line amount. The lease expires on January 1, 2017. Deferred rent payable of $43,704 and $46,254 as of March 31, 2014 and December 31, 2013, respectively, has been included in accrued expenses and other current liabilities on the condensed consolidated balance sheets.

On June 7, 2013, Pagosa signed a three year lease for $1,000 per month to house an office, pharmacy as well as inventory and is located in Lawrenceburg, IN. On July 8, 2013, the parties agreed to extend the lease for two additional years, such that the new termination date is now June 7, 2018. On January 14, 2014, the Company closed Pagosa Health and vacated the Lawrenceburg facility. The Company is currently in discussions with the Landlord regarding termination of the lease related to the building. The impact of the lease termination was de minimus to the condensed consolidated financial statements as of March 31, 2014.

Future minimum payments, by year and in the aggregate, under operating leases as of March 31, 2014 are as follows:

For years ending December 31, Amount

2014 $ 96,037

2015 $ 128,049

2016 $ 143,700

Total future minimum lease payments $ 367,786

During the three months ended March 31, 2014 and 2013, the Company recorded aggregate rent expense of $49,229 and $45,719, respectively.

Litigation

In the ordinary course of business, we may become subject to lawsuits and other claims and proceedings that might arise from litigation matters or regulatory audits. Such matters are subject to uncertainty and outcomes are often not predictable with assurance. Our management does not presently expect that any such matters will have a material adverse effect on the Company’s condensed consolidated financial condition or condensed consolidated results of operations. We are not currently involved in any pending or threatened material litigation or other material legal proceedings nor have we been made aware of any penalties from regulatory audits, except as described below.

On February 9, 2012, two of our former stockholders, Rock Castle Holdings, LLC and Jason Smith (collectively “Plaintiffs”), filed suit against us in the Hamilton County, Ohio Court of Common Pleas, alleging that we had breached the terms of certain incentive options we granted to the Plaintiffs in connection with our now-terminated oral consulting arrangements with the Plaintiffs, by among other things, refusing Plaintiffs’ purported exercise of options to purchase 233,332 shares of our Common Stock at an exercise price of $2.00 per share in December 2011. Plaintiffs have requested that, among other things, the court require us to permit the exercise of the 233,332 options. Plaintiffs have also provided an expert report indicating damages of $2.086 million. Also named as defendants were two individuals, Michael Peppel and Gary Singer, whom Plaintiffs claim acted as agents for us in connection with our purchase of shares of our Common Stock from Plaintiffs in September 2011. On July 19, 2012, the Company and Mr. Peppel filed an answer and counterclaim for breach of contract, alleging that Plaintiffs breached consulting agreements with the Company and undertook a series of actions that damaged and hurt the Company. On July 24, 2012, the Company filed a complaint against Dennis Smith for breach of contract in the Hamilton County, Ohio Court of Common Pleas, which action was consolidated with the earlier case. Plaintiffs filed an answer in response to the counterclaim, and Dennis Smith filed an answer in response to the Company’s complaint. On April 26, 2013, Plaintiffs dismissed Mr. Singer from the lawsuit. On March 24, 2014, all parties filed motions for summary judgment: (i) the Company and Mr. Peppel moved for summary judgment on all claims asserted by Plaintiffs, (ii) Dennis B. Smith and Counterclaim Defendants and Plaintiffs moved for summary judgment on the Company’s claims for breach of contract, and (iii) Plaintiffs moved for partial summary judgment on their claim for declaratory relief that the Company breached the terms of a stock option agreement. Trial of the case is currently scheduled for November 2014. We deny all of the Plaintiffs’ claims and intend to contest this matter vigorously.

 The Company was a party to a putative stockholder derivative action was filed in the Court of Chancery of the State of Delaware on May 7, 2013 against certain directors and our chief executive officer and against us, as a nominal defendant. On January 8, 2014, in a stipulation and order of dismissal, the action was dismissed with prejudice to plaintiff, with each party bearing its own attorneys' fees and costs.

On May 15, 2013, a former consultant filed suit in Boone County, Kentucky Circuit Court alleging breach of contract and unjust enrichment for unpaid consulting fees and expenses of approximately $55,000. We filed an answer to the complaint on July 22, 2013 and intend to vigorously defend ourselves against the allegations. The trial of the case has been set for September 2014.

X

- Details

Name: HEWA_CommitmentsAndContingentLiabilitiesAbstract

Namespace Prefix: HEWA_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for commitments and contingencies.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.25)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 460

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6398077&loc=d3e12565-110249

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 450

-SubTopic 20

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14435-108349

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 440

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6394976&loc=d3e25287-109308

+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 38 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8

Stockholders' Deficiency
3 Months Ended

Mar. 31, 2014

Stockholders Deficiency

Note 6 - Stockholders' Deficiency
Common Stock

On January 15, 2014, the Company issued 21,289 shares of Common Stock to an employee in accordance with an employment agreement. The fair value of the shares was $10,646 based on the closing price on the date of issuance.

Preferred Stock

As of March 31, 2014 and December 31, 2013, the Company had accrued contractual dividends of $74,730 and $279,380, respectively, related to the Series B Preferred Stock. On January 1, 2014 and 2013, the Company issued 29,564 and 27,630 shares of Series B convertible preferred stock valued at $279,380 and $261,084, respectively, representing approximately $0.66 in value per share of Series B Preferred Stock outstanding on each date, to the Series B convertible preferred stock owners as payment in kind for dividends.

Stock Options

Stock-based compensation expense related to stock options was recorded in the condensed consolidated statements of operations as a component of selling, general and administrative expenses and totaled $151,853 and $312,444 for the three months ended March 31, 2014 and 2013, respectively.

As of March 31, 2014, stock-based compensation expense related to stock options of $1,476,372 remains unamortized, including $584,803 which is being amortized over the weighted average remaining period of 1.5 years. The remaining $891,569 is related to a performance based option where vesting is currently deemed to be improbable and no amount is being amortized.

Summary

A summary of the stock option activity during the three months ended March 31, 2014 is presented below:

Weighted

Weighted Average

Average Remaining

Number of Exercise Life Intrinsic

Options Price In Years Value

Outstanding, January 1, 2014 2,543,150 $ 2.37

Granted - -

Exercised - -

Forfeited (29,000 ) 3.22

Outstanding, March 31, 2014 2,514,150 $ 2.36 5.7 $ -

Exercisable, March 31, 2014 1,398,475 $ 2.78 4.1 $ -

The following table presents information related to stock options at March 31, 2014:

Options Outstanding Options Exercisable

Range of Exercise Price Weighted Average Exercise Price Outstanding Number of Options Weighted Average Exercise Price Weighted Average Remaining Life In Years Exercisable Number of Options

$ 0.30 - $2.20 $ 1.11 1,339,400 $ 1.58 2.6 573,725

$ 2.21 - $3.80 3.23 757,750 2.95 3.8 507,750

$ 3.81 - $6.99 4.79 417,000 4.66 7.5 317,000

$ 2.36 2,514,150 $ 2.78 4.1 1,398,475

Warrants

Valuation

In applying the Black-Scholes option pricing model to stock warrants, the Company used the following weighted average assumptions:

March 31,

2014 2013

Risk free interest rate 1.74% 0.88%

Dividend yield 0.00% 0.00%

Expected volatility 171.0% 164.3%

Expected life in years 5.00 5.00

Grants

See Note 5 – Notes Payable for details regarding warrants granted in connection with the issuances of notes payable.

The weighted average fair value of the stock warrants granted during the three months ended March 31, 2014 and 2013, was $0.23 and $1.38 per share, respectively.

Stock-based compensation expense related to warrants for the three months ended March 31, 2014 and 2013 was recorded in the condensed consolidated statements of operations as a component of selling, general and administrative expenses and totaled $264 and $504,777, respectively. As of March 31, 2014, stock-based compensation expense related to warrants of $580,525 remains unamortized, including $3,685 which is being amortized over the weighted average remaining period of 1.5 years. The remaining $576,840 is related to a performance based warrant where vesting is currently deemed to be improbable and no amount is being amortized.

A summary of the stock warrant activity during the three months ended March 31, 2014 is presented below:

Weighted Average

Average Remaining

Number of Exercise Life Intrinsic

Warrants Price In Years Value

Outstanding, January 1, 2014 2,342,846 $ 0.96

Granted 150,000 $ 0.35

Exercised - $ -

Forfeited - -

Outstanding, March 31, 2014 2,492,846 $ 0.92 3.7 $ -

Exercisable, March 31, 2014 2,242,846 $ 0.70 3.8 $ -

The following table presents information related to stock warrants at March 31, 2014:

Warrants Outstanding Warrants Exercisable

Range of Exercise Price Weighted Average Exercise Price Outstanding Number of Warrants Weighted Average Exercise Price Weighted Average Remaining Life In Years Exercisable Number of Warrants

$ 0.25 - $0.35 $ 0.27 1,900,000 $ 0.27 4.1 1,900,000

$ 0.36 - $3.00 2.91 562,846 2.91 2.4 312,846

$ 3.01 - $4.95 4.95 30,000 4.95 3.5 30,000

$ 0.25 - $4.95 $ 0.92 2,492,846 $ 0.70 3.8 2,242,846

Services Contributed

Effective January 1, 2013, an executive officer of the Company waived payment for services contributed. As a result, the Company imputed the value of the services contributed based on a compensation rate previously approved by the Compensation Committee and recorded salary expense of $87,500 for each of the three month periods ended March 31, 2014 and 2013, with a corresponding credit to stockholders’ deficiency.

X

- Details

Name: HEWA_StockholdersDeficiencyAbstract

Namespace Prefix: HEWA_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(d),(e))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 4

-Subparagraph (SAB TOPIC 4.C)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section C

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Article 4

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Preferred Stock

-URI http://asc.fasb.org/extlink&oid=6521494

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 17: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 18: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph d

-Article 4

Reference 19: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

+ Details

Name: us-gaap_StockholdersEquityNoteDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 39 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8

Accrued Expenses and Other Current Liabilities (Details) (USD $)

Mar. 31, 2014

Dec. 31, 2013

Accrued Expenses And Other Current Liabilities Details

Deferred rent $ 43,704 $ 46,254

Advertising 75,000 75,000

Salaries and benefits 178,393 132,048

Customer payables 19,697 39,618

Dividends payable 74,729 279,380

Accrued interest 46,429 45,616

Other 3,622 3,136

Total $ 441,574 $ 621,052

X

- Details

Name: HEWA_AccruedExpensesAndOtherCurrentLiabilitiesDetailsAbstract

Namespace Prefix: HEWA_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19,20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19

-Article 5

+ Details

Name: us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Carrying value as of the balance sheet date of obligations incurred and payable, which are not elsewhere specified in the taxonomy. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19

-Subparagraph a

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Current Liabilities

-URI http://asc.fasb.org/extlink&oid=6509677

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccountsPayableOtherCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Carrying value as of the balance sheet date of obligations incurred through that date and payable for advertising of the entity's goods and services. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Current Liabilities

-URI http://asc.fasb.org/extlink&oid=6509677

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6911-107765

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e7054-107765

+ Details

Name: us-gaap_AccruedAdvertisingCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Current Liabilities

-URI http://asc.fasb.org/extlink&oid=6509677

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6911-107765

+ Details

Name: us-gaap_AccruedSalariesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

The current portion of prepayments received from customers for goods or services to be provided in the future.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CustomerAdvancesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

For a classified balance sheet, the cumulative difference as of the balance sheet date between the payments required by a lease agreement and the rental income or expense recognized on a straight-line basis, or other systematic and rational basis more representative of the time pattern in which use or benefit is granted or derived from the leased property, expected to be recognized in income or expense, by the lessor or lessee, respectively, within one year of the balance sheet date.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 20

-Section 25

-Paragraph 2

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=7501430&loc=d3e39927-112707

+ Details

Name: us-gaap_DeferredRentCreditCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Current Liabilities

-URI http://asc.fasb.org/extlink&oid=6509677

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DividendsPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Current Liabilities

-URI http://asc.fasb.org/extlink&oid=6509677

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e7018-107765

+ Details

Name: us-gaap_InterestPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 40 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8

Stockholders' Deficiency (Tables)
3 Months Ended

Mar. 31, 2014

Stockholders Deficiency Tables

Summary of Stock Option Activity
A summary of the stock option activity during the three months ended March 31, 2014 is presented below:

Weighted

Weighted Average

Average Remaining

Number of Exercise Life Intrinsic

Options Price In Years Value

Outstanding, January 1, 2014 2,543,150 $ 2.37

Granted - -

Exercised - -

Forfeited (29,000 ) 3.22

Outstanding, March 31, 2014 2,514,150 $ 2.36 5.7 $ -

Exercisable, March 31, 2014 1,398,475 $ 2.78 4.1 $ -

Summary of Stock Option Outstanding and Exercisable
The following table presents information related to stock options at March 31, 2014:

Options Outstanding Options Exercisable

Range of Exercise Price Weighted Average Exercise Price Outstanding Number of Options Weighted Average Exercise Price Weighted Average Remaining Life In Years Exercisable Number of Options

$ 0.30 - $2.20 $ 1.11 1,339,400 $ 1.58 2.6 573,725

$ 2.21 - $3.80 3.23 757,750 2.95 3.8 507,750

$ 3.81 - $6.99 4.79 417,000 4.66 7.5 317,000

$ 2.36 2,514,150 $ 2.78 4.1 1,398,475

Schedule of Stock Warrants Granted
In applying the Black-Scholes option pricing model to stock warrants, the Company used the following weighted average assumptions:

March 31,

2014 2013

Risk free interest rate 1.74% 0.88%

Dividend yield 0.00% 0.00%

Expected volatility 171.0% 164.3%

Expected life in years 5.00 5.00

Summary of Stock Warrant Activity
A summary of the stock warrant activity during the three months ended March 31, 2014 is presented below:

Weighted Average

Average Remaining

Number of Exercise Life Intrinsic

Warrants Price In Years Value

Outstanding, January 1, 2014 2,342,846 $ 0.96

Granted 150,000 $ 0.35

Exercised - $ -

Forfeited - -

Outstanding, March 31, 2014 2,492,846 $ 0.92 3.7 $ -

Exercisable, March 31, 2014 2,242,846 $ 0.70 3.8 $ -

Summary of Stock Warrants Outstanding and Exercisable
The following table presents information related to stock warrants at March 31, 2014:

Warrants Outstanding Warrants Exercisable

Range of Exercise Price Weighted Average Exercise Price Outstanding Number of Warrants Weighted Average Exercise Price Weighted Average Remaining Life In Years Exercisable Number of Warrants

$ 0.25 - $0.35 $ 0.27 1,900,000 $ 0.27 4.1 1,900,000

$ 0.36 - $3.00 2.91 562,846 2.91 2.4 312,846

$ 3.01 - $4.95 4.95 30,000 4.95 3.5 30,000

$ 0.25 - $4.95 $ 0.92 2,492,846 $ 0.70 3.8 2,242,846

X

- Definition

custom:Schedule Of Share Based Compensation Stock Options Activity Table1 Text Block

+ References

No definition available.

+ Details

Name: HEWA_ScheduleOfShareBasedCompensationStockOptionsActivityTable1TextBlock

Namespace Prefix: HEWA_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

custom:Schedule Of Stockholders Equity Note Warrants Or Rights1 Text Block

+ References

No definition available.

+ Details

Name: HEWA_ScheduleOfStockholdersEquityNoteWarrantsOrRights1TextBlock

Namespace Prefix: HEWA_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

custom:Schedule Of Stock Warrants Granted Table TextBlock

+ References

No definition available.

+ Details

Name: HEWA_ScheduleOfStockWarrantsGrantedTableTextBlock

Namespace Prefix: HEWA_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: HEWA_StockholdersDeficiencyTablesAbstract

Namespace Prefix: HEWA_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(i))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph i

-Article 4

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 50

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6406099&loc=d3e25284-112666

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 50

-Section S99

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 28

-Article 5

+ Details

Name: us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

ZIP 41 0001117768-14-000444-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001117768-14-000444-xbrl.zip M4$L#!!0````(`"$PL$1_"!/@'6,``"&X753=7@+``$$)0X```0Y`0``[%UM<]LXDOY^5?-ZZ MJ;FJR";X3CO)EFS'&==D8J_M3'8_3=$D)&&'(C4D95O[ZZ\!DA)$411)0!XG MXU0E=D0"S].-1J/QUGK[]Z=IJ#S@)"5Q].X`':H'"H[\."#1^-W!E]O!\/;L M\O)`^?O[__XO!?Z\_9_!0+D@.`R.E?/8'UQ&H_A$^>Q-\;'R$43H8>]YL M66#DI??LY>)!#1EXDL0A3FO+L"EY!EAQEBQD^@I<&\!9.B+\L MM[O0>H&?/GP=+DM,L!=FDT0X979X@T<*,Z[C M2:YRZ$N#LL#A4QH<%(\I\KN#E$QG(5C*45E5;OU^'&7X*5-(\.[@(HFGM`*J M#15EU1M?`*[J@6KT";@3+C8),%](HDHP[D_4JW&B\;X`@:1 M7_#T'B??KNX*N?:J.RW'^':5I.U3286WTSEO5QI;,9[\=@L5X_3T&OPK3A(< MW&:Q__N?;'DK)X?'4\QI8_DH`#)/LY#X),NY*@&!-_/(LA#MF,9&F);_\,<< M>)_%TUDVX.4GWT5N'$!8&=Q#'Y;V3QHW'-6+^J5WRY<59 MV[MD:2KY[!9]'T9R%L-4,,I@Z@\?WY#T]]-%Q636Q/T6_?<+,!;MKV4LVJNQ M]!J$7CW+ZS!4.]TO#>1:UZK']EE(^N*^FM9"5/&W23!^-5,FLVDJJF_ MH)U<1:]6TL9*EGKZ"]K(W6/\:B-M/$FII^_51MI.A5_735ZGPDW&\KKG]M+W MW%Z>.2W/"'R+^VQKAP'V[Z!K]KF_,86]\`W@AF#I!1Q8^3:BI96BOM=PJ6(E MY:CW83H+XP7&G-*^#X/)9;D$@WC"P5U\F:9SG*3Y`+@*G,JWMZKA>S6'%@'1 MJVF\+--XX3%1PS[VJT5]`Q;U8C>[&TY&O)ZX>C65AACX4^Q%PW&"V=SW.S$/ MWX_G8`6?XPRG5+YT&`47)/(BGT3C&^QC\N#=A_ATL?J]8DTU6OE>HYR569@# MU?[&IIWK2J("[#44U`:JL2T4'(Y&)"3078,/3(3OHR_=X)"*=`W>:W$'OC7U M?#H6I[3OK)ZLC]WUFOA3O7'1<']R*#B/2&Y.7V[/-PQCBKUTGN#WQ;VZ8WBG MK*Q\M`Y!:]M2?S[GWPI1*(&]U!L#^%UOP0G(`UCDIFYIV<_TEAV]`+MID!UT M4.585RL'>HZC>`H#P`[8W7JIXM957#Y?TT(+A5[CA.Y>[&BU&?S:OLT"3([S M3GB#QR3-:'1$[]\JA7W>T,N)35<+?V(7'[_R%Q_?*)>1?_CV:%O=F]AG;%,F M9+'_SWC1&IQW=%MKX^'.8W].70<=S5NC('7PC[Q^OGA=M=>LIW_(_4#K^GE/ MLK4V'FX(3P/ZQD7HC5O#C+PPQ3G"6@5\S6?S)*$?D]3WPG]A+^DJRZ!LK@@(\)5 M:JDQ[UP/-W@6)QE$F/G5]M9H_Z+.9E=MFZB,S1FH>QPG[;O4[=0+H9RRK%ZA M:\5>M.`IK%5=UQ'R)L\-^`(^:R_L/RJ=8*.F[7#4PKJ!T=_KX)8UU;1E/)W& M$9M,YH/;U3RC@23-];"&6PF;%>IUV8-B3%0"[!-0=OKNX/+S!7"Q3%/5'76M MJ1O`2FIL.G*.[[-+"&@3)D1A(5\B;TK;\#\X.`>QZ)1G"T.FC15#&GUP]%0@ MAS1'!VJ=P*0QW'&-N$+\*27'$0G?'0`6?V4^/T>XMB];;-;FNCW'*1E'-"IM MIZ4M[6AI)HQ*A:I:P5\QI1HF[0#18",J)T"1Q4&3+T' MQ\H)M6+2YXTQJ@MK6E^/75$NIY%5SNHA'>';$-D[::T#:82>AW3KZX)M2-/. M]2)(=]*TU8UTC?>`8E#&S^9>>,Y6/Z*@-EKOF]>C1<=T68S=DIL$4?H>E]PI MBFW8>G=)EKNMV00GMS!1AB$RSSD7#J-@&$Q)Q)9J,O*`/SS10T)M)_]-^XF- MR#6XB2* M''X7'DE8^L>K45[]1ZH$'$!)YA-E.Z;K+9Y6/=3T>F%V,90MG8BQ;Y,.'>J. M!.D8_GWU<&E=Q^U\BK+1R1JVI=M:(4`CB:KC^42\>Q*2#(9@Z-:LZ"0.@^6A MH[X30(0TS76Y6'H7D`QB`M,]9"#705I_OO)4-P`JR#3<%1=9Z`+Z&1BZ92+5 M[D+J!F?@Y7#PP4NHKTN'OC^?SMF&^#D>T=WMWBK2'!,A5>=TM!M,#CT1'6H. MTE7+ MQ2%5'@0I=#T]=_:]79AJ+Y?9VN!((2:@.U>E9S2`D"0@<*+[SV2'`9 MG7DSDGEA[]T2V]:0K7,.8PN```\!96DVLBP8-SO3X]:PA'H?Z$='M4MCM3VO M#:R0.FS5V=/+1D%+DB;VKW'7,NTM7K<5>6]&8AH1'==R^I(K!A"/D$(@Z_N0S)F,S$) M:G(-Q^+W?G;A2"$F,KM207N&`&%.W6=BJC.1X3BH?F)Z)@(N8ER:8;C\*NEV M3OE-4QQ@/*4G\NNV?\^*(F4E_>?P^7>-%$-<1U#9A(6L3X(<9=.S/\%$?C.YQ,Z<$G02T9CHULOMMN5MT377*84^_: M1+V6H_&C3S.(."417V;IFMZ7Z7G1(6_P`X[F6+ACV?P*9'WE_2F(3-5-FS^[ MT:VA[X.]!<4J+HUMV<9,Q5L)!)Z&@4S;*'QD:S1Y'`6T:6E(7`*+777L0F;LH]=C723S#2;:@654RZ*%T^V!&Y^R? M1$@BP7&;H0Y\L(0HTLIO=U(I).%+_:_NS=-RHA&$85OVYFC2 MB"6-H,@XJ-H:J@DB.A$_\]))_W'!X=N55M6V>A$W;]N&T8S*$B\4T4!OJU`= MWBKX*KO"B6R#0,]1M68:Q=&:^W.8XH0Q&^'.XC3+>Q2WZSW,[T*Q66+_=2O' M-(SE<9Y.F++Y"H7?]O*4KH@498A1B2[6"I_C60+8K##JJW=+=9"ZNE+3$54^ M9Z$-$,MT52FB=&RZWMK7#-LP^YF+?,)"5P19 M=U,[$]YVU5,&ZV?7?D]A9%QD;1*AK1`=KK=*ETA*6^U!T&)>=TV'ZCCBYP=L M.*<;=&7N@_[QCXOT,F[H@B>5J,@*A.6ZKB,@`+<:Q#46C-U7"N'M2XVSK/%>VW M@)3$<@]QOAAYJ1&^J58#E08D05*BIBF7JRQWN$H9V09*E)9P`&69FJNZ]<;8 M[+PK>0D^SRGBJ9<2_YR$\ZR\UKE-@(84H&U8&Y:C:\M=F:Y,]B!(31:(%M[5 MM%37<<4%61T3\>,I_A2G*:5U-<-Y,JCT%(_B!']XRA(O3J"@ERPN,SQ-KXOZ MAU'`0W1OJ09O-P!WMW;\1@K%9Y2\N6F;)=>MO4G.!=FG7)1]3K__(BAS3(FU M9.,USC[0(JI$ZMK$8COP#I9UF;BD&_QVKG7PDAB+:+Z):]LYF+K)A\N;@438M6YA33',E3^"F5K M7I<`#J-B)E%'%155$'H0Z*H.&R%>%SL(?/1(E%)#@DE;!`$^:&Q.T@GMW_FF MN>310PBWNV78KN;RZR\[8:L\K];M2)I3TW1Z!9-+&KJ)TY-*9R4A#1DZ?SFF M!1>I"7.;@P`-V9;%N?]^Z6*E9HIM/I6B.R[B<[CW(_PQ`;5?)_&(2`E.7,W*<+SU#H^D>9`0>%>U&-Q1@M;`%;K+^2085IGV-]^5O83Q MT)_0Y?FK$:N`>JKUFO>C0>F4NNI5MS33Y30K1&A-N,H,]2K:G,2NS[7VH6$I M),3F[ITI;&;)\,*K4=TRW]YT6C>WET%GWZ+UG/M+%VV]YPQ3_@3N901U1)A] MY^]7DDTDN.G*R>"5I^S+8V_"='9/T)?D2D,OU\*`FGYXPHE/4G!FRVJCC%]T MW(O#%P'O;MQZ>:VU->X:6ZIGFA#X:E3[K2L7<7*+LRS$^0RR2*4CNO1:N6?/ M??>,&)T]2]8YS+.0ZAA2):NN>M#$Q%(:P33K%E5H]5VANT6-()R,PL\'V^M?HEW=TZ\WGIJ M85$.3#CUO6@D_W:6R\BG9_#P.W8CV\;.J=>W`K?;?C3E-^0+GK M)*:>+SA=?$GIM.2"1.`\H:V&,/H_;*:,ZZETQW(J.R\MP>72[CSY,%0-&2*\ MEQ'#%42Z0>*-9*^#MP/HL9;+?1WO6O4U&;Q\C`-VT&XM-`CTO((T/K%:5WI;`/$;J/SP:?;U54A&K0?!E!N2PA?H:# MC51U\L:F/K"=(SJ;1G0:/_UO!FW9LY9[_)(]@NFZR-G9LVK0Y?+N?LK+M'4^ M8'P9Q%L<#T.J9MC.[DE:"^:;IE5)LR[%0I"]PYXKH%)8=IZRJX:!I)(L5BS7 MOR23)?10\3.W5:'F;YE/K.0VW.ZRW&AAK%+HNT, M]B!`YVC6@4'`?3X)6&)X25<+=%UO[/9UT/((=S9_%VG(ZLLWWW;9*%*?&KM( MKU23`[_O9,TQ]3*98B\2^Q&C^W**84H18WL;EHFU)?D7'2&CL7=R>,+DNJK3 M,4TDCUQI_:N4V7(V9'6W.8+9Q)7%M;.'L#3=$:/*IXM=SZ,&UCTE\ZD,G9J& MJG.#WDY,*20[G[\S=$OO03)W#M/9O,R9P/:XV9E.=LZ&W/>^@%CM/K:Y7-K= M"2A.KW/O[DUO_=C+'074KA,PV`Q?AYZ?WT=BRS5QLI<+;\($.AN;8VM;3OWL M0-\XH%M/4@"9(K+.V3(?_BJT6Q/)=17;^]3*Z\$A2]-[5EZ7?8G^>P)2J M^G7JDE8.T/(P5Q\2^Q&CA=I;[(D^$'J6^R).SN/Y?3::A^7`+$5S!C),9VW_ M9BN>*+?N4WAD:CVY725C+RIL%$:.-`Z+I+I@OS`&I^`5B]&YV.J'EBUOKZ9T ML`[C=)[@.Q#A-.RPY?W^AS`[F2EIM@CQNX,1%#I6D#K+E#LR!2/YC!^5FWCJ M16_R#]XH]$C;Z$29>LF81,>*>J)0F`&)`DS+JH<@Z3Y\<\+SD;\BP3\Z*`L4'SLG_*22%&K\2T%/`2H(SCX3*#%SJU/,7RH^KBGZ]N>8K\:)`F3#*/O!B?/`` MV$UQXB]I*MG$RY04AV&JW">T2.1-,2L[IA>EB*^`.TK]A,R8OPN2^1C(I<#$"@`3,-G/"$KN[.>$)3'!#?"QF361('-'()=F M;T!W(6$1/8C'6$R\-`WQ8)1@5IHNU"9*/*H5&30"\I1"*+4"4*ZSW.##Q:KM M&(TI--L@3BA"V7B%C2BF"C8,-I)2&Z'&\07Z*92[S3^DT/33;,B8)9GM]K&-1*@S?BR+:N^JT=0@^CU4<_TK8A;&.7\8BC_V_O2WL<-Y)$OS_@_0?"KQIK`RQ9%'6.=P:H MONR>[>XJ=+=MS*(EB9*X6(RK)9$9&5=& MQ@DXA'>Y""TJ.IRHCLBVL<71#]K3@PTO%IV7`A15@-EE&)ZT_#6'6EN`&2%% MD&]98"&;)9(-$@@*U.(Q*=@6??()8Z"::>@:GD*$35P6?Q@^H!)9`M,_!!J# MM>99O\;#F&L,`#%R^#I>W-^).,"EKE%N(2_'A-N0(< MZ8ZV9I:/K\ZO5ADZFVQR6Q)S9HIRA`#XP^5(U@6C/0%_ MP48<`44,'[=)R4F/;Y&%:+CDT@X"8CE7`ZMI"@+AS-&'!\*BI; MJ?6NV81*V=@_>T!<>.N,^?B^3[&P!GP`@LVG>`9--\"^VJB+\7_H9-93I(:S M7/`=:N"0RU(B6JBREUQ$0+"\Z/X![-]I2#1$!1BN)=>ZXK2WY&5C`0B(F6W% MHR.@@C,TPB9$G'4L[V#.;N3-2>%=]?=0;Z?UQEZ]+)X^< M$B5^2X?^56^L#PQ#[YJ3CO:6;D:TX'\B`(KY6]4.01&S.O_5,YE(PPY(1N\X M*M@0+"ALU$`0F-V!/NP;!.C5`&">Z.-)#TVK8,7M-3P(X_S?4GB'CX@KX!]&"UW(&]'9*R_?6#YQN7`+FG)9`NJM!5^]V MN\A')+&QF!++?#_]02.T(%2XJJ0;W1J(C14>U@F2"+EEDS4UA2U)*?R)1QV? M5X._Q<\VY1C/JA"`1JNH"&:`"/Q"AEF;0*Y.:@:,DO=U*M(Z^`6<%KWK0W6C)!2(L+X#2>%V^) MZ4'("*BPNL2>W*@/P&(CF@Y_H!/"$C87KLI!D3H["YHTZ$M`#)AW3YJU6J%2 MY18]0FGQL"G`["<[\1:QFH]W\0QTEW;J>L*8B[T3VBJ"OP*F`]OCZ8J_PC>=SQH5R5T78% M(5O:H2`!/.O8?X'IZ\'[^:57V6'X`!#*S<>W%GAL9:T)+Z@>Z-)/-R+LF4-@ MS",F[M!;GM^AZG]H1;.X:*HN'7[#G'GW8-VB@R,$2Q\XV64<]?RD5K2]5*VH MFLE9`C]:P"K*+4G7E@PT.E)<)&AKGI((SI4W6.G`UOB;:138+MR/N-\)[%RZ MO/B,&3.,X,) M"GNYXC7"(%"(R!3I@R16/^-Y%/>K'.?BZIOS$9?>@ M/W&7N(%5K.9(W:@Z@]\3YQ&J6E!4#WCS1!^.D[TU`B5FP4`:)*C(HA6HRC#> M1,*.DIUFL,LIRV`I,BTM!$&' MDV)J!7:0/DMF\NH-E]Z9V!`Z<)/31*=KM%2$^'F\0TX?0.2/P.EPPB&"/>6^ M"G#-!7^2SWIJN7_XT2JQ)*\D8+2*1>9XC39.`5C#N`G,FSNK_A)<9[*;S&V&RRLF?S:43)-A5]4 M./B`)_V`+""IH;EG;";*G35KR:-;\2(Q&.I+A;,O<;L6\4D)KZGJ0/.9>*/< M*(H<,;YL>T!@/&*L4D)-@&)0EWZ)O8]WT'^P.U>3QGT1;CQ,8_[A*_/`5) M%$<:H<>^;!54D%EE#),X56HL*9([HJ&_X.W@(?4)\$F@?O#A]C-\Z)#7^?-O M_-^OF7./*6*??R-MX'%K0,\CY[@&N&LK[TG%P_Z:!H`!UL^^>+2;Z.G M-U^(]IYK\8AB^N$;.`>7F&_`HRSPQ[4,CDXMAUR`B?Z#8SW@RDU5PTNV%<$-_1_1B[3^ED7+D,!/O>K!PFR!!V&UT"6:^X63Z1B6VHB1B$B-\7B0^?(>KN4 M_Z_E M]0?3F*0UCYS`O8O?^X0A92T6;,8=_L^,26W3D$S'Q@6F<(_2Y-OV'%\`L9@W MV+P9R>0BCO=+5(D)I#ZO:@OB(`[C%0Q@1B;1'_X@T4+$9F]F(E6(AWOYY6]N M`S)\:4ZB)RQ&7J;&W)*7$R0V(8$UW`%1CF MTDD06G_&E][T<_!^$0NTT;$?)12BR,-4;A<)_SGEKDDG8/QS*^3><^GB4;$K'>C3 M-3'LDYC^IEE\_)OFTOPWKK+HJ8"/^?24272*QA!Z0L$=0B+'&F5LP&<+!Q1I MP)_V,"9`055\@GOFK5"H&6^&$3=[`??E.$\"#!8>;U"E"B,NF$8O-DH@\"@% M95XPT1Z2W*LSWA.'#I0-U"B[T.XD9,Y:P(;&OI*O0>\E+35/[M6<-)8:1)EO M1X5-&M[VN;JC=(\GZ5S#6/-UO+#%!YMABI,\%Q8>*B8@P]\.Q:TYA81SW0S3 M0,$V!0`Q)YC^O4+GJ/AW8=">['GX@#_MOOHN6137\^7+J-<1V/E2H*9>&'K+ MY-?HD*`GYO()`=$U_R6\O3-8A5G[#.?[>\O,0TRY?_]N&*-E2O&*^(53QP)> MIM=J9`*D%<<,?59^9F@%_[X.[+\81W+\FRG^$9OX!-PTUK@I_VHVS*[WY%NK MOW_'__M=64S0G_Z9DK-7@)R9:]9#9;R^'8W`S<%P3:@T3UU6\F*Y##5R/[.! MDM."J00A?M*>Q[C_WYLW[]Z]?[]+GXDS;SA^E9M7;_F=-2]OIAI/ MFJ_2PNFC09I[OSU]8/1U8]"M*(W'Q,#Q<->'T^@[#OT<&!#) M>*\UI;'K9F)>0TJ:@.S+N;J=7K(#%@ZX;#G4GK` M=:JPXE@?]E;8'IXKH=Y8SS%QVGC-FH!/U81SAFF9=N89A12 M9B^OL]5<]L3CP`DR*;IB^7,9;Z8``Y:M\9`C90A92G915N;'?P5%XL69U:/Y M$O6>->M*-R7,RIVI<61"99M_[4OF)Q9S%]2'G=YH;NJ!Z(<*_5- M?=3M[]EV.4O$#?7>H'[$U20AE2-F-W-:+,`LPX-*QT&"2J,!=5PX":X_980T M1]]_M1RJUJ+;^VOFLH6=.QQ\2H0T1F/=G)2-FIPC:QMF3^_VQTWE[!808C>7I.NQS+'%@5,1+7'V&3#W"KGWUI[6< M+D)ZHXENCAMKA52WJ44DX0/ZFEAPX&OG04@(MZ)^R],J0@:@J.O/VMN_HJXG M=XVB?P7YO%@R5YNO1O:`/NSU2G+9`3SYAZ#>'LA4A1Z&65;J3S!U+8TJART* M)K-EE8]G_:555"6[,L$.E>R6`R=%O9A'2(KK]PU],"KK_]QS2MQA:'Q4G=0]V%1(95.&<17:S[19K;2)\\/[ZU[ANUUY1*G,SMH8TB,17WDJ<^X MI7WT+-ZH4HP6X$U3;^Y]QIN=;,P+HI_'WRK=4D1O%E#@U(]1>])=.D6K9"I'<35B'="3BKK/SX#1,*O M0*V+QB&\G;)XA=*L0&US1(!DMSK:TL&$=@,(9^2/F/$&#!;V3,5A#9Z_YFU& M-T!$'E,1*]K8+*R9;"2C;IB@^AZ[)BX)MNP.5-\>1&OH*;/\@#<:8T&<#!BY M.*%6MM.Q'-E[3)*%'N6=2^/1'0DH\6,$"R8Q\M:0^$K,2\2FKV(&"%*+_0?[ MPXA>LW<^,+CVA5K&.A%.!XE\GB7GLFLY6F"%0Z.0%_N@R%[]0`T1<$;,4OM^ MU!ET7ZD#4@@&29EL9.3GO51FIH5?S>/N/\04SEIV`>;-?<0M7>*7@!$X7M@^ M('QNT=0%!C;5FK^"=W%,4"_P2BV%`,V"-)MOEI0CRMB![&>+'W/FY!@8\`8U MGJ\!W1V;NF#PWMJ/C!-OSA86]0C'`3:!Q=M-.M2B,:L_)X>64+6$K4Q%@R>; MNBUA-S5ZWG9)Q1#U11MF;`\K6X@DC83#!YR)L&*NY80Y!BWP[:*2M6PW4%)4 ML7./BU5ZHMVH:-N46@T)AZV;1=-*@HJZH@$?A:!8F1A.`YAR:0['E"T\ZMS' M4:YC[QX1!7(]]YKZ&:3^ MYA&PDX5]LC=4+IH"7&'*AB_IKCR<^G$O%61QKE&NNAUSD'0UT?$S3C9CD.BT M&(8GWBZ;4LFWJ.8M'>BV,%'\9L%(VHS"(-B>3VFBXKE\*EM`;98)I-3#O+,> MM7C"ZAF:_41]6?FHDDE/'X"&3O9VU1L2LIY`E0`W@;3:P0.?SY;J[[1[CP1' MQFRGN.*4%7V+S7E2M8A@*[Z$[T/ M-!5O2._'4LX;(2Z%Z,B'L_2,GCXVNX#PI479\9&;AB%K2-86@9&"*OMO$32H(]'IIQN"#).893:;!PK#UW)K*IMSM^`)0AT9B1'&I_(1'VQDT[\2*@IH!T;CNJ\.RTF MQE%'>)ST-*/&8/20P"%@@@_KX`$Z:LX%QI1L1R9!%DM[[:`O-\$2G=].W MLM,I-M']=26L(>K_Y3-AN:+T;9@YNLHB#WQ8![\#`[X(!GN)HT@2_B`#-FVW MXEF9V*2#3C=EDEI3[Y&S!@'Z1",F5BO'GI&!EM8"&Z;_6PXE`8(VL7KVB\%] M\=`)Q6@5EA@VOG08G_=*7"^-[*45I14K<<7Q M$?,`G'`.<3W-/-&53OOPM\\LT+O4`X[S*J=:\GG[YJ`(7'&+T*M^ M7S>'Z10BK<;DA[)!,.X&`3I' MA9M+$K*:G[3"(.M5MPT:?CZPDSMUT@-'8R\5JD#?XHV@%6,/O99]?61VQ96. MY^RD%;BN=DT.DWERKS?;UG2T6^[#B<7WV<&0)<83?3`4OQGI0U-U7L0KS91F M.9OCG4@>W3]K0T-"[X_[S#0G3ATSAUFIC71!OM+`(!I1Q_1G:=FT&YQ[P2?72K`10P!SG\XECREVLLN#X M5CODM:I"CD-.O)A:RH,I73R)&/-#DS.<:)"/!UALO.X>G90>BZY,IZ!)4;BT MYXH+$4X5`Z'0Y3``,4D9G;PX*17ED0=QU'+\$),(&([_'1CZ>,#'(H?='0]T<];+,)NX>#%3O8"K& M-P#U/.Z:PB=KHY-?3/L2;E-TB<9GV[->Y_SUR;@#\H-W!C3;>OLD@^2IJ_'$ M@`-H0N/]E`D%^#H<\4_R\*@?R-2#[O/LH\U-9"8G M\-,A6J*?;N-5JJV.F)ORASOJ6U>7[Q* M/V_^4NX\IXOKX%P=IJQT\+*=(WX7Q]*&'=JL!C+U$R$C$ZR5AI;S]KKA&V[X M-7J_K:0UA!"7QGAU[O>+O",U>L<7*6IUDOFS'!;6:#+7N>-W(O_M8C;\T5Y< MSF8_N"%<:0-[ML<=UZ0B#E"KE_\M3>MKJ/KXJU"Q1?(.)-]A1+I%\3Y1_,'5 M_H6^Z!;+M:#S-PS+'@V7)V`;-O$:UL)T0I>9/?4`NDUR)'1M(T,DKQ2?4*N0 MGC[HFQ6&VM4$:5Z][DPH]PNNA]P\MG???2K#3Y$Z"Q_#JEE:OIXZ/@V]\_Q:F?)G(S32'KZJU MZDOYJ-*)KP5UE3(D:$\M[905#C6N5QTY=(0NA3U]8/0KN-3RT:8*(1I.ZAPX M+NKD.S9+="HW9KU8;C@=P1]TRKJ#+X/(C9'NP_L&*A-XWU?CNAT%AW,,[=OE MT>ZDW4DS'-7;+CA%#"?AQ,;:LXI7AR:V.=__.E4.#T,W)V.]/QK4[.DXJ0;F M9]^DOM<9E9V1=>X$;K9X]CO&)=/MJ#)X/(N\QID"\4?UE>WS]-,*5>:';:NZ M\!S'>Z(>HY9H&Q10`Q;;I2855-0OVE<0B,_Z=%CAAE5R+F7[;P!E4]_6M5^8 M\\C0&`2P+#>XWD?=?I;?W;%==OW`>$,+PQ@4&.6^170JO+'Z&^(=#BME=O^D M;8$A0_7D8;+XX2G^(8I#-,5A3UN:QLJDO.)J!O:-[@F@7[GT'`7]):Z&>:4Z M%TJ?><5><]JD0VZUH/R+Y=Y3$SJ9+:756[N3L;=G\;X25E?=KST!2LF.#)HH M&&\IUG2**:>(%I=#:W47(+;T:B6LI9B@6-Q<0DL7IVOQ([773;;4K(N:BMG7 M9'VY1^OP7.]\[0[;';8[;'=XM!1.3.#8@^>B;.++^%6&"WTO$'8[9E>[UJYZ MG5Z-^8W5N5EY67Y$E'M_@^AN'HSN1L>H&AT[,WJ7S$L\$+ETTYSH_C9;37J3$GO*76GJDU&)GZJ%QW M1F=*@=("6>L:!Z*B,:JAB4Y#"7DZHC2LZNYI*5#MGM,Y4PO[DG29>7!==F3? MV]&8Z[1DH`'F\Z$&,C9J^"# MJUFKE;.F3@4/C->@7'^=/7@.K,9[$6@KW\;Z?@)OZ<]U^K^ M79+O;AYXBES<"F-#;66=C(7\%%LPO)&F-#0JI'D=XVFR9G ML5'S0,QW+/$^W.^*8FE/@VR^V,$?VL)G3+.1*5@0:KX5LIQ<7+MVS;A`%>16 MHS/JOZH9_!K`ZG;&X^U@U<$,E:>7O;4?;;`4YMK:9D[>@28-Y(!N!\R+)G+` M+K`:H@[>_;EB,[11'ST';@B.':Y/EQ&,D=%I(B<8PW[';+@RB!G!L1=X-FCK MN+'!2?+"H),[4-@4J#+XH.;^@LWP1OR0HM3./-<%.487QI,=/I!' MP@Z"R')GZ-Q8:"Z]?,5?WKE@DP/P0:6%3P;;J1I6:!F877*1VH%FA7W4[/I,^NC(XYUE8,]/V# MY3-=`XL<%;']R)SU!9/G*^+]>FJA5VWF+5?,#7@#4?8G_LUD(U$X#]/407$I M1A*BB,]F>*4F&<+'08[FN`ZN[M*5FE8+0OC/DKJ:`H-X0#>+-Y1!&.`U%@'K MN?`+_$'`'(?F--TS%W[JT)K6?&F[=A#BHX],;BB@[T(OM!Q8YZHWY`!>#;I] M?30:;3)&0JKXKQN"B39)X,B-ZIR)\R$S42KPKJO!N*L/>@/X'CLA!5KD6DL/ M[)&_V%P'3,V1[P/=G#6H6Z`QO60*VG.Y\KTIJ6(DB`MO7H+E%<8;U>)-7K"\WFA! MM(1GURG%&2/;0L:%NX50F@1@/BD%+(M&PO#=E#G>4^LZWYV`=@CW6M/'T]9@ MJN-OR.\I^\+1RH5Z8='_KM'[K9_I"MW"6TF[5,:K<[]Q@\E&[_@B1:U. M,L?M)QM-YCIW+'O=7LR&TPUBSWRS']P0C/C`GNUQQS6I"/G$J<[#SC5MO;1A MJR;(52%CB^4=6*ZWW7>+XDR%5',;[M/%R3Y#U6`,NA4Z!5RV8C#+%N"=EA`V$:;F MF!+2@W>.RJ'LU.!+5@O[QEDSY*^),.W;6,AQ3\_!'^\]?\'LXL9$#J]0C3// M7W9('6J=)DT]K]&[U5+N5"EW#.]O:6UYZO@X^,;W;UAN5*F:PXQ1B&:!`R7E MRTKG!!8\8I2Q"QD`U:&QE!7RM%/9BI822YKEUZRBR'IZ?U+%]9:/-E4(T7!2 M[\&X/S)+=#N37LL-YR[X9F?4$GD'PALCW<-\WW;KO_8?S!^W;@]'N MI-U),_S3VRXX10PG9?1[Q:O#GDZ40]D*1[D8]"K%Y%^D?X5[?1.HMP?+X"BV M_JAJX^)S)7"SQ;/ZG*N3IMM19;`Y;N/"9GC-;4@J%-L>MD%$TLN3%_F*2N1` MLUVJ+*E%S3B`^:Q*J6>&&"=*T\N6#-A4N6RO]!@@T]6U=^X4YCPS-3`#& MYK&;%=> M3]:,T#V3R>B>`IV4RU@..I6X8.:5X%P8>.9;>\U1F0[:,(+?Y.E+9KSRMCD]^T]#]M^BM'DA;7?&NU M5UFVA#V68&NM%%\@L>,N'1I6^6NU%YNV)#XTB16;M)RBWJ.9VL2+9AVWE7:' M[0[;'9[J#DLHO&KYHY@]TH`ADA*:R:M#3<'K=GH#[1H[!)>NP\N/RG)94'N9 M=MA,NIN'I'N-F77G0.^229&'&E8YZ58I,3Y3FK4R>EGT;K2,5I\,W%*K21JU M)B/TQ4K8!NBV0^DS8GPH%!L,ZTE9;(K1B M<.(4R)TCWQ)@'P0PC=UZZ'">N)>3BAI@*!7+?-HCV3I=`TVI?F=2U6W7"E#% M6]^Y4J"T0-:ZQH'DJ0[G6D/IV$I22X&\I\J9$J!59:U7:]\1U(M37^=(RLH] M91I*PCP%@X=9Y4!^A9H:1C64G!4`)>G$E]JE9%A M&FY68B?_X^RQE'?J:S^FP3C]L;#^7/32%9:V3&NSF'R M]G7HK6AM\4^?LUSR@>3<;/`VR-B/>^(L%GQX_,9<&%/7+)P#SV81?>LM%H!D M7T[Q?N,M5Y:[UIXL^)*7N*^L]1+'VR\\N*5(FLP2FG2TFT"S<%Q]Y(1ZZBWV MH_%Q[9X++U.'UA,0OA52-?ZC[46!L]:LU_K&TPY#Q`>X^FZ$*`(5@.8@']B?^DD"Y&H_T0;=+6V/6[$&"ITPI M%S/J`X(BV5L;)__>/47!];UFKOWU5GGKWG\@.UY^]D+VU@YGC!9'/O@'Y7SOP MFW_\W_^#VN^_Y8,<"TBZX,:=HQ`!.+",S8*,IXD2\(\O;/'W[][[WA+W=MTU MX/]#C_]M7IO&=_\X@.3?`LZMD`IP&/!$<(927ZH[12Q6*&\KRP_7R%:6YB"6 M-.L>F!;)3=`A2Y.0_&DO079`9(8]=$MHP7]`&S!MP5B([,[EGY@8^)/JG[!3 M`Q/,#*H"^"8$UDQP$?^%,)&0P-LY#"2F`-Z5T=6'(P,%BZ!98P%52EP&],>5 M8>B3T4"S70U_@E\,MRXEMV_-9EZ$I>:X1Q]5DQ3I**#6':A@0M]"14KGN+9D MX8,WQX&\"(QXGAH-@_`QWY=/S6W0FO!&V/Z4A4^,@2Z:A9'E\&7F$4?4\P6L M);ZQHR&8'!,`D@U:`-596@&/.@3$6UJ8S?F;0<=2<1+JI+ZIC[H<3U?]H=X; MP-\!?I.A=]ZR&:-R)C/6[JAZN.9WUKKV`(].<1^V.W,BU%XV[FGF1T*["]0% M]#H/=N9KL\@GH!S;FMJ.'=I\&[AK4!)S_#G6%[CD5+.XYG8L1%KP`%P5=(XO M+4V2W%O@@`AX9"0I=&?=>X&E!?!+P)TE3AOD?X*.\P_R]I5!$@O:4)Q%(.T/ M2).0[^UW8?`3(/>`ZI"O((&IX(!<3_:#T1AT\C M'_C_P^=,<;OEI^X_(Y#LL80;&0"U#O(#*9LY`@2[9D(F$LC#)]!+="D38_ M$P#(`6^?V&60RIM#K8(1P?^6,6'MK!FR/%K+LF*OA4RX:P))$#C'([0*`@` M\("K2OXN=^Z`L0%">&_Y=/RK.Q36A5"5O(L0HA`_G$:V@P]D[C2M!\&J`JTD MWJ:PC+K4$W#!'!2?[=K+*)"+;!'?!3P%=@$0*@CA`S(9,G7./B7[N%9W.2/[ M?12"#26PO-2$I0QK@55*YQF)'U>=UOT]\#BEE9.0L)LK&MX7EN! M:$X5-*V?5-D63R^`5F^'IYPAHJV7_*VS<]^#MN/6#>/VOGHD$\JFL>&:W[=W MJI.$;\@.*K[MXTV]R.*6RMZQ2I0ZK[Z^0HQ'.QQHSUK*5AKY46/_]]P0EZQD MZO6VPYMCUCY0*.J"L\[+-*B^YL7PNUHD3;W M^:U+&OT5.;-MB?Q"(^OA2!^-#]ME/H,S#]88V=D,PC7(H_4VBCVF2J2$;D#/ MPB/J\W$<[0@3XR)FD/Y_EX)%X,C<07*HJ$ M?+1#^Y['Q]+1D>3>=5Y8RRE_R#E>_-&$,=$G!/YI*"`):/_5P7 MO@>G0DP86"2$6W2@49CB/G(L[I*-YO#ZCO85O:'B)UQ*X&Q1`(G<&1Q^ENV& MW(WK12'"&Y`[R%N$S`4M%V)0=&[/N!.&QVR"(/+1'=_1;B,?5G"M>_+I@19F M@7PF(&\FR1HN!UL1DKKF;EH)^Y/M.-J#]<@T"S\#VL!!:,WA7,8@!P6997!` MR'42V@Q>=CCB#VSN'/637Q,HJ2=X=)F<8$O!M]VM-\980/W%'MHT?OM.8\B MU`'[60G/#/JE05W!^]#O'F]&(1C\@E-'1E:J:!4O?\T,4E`BPT8,% MU/S!S2K>Z:IFV9/"QXL"J-R^@LD4DX$ M3EK@J2S\12OLPTI&0Z\CHF;T,-)(.F5E0,G(#+,HV"/I]ME_(A;P0)$5ZIE[ MYF$5I#'^VO8Q"$T;0?SR0)>Z5?RWV!K!(K:>"QS+"3Q40X\V&4TN*6]:&'$* MVX1S@*=-S*TEZ/Q`(F,\A&/*<6"ACG:#+W&M);XAH/"W.ZU M`Z%%L[&P32]JNW0BW.#A+=8L#F"F+`")'IZU8/F.C989L,Q+LB,V$Q/2=C6> MGH4A4QD73>BJB\0*=8_;WT#0B+=DVC\"@=N(<`-:R]%ZPS@W((%[;@=+.T#; M"3F3"QMG?@HB]MK+KH.P5QNX&0+)1%+0[75L&&90`V`"YS,4(CQM"S%[7%/8)^.V?PMT_V M($]O9,#.BR0W0J(WVR*PN`$DSLU$AW2T;V31BG,&A2.5NZ`%^*[($0!_!M#I M4,Q@%Q[MS_CB=XX]L.;6Q#QBK:P37[TWP9>4)>+Q/,,`MPF@\5N&]FC?>SXE M=IZ/[5LIPZ#7?>Z8VMM?W](20:HWE5^XBD*+#$_%[@86]NU'_K&BLKD.L>6% M4.KY![R/@DP(;OF*:2;XC[?,$;G@H=$>=.Y!1=N4`=HGZ)I*&5%9`R3IN'HGL+!)C-"T`?A/<&* MP#>^R];!?V'29B`,D6"_>7;'OB=BBLW.:R)RBC&(4]KES5"85A;FJ\<7-IFS M]=KS7!:;(O\#"T6S/];:&]N?X;6.LVMLOF58-8CZR$5(-.;"=>,A3HR/W)5E MIRR[F%8RPU*:MNFLW*O!`)/\MNC:9Z9';+!(P\R3AEQ/BDU*VR::53"^1OXP MYU'`(\6$V!=W;FV_CV#N6?CL@(DS3`/&49$RQON9.>W%4M.?)[;339@[@;[8 MP1\-2&??@^><.Q'P-O8(7Z/>@XL>=]S!;P>C5T1J8_B*R$$!JB3O4]ZG@HY6 M8$V3.ULRUB-8S*Y8T]B]YE87O,;D'6K*;SX(A+@"G0[Y7XND M9)"23Q>)NF1RF(6E.3;( M%%!4IFVO24O@@4YFY92Y5&@"4K[&A5G[I`L-ASE'C*8.88LAD5`D_O.J9I&:Y(R5QV8)`>-'] MP[,TUPQ`/K@I0I'YFB+5H^?`P0);=S"T);*[-]'#$XL3]XJ22$W[H]_Z\0`: MF5A/=H+$4U(H!?`L1=&%(!,^OK!]_)$(=VAS:YTH;`=M'U_#&A!X&8>&%R]D MEPI\S:Y9>AO7+*%QI9(?WB(N"-S#*)/$A0L,C1H*_`8Q[L&^!,:X5PI8Z!C! M4LEA5SJ"R!O@H/S[EI-)GYO-N:NQ_R2C2$*%&#!*AW%&F5JR)#H;L:AE)`M7 M)L!.QN%BD17J'A*E6T"!;NK>K]$T0&^H&[Y#=1\T7=.JZ?L,:0H;!WDEV+D^ M)$W@S>AR+'Q]BY`U M[9.B1K1P/X1/50N<)AN_Q M;4G\+S[E^_PG:A"0Q575XE<3N5\.<1"M,#`^9T$"8NS7#RPXK#_2#OG!N[F2 MB->AMR-(Q1@285Q;#E)>HJZ2R1.6I@C]PS$7UAEN]2^%KH,6E/ M`+&L/_EEE4!`90-7NX?XYJHKQMH<[P0`%E=E8#KXH?U7XAHA#]$U-U#4(F[M M^P3![UY_^/;VYJN"6%XSEF&@!''Z4%QC05%RQ8R6+)=9#]GGB.8&U3PISF)PZDQ.`['MO`K3C)*PJ^<`G*)F+UGH#X\\I/#Q_;UW'8B0@5M M/N#9'>J#&!^W>-$UP(N2QQ2T+B!^%@8!LHA;@;6!_"]55GHGA?I*#L[GED!4@ M3>B;D):XE9#B)@`+1Y<`VA=.UCY[;=7>#0]H*+I^R0P0\/2DXB1D"KCO?#(-D11^CV2.8;\K4G M1+OEOG;U2"27[/X+16NY"FV]SV0X&X55#"B^@[]FZU.X^Q2H]!5*@^[\(HPA M^BL`9_"BZ=]!CU/A>0?.=%T#3=;1M5\PEXFP]CG@\/<"=>WWM/;GBG@,GH84Y#YV-M]'3FR\DJ\;B M[)A^^`;T?7SJDXJ\ENXQ<=M+3M=0N1LK'B.&'C97UM'/5,8XQQM0P?8&_2S? M"D5E\.!6R2HS;CEUUFCT.<_*]#%C3[$9^9>*R5A'1P"D]1R,V;F`";3?P@/# M!%UKR(LSM)(II+,DLXS2-'G,77K7.O)=W#Z1)?=V$%?I;\V-3?)8-6']BB17 M;G"*SUX,$VQSKV_56IL:[M>`W2[>"2=8T&"=MD(/:6(QOZ3B.)LEWADNL\B1 M:)SS5.FX$PR:K^AG=@#V>^:BR\^A3C,8S(H#VK^ZY&&G\#6I1[AC@MEKJ9SZ M:^=K1_OYYN9.85:1XT'7MD#-R,9KF_4'BWV0/&*(&=S+E9+>9?$\ZS!VUO(T MD"!@(OM%;=5"7)WX>43\D@)L(L=[RW-\@;FP&@OWBQ!-0'@V(@I]`JF/7JI( MN6+&76?F27"*/TBTH)9;H+-E[QV>^STC]Q;OT2,=ZUZ@(.^ESD&J]*%_W@83 MQA)(22@@CT(,??F/+%`[=<1'(W=I4-(]#[B*()@NMH)W=E_&82AL'+!%A,GF MCYQS',^]OW:X5X3HH:&X^;G_&GY(U: M"5DI0B!87V%DBF#@[1A>FK$!GRTPB9W[FU9P*70I"2V^3Y/^X))#SF[-7L#% M>(8>"DHDE14/*J.$'K^,/H__48*PO/+/1$BAIE%]J=A`P3$0@V MM-`2."QZKX@[QK^RU(Y M[DYR#`(W!\,UH=(\=5G)B^4RU,C]3.Y6'TV$J00AJO4B&H[S=_:YY=>PO+Q9 MH*G.OI[,'."*/C#ZNC&H;'YL'P%U-0E.Y)=/O(GJ5 M<\NU:Z;*396JSBFI>T>'V_E0[_9'NF%<;D.IK[R8\C5.&""P\*9UYTO_"@]U M%]/\]1AT)0W<0ZU3J8^//H(#IM^O.JFK$99SH69@M=*E"@'ZW9%N&E5/J?-M M\[7*]%61VZZB-MC=;JH`+VRTU3KB.E58<:R/>F`P]:N.@*]C^X=!X5ZH4J'A MGZ%/N@-]DK^MYO[[JB6!B!="#9N1B<_LZ2:.Y]WYGNMA!R7R:/,G3R-4H6:N M/U#N6E)(\8#N=][P"-OG\VA>$L.D@((HBL&H(?G4L3R!!XXVNSAE1JC_*T?3 MIB3JEQE`*DJ(9[4&HDK]=G$#KY`:^&L<+'@GX@1(LS=)A.!VL*N#8JT09&3 MV7D;%&F#(FU0I`V*--?>;H,B;5"D#8I<;%"D?N?X#O>[J'81G4YNW/D-GQS] M,2D;^H;?--W1+L#6\@V[)OP+3S@6.1S"%WY&?N]].EJR#/SC>Z9/9"7XK?5)? MF)@YGO\2>DYS@6EJ:^Z)V25ME[-$W%#O#>I'7$T24CD,<3.GQ;"OV6&EXR"> M>MZ@[C2X_I01TAQ]_Q7[EKJRIWU`S3+B8"T_;67+U1!].1BU3)S$G0(C16)ZNPS['9CJ,>OPEG;+/ MBZE'?7W4JS]7X'01TAM-='/<6"NDNDTM(@D?1)/=,^1IN!7U6YY6$3(`15U_ M*M3^%74]"4&W&"2RP[@R3\$]1J6$V289:7^!/.! MJJ`JV0PE"RE[V_F75E&K[(+Z4,E$.;!3U*%YA*2C?M_0!Z.RKM`]IQP=AL9' M)6>%A.6>H7<'=9\;=:-SLI(Q.)0Q^/YY$3#77L'TNS6'@W8=[J60PP9+H6\>$U>?7%# M7<*+;[M9^1>'N_:^E!M6+1&@";=5(<:C0?Z"Q#@;*K^\[#.?8P]&A%BAUZM4 MC#<9ZEVSK`_^"$DBE=UU.)"M(*;/*<'!Z(WU;O]R:]F`_+EO\,WP?1SJ_E&3 MC\2@W*.J==$GY"7)C1E>-;5(F_MDLL=&_ZEX/T[T9FP.1_IH7+<'K^:;<87; M[/8K,M7WT`!J=3X@5>Z*U@TW."+-#M>G4;VC!=%R*485TB!=FD7B\4E,\U.`MGO^!,+T:C4:<,;LKM17E_5Y\R%YSZKS'G"5.6I5CV0OZ[F&!4 M^4I^6D0XL".@&9MN.>^H&[[A,\(:O=]6TAI"B$MCO#KW^X4M+=N5=1!-W?%% MBEJ=9/XL9RTVFLQU[OB=&,5X,1O^:"\N9[,?W!"NM($]V^..:U(1!TA`VW,P M^/:NN&EH4[]1'VK\P<:'%/[1TWG]]?*?) MY?''\.J65J^GCH^#;WS_%N9&=8TY?%6MZ#SEHTHGOA;454JEU)Y2T)45#C78 M0^VC>X1Z^]HGRM6+E>:3.@>.2Y;8'8TE.I6[C5PL-YR.X`\ZM95?GB61&R/= MA_<-5";POJ_&=3L*#N<8.I'YE.U.SGPGA[M&5#&8DN@U\<#5K MM7+6V)D-^PB\1EZ\AHUY#JPFF@ZL?'LFFPTLO3ESM-#3>%N")[%GG9Y&7%KN M6HL`K^DQHMJ3*'?5+%Z-IUE!$"TYJMM&!-NLXM!;->IN&D'*\S>^SCWF2)49SGN9&\PS.K(/YCB7>A_M=42SM*8'M MBQW\H2VPO_=!G!&!F= M)G*",>QWS(8K@Y@1''N!9P/O8'VZO##HY,X8;`I4&7R@]A8L?/_>T3\0GX7[ M+MB0P;O_1"#TG[V0R9?=^E_PXAHT_2*_I6V@N)^W?0,/MTB[T'M;"=$*WF;956AU]07JZV>_IXW[92KZ:(,V+ MDQP[.ERKM&YGLF^T-4,ZFPA331JC;96V/JNL*K1N]52[E0I=PSO;VEM M>>KX./C&]V]8;E3&M"W5SKJS4D_O3ZJXWO+1I@HA&D[J/1CW1V:);F=2M6/H MQ7+#Z0B^V;94:UNJ[8G`^[[IUGWO/YP_Z!+;=[4[:=Y.#G>-:%NJG6;/II[> MJQ23?Y'^%>[U3:#>'BR#H]CZH[I'0)P+@9LMGF;GHEOA'54&F^,VKM!2+;.9 M6;$*YE0/L]\]_P\`[8VULD/+>X;0!%V`\.?3?[]Q7+OV7LO\C\QK&K:#4"03%-ZY_U)#XR/C17E6PLO66'OPVY_ M9!B3(I!@X3<+7K_Q7#*E0>+N?+9@OL_F)&)ED6*.C'Z_/]@`Y:75:@.Q`A+- M?G=D&IL,5`CR.U!%;FA;CK-.GI]%/L@B*\UFXU$/4&H(N'8N40V8"K@#YNL. M)L:@")!2M]_,9G!?"X,[:XV*_\:=PR=^Q.8?;6N*C6G@F3<1(!S.K;**&C34 MJ)\<)P66K!G:*D+>,[J#WCXV<1L^,+\BBLUA;SMLZ@(58:DBX(8Y+`7B!]$P M3?RT*C,.^[U)`D?VR\N#4`%!_<'0&!:%3#83"^K!S@B,*@4[6]Y>`8@J)L9H M8J*Y5Q"X-[02\V_FCV"&559FQF0X&25`;'E[!2"JB-AD:(P+PR;TUE?+L?SJ MRMX8C7AZ'*,6GVNOUQ2=``B6B!!'C'J"AC`[HOO/C^2H!40%-9 M^-X*P^P+?/<&_FN'556U.>HJ9L/6]U<"I(K"'O8&9>"[73'?"@&1'YD5L.!] M%$8^^V2[]C):@BY;PB/!VZBJ*I\,NZ:BJ(HM6A+D#^XW[/)%%;JE%0B2O5L8 M<'7IDM"7-[Y&H_&P,,3E6_@'67_N8FZ%2U]\PS1(M@BA18RI?+B MI6^,4A>&\T7+K9L;*89I3OJ7@16P"O-B9308C4Y*@JAL/OC@WC'?]N8_^UX0 M%#^H)3+^#.R_N;;S]^]"N%!_I_WX#%B,:'P(`KAMOZ7>R7Q5_K@Z,"JNV-TC M+!41)XH$X2(18Z\\L!M<=-V;U*IP,F#=HW#)'L.B`ZJD)?4.RVT0W6T[HSJJ MD_U`4#<(644,MQTX'%TR#O,;!#N0V.^,)BT27S8?=J#0Z!A&B\*7;8T=*#0[ M/;/Y*`P*&2&YT9C7B1`CK[)-\-)&)*RGL)?\-L.-.R?7![WA`%M[SN.]O=A" MQ?>5B>3IR\!,"PMC>M'ST[XZSX"GI&EDM,U9IF]@7?,_9?W+IHU>Q>;BY8"WL7! MR!SU+H-7\CL7!]UZG8M;D<+K#7:H&N7)&CPZL:+,N63-8%;U`PR'S0&_\`U\ MT"3<%[O[]CJ307W`QR89)8!@+#.VS'`@RBXV3RS'$B_>#TQ;>?H?=Z-_#3\U M%=*$??]QU_O7J,DXC7GU'W?FOR:?C'$-H/)9J7/\_(/[/`/JA=N>#,H_>TF) M-;)2AW*M4?EL>F_9/J43W`1!M)0'%9\A^UL\2Q@3/CY9?V("5W&K'>[Y.$XB M0QN.C#J.U\);:!;R=J>-;4?>L%^'*[(T\JI=M78M*_/P<=$2E\1M&,,YWG%= MY?X!;P">RG'6D?#TG)-_]KPY.@T_>RY;KAQOS;!\[Q%LC.`;K!_@8&#/Q44( MJ$\L?/#F7^S@C_=P_LIJER\%\M!RX<90*\_V`.R1\%&>5\;C@^"C%M=.1OI% MC4ZZ01V"LP/2-"H*)W=4V.FVZ$!>DS>6,P100OIW\O:HKM,C M+_RY;N[*M5,)2>:_*ILR,%IBE:(`;G.#O0!@'H="]BHI`&_N[WUV3\418LPM MS]0OCK6-BH"=S+YEU1*HR+EJ7`_L6$%PNQ"-242SGFV;S7;NW'5[@]#KFH/< M>="8JJG&;UX"8B]`F\/0,W/'$8;\8#\FQ"92NC_)C6;SZ$@N7DXA^_<4!9I+ MO6PY55M^V7;6WGD&]$92#Q6#:.^[R>;YW0$#HYE[V2H-.P-/2?BC4;LIE9., M'=?KVTU.<^-P0I,3H'WOI0:1:<9.ZA&81NREI+C$IGF%O60>2,4"M^7MI5P0 MU`]N(4O)-!07R,%A+6DC'078XM91RKU4"-R`PH&UR8M[K]!;HXDB":*)TX\Y_A\=*5$EFM5X!M%YF_\/PEMMHB/P_W[?S&@C"_(T%2B0("TM++T75@,!J. M^U*Y[02D?I`%*C9[DYA!=_=G/O,_(IYFGEI1H3F^NESSC>]^FU MY_O>$TC_?N$R4D;.]J53(&*GZ=?HSML:&RT#W(Y0Z2CNJYRY=.8]D4?X*D.5 M)V297G*#M40T_PO#CB/S;UZ.;LMEB6E.>@.%R;:MG!/`FP![9K^U`^H/N@=P M>\-N#FC38&ST5TJ^N(DY0D@Z<*\?VG_5P`)9W;#Z<30M'Q!IE9ET<<\,5ZA! MZ)M9:#_:X?H;6I=&W,\]MX\>.\FOU#[WO,7]CRYJ=T?[9B_A?/[,GK0O'FA[ MG7^@:]CN>?&3MK3\>]O]F]9-=]+_7T";O5B+#VUWSO"]W<[`=JG'_;<'IBT\ MQ_&>\/3B?>RQK?T*4(-A/LUVZ73!'6H^I[@6>@`F;LT3?=&M<&.0S-^H+?XJ MZ9(O6^77M\'G>]GHUY^Q>LBO'LS!D:387AYYA/XM9@#0OY]!J+T!;$Y]6]=^ M85 M1Z16>&/U-\0['!:8D:NR-1X_S/])VP)#QM`(0EAR+2BG>Z[F+23. MF48.OOVA/6/P=8EY.76_]@0H)3T.FG`YM!1K.L74R+`HYP-!$TJNI5?CZ-5* MV,E3+/;#:IC7E%!,BQ_YX&J4[-12LW'45&-%#=:7>[0.S_7.U^ZPW6&[PW:' MAY^:+=UTK_;BN2@Z%%5",WZ5,?QT+Q!V.V97N]:N>IU>U?G$+Z.R`#[[8R>E$R.J@Z>_S,Z-UH&>UUABVU M3H9:@Y&ICWJ#XU"L)OOVZ<$.V2[KM@%J\U"RUS/0C#4[XZI'9'5FWHNX'1*L M*I3`7N$M!8Y)@=%@I(\&K1@<62%-JIXM+04J*J*JQG-+@&H65O?0>NAP;L.7 MYX MKZ/@,FK0GV27AK8(_0*+T`M4)9]-87KDU(W3/9&IT!7M,IWV4L%?% M:`G/2%X]T;12LGV7M>?<;QV%@(=8Z@0H*DL]$Q(F-9V;];I9OVGI?]KTSRZF ME_JV)>S)$G9KU7TKQ1=`['3!OE9[=7Y+XD.3.+N*OW9%71FS>[2&FWAK/J?R MX7:'[0[;'1Y_AR54:%O&7PK";J`\LR+$8]#]<%6,.`.HI7?% MEQVRC'_2[=:0[W9F-&ME]++HW6@9K9Y\TE+K8C1J319N6\BO]*,:\D+^ML#E MV&F0DS/-PCL5"@R&/7W=M,X1\ M<0KQ'$DYZ9TG"2^M@+:G]R>7YP0\1XD9_=6R'AN_.U"/O%;OM,BU^;/4-^!X#MMSF;VTG*"OW_WX?/[[_YA=`=@OW?% M7EX`(@5P^BM9G$.%.)6!_?7KV[LM`&.FHX!V!P3I9@F9+1=N\.%[6O_U.OG) MG;7&CVZ>+'\N&C(H)68<+T;6!LUKHZ=LD"I-WWN1GY<2/;/?`^Z67%4[S/M" MB2S=$94[*3)40]1.+ICL`5,[MY+"WULV#=_:P0RNE.%-\`&K:U@0OOL3UV>_ MNM;2@XOH7S6(+>!`W7P7^,3HC4TIL'GA2!,?]=1T$V/BH9M,T+P'VX753=7@+ M``$$)0X```0Y`0``U5UM<^(X$OY^5?R,W=%@,Q2Q00J M,+M[GZ:$+4"UQF(DFR3[ZZ]E;&+C%\D8D#)5DX1$W=;33ZO5>O7'_SZM7&N# M&2?4^W31>MN\L+!G4X=XBT\77R>-SJ0[&%Q8W$>>@USJX4\7'KWX[W_^^0\+ M_GW\5Z-AW1'L.C=6C]J-@3>GOUKW:(5OK,_8PPSYE/UJ_8[<0/R&_GG[,(2/ MV\?=6-=OF\AJ-!24_8X]A[*O#X.=LJ7OKV\N+Q\?']]Z=(,>*?N+O[6IFKH) M#9B-7W3A1_3MJMFZ;K;;K6^MYO>W3W,F_O]J]9`/!<3?_GW5:[Z#+ZWWTV;S MIO7+3?.]XL-\Y`=\][#F4S/ZMQ7_Z!+OKQOQ988XMH`/C]\\+'Q12PEM.3)M3Y\^'`9_C4NFBGY-&-N_(SV M95R=G6;X*RDIGZ@))S<\K-Z0VL@/W4KZ&*NPA/C4B(LUQ*\:K:M&N_7VB3L7 ML?%#"S+JX@<\M\1W<)3=4Y<8N?[R$3&\I`''X".K2U'F$G@*5MCS.Y[3]WSB M/PO2V"JL,^`(E2X9GH,F\(]&[!_BR3^HR/K/:V@MG*S6+MCELEYEN]1SL,>Q M`S]PZA('_-*Y1:XP^F2)L<]E55;7<.:*CT'(\Y?8)S9RZZ/(57=Z2**58^$2 M?#0?K47D`U>%TD5\>>?2Q_I(,IJ."F3$%L@C?X>F@D9YBSB!9XX9 MYO!TI2:MKN&H%?],H:L%F]F8B<=^01Y:;$TV)-\#XD!L&8-W2^U?5<]104R" MU0JQY]%\0A8>F4/+@]!HVS2`V.@MQN`.-L%2"-6T'!4`/(8%V.D_K84/"_(\^UGJ!*521PY^JQ7QPS8"/$';$6Y6C>X**HX=MVUXC'HODU/ZJ!5Z MP*X(^-#Y^L]3!G$&V4I5D\D=.4S-./X>@"GZ&T&9/"#EE]<0.X\;0T\:2]6J M,!5QYTAPTKKT=`QJ>`Y4=X:XK,B'@NRY8[1:S2LKTI+E];"/B,OO$1/!>B/M MQ.OJU=#PHZHO MU5&H2)]E=%NUZE7UE(&PD6L';FB$(7Q.2>`G'WL.=F(]`L1Q%D3@UT)5M(+5 MLAI6+)7\$7F.M55AI72<&D&%-8X4CBNH_&ZN&G[NCNY[_?M)OR=^FHR&@UYG M"A]N.\/.?;=O37[K]Z>3>/DIAN-2.P7!%>M?E.WYQ!9!N,@U1WP6KG0%O+%` M:'T)OM*^Q*[/X]$[VDWFJUHP>N'Z-??.IP#EBASC!_@HAEVP\=^B\KM%;O4 M5V$Q^5]L1DL?2A>EK-/&9XC4@\Q(A'&(K>HB2L1M*5 M9I(JV,$X#J-![FY\^(!M3#;AU,0]]N5M7DUV9AXKV<(X)@>>F#6F[/F. M>(0OL?.94D=4?#1_P!RSS8;:T#6(B4#7RGKM\JD3.FP"GLJ.>1C\I09DOS6_Z/S[0\\ MZ^$-=FGXZ"[E_K9Y0OP-5D$X9NFL*/.C[1$Y7`@UE;68T@GM8HK9JH=G\D%];F$UCMZ9P%$)V-,'O@?L8+P2@7<,Q3`\ MW0G7IR:8B8KOM?;G@O!768L:/>^U!\$#S6-<@^H%>$HKYHAE,FK\_6Q"\Y)# M-X^MR-4>8(SE!?)4L*B\&DN_&,%2*63C&$K@NJ>>76'LF"QN7FZD`D9!U*B! M8Q:36I*4(V>:&^8=4\@2EBYEU-!0RDWQ00R#:"@?'V91&]9`BO+2XMBM1(!6 MQY)C>@7-.[E33,Q]Y^;?4>&\LL<<**3SWX[C$,$'9<"<\OUTP.E`3U=\D MBLV='!)4,<3IQV_EM;D]G);;2K2Q%B,VAERR=_0KI>(%/F$>\!4^LU6]/(90,^55D]4$*M.F;@KC>J;$ M`*;C.54&"'))_1FX*KKB4=TK&J)605A2L!3HQ\M]G$/XK/V@0?XU1*E3!^U# M3AU8;U*:?])TJ$)R1U$*Y[4:SLD4OGWIWP/&T9TU&O?/50`(D; M=G[2>.;B,Z.3)34'^$S#'T?JC(1V=<3R9V M#8[FX6YG$0DQVQ!(=2<0X\I&O\4R^F.[G!LY9O/RQBB`>8N!!U$/#P%C,4&Y MA?6WFA(,>PSE<6A:RYE@%W0NMG>(NN!('6^K1-%@IC24B6L_U^)AA[DNKGRFH/TQ(2M M!_.1UW\2^`+"ER+E',W%OK.2I$TNJC].5"5.V1[&Q7[(Z%3ZX;UB!C2MO'KO ML5(6[0T=SJO`DCNGT4[6V2#BACOS:6+])IJ+$!?!VHINJ*+(,$=5Q[[/>:Y? MF,9S>LVT1S;$P9[#MS7?34H,5FMDEQ^-KZ#%L#9[,,.'V.ZHB4'^&EJTW-VE MW@8SGX27D4%-G%T%"Q;0%.3T+S379$X1IQ)7YDRLEE\CGIIK?'?(7&.W,_G- MNAN._C!EKE%<;@`X89`N*'-NG[^"10;>+GOHV##BDVS&JZ)#[YGO#1&O`[FC MK$>#F3\/W/B\7%E`+I,RHHNM2&#V7+C4+,9UMCV\9M@F*+I"7W)D/)(J%3*B M*ZW'I()1C",RW'\!'8P(PRN1R$LX+"IO1']:C[YR4YSA:@9Q)QPT^@'G`7:F M%$I@L"CSJ:A#_X:NPUD[`*ZA;="$":U3[A.KW3+K MS'`=>TP"@Z``:+`1#9KX'XU+3;OYJ1#XG):7I%VHR>(JMGJ]5&=OLZB!N?[BA3) M-WI.Z4#KO0XO$%=RI?>0AR%L9QVEH^CU-2OZB=&35\>R[RMPG+W;5:IX1D94 MD7HS9\#481K*[4GW_Q@]HW7R+17YB7AWB;P%.,@=(BR:IGDYCCG!=L"@\OL' M-@L2\0-U*;)G[BQ7+1N:V`3S;+&=-*^W_IRKPZB>Y`'JQX@-Z5/Y6TODDL:N M0Y<0*>U&\LUCWH9@R(3#+2-3VK&_!X2%8V,*K8Z+EPY`39>0^22N^"[9;%!9 MD['+UNK$'VH^\QRAP!1WQ(,@7"^8Y>K0>@!^'=$VFL=WKA9<_5:,M9(28T-< M";V9H_*5C6:>DX=M$SO\#LRC=F5>L82QT4N=4YDYC,NXDDZHQE^QA+&[;@YK MDXK\'7M)?U<%DJ"P7-':+C0)%JAA?0Z@46X3$4$S`V&VP5HN9 M!:+&;JPY+'B6&N@,4Q,`9`3NY3`TS\O0PZ%WNHRQ^V44FU8N9!.WZH_8`GG1 M[@\8"XCS"!"MQPR&!YZ?WB69VJ+_7KPIEG#;I3Q@ %86OC@U5671NI96= M^J*3SQ3("=\NS`2@+\A#B^VQ@R&!(9!#MJ_I*CAY\/,^K%"=%>D+<;UH_)%; M.YU6I/34\";">]GS:#XA"X_,B2W>.+9=-H**CJDK7M-=`.Z7?7"1,D%20IWU MHL]Z47AJ8-5?XY+"]F$?6Z3/BA6&W(4JK4BGE;M2="I\N=UJ$D*KN0\A%+$R MZ<;)7"OW?>_Y=6UE7"DA_*.5%#_]S4;2]Z'G8[C:QY#0%'K+BZ[SNDKZW>CY ME6]G*Y\6.G4EB]Z"GE_=Z_WJ1N)6*&^E%9P^ALXX_AZ`M?IBQU1!E=]EHV4L M9L5R9D3[TJC?RO34ZE'?>A/_=(8;RM2P3L/W!N59!N%9\!IW)'5P8U MTY57Z^[."#>_5RG#ENG*B_J6,Z)0Z&1*(%UENG:UKN:,`%73YIZXDM3E]^)T MCKBP*!]O)CVHED9;;Z+'6+OG&!.`HIKEX\ZD%%4B4*3YP"/+!=?N0PH)ST&N M^]PC;B`LN5W'+GE'I$3FF#,#L?[1NF@Y0Q3+E-*X7J%@H.QL0`',T\^\Q`^. M#]-)#/Q23./J02T+[P,]GXFS%S:D;]Z0F%XNKG%!H!8EJH8Q\()@Y52MM%/( M#-6JYFKU.H93O/E9'('/[$&M^B;HEX-[MP5CA_OQO9ZL71R@>273F3`;%:NJ%`7-X+V?#Q8$(?A?X`.$+\<@J6,4'A7IEAZZ5%9CP%J#R.DJ3 MJJIZ],_R5:2WZ)T&E>QF7`*M"&/@31_I_S#*O6RSFD62JO1/$Y[%";+6>\5^ M`$_%1_.$A#+]DX[G\H6,!0T2>4#6`DHVE>H`4;395 M@U1A\VDQO,AMQ9<9-`CXS?\!4$L#!!0````(`"$PL$12F&1%7PX``"W&```5 M`!P`:&5W82TR,#$T,#,S,5]D968N>&UL550)``/>X753WN%U4W5X"P`!!"4. M```$.0$``.U=;6_;.!+^?L#]!YT7A]W[X/@UW3;=W,).G&Z`-#9BM]W[%#`2 M;1.5Q924DWA__9&RY(B6*%&V7NBL"[1U',YPGIGAD.)#2;_]_K*PC2=(*,+. M>:UUTJP9T#&QA9S9>>W+N-X;7UQ?UPSJ`L<"-G;@>*/QBU8P#/C$W0@`2XF'XVOP%[R;_"?_;L;]N.ZNS.C M>]($1KVNH.PK="Q,OMQ=;Y3-7??QK-%X?GX^,;D.STQL9JZ,5X2$[[J M@L_@OMUL=9N=3NN^U?QQ\C(E_.]'XQ*XK`'_W;_;E\U3]D_KW:39/&N]/VN^ M4^S,!>Z2;CIKOC3]/VOQWVSD?#_C_SP`"@T6#X>>O5!T7@M!?.Z<8#)KM)O- M5N//SS=C&]]N@::3ERP.Q@SXZC<"YQ#8[OP9$#C'2PI9.BT:O$V#A72Y@([; M-+%I[-#(>G=$[@E&EBJ50/4HGW_).*K+MZ9`.+HL6CS?S2V,_8 M"^Q8T*'08A\HMI'%4MCJ`YL[?3R'T*5I)JMK*-GP$1-RW#ETD0GL_5'$JBL> M$B\(D*<$'4Z'C[Q(LE38+2C)JLJ%<@'H_,K&S_LCB6C*%:PTFB9>LMKHS$8L'4P$4R%DTY(K`-8-64)K M\/+(@.VKS@L\G774T(JS/`5#(M32[G,O5`X8\E<\7@B8!G?*-[B[E\'=\@U6KA39M)2]8%`L(-DU501$ M.2Q[J"SPZC4["A7I4JYNLYJ>54\2"$#,`$=<8\&0>'8E('DXK7+JV3=G*HBY M?(!U"[$TH=ZFI]]1V%$;+BH=`D6>SW5 M%W#Q`$E&+L<[/:RFA;(E)J3<`J6MKMS4@;BHLWL:^0@ M7CYNV(^"W?#%A8X%K7_--X>'-]V9NP'_J]F][MQ<`8_S$83,8:H(EG M.@5HG5V@&;$FO]3#=04%E2`V56#.9ZP_SX/;AG$X94Q'`WN>I-KUL#XY8L# MEA9BO6H`-DJ4"EA/=\%ZT1O_85S=#+^5BS4#IRI@?,>K":*FC>F20/9#6)%7 M7CQ5!IX:HK*"\60F6054OVZC\M09OCX/UJO&GZFQT6GX2@M&EY%_%;"]W\;F M*^,A"JDS7O49KPH+QI6=DQ6@?=B&YNLS`H5>Y#R5AJ_3$)06#"^6R`TC:#6W M$7@BQD:FZ+Q*IG0%4UN1/`H)_VR$Q0NOT^K4K@"AO0TAI,E+E5==I>:)A`46 M;.]$;1>%"K8QE0X6K.UN6^N+&YZ\(2HHO'A*N&+!XM-HF0S$C$!.BRJ?6.U; MD?E9O=JSQ:7_J?CEQT[LL0`T,F5G`;I67#S,74EE`6ED`L\VRY6'5HF"%J!% M)G#9G%(>B.QL=!A1.S*AJTTQY>';FY<6X$86!=D6SL8O?C?&IA]=:L\V@2#` MCBPDLA0?7[-&U2<1:V3AD;7\E(97B047L$66*<+R.S8[?0@!"!N;@N4VO[4" MD]B=26]'<0KH@[>MN*3U&0"/C39;VS6@[=+@&TY,=.K-EG\OQ4_^U_>;K07F M+GC-/FX"9H,':'M]W_N-X]HV-#!]$KX42C![(E[^1%.F1P+C_6U9Q;WO]5[P MFWU=EZC<,8_!)9-"5ZD^M/W'4Y$$'8P,Z1F8,+FMO-:J_EJ"\L^ M:)W77#:J*HV27ZVH-PAN,*O/K&1<(0/T^84;T7E)"* M^VG--0-B.;"TB(N!Q#EBD^9&I5D@6GKI\VZRZ,:WSC5J41)0$K)>.3N6S$(\@I>0);M6()+BJ[G`EF`.SL'.'+@X(_!M]X]A]&;$>BYX+-/ M&T<"QIO&M+R/2[?]@B7RUY)`)(X)G&ZR=/3L7/?BG7L%3-A;$P93KDM$L]N M-[OO5N/6]"6&U%J91W/.5G]UW\>$X&=H*?@V04)O-Z<9GOO4'>]Q7NOZ$!!Z MS6HE@=2]8\9+?!W;5F\ORTV6UHA\_=N;L?HT8YW>+CFUS%>.ETU^^WA=['KRPM3FB<$20*EQB2 M+P[8)R@A\0,.RS8*66`^5+L?N[;1.^`QG(8!C0A&J&F>..C@"-Z`"4-A]$ZLFI'5NW-LFKC M.1M8?>`=*U_PV<@+&YW$&RK#1_Y[[WA$?R5<*=X!9Y9" MMA72F=X<7('^U8V:VP-J%&@:/U1(9]40@T6F2&[)F!8A[>C&0\]&G#.+N(M]:^H<.E MZSU&'CFS-=67=7+=HZO[4\UWEXI!+,NDG*>\;Q#-YBZT>D^0@!F\@]PUS)+_ M<2I]..5W&!!@NDM@WZ"IE$K-I$3?@.Z(Y9`N\'9*RRV?I+'K^8^+)`/T3:<* M_""=?PXZ%7V1;CO2;?IDXY%N>PMTVZC9/G5QLW.:2"MLM7K;A%L,V)(8 MMU&S\\[%G910A-J\<;XMBK4LNFW4:;9%#2C=W)HX)'=\NRVTIRY?N*1)ZKNOF`5` MQ41CB%";0!)W&T(2*[P+WSEY$S=KF!RI]TD#TV( M&\_I-$F:F-[Q4+*^++IJ;42H]]U'BZ(2O8.S`Y8#Y+"2G_S7B3RG,YTW.3X$ M\,B?O'W^9'UQ<HB\\]@5MH^<2_L'BT<8K"$/;/]*-+5]&*E+1 M9GS&`8C5P>A9B3=3S1HBW]G#CO=4^>03!L^<2IAU.^BZ96M:)94TKXAI M5W(X5@&@Z<271W1TGM9RBZ#.T]<8$@1I?\140D+X._58&4^;P!*$JB)JDH<. MSF2^ILR+=\H\_3IOJYG>TU(LIASW'=8G!2\!8L=S_?LVUM% MCWV/#6_&&R[V\*YV<^;AIY+.,W95Z5;J,2]OM@I8M<0S%#$M*Z,_BASD.!VR M+#BG>1\V$M84(2;Z$CTA"SJ6[!&TZ8(LR72FKE0!R")1[/F(S>-9^6NQN;<^ M\0QAF0:)EW9JYR32M&@>HIW0Z+F%X[W3;`QMIGCV"3H,C\WJ0\]:,$]3=\T% M^@\43=AY55>B<61W!9/[ED_"=/6P7?GEL=E4<9F,QJ%0M#WWJYP=/)_V^&F+&!*%-(^!BO$R MY^?\[@#6Y123!7#,]@7;99[?^>4`^6Q<`!OP M75.VIOC&]HZO7GQUAJ?/ M""L\7LD],ILA$W>."P]<8J[21[?/NJGOZ4,&*PJMG2 M$9;[23?DF.@1V'?P<7UX753=7@+``$$)0X```0Y`0``Y7U[;^1&DN?_!]QWR//. MW=B`U-:CN]VR9W91DKK[A%6W!$FV=V$,#*J8)?',(LLD2]V:3W_Y(%E\Y)-% M9D9I%EB/K8H(1F3\,C+R%?FW__BZC-$3SO(H3?[^S>&K@V\03N9I&"4/?__F MY]O]V>W9Q<4W*"^")`SB-,%__R9)O_F/?_^?_P.1__O;_]K?1Q\B'(<_HO-T MOG^1+-*?T.=@B7]$'W&"LZ!(LY_0+T&\IG])_^OTYI+$__\; M"/L%)V&:_7QS40M[+(K5C]]__^7+EU=)^A1\2;,_\E?SU$S<;;K.YG@C"W\) M?C\Z.'Q]<'Q\^/OAP9^OOBXR^O\_H?.@(`3TM_]]='[PAOSC\.W=P<&/A^]^ M/'AK^+$B*-9Y_;&#KP?E_W'VO\51\L>/]!_W08X1\4>2__@UC_[^3O MTNSA^Z.#@\/O_^O3Y>W\$2^#_2BA?IGC;RHN*D7$=WAR/# M5U_S\)NJ\5D+9FF,;_`",3-_+)Y7!*IYM%S%5"GVM\<,+\3*Q%GV/>7_/L$/ MQ.$A_=`)_=#A6_JA?RO_?!GE<[<]X6(MO^-RW-!E1\+"6;G"VU8[I M'R_)O[44QU\+,A3AL%*=RE($./8I%G=+V;7T=-Z2&]-@F6;"%F$B%T%^S^2N M\_V'(%@1^8?'W^.XR*N_[-._[!\@+.3Z^)2)QEF/2)=/[' M)[R\Q_7GF*U__\:(X_NN)91WEE7F!-EQ)C0;YSM'W_[?O,ACS`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`]34N5DTEX4T#=Q&W4Z=8X M<2#XJH\#;1JG<4"D7BL.-`G`X$"D52\.O\@ ML)`<#([T.DH.`I]-=Q!8LL&2)D\X*Z+[&)N?);?B=+<=8V7*9I?&B,T[M.QU M%6R\5\Q(=NY\TNUWQ5IBA\#Q]KML+;'U*PP$B%22;+\?.YF9?B"V:::F31*W M<].^9W&-X5*]5??>`[=^.N(HZ2AE2'RAO;%\HD1$'O,@71JMU,0*3$ MWC%DJJ'X6"\G!`8HKM1%$N*O].KD19ZO<9;S6RR:8W]FK"YA9F-,$W$F?&#` M9Z%L%X5*2(<_\U1YQ_S\%1PBF4+(>X00T MWD&B4:P+"$J):E)@H6DVGZ?KI,@_IP7.J:;Y+`D_1$F0S*/DX0;/:P)1PU]XW2`Q2**(WH%['U2 MD.BLS/1DQ$Y!JU2X!4 M9:3S!'.:#N2TMVQ^4>UU6`AP>T/4UK#VK5%3;C#PM%99#=E)T[WS=+ZFR06) MU+POT?).V9*=S)O=YT5&=!^1?NM&._.EWKL4-?HBHYDE!:XEUK):3N8"43DF* M(!F-=\!H%.O50>"0V-"RTF[^8''&+L?%;!+\G_A9:ER/SBTP)&JVD=$A`@0- ML682;)3$?&$"$7(?Z*CB&)T&",QJ_^P*"R*E*@@T?P/A>8%"TL&"TOCT2?DEN<9"G"0[Y%HHT$9+2 MNTTG-6JWTTH),0@0F6C81=)%7DU,`T0Y]_^@K*CB+7?!_&'JES1>)T60/7^( M8IQUE]\4=&XQ)%&SC9T.$2#,B#538:7F0(SE/SQ.6GDLO,&K-"NBY('719?/ MOB3DCJ>P2J4[,UDA+2#T*!64@NBO.:HYRF+VJ)3D#TP,S&=D%'U(,_GZ1X?* M+72$*K81TR(!!!217I)U#T:**EJ/T25=+M.$G5+BE^4;FUCR#J%DMZ$4:J;G:C*`:.GJIL,*FZ2/ MCI01"NM?+D"UB`\?P(`S9G0?XHL8W_Y+3Z<;8YI)Q_QD6)1!FFS7A]G&4W,D=T:%W)"`9:-MH* MGOM@O"BKF?90@EDF$\1Q^H6^($/_XR]O3O;>'+]&9!*/_G+TYF#OW=$[$I/H M3Y^(W8_H^'"//;G)*,Z)-'H"N?KK,0Q\7R1/I"E2NA*?1/DC#C^F:4@;Z6IQ M@W.UMPQ>:>%B=F+_SW6T MHNL>)"9+.XV*Q6V$TBO?#DUR>D`Q2:MD/QAQ%A:$<$6_2?H:[[^%>$72PH@_ MZ$)SP+<'[_8.#TYX$OCFA[=[;TX.7":!XIL^O^+[<_R$XY19S^ST#CZJM`EOS>D;V%TEVD$RD$PK48-*=RA$`/&L(8 MT(]>[_WP^@W'^>'KO;>OCW=NKL.'&N4XY&/&7!@Q\;RL,7Q#9MG)6C/8RHA=QCVUPLU()Z;T M#C4C]7J'):M2T!FGA@&>LV`5T4DX#G)\=1]'#VSY13.4ZICWBT]^Y8O",! M`W3G:WR7VDP=5`Q.!TZMXJW!4TH-!I!:%46X5,#2V0SA!H<8+ZD6[2@KB-:8/A!\<'*(5`7%.;^G]A`X/]@X.#DA@S:.'A$&YXONQ^BVB%0M"CO]& MP5'SS3'T;?#PD&&24F`RGR$)0LAWW;C.N#IM>$B_1O__.QB!N[],:KR>ZGN! MVFQA&M;NFU0_]6$9]LMSI$/)[`)%=?@JL^@_=H:Z-EOV(]"7,% MR6`!;GRPE+E*PX/O*7H[RA:+QDYP.-*;ZPTS&J2`Q8<:%="P0"O71`6->'3W[BQ- M:/$L,B.58T/)X71&M'DY'#&,JV._7=0:PZ66=^XC8BP:!]'#L$]QH[Z\RJU>5@73RF6?1/0EZO[O+? M\I]&6%@4;)K.?T.O7>Z]?'UP\1,2L\+Z(G'#\;[@Z^WCLFW>ODW0]\!?7UWM$/ M!WM';WX8_%T@NXR-JJNB+B@G&R+B^-U!_9^$]>#DL*(=HX?! M`/HFEET'47B1E`O7$J=)J9U>F5"KW+HE(28%TPG4^O4.IM?4B%8QV8\2-.<, M$R4G[Y>K.'W&>%8>K3HC:3T9$+(@IKV,3UI$PZ49G[/DQ,:,.CDQ87*#HQ.. MHX0-QJ%HP==6X5[!\)*U/D,'(S;=93@@L]]G[3`L(G09D>2*-H-1GPH*?K0: M]O8-2D(^+N^A@-=TV$.'>X<_G.P='1[5TZT=*]9P@XL@2G#X/L@2,KKGC4(7 M_.JV;('.A-'MD]BFAK2?PM9Q@1D[C545W.]J%-9AE#"PUU\)-UXR][T'8;;W M`&M[5*J?>)6:>Z6:L8U'FC4-FA>"7-6HC#1!]-MU)[I(IV,*K1">%J M+P-J/;H^6&T%P,#J0*W'*4DW$5+I7<_BYZ3\,NE[Y3%F47N8 M\SI#IJTY-2)-&6$@T5);V37MZ_*@[[#KMG[N-E8G%43-8LP*Y2YCUQC3.XP5 M'PPTVBEK<6>QNGFXM]E\\0,ZOH1Y7N^+#FB%O@@H()099PK&+O].@%*B]"!P M]K;-?8*4/2<^'*`5.RQPMHVR`R;GW2%0MA3>!I!\6]DG&.5/^0Z4`0N6DH=^ M!PG8(8#JGP&V0>GT!]TT1LVJTT:7F\-&U_59HP&MI!,(!<1FAILB6BUM)^!M M9,(@K.M.M$V$_'*B5\[SFA>:V<(%G4964T7A&I0=OS-<#S&KAK$-,PS4#M#8 M:L8_T?1^@BLM9"IYE;&7=D,VI;S&&1N2)%L>ILS^+JCH#)+?0Y%Q>H?L('4U MMTK&7`"8`)8\+9K5AT"-6J3/Y`^&,@/D\.MR`(6=1$TMW#8'>N'B33C3-V'P MC;/^;%Y/#1I?RAE[#UOCSLXG@Y=\[F[,Y1MHDOFY(0MHR.GGX#+#HT410P>L6=U!`E['I<<%$G M4U4"NE,8B:+"$KN1]!302"HTP`1GT$=2D9I;X"05<4)`F>U(VF<# MCS?CD=0,=,YK^5B?:+#C]U7;Q^Z\@@TS1$0..HU@ALO)CR.,70G'K@`TT\LA"@; M(T">DSY;0P?Y[&=!I! MIR[DGZS^_M7B:H4S_OK,STFP#B-Z05I<:WP$>>Y.'X]@]N8T\A;"O.-S+`L$ MA6NY2-24B39"T=4";<3""(FW08SS\BGVSUCZED.7RFGQ)+&*K\3,>8] M],#96=6?H"6@1BH,H-8]Z"*9ITM\2>*RKF\V*;W$NKZJPBBW(8,U/,H5[#\> M2T9)V@@H!38M^YPF:=N,LF-HADT#/KT9.+]*WG^EMJVC_)&N8/!;V[*L5,_G-+DW-:.5\NN8 MP$#/5%-AR$L3,DHV6:IK]#`0>)$4F+17H<[B>E0NT251L8FE#@FTIPO$ZG7A M4E%5614,@$CCKFV"R]- M`F`8$:@F6@./R<\PP-`^TG@>/44A3M@B+$O=9N'_6^?E`]\VKQ";"?)W_]S& M4/F5=!,I8/*HP:IK+JX#2>8EYO'N6.],7BQ7UA"6B```7J5Q!K`5\D-+WP;H M+CUT/6\/,]SDF:H>U-:*->P,FQ_?9#0SH7%Q7 M<$#!F96V1L@*&>N(H!H_[6O0N@:I3NHE(&2V8 MQ%*C8"]]K)YE1F%0!$"RQZX-K'^0U/@\BM?].^[&7#XQ)3%!!:T."UB$B?64 M3;31/KJG#&P+->0LSO*\LTV6:9GLB3D]9GPJ4Q1IGXC-.[+L==VY.<60-!?0 MC,)Z0@$54T(M=W@>LVNCB/;>.::Q1SKD&TQ?'*8%O^+HX9%>JR!=.WC`G]?T M=7-F5M,F70V2(5(CN]^P]/+LR!__!"G7W1[2&H6M\^8ZY5O/V@NI_>.4@LE>WE)Q4)! M2)D0XT*_57S_@`$V$OBI=M=92G.E\/3YYQR'%TE]0'(V+T@6Q=[6UAPK'"#( M\1+G0$,[JYR64L"`>+#JO1M$%,T+AN;FP5@24H-:A`K<<(Y`'$%RCD`OV"<@ M&AO?GXEK""I8XGF7WF#JJHB]XK.QZBX=)]!,_UF78),(P"6>1G39*3V>:'-#M/U_?% M8AW/YNPQ+=DY.#6+VR,@>N7;1S[D]&"0;:!D__11R8(6:8;"DHF`C7--54KC MD>B`+Y(/0<0?RR8I=!K')#G.@O@6S]<9O6JX7,7I,\:S\EEVT61QH"!WQ3.V M,713-6.(%.^HW%IU-59QR80"SD4B:HZS)R"G@L_QBD3XB*W&T;N*2_H2X3_9 M?THZKY+#96@T4+T9&17DWB%HKF,7:TT.?EFTP0,#8M7>+2U%LZ0'XE7HDA$[ M7052*MQ:_Q%2@H&34KW^FD\Z_V/_GE+3=<>:?*K%\2#+`C)R\]I^=RFA.+K. MHB<2<:_C8,Y/=R9/."<"A4.JI0!W2^)##-NLAMMP>P?:8)5[:^"EC+)P(YUB M4#%HQ>6@526(S#5*29X6:2:Z=NEH,*(@ M<[%+JKX0.^Y!MPG%KTH8,#D+)L8&U`%$RP$C:)BJV;NOR?EX*6I6 M":IDY8=P."^,O*>9O;6?`[_.\#):+V7K/GH^IVM\IF:T%NET3-Y1:*MI;YFL MP0?TD?:+9$[KCN)SS/^WL1IX%JRB(H@UB]4V`AP?O+$TK'.VQI`;#$BM5>[M M>K'EC;RS4DL&]X*/QW$4W$\I95_MCPS0O*S+G[.7X#3505C'] MFL_P[[(@M!^PV\PPAFR106:#=I,3"G`':2T=O\OE'!)A"TJ^(]B\P72C+[P. MLL)F6-=(`856L8E6L&V+V#G\"M4W`'+&^>@#:+JS@9XAG:UQ>+F9R%6C33U5 M;/QFTXA68KV#?D`C:'N!AL.$WSK!6 M670*7GMR%C1J^5[^"+=KE((`H-C`4`,T*Z1`1[5>==WMFJB2``[<_0'FAFB: M17.2ZU,KC,>E+IO?7$!LA#H5:/-`.XABJ*]XQXL&V*PF9X$7!OS(I)1=L;A+ M9_,_UU'&U@K3.7AAH9.M"@Z4,:/`= MJ'__DOA]'A6T.$A-B>9I#F7YUWP`V7H$@IH:;)<2@*LH:*>W-,O]MDQSOV,K M!*M2(+I_!IP:2*S_$"5!,A\A[U4*`@!N`T,-0*Z0`CWOU:NNRWL7E01PX+[! MJW)$NEI7=W'T0,OSB-I-"L)+N$\P+0FCBW8H249]JKW MMYLC@M=5$*-*$CO"33(6GFO$5,QXQ[7'NM@[QSAD):4^TZ/EY4Z/+!.3DCN^ MT*M4NG.95T@+)GYJ%!1^LR\`9A7,+G:XA4FB$;*X5,(`=-E:;JT;-XQ"@/8MPL$TB9 MIZJ$028X5P3[818LNM-=$8&[RA4BQ385*9J_@@I((LW4'D\7"TRK4-!+L6G& M:_,$\T?Z%_H^]'+=(`F6<*XAF4^RMYZE0UT^V6[99"?6!N5Z2]<&FZN!KW^\2LS1`[7#Z!2A M*X:WVR+("E6XM5%&&G MN,2!F!ZN-7&=PZ).Z]4J9A59@KBJ*GV1+-)LR8M7:2I^FW([+?MD9U*K#I09 M*Y@1T$Y?(2K9Y33"`>:Z.'_'_9JH)3U(U"1Q>TRKKUS[2-;F=S`8$2C5OU/+ M26!`H`)R52RW/JR0A(+)":WR$:?Y6OMTX/9B72=(8S1"=_#=1B882(]D2&]" MFR;[;$+;.-)"1FS1E';[:"FY:EZO(Y8O4;6?3_Z09K>X*.+R&8CR]H[R9;IM M);J[?#Z*Z9M;Z%N)\P[U\6SH!?O&=FW];MFJ_2@\*WB;U[(I:5#>%)OZ73S: MMV.Y<3VNBYA4J3R/1!;9J<+VU8&M1:]C3AAH-5675$Z2OD1+@50 MV'VI"THFG7?`G-0SG>7-2F(7R5F:)'A.<^M?H^)1MS<\7):G*J?VYDH*GIH+ M@H'=+;77E4$-\G9=.;:V6`M%7XA4)T<"(6FYK MD*WE`<#^.,8(;Q6'L3E48O^F[KT3*+PS=1.'C)1-VB_Z3H0^`.$ M.(/Z8`-K<%M+@`'GH6KWKY^WW^[U#-A&\D3FN.W!ZB)Y_W7.+LF5Q^KH@P/M MDBG";&U;D>X2Z'&,WZ35V\F#`?1QC.BEX(W\FJU]?.DD,A$M!\YE>RD$SOMQ MSFK\=NM:I;ITW(+9(;@M#6K`V)`3"F#MU.U#L^(O5R/:]9WH6V8.$NBK["%( MRFK1I%?19X+SJ\4U?0HH*50[9M;5-;:\6Y9IY$-?/!3?6S._PU^(TEI\Y'O\S+K=9 MIFJDYK;+V-_PWI+(_S&E1=HIHC)JWZ<@ M"1ZX)9?1G^LHC(KG:Z*V["KQ0!G.1H&AYM5C@:T`[RC>1NLN1)D85,IA`T-# M$JI%(2;+,T!E`7VH$'`0%0;C81)V"Z1&@?2(!-(V7(,67/_J"J^WZ^4RR)ZO M%K?10Q(MHCF99Y83`Z+=-1E,YO+*#(,D.$/J,--JF-JQP\#H()U[3Q=R(32? M;HA!&SFH$@0CQ5;:JDN<39F='IVT,JAU$VGQZMB M/P]7SQ+4!8#+=PF:I8$5872`$+=[=D,,;._2V4CPCM&MU)85>*X$L>24B4*E M+'0)KY>:U"SA\/": M#`^]OA=,VO?$0P35IC)7,0@(R9R%>862=2`7T'C'E48Q$3)R=`VIU,2G-"L> MR-2ON0-COOAKS.TR.EJ:U`Q[AJS><3=,7V&@>D,"U;BXE$SWZ9[R8QJ'.,O/ M\8)FQ]+S!A#9<,`)94SEZ0[-XIJ@V M#V46_$YGY+9FM2;EILS>03E48V%(>TNGY@U!?QT3K/(#6E'!UF3I+>&4S?[- MI^!6[$X/7ED:U3ID9*N.GV)*E\?X%*HV MS^P)R+QC1Z^;X#1>@QA*3&OH=!/E?]A$,A-6M_'+W)AVU-+S>H= MBU"C(E%6&K9^<_3Y+@N2/)CKSGIJ61P6A352OE$15DGO'3T62O:+P/(W8!D; M:O`!"6$2JRQR,BL);BM:6YO6+G)MS.X=H,-U%D:Y$Q+E)@2N['3.?8[_7)/( M^OZ)_$-]#$="ZO"\C5+9QL$:(9UWP!@HUS\J4U$C1@XD@'6,T!^"D=.[+1FF M4;M=)$Q"[!U'IAJ*3U@?L!,M8\-JF\-_XQT"!'\8<*1#@;M\.'#T0X+`3@NV MKD@PU9X-YJ4*%L?S4:WRG7FHE-X[*"V4E+RO%&-V[Z0E``;*?J:%=][G1;0D M":.L$GN7R"62Q`HVL=.F`(,6H5I=?/S,RQ;59#!`\3[(:-U@6AO[]C'(L%GT MT7*YA(VA"4T<:5C``,M,3U'Y_"_':48Q4C/1GQIC/59 MFI!_G?/K*]Q0,S#:BW'[A,0P(]L/2=C)`(/?@8KW%^?H0F[\C'@5BU9&UQ+J M=4YR1\](C3`CZ^_SN-UB$/ZKA493E;KZA9W=YS2+NY,\"&GJT*3-51K M.6GTKWCO:).;UNN)Y8=8+8"T((-$%,1D)#DO/XDVW_1]$TL_?@P6!>]6EF84 M&2C'.[Y'4'Z[>UI0QY/.]1I6=JQSPX9I;C%R#!#I:8P8;+QD-+"6Y[1?/.'L M/LWQI5GX'VJ+K)O@YI6JE'63>=E-XLG/I8D/SQM,#(SX/%]KT"7^!DPPXK.% MIH87'8!&798AG08Y#FD.1;H%2Z*8#5(VPB>W;R_0.^I$- M,87\U;K("Y*+5&\&E6]@3'F?`2%N$EOTKKJ^PF>G@T.#HV7)ZG]&28V9*LQ$Z8=[2/ M98$V()<"'"8A1G88YQ[6TGR%Y@$FRP*UA2CO0!Y'?U,8YQXR"X.;L'PB+&H9 M"V9(]YC;!MG<8N:<,&!IJ^ZP&\Q`ET$^K(MUAC]%2;1<+V]H->CX.GAFQGQ( MLZL5IE?$DH=+3&8#MJO06\GVDVV,T!SBS&,+P=Y[R136*$(Y%XZ67#I]FH+W MK75"A@N45L)1S*1[K@M]CHL@BO//=."A>Z9C%#*7RP17-5IGOG41:9E`[YU@ M3"NV*H2.2N&HEC[5FYYI]@"P^HPRFP^7R_7[!XFUTWXR+J>Z_'UD@&ZB[Q'92#*2A_3 MJYG1AGNJ&A9!1#XZ"\GX&Z4)#DP`#E-JIO<3"^ M%#C50\_E^=]RKU=D=X_$W2/-8N4V3S"W?XS[$5`2S/=K3J3=/*GR?V[:`7V8UYG6/!_OUU0T98V!GXVGK]LGJ# M$=6<(UUF%>.M<5ODO'<_162JAL$9LHP4K^&DI':*H2(M@E@TS3+6LXN>.RH1 MK1K7?JJ;1BBGQ[^\7_DQ2(^'RX)WZ4>7)`\5!"/4;:G]EO=^QDJ71]E[/2\# M--TV.R/_&Q6ERI(%%`6]RSU2K=K-!2LIL7ME^R45.\YVCQ.\B*"4KSQ;YT6ZQ!F!=D"\IX&0E-II83:URJV: M;&)2,"A2Z]<[K%92TV,U@`ZDG4=T=R@)J[NNFI1(1NTT(5*KW$J'Q*1@(*36 MKY<*5=05AF!`Z"(I,&F8P@A!,F*7`%(KW,2/F!(,?)3JR:9N4'S65J2ZXHW:)CD80.EU[&V=4!*04!)6;;""EEJ"SQ>4#4Q3/8^L M8(>QN#I<<>%J*PQ\WA9!P4Z6LG/9$HN[1&X?;Q0IV'ZAL4D!)FP)U>I7R2B) MT&^,[!_`4'$9)?B"_*NL"+*(T`LZ>HH*$5)3P4-)5S4%4B@I8K3;PT6\+?,A MF./9DD:YJ\5E&B2B1?P^C;-M%)EZ]?9(E\"[NU5:=3U-R5#`Z.@%F)A03G5+ MD8]2IVF6I5]PJ/.XDMS=342]TIN[AW):&)#0*]A?LN$[6O8>+%IX4ZOCL7=UKN9\IL==C4]#+"8*=E;=*FX4,+8:.RH[\IS MSJDND;74*Z_AX^LLF@N#B9+(.#!@$0G6[FY\EF%E'V2Q"O!$\55/HGSAJ0L+C4CR4%8WI)L5/B[2>/X0YK1'V5[+A-]S.G&UZ0-UMH\ MF^1+WCN6$_-Z"[;U>EO*N?=0NN%_<5V1FSM]PU??V=$.V&ZFB?H>_XC3;K?" M692&MT60%:KS-%,9V3L5MJ';0_?X(4IHH2;:&;FBZ-LH*6\[?O@:NK3_)BOC)^O,UJG MA8B4*$\$N[-$PHFFK,84+P&3B]:#+;>EL"G%+=S0"#Q5.*[ZCH8RO) M?Y\HRSY.9Z0RRI>!F'@I7`R?XBKO5VLF::+.R._HG MO,?>:>V2I#>4<`]](J8^HN/#/43Q_C(2GD:0^!73QV5P.'O"6?"`6P>BZ'K> MPM5*LK$BNY0N#6_HB89(0RV\=WCOIDNJ4>ZA+Z48%'`Y"%?G`5>CG`?W5&*G>OJ@!AZULUMI\.+Z M^Q#K_W6V.V8)+4(;94S"I#%@6IU`A007S3_19HN]0CL7,!PTQ@O>QX$Z=7W9 M>SY&IEON!$TP;9U\4TC5#E-O%6F^O8L;2$;-.<6VDO+#4$84'T:[W(F27#QO M:WF#ET%$%[TNHP6^2/Z;UMH0M9,1F[LKZN9&;.ZMZWF\[XI8*MJ[X5YM792L MJ.9%E!E=)(BQ`YKFW.N[WKWU^%F;?98F[.;0.HCO<+8\4HWDKC5Q/J7QT]2] M9-&M&MZ[M'_;;:,$31Z?:9CX#EV!O+NS12O*AVM9*W;33J^:[%+,V**IQXP9 M`]1X,3%CN.U;Q(S&1Z,X*P=`_-<9*,X`"T&>7EM6W;O8QERT' M*_/REC&W;0KCZ`$T&QV_Z1HC*(A(8J+/"X@DYLWN()+HE?F7B23&36$>20QS M5.<89G_-9^OB,BAN\ M)3R.D;*C(KPX+&(,Z#?*HGRJ`'`T]'2)[]C[S&9ZVQ0[MFA3*:<4XWB_AVT$ M7"T:\W\ZD;?9CY!)\+X+I#9-NR$D9O<.U^$Z6RSF,#D4E`U);(5G]X,;U),M M+S(0&EFLQ65GL'UQ\[_>A=6)'"/XSB[-UZ3--&9W[7WDQ71+F66*LRB^LI-6 MG&CH8S`4REE]Y2,Z8V2)B(S/.R`'*&L;XJ??/%*6FCT>7!CX&%IAX)XI9H6! MCW>H,'!75\O"P.@(6A;Q,4U#>BK]$S#FRC_XT.&L>+ALDF_Y">3&+VIQ+G$:)_QWIVFMZW;_2@I6A!: M)V^W#HA`G(;5RW//G%E^%?_+-?O-ZH:XY]]VIO)_3D[YT%/-=-$XRO_4JBY)B*B..XK+]-<,^YMTT]RH5CT%?@3.&T3 MC79)N/\)2%7IIC71ZWLMTW0JP9,8DW0K\7=VIF.IFFFTKB7Z")2C>E,;.%41 M-T5>;/7.AKA3#!'C-F,>9F0[?;:3`0NQ@_6?KL38-(%<\&C%)(%<_)V=">2J M9AHMD(L^`JM;3&<@E-):.YQ/`RJ5-;6)+_MQE&ZYDLF^LC/A5]Y$TSV.`N:Z MR[3F`:A,52XF650GM>!S=PK0PHS-$4`#)AC+A1::]@[_U:N%4[^Q,?D*HO-" MA>;?WIE@;MN<4^1,<`H5.EZ9'%*LT-=K&0-[\W@O!0SKT:-^'TZOGJ!9S7OV MB!_?K;1N?,,=+YEN:Z!5G?]I.JRM"KO39X7[:ON M3[T0/4@C.)W;2=-/L;@]0)W=ZOHNFN*E+I@#G1*^X,5U,\/_Q5^AF'I-7O/M MG1EU;)O3]2L4+W95W\1H`&O]^C<.-">!;25XKTJD-LWFF0I?1XAU*!ZD.I#J M](-A:E>E0BL!$DPM:E9HV'<-I@,*60`LB*Z)H"9/Q#D%+1OP>0?8`&4M M\K-F:5,J8>+C;)8E2$5GK8Q%.#_D-J"^ZA!^6/.'0;K[+'8J!J@P?&L2/#V/ M,PB:JE]C3L<`(^P9:FE6O'/J096+-UQ]5/0E8PFN`YRE:=WX9L@.,;S9J0ZO MSN-L)7,U MKYLY1%W#Z6K!MV'*$W37.&.;-09)K5Z$KSF%J7&RN86.'P8,ARFM#794#J07 M#Z^*1V(!CHG@AX\X(4K&LR2L2?.O(=*=D3X45L`*B5,6EKLOKOC+0:A"8/;L@@ZQ=L%$&34 MWA%EK**P6M@^.XV`FEP5:E"&XX!&Q")%.1NG4WY080^MDV"99@5]D\,(`VI=0\R05G'M`-`Z MJHIQQIC1O(DS7,:[JA#>*P?Q3;8PSL\,VRRE5QS>-R[:JFOW*S@Y#%@9Z6BQ M.\'YIEH4P=DBS98!\1(+FGR60Q]9E9P1T3"X6PHQ47RS"J*BA@$;$Q5[:Q\; M'L1C$<^JT!-G@S'9O`WB((O8E89?";2[@Y^ZY$77H:AP!(OFORRBXI^7(B9IE"6'A9H<%M[N-)6N3 M-EM,QJS>P31,WR[&&@+8(L)&!&K(J*I(PPA05RM,USB2ATM,@FC^84UO8'TB MH^]RO2S/UN?G:WRVSC+RK[)%&$LA3M?$!AG86A:SDN`=RUNIW87T*+<>7`+U M(KG[DHI>9-A"#D"X]LT<@-B-D%T#;4]S`6[?[!INR5?Q.,AM2(*)W9ZIP]!; MB]E!_'9U%R#X[4XA>+L6`8G4+=#I%)%%6@2QZ`S+,*6[4+RCXM&",:$EYT(Q ME816);/W"=5GNN9(]^I4#_%L)0[@E$MJ](`Y6$^6]Y@ZD@';S=)0+78BB'\B MGW^,GUG'O&&76"B-J"EDE,Z`J5:UQIR8#`:`,8"V]LL;#]-,,""V^-[7CK&PMOS;#P%C`6WMIB8?N$ M78P%IA8KB41&N_Z+YA(:9_Z7J5=[ODL`P^<2K;K>9F1TXX#2H7"Z1[O/R\.\ M-R05(4FY[-:)D,R9KQ5*UNX6T,#PN%RQWDO1U<%JNC9*9SEPK@(S/)+$E1H1 MQ.J3JA):EU-MI;K-B;60T#MN3+3K@H?25(>N8&#FC/HI*7A%O9LH_^,:9_0/ MP4.OGJ09B]-KXP;*MZZ,*^C!X,E`R?[$M<&"-O23W1F*DGFT"N(;7*WRW*6T MS%;SKN6,EE4LZ-E]D?4J:G>OL6M5WKS*+B6%@2:M M?KW;N!4#>F+%5=(%FM<\/@JSSN;S;!W$5/7^5;NKY!;3\T2GY,V\;!`1N7<<8WJE=KA4[OO-)<6P$HS(B,9%HU-* M40E'J_J*([LZX0TN.*SN`)$DD%TZ*@].--:,Q<`PX00(`0NUATH/H[B#>\K0%[;LDKA+GBMKZ^YUQIYLA>OG07YXQ497L,L6`CV MBYN_PO*%2#5)<*.DJ*;UU;PCUTJ$H1E\4K7GAQ[2.M0WZ1-.HC;*9`MWC.GD9_OUS%Z3/&TF6$ M05*`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`#5&F6M"9DEP"F5SK:]6Y#=,A\M'1W MUV>S+T23'5:1O-_Z)DRP/&*A<>^,9GB5CRH8D+^YKKC M'$.&Y1*=GC*W2/F\.(;,G^=%V'AUM^^0'@DP1\CTZ[_.Q`A13"B][`]_".98 MN7W0)8#5T!+M)#CO4OMI\/(XQPVOA'^72O,E.2DT)VCTE+I#Q@?+,;.\N=!G MX:8VXZXX3:BUM0O;4GPX]&/*'P6=XRR9)>&G(`D>,+NL=1G]N8["J'B^)C;E M=_AK<1J+II?6$F"Y>*CZ75\S.:@4Q"XP;$3]-4>U,,2D^7#UQ7*UWJ0O9(+\ M%+&DGYXWOJ>_]%RKY8#E2E-U)=VT9*\>B5^@2@)JB/#BN&2>T=ODYYC_[T5R M3>]41M6%F\Y]FUF>8\%`.4@*,`=O88+@*3S*J;IS%#!^+QDG/?U&YWX,QOU# M-1_2[!871]/R1\VW$X<,!",88LL!)2RR][/5Q"[CR:2+Z#-)RAI M=7_-Z`G%J2!C7U0'E%LEVDD$/.`<81Q73_XCG@SP!'*$G].'6%<5`^^(]X.<(2ROMY4 MCJ`'8T[I+-I<*59>,%;3`'*)55'+! M*EW4;^QYOT]\?7#TID@/CM](4J;.[[`\(%:N-[K$$XI'?+(0 M5N,;J"I#O8K5BY/(:)\441#'SYOC6O3.M;"XD9(:F),,5)4Y:<.**EZT8?;B MIM8"V2P,(VHWO1_/WD$45S(R80+F-'.-!94R907$T'ZU$CA#_R=8KGZB__]O M[XX.#W]"1+F]@X,#E+.C4BC$>?20L,)U%OCRN2X"F(8GH^E[[M M?H]1Q&XY_X22M*+@?^&KT9M,#1YL3H?`YG3G8'.Z-6Q.>[!Y>_1 O3G]#Q MR>N]M^_>,!P'>[3"_!&C(_]"_I,PTX,T M)""1V/1M4%<)*\2R\W`=`V<2/O+\=[)R<'>NQ]^8&+(?_YP=+)W\L.Q MY=>^`X#?RMS+C;77M;$Z'"N90>/91'.CP],=@.\A'8#\^UQ4D5+C:1$+9/\J M]!7L>+;VL1JLFYTK/\E^RZ1RO.;GC\_KX*AQG(0+LN_4*DLZY4S=*7MC"C!_ M\K(N-K[D'#OCQY:Z6_F0C_/`_*=:1S5CVQE/ZE=7K=P)*ILOD]M!,;;'!=^C M,I6')3Y@8^RI=8P]W:T8*U)W*Q_"BK&GPV)LGVUG/&D<8\WC>O99RIG6&-F^1-#Z`-E\`B)7.4U//MNCH\N\4'B3*]U^9 MK5TOW:P^0]_F&"/RZ?2+ETU;C:G7028^=V#(MU-^[2B]18\FDOP]UJ6Q4KL& M;V<#67B,Z]+DX;62U9IK;@W4%7*Y>N[=U\X6W]VLA:U4JVK8`= M=+9^==O>XU=^E[CK55GVWFNU(*]\ZT3/`LVUAOI*G5GRTZOAS5V+5L5D'\Z[ MG3_BO2FGS3%,PUE]2U$_MI;;A8D M+$6!AH"]'::`*"4C+IJ-'!N,7&6H%.\[$/1J,QN=N#5C`^9Y&YUE7A8=91"> MPH7AS/8[`@9N;#-`=Z!06QO7=1Y&@.@TD\[7X=@MMPWISL.O%\QG2;C M<$9R@.`!E[^0W"*:CSD26G[XQ8+4Q.I>IL860._9`NB\N0`:;#1`]\\\5ROI MJN7U@*J!TG*-%&\405]*34ANQU2I?J1)(%5FUR.JJJ4GC;/*#_]+`MM=3%9J ML8N`_I!F"QP5:SJU2T)6S9=)R"^2:S*!2T.W\7L[=5X6^$=IB^EB_6*C'JLX M@C<*HBA!*Z;BRQP%&IZI?#%I5Z@_\F(!WK6P"]N2=->6A$I#V89B;>/'+,WS M\?$B^LC+PHO"PMY+,'P+=R?1TCA=--4*3_\3+PLI4OMZ;PE[+L0[HJ%N$S73 M#[]87`U)OL"C+3>;">&I9@?C?G_'L#>)\4/R_]QJL0?O?KJO:_EVXN$8\Q8? M?V&`M[<<5!I(-[CY#OGY.B,AGYO!M]&;!U@K2T1S2'L9P#`PV`#)7IQ/9U:' M_R27D@4T`)TA5%"V<-H^%^OOEC)3Y+X;2LH7!\6.D%$#=(E&U=X0SKPB.*]> MLOGK(#)#I`]'&W'MD,?,GI,V$N'#B;_@)$RS0TE\:_T*RRDBU22-WR+UU\A' MRD8^@MO(1^:-?.2[D64/\+1^A=C(1@_PM$A]-'(9J@RW1WM>L&.'Y:9!NG?] M^*MZLMP\3>%E3*^&(LFIY_;/(/UC=-6[3>N_H6)V'N7S=)T4%\E9FB3T M$8AYW.%OJG"_C`^UQC=): M-V<5/W'SIOI)021`Z-*U=9?1`E\D_XT#T?*&GFB92H*66HFLM1AY->P[Y^@!(Z[,T:GG MX\(R:_D9+F/'8Z+O'S3J.DO M(<'O1[_'][$SW[3T+GVBUJO;_IQJ#Y5T7AM9WKK@FE73GN@WDHT%Z[A`EY3[ M'YZ:M7J"B]8RE0.X3P6HN17*=9N^0>H;SPU5/A-JH[;?$,)L?H%^2@]LZ/T[ M0=/T,!OO7\+(WIF84LB.DXS3?;>HF-"=/OQ][=8*]K M[W*F`;.G#G&7X2!?9\\LY^J]6RBG`M0]%,IU'5&1\A0]3R M?2I`+:]03IC3EZ1_K=X,F15%%MVOBZJR^74`8VB8):&9=W0\@'QEK*IB9&$' M&CBY)R>QJE;76;J(A*E3XV=`32_2JE^*@=`@3N2I;:]6F!8H3!XN$C+MQI=$ M(5$;"\@`M;5*NUZ]H8H6<6+T+25W_:9PI7EGP4O4]!T20,TNTZS;Y!5==1G? M4UN3>4C:!HJBU:7$@-I?KV/7$TV.&O\EDZ\NT'Y1I7[\AFMW6Y"4F=UK6JZ" MN3#\V_`#E%Q#S&)/KHG M493.D`G^^/]>)"2LK((HK'9NDO"J>,19N9+:7Z(?+@5*-]Y.^7Z^,T":MP2T MJ^MLSC93JPOD=UD02O)2$TY`G=M289E7T;>5@._HL<1*1G4C?@\Q,5#=>8/9 MM;+K(),MAUN*V"4'2S0?[.E2'BH%0O)YML9A>_6'A9QZ]JO9$]E6)G14##'% M'"94.NHNH;$/H,WR@[_-&WG+G)?3B1O\A!/QKH"6";3K9;H:^K9B1R4_&,?= MX+S((OKDXUF0/YKYKM&VOL7`!*&&)``.EM69T]$"=9U01;6?O!=_J]5AEYBJ MI5-E`4`]"Y1E*`M-I6Z2LOKP%HWA5T29,`L61<\QK5^A^$"L5+>Y6U2P4HL/ M41(D\Z&IA8`;4/0:H+1E:E&+\I]:4"U)3DS_AQZ_>0IB&H5GI`6R[)EH*#VX M9\0(H+\-TU?4%5FRS_ZE(6`/!=357(;?4W_S1QRN8\PJ>S47)(G5_<6H.[86 MC;\6IW$Z_T/DX&WD`>K-HYC1VU3#""JNAQFS@ZH MAP[1NG<1RK`3^KZJX_!I+F%,=_=Y0`#S8;7P^;_]^_[;04TU:);8)"Q504R7 M/51JLX<^EO?)D[+NR1[JE4:IM$(^"BZ/UO!6+R].`G@K#5X2YH<9/BGL:Y5> M`/+-7V@GX^'[KZLHXPN4DW6$*17:I7[AI!V&=!/37M+0D-^JV>@(M]^,\DBT MX:-`X[_);?IA*!,FY_8*\>Y`@1V-_K_@G%K$X@NF1PKN4OJG1H7#ND;415)D M49)'<^E"G3=E7E#4W[X-IHSX7+LJV#/]Z+D%^F="M=%Q#]5:HEI-OVN6T_BE M$1[\=Q2],B^_HUBT@;>.TM`13D<99;ANA`!>4G#\#*C_B=]?>P?UU):-G=7T M/[6+:&LOEK';Y^/C3?21EY)=*VT;&W.BCWFK8,AK:IZOL[H@-*]@PW[LK$N% M`E#9RP"#F2U4%Q9$L9.UBW&FLH7OY67Y9O9.F/M#6M$T:]SQ M]L\'('G$C^],G)W"9FM$CZC$3J+::H=\`F#;??_%8'N@V:/#VTX/D`B?3Z<-O,PPW;X)"011 M`[66/3UG)@:H=T=\VG5WO"O2>H!W&V)\OH]F./?ON]>.'XQ_!ZHM>U?-4(Y' M#QL.(#('&[(#\Z^MUA+W&HKQ7=F<59+(/ZQI!OR)Q)GE>EG5D#D7'SX753=7@+``$$)0X```0Y`0``[5U9<]PXDG[?B/T/M9[8 MF-X'V3IL3]O3O1.ERZT8654AE=TS3PZJB"IQFT7(/&15__H%>)1X`4B0``'* MGHAIVQ(`(O-+)!*)S,0O_WC<^),'%$8>#GY]L'ZUQ>?;O:F M-R<7%R\F4>P$KN/C`/WZ(L`O_O&___D?$_*_7_YK;V]R[B'??3\YQ0#"E#HQ#C\^^2SXR?T)_A?Q]>7Y)_9Y]Y/7K_<=R9[>X#!/J/` MQ>&GZXO=8'=Q?/_^U:MOW[Z]#/"#\PV'?T0OEQ@VW`U.PB5Z&@M]<[X<[A^\ MWC\Z.OARL/_UY>,JI/__^^34B4D#^KO_/CS=?T/^<_!VL;___N#G]_MO@1^+ MG3B)=A_;?]S/_Y=U_\7W@C_>T__<.A&:$#R"Z/UCY/WZHD3BMZ.7.%R_.MS? M/WCUKX^7-\L[M''VO(#BLD0OBEYTE+9^!^_>O7N5_K9HVFCY>!OZQ3>.7A73 MV8U,?NMQVI=F$GGOHW1ZEWCIQ*E8"3\S8;:@_]HKFNW1'^T='.X=';Q\C-P7 M!?-3#H;81]=H-:%_$D'9??4..7Y\]\T)T1U.(D1D9/.*MGE%<$HV*(BG@7L6 MQ%Z\I:"%FW3.A(YTT+L0KK)?(V]S[ARZM^DSW! M@8N""+GD+Q'V/9?(I7OL^)3I-W<(Q9%HRO`1!I[XG'0*XCL4>TO'[T]%ZW#Z M2:*K'%&1B&:KV3W5?$04NH'"'VI84DZEAX0DR(VBE`#R MF3!![MGC/97AB#!P1E1(>)*$5)E<>LZMYWLQ@`;I@922<85C1!3@UKFE@_%G MVM96K5#$>/G''?9=8NZ=HA4%+UANA4+`[:58^6TV7IRN$8(363M4S.3@EAA" MM=Y>DL_`=YF6UDHG=(U\JO#)YAMO%R'1,\X2-#51/\5JZC9"7Q/"BK,'"IE8 M(;6W-Z`[U>I0K;H4-H4%U3N*R*F.969C@-'3<;@!]#(0#T#?H74T;.;2`QFQ M\DY1['A^=.6$5%D_"#?QON,:6/CY5-2L_-I@9I8^D**NXVFS$&6%#=)W`$T% M%2!(Y^&F>]!KO@?#3_BPUX0/AY_P4:\)'PT_X=>])OQZ^`F#-87<*$,;#$`% M(C^2(4+`L/084N/I59X*2.]!3K>R4Y<=AT?$?4E^4.F"'F,4N,@M!J)4 MJ+D1(3^F0^576`>3O4G1J_Q7)W`GV1"3\A@Y`04)/EY69NW3&R,R[@8R'=ND9\._X7VA75]U6FR&8?3.ZP(+5^N\<,K%WFOR/R/ MZ%\H(4=[^P?Y#=9?R(^^9'.X1FN/?CJ(Z:UAR\Q)T_:6]8F6!6,:+B6=Y^\D:17BC2PK<[9A`2%E[I(I#`[!2:I5 M_`NRWF-M[?D>__,\#?@AOD1#A`[D44)2CD M;<#,+D!DWMJ$#(@+YN#YC/V$<##!.6Q2&3DARG2-0^[!H=80B,0[^Y!HI=C@ MXL";#0Y2O^/-':$\FB5Q&K1,A(2[1+C]P*G9UK57%\T(%P$-1L;4,1%XT1UR/V#LTMG.5M>$T>$#:K/<\MZ@SL9$488"%W%9+9$$Z&W-.=X!/@AMVP`<$JALDZKW2752B@/ED[BM$ M?NE>9E0S9YA.+\:QXZQGS;G=:9 MF/[>"ZP]4N=W='N*'I"/T^^=X"C.U#/9>I--D@9$33?4G?MG)="H%K0C/8HQ M)[<,.ITHLT\=BO2@04>W_!GIN:B\4E0G6?#ED%RZ^..M^+P+'\&BX"'SP;NUDSN\.9WW[H9O# M`RO!*H5O/]$*1HW1&PJ?-G=)7_BX7-%D4TJ76:A9DQ+]H?AH\X;`\9&DS*:5 M=IH;6-?$$@X2L49DM8>BI;BT,:'P[-=H!RFJ`%EC0D M>'V@$&GS<\@K/"$'-!D-U\A%:$--EGEQGL_BHU!(YU#;(MO"^.@PTJ-`$=+F M^Y`S(#IRR8[5U215YC0L<;UL'BL.%<_.?W6%@V4')T=;-RC"(_!SL+EBQV)L MJS#7Q*O:"@K/$,X,#G\QAP2;(&"8JT^42=ONY:Y0L(9P78#!`K/$#@1;2934 M?G"DAG!B@)'BDOZ,=C<0FG`,AW!M]-RYG@N(C((J2RZHW$Y0D(?PB'0!&<`1 M._1JE_M0!3>@AT.X2KH`-Y9[S^JA]"K9W*)PMLI2G.9.F#ZR4#B]3[UHZ>,H M(;\2@]M[8*@$://$2&.NB)>:W#75V4U=-[W,=_S,$3%-9\?PT<"Z0@'3YIA1 MQ7\L2[E!W(Z[XW8LA]N1-B?-X+@=J\5-F>V3)YBR("W9!-664`2U.6$ZV35M MU-J!Q9.\S!W/O0CR,RXG-('5`8J,-O^+-#("VC4IN;/-O8^W"$W=!YJ!&9U@ MGUYHA([O_4D6<:H*&$H.UA4*A#;?"AP(.%%=3WWOLE-?@-;TTLC\N6\1(H>H M]"U$^[6UA8*KS1TCOJ*W*`/+/9-E`M:2`"OY9J>( M$#004DX:,$C\UA(CV-'H0Q`#%1G'MF10LF"3'Z8493;Z$::3?:KH60NC<=+ M%=EXP^I%&C%\$9!/I?7`\F]_"IQ,:LAZ]Z(T[86QMN#=39=GD`L'E66+F=C= MPNO.``?AVFGN_LAS-J>V*@W+8?GI8 MI+9N8<^RSM!R0]B4W"^.NY:GSZ:E9BBB4U\J>8]%-LYH3G)@F84IU6YZ<)FC M,-V\V?A!^QM/-.\9FRGBC(UH9G;7-(GO<$@]!5`4F_V,IZ'W1(_%"7M18Y[] M./1)GO;T9:0K04OQ`4\;4OSC'X?`3@^=:#OQ*<%LN#->V[ED"O1T`?L:3U26 M"P"4XH@F5/+S(0X>$+%>F\?'3`T_.)Z?EAW#QXCKX^H^G/$L9CGL^O)M^$7& MQ0W0SWCFLK+%91H)L?L1VMEXCK(R3,SN0\<]]J&6OL8S4OO#PN3(\*A(*Z[C M;HK+@J,0D")32'137&V=1Y3X*4/6@,!TNA.1&\)XLFO,;KH1`W'K?3^!(+`3RP%"R1]X[9841)AR)2K`8(Y+13\C2Q12F$ M0[](K"B]DYG+VY89*9N]:\&AB4<&$Q2;QJ<3.9G4]F\[/KZ>*"-)C\]"EP$M#)W[.%>CH:D\H/[L;EV1#$;8H2)IAL5LE;ZU2#,14?C@ M+5%T@WVNV<'N8RPU2!-X8O[8@>.'$$?1/,0K7I)[I9&QE"!-2+5P8.PIU#D3 M@O7N%1!A(!2G"[C].U6;:Q8>S85J^Z3[T'C[#-W;U<.77_+XGRBO*21;QA M8T&E9#2^I^X,M6-[9LP_D_P=:RXV]UU$@3&*N8S*886`RT2CY@`OI/NX%)M\ MBLC,W1U!C.L/0#]SN9FJ(0<2;`'(ZHV!4EAZZ8(YO_D\=B)O"307(`-!14:] MLVP(@P+.RK&;'$5=VR+X2FQ8L'N82Q/6)!,BYMAA)-1GFW$YX3H)\5]C%8X1&>/A$S"72]PPNT%T>^4`[6U+HBN M5O8!X^G"DBI2,6>U57GUUG=T?R;"ZJQ1]JY0.H_R)`")*UT&`H=UF(:T*X%, MZ&R-93QQHKMS'W]CA#*^Z1+*>#*]^6UR?CG[74$HH^H"YSMZI0J;M_0R>S2E M$YJ'F&XP[O'V$P'X(MC==D^7,=EZTOK]XLO@#F/94PJ=B6;S!-J18W9LVIIO M)G1=-'7GNMR-A-%'T79^;EKZC)";[NT+?(V6Y-]>6M'L:?(+K&SEZO^RZ;KL MRN1G*)#L$,ETXA'!Z!R'ISBYC5>)/UVFQ?0XNH/?RUAXYM`(UN\WQ*S4547R MS@G6Z"(X=[RLP#;9[7;/W=V@91+2:,;:@W@,4[WC6*:#-H<&O0>K;%K_Y3=# M:.1JZ44*]O+G=C+]F("AU0]@I!V(%QY9>LS;T)`<`=BL]J8?)C"$,Y]]NOPP M3A@ZA-`LE7B!28O#>>@]$$TS]YUE=G$>/*"(#,C2ZY)CF`[\-*'/.['9CE5M M112P-@^[H;7>)8C8EC"5B\U]4E3TF*V*=+_TWL>[9=Q'THZ`?J9C4DVH!C`[ M[5`'9?.C6B)]'J*-EVPXK@)Q5^./-QC2!V"NVB$$A`&TA`(Z1=F?)9+S)^G% MCB.9,D`S@B=-EKVR,H)OQAT,T(-G"%TTGN.:WR99Q[WAND4Z3A\(7;Q&EKXRR3+1N8YD+ M%>T-8`^JNQKH>7CH`PIO<83,!XBRU5#^&,XB=-Q.ZKK:W_@;,QH5=ANGO@/) MN$;I:\-S)XPE-P#!0,;C4O7+2COOGJG0A`DAX^EYKD*C[GA:^IVD%$F-;#RV M5H]8=>#NF MRMX`\,P.>^,:W>>Z<;:ZQ,%Z@<)-?O2ZI#OK[-;WUDZE`'L3;*E!H"AK\Y#V M@`QW)_NY;"CIOHG<-.^R_)@\Q_!@]C#^$ITR41!QQ;[%#L..W8H]+!;=VBRI45N%`L>:90^4G?ADQWV M=?O,IT30PW!+9#H-?Y>%MM'=@C<=%6'*X$SGA7Z?R@B97AC;NMS5"L.70RO> MC=0C#I0X)0)Q%EA@*=PD]_=^RB;'+]AT$:QPN,F0$I?(@0X`%0AM#K8.`B') M'3O4??$&P]SQ..4IJZTL>$=4&IPV.NU`H*"@2%?9W&(JW-0=91+ZO@IZXL@-V1/:\#6:V)?H[#&Q3'?DYT'C,H*EG:=U`HSMK< M9=!C/E>K\(7`>P/!5>;ZTL'N-+\&Z0L MPS0J9X1>!"!?>]1H2*@S;&F0P04\5J3)-2>L^B,?8=QH&AKC(A!NSL$OVAZ&KSANE!5Y)_]A3%GH5K)\AK?A`6T)+>T6PU+WUH-^=*,>RW MD[W)$W/(/\H#39S`G:1#3?!J4AE,H=2*I\YQ(]`19`8P^99U:9I/I1IOLAM0Y1M((!($:U!V$)-W MAKP9`O9;:'^3J[,;IO7K0RE&V;,F<\=Y7H)G5],@K\'35M&@LBS?U9=E/MZD M&##=(],A)_F8D_*@JMUZ$$H$J[/#.";K1%8/8^PJ%:4?/0&6$P58R*J_8W+! M=Y:4>C5)+;RW1S>TGNO+R_]@O[[\TRZ3HH_"U4T'+OC,7[^M+0VNT(\XC-?T M1;$2-Z7.K.`!3*XI#CZU52/)#WN60_GIXE.THCM[L-RV+XR#AKE:ZOS72:F[ M2N.T=8(B8U30R:3Q69H:#=*+MU1FI-:.Q!!&35`0EG@975^ M:1`F3JUE@+UY<%A?5Z614E/S:2Q==B9@[H(E)S6"R=BV]GDN*V8,8!'*CF-R M)79`MQ[!UHEK-JW-8(GH97TU;;RR#(^:R[#22>W-76EDXV;.N;I+;"'U-R*AGM(H[8SV] M:7K^BVZ3O)]2!W]E3D)//J.UT32?*E2X6C00>`=TV"3[DQH%[ M(7;0"$^!7XA-?BK^UO&9]CYW8TKOR*RZ*ZL$4*0SV\(L/$XO^^_%@/=C$.;8 MD='UB:8CG$6QMR$[*Z=H0KV=L??7E6/5S@$[T#ESPH!01)/QTX<\P>M,V-'8 M^^?*\0/RR`Y`K]"W$J$A#LA?LX%C$L MHD:PGHQ%E`ULP![*/JS$&JH/9?(0LKQ#;N*3?61*INAZ?A)[#RA[49WZ4,\> MEWY"9(26P:+/,"=%G&E==T%.+QJ^9;_=U2XW]3.1-ACL41S@:`Z>[FB$%\K% M,6G1'Y*$J0IKLE.+U$)MTORA6K1-.G$Y?=%AU%$$+LDJA\[<5?RHC561'3Q] MT8A[9,5WZ+$L.//M%.YAY9I/-YYC)T(NW9J(Q*>0IP3,[K/;IBR+;2N_\KN/ M;5^8B.1B[\M631F:G2=X($H643*R6>].!]R543X4ZG0N1=KP!_I?Y`K7=8U( MP!!FO3S]<01SR0[O3FWFC6BU@I19>.VM[V"75=V'-.OO4:*\NW%QF-4KG)>, MJI8>$%Q"QQ9P^Q)LVT$<$#K',:D/&[D$L-!.+0:V-"GR$9Y%?RN4\WD2$YY_ M]`)ODVRNJ5SXQ8-EY[CTP"TM>-SAG-UK>,NC06LBS5+<"CALSTJ'YB*?HMCQ M_.B**C'J>&Q?^(U<";DD^\E/^65FDA/!S^\?3D<3.[ MI5[HCME\#&GV(J0J->P$C+'#S+ZF%`7(+=SVT^4RV21I:&`V94Z=64A?HZ=? MU;!*T-W5R6GA(R$7`5'?Z!)'_'=`RLV,GI4UH=[*B6L3C>Z/ MM%OS+IOCD5E/7<($`@7=L6[C7=4WQFXNZ&/T8*UC3P?QR!YK&Q8/D#.@W<1N MI$W*A,;D(QN(C61%[DMG3+31ROXH$P8"E:*O[;3K*MF; M?ZUPC`E8_=1L!.&Y$LRNDZ^9VUWK(H.[CR#X5@(=PV6/YYAL,['G^/[VM!'R MQ8!*T&<$D;(`?$",4?K(G^TQ<5RKH9'E+1L4I\-RD"5-55B<(OM!R6GO-!=+ MZD<^(7]Z<3Y?]N&.TV44$6V"U2VFTB9W74[UU$VWAXB><$3X<;H8M6P4`RCD MC%4`WCB^0W=Z*'J-]D;-'CW0,7AB!VXG213C#0J)?-&WI<3`,3L8-8@4(R?@ MBAW0[5X5R8.4Q3L>JX-1?Y;J#8_/%3N@>WJ]$885N=>Q.0`35/SVJ9[\3<<=*&%NS.V1AY0\"A%G]NZ/Z889P[SEX$"K5 M64%A/(VZ5Y5:P+JC='CS!10,%GG; M*:77S:[1$GD/E++C[=/?%V12TT>/@U>_44>$;#]"2PXEHS%OY9F=XHWC!6QH MVUO;`9D*86X$M[61^^3)57G=1&<\78%RZKFY1&' M3$WW>.?.$DTW5#1F*_IU!E>;S4QY]#G[1I.?+.HT,3.WT8]Q&.)OR`7PE=O# MF--=BL<`HC6QF^JR8^2$4>'HN";SY1C@+6V-.<>E6,PE5!-SIVNBAV@$X55" MU=!L57UNEW75*>IE6A/#&`XD7A/KJQ\[>T3ATHO0//26+.GF]C#FBY9B.8#H M0=@-XK!!/W$/IFHW);SPL^,G*"\8O<""`#I>!V->7$G[0D3RX+R>1C34F#K) MZ#XLS?EZ=V-N5D4XM+-#5RACZ5/3W6:=>XF)813&WI],#0/M#$3D9[.(R+'" M!!Z?`J68Q)"SLLN5K*II47#2S3,`_1QDLV'%^;N"OXC&4..C@Q M3-BLJGG&C0=MOL3`+'JF)6>$-^.#3G7/FIU-WBRTUFB:TKTR2WDZWCXUR8L' M3`FR;IYY,4OB*'8"E_H,L>^?XY#^DG,[H>E[]E5(8\E(_;Y#*P!V:&R%-&;G M[T'DJ_B4<:^;7@G1)HY5J#K')]RCT,,NV17#V'S*I#R,V, MU_(QXP[.,4DS!RY+-"O=>C)GSFD2TL2D;+50HJ)RI<7"?\;;FCN,9=Q[.Z@T M=6:V)<+2DUF$.RODT9)2NR6A3WFU?LRXYWI,RHL#U_.01Y-FX9=#"US^8Y+& M5@XJ,0W/`ATU3?K2F^\!-,0CH_>`Y230\"'CER6#2*8N[CU3'?D[HM5F(Z@>R'IG19T78WA?L^L^:9$/GXLL[$UXCF:WGBK,XP"PR%3ML[@>8[O*S](QIDE\ MAT.:O/Z)J,"PE)V1OMQWO*UZ.>DFP2_3J.5C8Y(#'?3;4=2Q!VE-PD0U(;5\ MS!(YTK<>U0DCFXEZ"E6FGY@%B%NCLM[(SI1C)2NB^B9J&V\T.:;2CRV^83$0 MI49V9LOJ`:+!&ZU`D":`-5%I9F>RJ28PFOQY'N[#4=1R,%[;1QN7=95,9#C, M4U?Y;%6Z@Z`N=,G[<-8@QG=)6,G%3JQY=HO=ZE`V"S9Z`YI!,AQSQ'+8R/+4 M)W$MGS)NMPPE6TPV#[/K5`2X-!?8=L/N;;SJ1)=]1L2,D10%?(JTJ5PX_$W^ MPN%PN`N'HSX7#D=V7#CLUOD'C%T:SW^%`[2Y]_$6T:?F'XA410NB&"(R4R(+ M]"HL%8J/B!R$W&LO^N.D?AQZRM"-B0#J865LYZ37JX\[ZQ*],\ MC:)D4VPBV?UK\&^)#QM]Z;J;(`W%FF=A(O+H_8Q],HSOQ5M*\4?G MT=OPR@L/.0>CKW@KTF]#(:5)[67?=L6!_FT-C;[EW5VML&D>B4%YU&Y0_BQO M4!X-9U"^[F-0ONYK4#(>6ZJ]A%-R+#!FR>UAK;G6X'WE(28Q$VRSN5@>8ETY M=6T?,FI303!3F.+&9K3Q^C5Z)*NE:*XNV6K_E%'3:&#IXC';PF1)^1*Z3-'I M,I)1HTM6,KJSRD;@U=66*(1=EU)I_Y0Q)[`!I<)C]C.4+8.FD-$RPE880]]/ M08N,X+:D;RV%;.&2I22<`8#97.YQVD9OMA_ MKC91P0;^>6-5:Z6!UK/_Z*TW8_B(KJYP:&=!53H%8R5CM0JK!I0LW.QZLT&J M7*96=A;EZK49EMAM88Q1;G=4P!_!M=)J4N6*I)JT&-5`^0QD?B;%KME+I M&.S=[\<+PV/#`+X9P>?-E14U*:6R\%BH2;_?*J!\A\Z`54`[`R..7)$=9'25 M-+L0.>:U*)T=(AQD=!4HNQ!I+>3/HNID=S6KN_"D%-/%ZA32T6QA1A%#Q;P? M+A*0,0&QBH-T-%L1L#\,X\U\>]T>J/Q./E#Y]7"!RF_Z!"J_L2/S[9F6VFM` M\Z/4W@"P_"BU]Z/4GK0<_"BU]Z/4WH]2>]*6R7S_\$V,]X_><.N*-5H9+R,T M3%DQ!G(S`Q8];'+'CMH")[X31;M(YEEX3;VF?#=7WE7< M(9W]&E?HZD67MU4KK MPA<[E\7=C%L9(""AY.M=9,`("?X:`P]BW.:066*2K%&\PFR\.;BBC(F]AR>: MRS<(1_OR-PB[$8>[2=A]LL^-0LL@-KBRG]G-`A.J'S<,MGF6[;UAR,Z-%T05 M/M*WU]+"!V%T]C7QXNV"?)Q_90#K/2*D8`39X=07S57DIX?VMP,^&4&5!%65 M>UP)JF=%Q=$GKP[31B@ZGA<'PW3! MB[0>MY/IHS17VNK+1TR]'8HNS1T1&X6U9I8M&9XBJ\V\Y`FS+G8#DAK\1$[@ MTINA*V?3,7BC[]?LD(%6^96MDMR)?CV!%ZFB*#S>W.O-UI;&RA1I97738:O312:4.798(;/XCLP+^63@]0<4$`I\H@:F[L8+/.H'I1Y16BX]B#B^ M7JE![+_Z[$*5UN67+OO;NFYGP[+3T^P^X[BW!!%N@NG3#0YC&C/4A?NESJ9/ M5@I@:+#"!!Z%0=(%CJ>^QHJ8JD.CSHB!(YFR2C*2`4Q%)^,F=*^XI2KINFQA M%*YPN'&"96;'9Q;&9Q3%[$1501]C53;E3&`(X7:85#>.[U`?%#$6?B<"PG-: M-UH:JVB2;Q`!&;V$1-:R#]24BJSPZ3VB]LH]$ MOVZ23>ZSB$X3=)*$5)AYM[%RXYA\N*>#H-9O9+LPS0YE"9S[1;#XAED%B.38 M4![*Z!,^0^'>Y-W8H"=?1%O\&]4`M`;=,-/Y@P%=`NX'Z:VQW79,;$1.&DV+6V-/I.G6+.B@:AE$[0\867O8SF1A^`4P@9GTK[G)S!$@5Q7LD?9A(?-4WB\B#Z35_> ME(56+JRS#0'LXTN0DX/F1V*<90&W%B?&523KVHO^.`;DPW$[C0@7+AUV9+\U MI@A)>>-VL@,?@-R)P%*9T]:^(WXF&S\.#[@QQ[4VIB,C`?)2MH%;*=1T],B^ M=0C@YJ$M1=LZ;E`?4?9Z`$B(X6<@/8X-1.[XS1E>X?IPV M++-J+3YML&3L>%O^#?_P(3/&B%"3([.]"D%:.S*/8V5"[R]+\3[%.1"AV?`0BO@^D3/HS] M8I*E3CSY;^A_:((+^'-D550)``/>X753WN%U4W5X"P`!!"4.```$.0$` M`.U=ZV_;.!+_?`?<_Z`+<-@>#HY?27:;;?;@Q$YK((U]L;OIW9<%+=$V45ER M]4CB_>MO2#VL)T4JSIK9>(%M76IF.#\..1R.2.K#OY]6IO:`'9?8UL51^[AU MI&%+MPUB+2Z.ODP:OFJ%_XFQ M?R:N'C/_Z[M]ZO[X=$>^+D;63_ZGV=>A.T+X=H)&QN9_EQN,OSVY']O-^<3\ M/M\\FN[0UY_(EY4Q,^Z_S?XS"*K\X.I+O$(:&-MR+XX23?G8/;:=1;/3:K6; M7S_?3!C=44!X_F02ZUL1>?O]^_=-]C0BS5$^S1PS$MUMTL+39O`P14H*2<\"4A*1&EB,SG<;"X36,>T812>8$&T>:AYP%]F@?=-=( MQV)"H_Z,+,N&;@^C/"RA9>LU@7X-!7_Y0#O`N6.;>`H8-/H#QC:W"DK3A+'A M4YU[EC&P/.)MZ$!Q5JRB(XT8%T=<"EHU*,(J-_"<6(1I&`['MM;0(O;D3V09 M6B!+2PC[T,R*20@'I8V1]0O[O7:P"V(8TPT4A(PA20F3CDS=-^5XMJH4LH0% M4:,_QPQ7MF5@"R3##]U/XQV7OIG=[-=`FGP:#Z>1@&5Z+CX')\I;8(X!$U$QI M)K[-NG5LIKU+5?'/@PTSYHA;U!W-1VL:6($FO&%6PL"WW8F8[293^.OSX!;L M-KK61N/!76\Z!`+MW1<+^0:!Z@\6Y!GD"KG+:]-^%#7@EIYOO],Z]KOJ33YI MUS>C^X/]0ON-G`6RR.],/0@D+I%+P`CC!-#`;@)T?'N=T3@#XGO3=GT'PS^2 M$EG@P61J]EQ+2GW+MOEHPUH4QHF.'=KFGY&%%L$PN2'??0*==S.&F2L<6<+4 M?#O]F+43DZN%@IFAMJ)_<+58N,:DOV5[3?S5"CF;T7Q"%A8L+70$P;FNVSY$ MU-9B#-Y.)SBTEB`MWU8_96T52J6#*"%7VPK6(LEOV4[0'(Z/C<'3FLY$+@R6 M$41CSI7OT+CLAJ`9,4&1R%3BY'QKO<]:*Q2L19+9X&*RM5"XEI#^EBUV:WL8 M(O,-FIDX,$JJA-ON[5:VW1FO%C*_Y6:=>+;^;6F;!G;6\Y5:_LE(HE4O!MU`N MLY%*7!^^5Q'E3VT]L$B9:W= M$;!(I$B^?1%I44Z!XN4M797P"+="HOD]P=46J1[L$A9:Y\(6.2DPB(2Z8?( M(B<'BY2U=B;4$J3E6JB;RSU46^@0?PGFBE+!F`0]WV*YY()HMN@0I\E8+3/8 MZC#R[5ASL$A'/(V,)09CTO#MU/%!H>#/<0V/11;1IB:;R.)31%_;GO1/^CQ MRSL\U]BQS7-ZE/#BR"6K-=U+&)0M'3P'2^)'U(C/Q@*TXZ>5&9%0T9QCF\S4 MV=8(*XY$($?/2JX=HD6A3ST1V/++%H_][@XK_Y"QB8V M/3:8V=/"X.U*'R:JAC\#1>)&>DN2\#1AI5WE/NTK[[)G*U%.D2HOP/#Z+ M>.@Q_M\&X,3L#<8]XX&.-_(6$,/KR@9H/-G+G@EGY)^=&Q_?7$4R")` MPM.;)0?N:=P$BY2TTL6/]JYQ<+U(.ZUKME`1+3M%6G;4T?+*=ST;NGI&SWRQ M,IJVBS55R/+C5N?4LUO=T[2F^6(%-.V>>78WJV>Z M-;U#U@)/(8+%:54+RM70=605:9HL54//Z:-=U**)TKWK>65;#W2U`$I,H%KL M7L(B=XX=AUX.`/-HQFV)4N\=5S!E=8OF,85\!.L/U[;O%'235/'>-;VQD=5; M@"N@Q6EMBQ_M76/>+4T]D.D@W8L@B-&B\%>$21YC0`%2B+78`<1[/.OC!VS: M:UI^9;N>>XN]T;RG`QR?Y1U[*UAUA)<]1&CEV2J!!NMU+WHT"R[V@0;`,^*E MT:]L"WO(V>P`O\1Y\@"Y#$-MS#IXPQ<$?8<-&&I4M;3O#1SR50;+)O8ITFRJ M-D!:_YYAL%06,@,D/7:+81QMB=&^3JB7$E`O58>:335^`:8F< M[3`6I%74:XV#!.V&3C;??<*<<-;_]O':P3IA_K>]M;`\HZ)M(#D%M6M.70JW M0!_/O"'4[+#`(W2_7P`ETQX,25RVB3\.4<3I%45<,0.-D9/R9^+DXGA341AS M$R^/*W!'?>R2A47[IR"^`K;7@'/HNKXDQICE->`;^1[5@5Y6+04RS:_7*W)0H\9[-&?:Z;7XJHS>KI_>`"--R:E_BM*=Z!O^>D7,,E(8H0J@N ME@+'*TRM(*I+F?%61*PNINI>ER54%XM@KRND5@J5V)PNR:/J!"=Q675\&7$V M)?P\&%;C= M6IQU1]W.%AE+^B9O:%TC$F0K1O-MKG*"=9^.[FPV,_9`-9GKC\X7=LO1GJQ@ MWI_:G5:[,W;(`R`:FTAGU$/HNZYG.W$KR#(IBWZX6M-N&EH2QNH#8:EK<#ED MYBT,+AJB%V2&N>^(MB\;S,_B5'2>LSR*3>:A@2D]F`\ M2XRJG2:S4!)ODCJ,JC9"8GS#=)T>!T-K\*2SJ'8T9[T>*,*[RK(#Z/EBU&T@ M*_SX*9L&DEI/[2)?(L.@K/.H_HQ1-@$CPZ%LPUMUEZD4R=I&>$;KA,6MI62[E["R\ES*+O`:CX2/E`!1? MV9/KI!54RL$2N!PEG^B78%$02'&VI/_\HW!.]K"&(SJ?H0]24V M?)-F->D[,5B$T1?B*VHZ5BV#-5H'TPOXX@<(TAFH=BZ\WXTH)0+^+9+D50,? MZ9_88#KST(OP*`@S[+STY(&WH4%NA&'DW-%7LR[7Y/(25&@"B<]P"`>3$8-R M8[WN)RCJYC#*Y2C7-/>V\XV"0FOB(3/YQ$J,O**Z) M!54G=[97$*FZ_TOJFQOUHK0PJ(D6QR7X%IO:Z1WW7PONT2E$Z MM)I6.8C72,>]%77ZHSF]X"*"4U"NZBP8]JQ+VW'L1W8N-H>&3Z(J,-JE+C%R MZ'X2[NT,>3O:WHH>RN_'#C:\T?;H+YQ%MI0_VK2:VQ*0.2U23[?E005J? M:(?/V"';,P1\DIIFV-G^X\)F5ZV5XQV_8;Y[:F>#("Z%JN.V7.GT!JEJD#EZ M16.&I):]V"-%NUFCH_O;;4""U*\1;>*J`B&\:7I%$?,_I"66`\Y3*Q<,%2=L M>W0L!IF=R\V69!QL9.X](L<(%YGA),`.2K.)+3Y1_2*2]WWJ8X>@,J=>4K/I M2S1B57V*G1^ZP_2R..CD-V2.A]9_:=Q79]KNJOEG*52\@C;#O'F?*,23\1PE`#OF> M%P3\S_Q)==.NPMVT]A01Q^`]6!NMHOEBC75ONV&=KK"?/QG)U%1W&MK1:CY0 MRRB8=`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````"``A,+!$?P@3X!UC```AG`0`$0`8 M```````!````I($`````:&5W82TR,#$T,#,S,2YX;6Q55`4``][A=5-U>`L` M`00E#@``!#D!``!02P$"'@,4````"``A,+!$]-D#*WX/``!WPP``%0`8```` M```!````I(%H8P``:&5W82TR,#$T,#,S,5]C86PN>&UL550%``/>X753=7@+ M``$$)0X```0Y`0``4$L!`AX#%`````@`(3"P1%*89$5?#@``+<8``!4`&``` M`````0```*2!-7,``&AE=V$M,C`Q-#`S,S%?9&5F+GAM;%54!0`#WN%U4W5X M"P`!!"4.```$.0$``%!+`0(>`Q0````(`"$PL$17R?$/8TT``%J-!``5`!@` M``````$```"D@>.!``!H97=A+3(P,30P,S,Q7VQA8BYX;6Q55`4``][A=5-U M>`L``00E#@``!#D!``!02P$"'@,4````"``A,+!$]EVBG`8H```4G0(`%0`8 M```````!````I(&5SP``:&5W82TR,#$T,#,S,5]P&UL550%``/>X753 M=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`(3"P1*,#/Z@:$0``6\L``!$` M&````````0```*2!ZO<``&AE=V$M,C`Q-#`S,S$N>'-D550%``/>X753=7@+ B``$$)0X```0Y`0``4$L%!@`````&``8`&@(``$\)`0`````` ` end XML 42 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8

Subsequent Events
3 Months Ended

Mar. 31, 2014

Subsequent Events

Note 10 - Subsequent Events
The Company evaluates events that have occurred after the balance sheet date but before the financial statements are issued. Based upon the evaluation, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the condensed consolidated financial statements, except as disclosed.

Notes Payable

On April 30, 2014, the Company received an additional $50,000 from a lender, which brought the face value of the Note to $750,000 pursuant to an Amended and Restated Promissory Note (the “April 2014 Note”), effective April 29, 2014, which supersedes the Note with the same Lender. The April 2014 Note contains financial covenants which require the Company to meet certain minimum targets for earnings before interest, taxes and non-cash expenses, including depreciation, amortization and stock-based compensation (“EBITDAS”) for the calendar quarters and years ended between June 30, 2014 and December 31, 2014. The remainder of the material April 2014 Note terms are unchanged from the Note, including the March 1, 2015 maturity date. In consideration of the Lender providing additional funds and entering into the April 2014 Note, the Company granted the Lender a five-year warrant to purchase 75,000 shares of Common Stock at an exercise price of $0.35 per share. The warrant contains customary anti-dilution provisions. The warrant had a relative fair value of $14,900 which was set up as debt discount and will be amortized using the effective interest method over the term of the April 2014 Note. Including the value of warrants issued in connection with the April Note, the Note had an effective interest rate of 40% per annum.

Executive Compensation

On April 28, 2014, the Compensation Committee approved the payment of an annual salary of $150,000 to the Company’s Chief Executive Officer, effective May 1, 2014.

X

- Details

Name: HEWA_SubsequentEventAbstract

Namespace Prefix: HEWA_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.

+ References

No definition available.

+ Details

Name: us-gaap_SubsequentEventsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 43 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8

Concentrations
3 Months Ended

Mar. 31, 2014

Concentrations

Note 8 - Concentrations
During the three months ended March 31, 2014, two vendors represented 57% and 16% of total inventory purchases. During the three months ended March 31, 2013, two vendors represented 30% and 11% of total inventory purchases, respectively.

X

- Details

Name: HEWA_ConcentrationsAbstract

Namespace Prefix: HEWA_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6327-108592

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6404-108592

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13531-108611

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 18

-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6351-108592

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 21

-URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13537-108611

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 21

-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6442-108592

+ Details

Name: us-gaap_ConcentrationRiskDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 44 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8

Related Party Transactions
3 Months Ended

Mar. 31, 2014

Related Party Transactions

Note 9 - Related Party Transactions
Between June 2009 and April 2012, an employee who is the son of the managing member of a limited liability company that beneficially owns over 5% of the Company’s Common Stock received advances from the Company in various forms which totaled $391,469 including interest. Principal repayments towards the outstanding advances aggregating $235,000 have been made through March 31, 2014. In April 2012, this employee voluntarily resigned from the Company. The individual agreed to repay the remaining balance with interest based on prime rate on the first business day of the calendar quarter. The amount has been included in Stockholders’ Deficiency as the Company has determined to exercise its rights through a pledge agreement for 42,860 shares as collateral. At March 31, 2014 and December 31, 2013, the Company estimated the value of the collateral at $10,715 and $9,001, respectively.

X

- Details

Name: HEWA_RelatedPartyTransactionAbstract

Namespace Prefix: HEWA_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39622-107864

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph b

-Article 3A

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph k

-Article 4

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39678-107864

+ Details

Name: us-gaap_RelatedPartyTransactionsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 45 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8

Summary of Significant Accounting Policies (Policies)
3 Months Ended

Mar. 31, 2014

Summary Of Significant Accounting Policies Policies

Principles of Consolidation
The condensed consolidated financial statements include the accounts of HealthWarehouse.com, Inc., Hwareh.com, Inc., Hocks.com, Inc., ION Holding NV, ION Belgium NV and Pagosa, its wholly-owned subsidiaries. ION Holding NV and ION Belgium NV are inactive subsidiaries. All material inter-company balances and transactions have been eliminated in consolidation.

On June 4, 2013, the Company formed a wholly-owned subsidiary called Pagosa Health LLC (“Pagosa”). On January 14, 2014, the Company closed Pagosa and decided to focus on its core consumer prescription business. Pagosa had a de minimis impact on the Company’s operations or the results for the three months ended March 31, 2014.

Use of Estimates
The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company’s significant estimates include reserves related to accounts receivable and inventory, the recoverability and useful lives of long-lived assets, the valuation allowance related to deferred tax assets, the valuation of equity instruments and debt discounts.

Net Loss Per Share of Common Stock
Basic net loss per share is computed by dividing net loss attributable to Common Stockholders by the weighted average number of common shares outstanding during the period. Diluted net loss per share reflects the potential dilution that could occur if securities or other instruments to issue Common Stock were exercised or converted into Common Stock. Potentially dilutive securities are excluded from the computation of diluted net loss per share if their inclusion would be anti-dilutive and consist of the following:

March 31,

2014 2013

Options 2,514,150 2,451,483

Warrants 2,492,846 6,047,119

Series B Convertible Preferred Stock 3,714,445 3,407,313

Total potentially dilutive shares 8,721,441 11,905,915

Recently Issued Accounting Pronouncements
The Company has determined there are no new accounting standards that are expected to have a material impact on the Company's condensed consolidated financial statements.

X

- Details

Name: HEWA_SummaryOfSignificantAccountingPoliciesPoliciesAbstract

Namespace Prefix: HEWA_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02, 03

-Article 3A

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2197480

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 860

-SubTopic 40

-Section 45

-URI http://asc.fasb.org/section&trid=2197723

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2196966

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 325

-SubTopic 20

-URI http://asc.fasb.org/subtopic&trid=2197087

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.3A-02)

-URI http://asc.fasb.org/extlink&oid=27015204&loc=d3e355033-122828

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=16385135&loc=d3e33801-111570

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=18733093&loc=d3e5614-111684

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph k

-Article 1

+ Details

Name: us-gaap_ConsolidationPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2144384

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257

+ Details

Name: us-gaap_EarningsPerSharePolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.

+ References

No definition available.

+ Details

Name: us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6143-108592

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6132-108592

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6061-108592

+ Details

Name: us-gaap_UseOfEstimates

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 46 R34.htm IDEA: XBRL DOCUMENT v2.4.0.8

Related Party Transactions (Details Narrative) (USD $)
24 Months Ended

Mar. 31, 2014

Dec. 31, 2013

Mar. 31, 2014

Related Party Outstanding [Member]

Principal repayments towards the outstanding advances $ 235,000

Estimated value of collateral $ 10,715 $ 9,001

X

- Definition

custom:EstimatedValueOfCollateral

+ References

No definition available.

+ Details

Name: HEWA_EstimatedValueOfCollateral

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

custom:PrincipalRepaymentsTowardsOutstandingAdvances

+ References

No definition available.

+ Details

Name: HEWA_PrincipalRepaymentsTowardsOutstandingAdvances

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 47 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8

Going Concern and Management's Liquidity Plans (Details Narrative) (USD $)
3 Months Ended 12 Months Ended

Mar. 31, 2014

Mar. 31, 2013

Dec. 31, 2013

Going Concern And Managements Liquidity Plans Details Narrative

Working Capital Deficiency $ 4,727,480

Accumulated deficit 28,511,039 28,130,668

Net Losses 305,641 4,078,366 5,489,892

Net Cash Used in Operating Activities 59,918 457,373 1,024,781

Raised additional debt financing $ 50,000

X

- Details

Name: HEWA_GoingConcernAndManagementsLiquidityPlansDetailsNarrativeAbstract

Namespace Prefix: HEWA_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

custom:RaisedAdditionalDebtFinancing

+ References

No definition available.

+ Details

Name: HEWA_RaisedAdditionalDebtFinancing

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Working Capital Deficiency

+ References

No definition available.

+ Details

Name: HEWA_WorkingCapitalDeficiency

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3536-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=6519514

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=6518256

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e565-108580

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The cumulative amount of the reporting entity's undistributed earnings or deficit.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.31(a)(3))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 48 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8

Stockholders' Deficiency (Details 1) (USD $)

Mar. 31, 2014

Dec. 31, 2013

Outstanding Number of Options 2,514,150 2,543,150

Weighted Average Remaining Years of Contractual Life 4 years 1 month 6 days

Weighted Average Exercise Price Outstanding $ 2.36 $ 2.37

Exercisable Number of Options 1,398,475

Weighted Average Exercise Price Exercisable $ 2.78

0.30 - $2.20 [Member]

Outstanding Number of Options 1,339,400

Weighted Average Remaining Years of Contractual Life 2 years 7 months 6 days

Weighted Average Exercise Price Outstanding $ 1.11

Exercisable Number of Options 573,725

Weighted Average Exercise Price Exercisable $ 1.58

2.21 - $3.80 [Member]

Outstanding Number of Options 757,750

Weighted Average Remaining Years of Contractual Life 3 years 9 months 18 days

Weighted Average Exercise Price Outstanding $ 3.23

Exercisable Number of Options 507,750

Weighted Average Exercise Price Exercisable $ 2.95

3.81 - $6.99 [Member]

Outstanding Number of Options 417,000

Weighted Average Remaining Years of Contractual Life 7 years 6 months

Weighted Average Exercise Price Outstanding $ 4.79

Exercisable Number of Options 317,000

Weighted Average Exercise Price Exercisable $ 4.66

X

- Definition

Weighted average exercise price exercisable.

+ References

No definition available.

+ Details

Name: HEWA_WeightedAverageExercisePriceExercisable

Namespace Prefix: HEWA_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

Weighted average remaining years of contractual life.

+ References

No definition available.

+ Details

Name: HEWA_WeightedAverageRemainingYearsOfContractualLife

Namespace Prefix: HEWA_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: instant

X

- Definition

The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Number of options outstanding, including both vested and non-vested options.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(i)-(ii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(i)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

XML 49 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)
3 Months Ended 12 Months Ended

Mar. 31, 2014

Mar. 31, 2013

Dec. 31, 2013

Cash flows from operating activities

Net loss $ (305,641) $ (4,078,366) $ (5,489,892)

Adjustments to reconcile net loss to net cash used in operating activities:

Provision for doubtful accounts (41,458) (31,528)

Provision for employee advance reserve (1,714)

Depreciation and amortization 41,621 35,846

Stock-based compensation 162,763 330,021

Warrants issued to 2012 private placement investors 487,200

Loss on extinguishment of notes and accounts payable 2,792,900

Imputed value of services contributed 87,500 87,500

Amortization of debt discount 54,035 44,363

Changes in operating assets and liabilities:

Accounts receivable 273,902 (6,238)

Inventories - finished goods 31,149 85,519

Prepaid expenses and other current assets 18,531 10,451

Accounts payable - trade (383,331) (91,216)

Accounts payable - related parties (5,445) 185,999

Accrued expenses and other current liabilities 25,172 (340,265)

Deferred revenue (17,002) 30,441

Net cash used in operating activities (59,918) (457,373) (1,024,781)

Cash flows from investing activities

Change in restricted cash 725,002

Website development costs (34,866) (25,490)

Net cash (used in) and provided by investing activities (34,866) 699,512

Cash flows from financing activities

Principal payments on equipment leases payable (13,159) (11,759)

Proceeds from issuance of notes payable 100,000 500,000

Repayment of notes payable (2,000,000)

Repayment of convertible notes payable (1,000,000)

Proceeds from the sale of common stock 2,526,973

Proceeds from offering prior to reaching minimum offering amount 125,000

Net cash provided by financing activities 86,841 140,214

(Net decrease) net increase in cash (7,944) 382,353

Cash - beginning of period 67,744

Cash - end of period 59,800 382,353 67,744

Interest 25,523 367,978

Non-cash investing and financing activities:

Issuance of Series B preferred stock for settlement of accrued dividends 279,380 261,084

Cashless exercise of warrants into common stock 6,934

Warrants issued as debt discount in connection with notes payable 26,000 315,300

Accrual of contractual dividends on Series B convertible preferred stock 74,730 69,840

Deemed dividends on Series B convertible preferred stock 1,532,722

Common stock and warrants issued in exchange of notes and accounts payable 3,625,900

Conversion of accounts payable to notes payable $ 40,000

X

- Definition

Accrual of contractual dividends on Series B convertible preferred stock

+ References

No definition available.

+ Details

Name: HEWA_AccrualOfContractualDividendsOnSeriesBConvertiblePreferredStock

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

custom:Cashless Exercise Of Warrants Into Common Stock

+ References

No definition available.

+ Details

Name: HEWA_CashlessExerciseOfWarrantsIntoCommonStock

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

custom:Cash Overdraft

+ References

No definition available.

+ Details

Name: HEWA_CashOverdraft

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

custom:ChangeInFairValueOfCollateralSecuringEmployeeAdvances

+ References

No definition available.

+ Details

Name: HEWA_ChangeInFairValueOfCollateralSecuringEmployeeAdvances

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

custom:Common Stock And Warrants Issued In Exchange Of Notes And Accounts Payable

+ References

No definition available.

+ Details

Name: HEWA_CommonStockAndWarrantsIssuedInExchangeOfNotesAndAccountsPayable

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

custom:ConversionOfAccountsPayableToNotesPayable

+ References

No definition available.

+ Details

Name: HEWA_ConversionOfAccountsPayableToNotesPayable

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

custom:Deemed Dividends On Series B Convertible Preferred Stock

+ References

No definition available.

+ Details

Name: HEWA_DeemedDividendsOnSeriesBConvertiblePreferredStock

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

custom:Imputed Value Of Services Contributed

+ References

No definition available.

+ Details

Name: HEWA_ImputedValueOfServicesContributed

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Prepaid expenses and other current assets.

+ References

No definition available.

+ Details

Name: HEWA_IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

custom:Issuance Of Series B Preferred Stock For Settlement Of Accrued Dividends

+ References

No definition available.

+ Details

Name: HEWA_IssuanceOfSeriesBPreferredStockForSettlementOfAccruedDividends

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

custom:Repayment Of Convertible Notes Payable

+ References

No definition available.

+ Details

Name: HEWA_RepaymentOfConvertibleNotesPayable

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

custom:Warrants Issued As Debt Discount In Connection With Notes Payable

+ References

No definition available.

+ Details

Name: HEWA_WarrantsIssuedAsDebtDiscountInConnectionWithNotesPayable

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

custom:Warrants Issued To 2012 Private Placement Investors

+ References

No definition available.

+ Details

Name: HEWA_WarrantsIssuedTo2012PrivatePlacementInvestors

Namespace Prefix: HEWA_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28541-108399

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.8)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 8

-Article 5

+ Details

Name: us-gaap_AmortizationOfDebtDiscountPremium

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 1

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3044-108585

+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 230

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6450594&loc=d3e33268-110906

+ Details

Name: us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_DepreciationAndAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 50

-Section 40

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6850294&loc=d3e12317-112629

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 50

-Section 40

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6850294&loc=d3e12355-112629

+ Details

Name: us-gaap_GainsLossesOnExtinguishmentOfDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in the obligations due for goods and services provided by the following types of related parties: a parent company and its subsidiaries, subsidiaries of a common parent, an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management, an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsPayableTrade

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in the aggregate amount of accrued expenses and other operating obligations not separately disclosed in the statement of cash flows.

+ References

No definition available.

+ Details

Name: us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period, excluding the portion taken into income, in the liability reflecting revenue yet to be earned for which cash or other forms of consideration was received or recorded as a receivable.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInDeferredRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInInventories

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_IncreaseDecreaseInOperatingCapitalAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The net cash inflow or outflow for the increase (decrease) associated with funds that are not available for withdrawal or use (such as funds held in escrow) and are associated with underlying transactions that are classified as investing activities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3179-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3213-108585

+ Details

Name: us-gaap_IncreaseDecreaseInRestrictedCash

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The amount of cash paid for interest during the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-Subparagraph (e)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3536-108585

+ Details

Name: us-gaap_InterestPaid

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3574-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3574-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3536-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=6519514

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=6518256

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e565-108580

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The cash outflows from the purchase of net carrying value allocated to in-process research and development costs and materials acquired in a business combination.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3213-108585

+ Details

Name: us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The cash inflow from the additional capital contribution to the entity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3255-108585

+ Details

Name: us-gaap_ProceedsFromIssuanceOfCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The cash inflow from a borrowing supported by a written promise to pay an obligation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3255-108585

+ Details

Name: us-gaap_ProceedsFromNotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Amount of expense related to write-down of receivables to the amount expected to be collected. Includes, but is not limited to, accounts receivable and notes receivable.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.5)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 5

-Article 5

+ Details

Name: us-gaap_ProvisionForDoubtfulAccounts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The cash outflow for the obligation for a lease meeting the criteria for capitalization (with maturities exceeding one year or beyond the operating cycle of the entity, if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3291-108585

+ Details

Name: us-gaap_RepaymentsOfLongTermCapitalLeaseObligations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The cash outflow for a borrowing supported by a written promise to pay an obligation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3291-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

+ Details

Name: us-gaap_RepaymentsOfNotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 50 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8

Notes Payable
3 Months Ended

Mar. 31, 2014

Notes Payable

Note 5 - Notes Payable
The Company is a party to a Loan and Security Agreement (the “Loan Agreement”) with a lender (the "Lender"). Under the terms of the Loan Agreement, the Company borrowed an aggregate of $700,000 from the Lender (the “Loan”), including $100,000 during the three months ended March 31, 2014. The Loan is evidenced by a promissory note (the “Note”) in the face amount of $700,000 (as amended). The Note bears interest on the unpaid principal balance of the Note until the full amount of principal has been paid at a floating rate equal to the Prime Rate plus four and one-quarter percent (4.25%) per annum (7.50% as of March 31, 2014). Under the terms of the Loan Agreement, the Company has agreed to make monthly payments of accrued interest on the first day of every month. The principal amount and all unpaid accrued interest on the Note is payable on March 1, 2015, or earlier in the event of default or a sale or liquidation of the Company. The Loan may be prepaid in whole or in part at any time by the Company without penalty. The Note contains financial covenants which require the Company to meet certain minimum targets for earnings before interest, taxes and non-cash expenses, including depreciation, amortization and stock-based compensation (“EBITDAS”). In connection with the Loan Agreement, the Company granted the Lender five-year warrants to purchase an aggregate of 1,050,000 shares of Common Stock at an exercise price of $0.35 per share, of which 150,000 warrants were issued during the three months ended March 31, 2014. The warrants contain customary anti-dilution provisions. The warrants had a relative fair value of $392,500, of which $26,000 was established as debt discount during the three months ended March 31, 2014 and will be amortized using the effective interest method over the term of the Note. The Company amortized $49,435 of the debt discount as interest expense during the three months ended March 31, 2014 and $212,830 remained unamortized as of March 31, 2014. Including the value of warrants issued in connection with Note and subsequent amendments, the Note had an effective interest rate of 40% per annum. See Note 10 for subsequent events.

The Company granted the Lender a first, priority security interest in all of the Company’s assets, in order to secure the Company’s obligation to repay the Loan. The Loan Agreement contains customary negative covenants restricting the Company’s ability to take certain actions without the Lender’s consent, including incurring additional indebtedness, transferring or encumbering assets, paying dividends or making certain other payments, and acquiring other businesses. Upon the occurrence of an event of default, the Lender has the right to impose interest at a rate equal to five percent (5.0%) per annum above the otherwise applicable interest rate (the “Default Rate”). The repayment of the Loan may be accelerated prior to the maturity date upon certain specified events of default, including failure to pay, bankruptcy, breach of covenant, and breach of representations and warranties.

The Company recorded amortization of debt discount associated with notes payable of $54,035 and $44,363 for the three months ended March 31, 2014 and 2013, respectively.

X

- Details

Name: HEWA_NotePayableAbstract

Namespace Prefix: HEWA_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for mortgage notes payable.

+ References

No definition available.

+ Details

Name: us-gaap_MortgageNotesPayableDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 51 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8

Stockholders' Deficiency (Details 2)
3 Months Ended

Mar. 31, 2014

Mar. 31, 2013

Stockholders Deficiency Details 2

Risk free interest rate 1.74% 0.88%

Dividend yield 0.00% 0.00%

Expected volatility 171.00% 164.30%

Expected life in years 5 years 5 years

X

- Definition

Expectd life.

+ References

No definition available.

+ Details

Name: HEWA_ExpectdLifeInYears

Namespace Prefix: HEWA_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition

Dividend yield.

+ References

No definition available.

+ Details

Name: HEWA_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate1

Namespace Prefix: HEWA_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Details

Name: HEWA_StockholdersDeficiencyDetails3Abstract

Namespace Prefix: HEWA_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.

+ References

No definition available.

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition

The risk-free interest rate assumption that is used in valuing a nonvested share or option award issued to other than an employee.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 50

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6406099&loc=d3e25284-112666

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (f)(2)(iv)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

XML 52 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.8 Html 28 228 1 false 14 0 false 4 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://healthwarehouse.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://healthwarehouse.com/role/CondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS false false R3.htm 00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://healthwarehouse.com/role/CondensedConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) false false R4.htm 00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) Sheet http://healthwarehouse.com/role/CondensedConsolidatedStatementsOfOperations CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) false false R5.htm 00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Sheet http://healthwarehouse.com/role/CondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) false false R6.htm 00000006 - Disclosure - Organization and Basis of Presentation Sheet http://healthwarehouse.com/role/OrganizationAndBasisOfPresentation Organization and Basis of Presentation false false R7.htm 00000007 - Disclosure - Going Concern and Management's Liquidity Plans Sheet http://healthwarehouse.com/role/GoingConcernAndManagementsLiquidityPlans Going Concern and Management's Liquidity Plans false false R8.htm 00000008 - Disclosure - Summary of Significant Accounting Policies Sheet http://healthwarehouse.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies false false R9.htm 00000009 - Disclosure - Accrued Expenses and Other Current Liabilities Sheet http://healthwarehouse.com/role/AccruedExpensesAndOtherCurrentLiabilities Accrued Expenses and Other Current Liabilities false false R10.htm 00000010 - Disclosure - Notes Payable Notes http://healthwarehouse.com/role/NotesPayable Notes Payable false false R11.htm 00000011 - Disclosure - Stockholders' Deficiency Sheet http://healthwarehouse.com/role/StockholdersDeficiency Stockholders' Deficiency false false R12.htm 00000012 - Disclosure - Commitments and Contingent Liabilities Sheet http://healthwarehouse.com/role/CommitmentsAndContingentLiabilities Commitments and Contingent Liabilities false false R13.htm 00000013 - Disclosure - Concentrations Sheet http://healthwarehouse.com/role/Concentrations Concentrations false false R14.htm 00000014 - Disclosure - Related Party Transactions Sheet http://healthwarehouse.com/role/RelatedPartyTransactions Related Party Transactions false false R15.htm 00000015 - Disclosure - Subsequent Events Sheet http://healthwarehouse.com/role/SubsequentEvents Subsequent Events false false R16.htm 00000016 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://healthwarehouse.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) false false R17.htm 00000017 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://healthwarehouse.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) false false R18.htm 00000018 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables) Sheet http://healthwarehouse.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables Accrued Expenses and Other Current Liabilities (Tables) false false R19.htm 00000019 - Disclosure - Stockholders' Deficiency (Tables) Sheet http://healthwarehouse.com/role/StockholdersDeficiencyTables Stockholders' Deficiency (Tables) false false R20.htm 00000020 - Disclosure - Commitments and Contingent Liabilities (Tables) Sheet http://healthwarehouse.com/role/CommitmentsAndContingentLiabilitiesTables Commitments and Contingent Liabilities (Tables) false false R21.htm 00000021 - Disclosure - Going Concern and Management's Liquidity Plans (Details Narrative) Sheet http://healthwarehouse.com/role/GoingConcernAndManagementsLiquidityPlansDetailsNarrative Going Concern and Management's Liquidity Plans (Details Narrative) false false R22.htm 00000022 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://healthwarehouse.com/role/SummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) false false R23.htm 00000023 - Disclosure - Accrued Expenses and Other Current Liabilities (Details) Sheet http://healthwarehouse.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetails Accrued Expenses and Other Current Liabilities (Details) false false R24.htm 00000024 - Disclosure - Notes Payable (Details Narrative) Notes http://healthwarehouse.com/role/NotesPayableDetailsNarrative Notes Payable (Details Narrative) false false R25.htm 00000025 - Disclosure - Stockholders' Deficiency (Details) Sheet http://healthwarehouse.com/role/StockholdersDeficiencyDetails Stockholders' Deficiency (Details) false false R26.htm 00000026 - Disclosure - Stockholders' Deficiency (Details 1) Sheet http://healthwarehouse.com/role/StockholdersDeficiencyDetails1 Stockholders' Deficiency (Details 1) false false R27.htm 00000027 - Disclosure - Stockholders' Deficiency (Details 2) Sheet http://healthwarehouse.com/role/StockholdersDeficiencyDetails2 Stockholders' Deficiency (Details 2) false false R28.htm 00000028 - Disclosure - Stockholders' Deficiency (Details 3) Sheet http://healthwarehouse.com/role/StockholdersDeficiencyDetails3 Stockholders' Deficiency (Details 3) false false R29.htm 00000029 - Disclosure - Stockholders' Deficiency (Details 4) Sheet http://healthwarehouse.com/role/StockholdersDeficiencyDetails4 Stockholders' Deficiency (Details 4) false false R30.htm 00000030 - Disclosure - Stockholders' Deficiency (Details Narrative) Sheet http://healthwarehouse.com/role/StockholdersDeficiencyDetailsNarrative Stockholders' Deficiency (Details Narrative) false false R31.htm 00000031 - Disclosure - Commitments and Contingent Liabilities (Details) Sheet http://healthwarehouse.com/role/CommitmentsAndContingentLiabilitiesDetails Commitments and Contingent Liabilities (Details) false false R32.htm 00000032 - Disclosure - Commitments and Contingent Liabilities (Details Narrative) Sheet http://healthwarehouse.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative Commitments and Contingent Liabilities (Details Narrative) false false R33.htm 00000033 - Disclosure - Concentrations (Details Narrative) Sheet http://healthwarehouse.com/role/ConcentrationsDetailsNarrative Concentrations (Details Narrative) false false R34.htm 00000034 - Disclosure - Related Party Transactions (Details Narrative) Sheet http://healthwarehouse.com/role/RelatedPartyTransactionsDetailsNarrative Related Party Transactions (Details Narrative) false false All Reports Book All Reports Process Flow-Through: 00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Process Flow-Through: 00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Process Flow-Through: 00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2013' Process Flow-Through: 00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) hewa-20140331.xml hewa-20140331.xsd hewa-20140331_cal.xml hewa-20140331_def.xml hewa-20140331_lab.xml hewa-20140331_pre.xml true true XML 53 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8

Commitments and Contingent Liabilities (Tables)
3 Months Ended

Mar. 31, 2014

Commitments And Contingent Liabilities Tables

Summary of Future minimum payments under operating leases
Future minimum payments, by year and in the aggregate, under operating leases as of March 31, 2014 are as follows:

For years ending December 31, Amount

2014 $ 96,037

2015 $ 128,049

2016 $ 143,700

Total future minimum lease payments $ 367,786

X

- Details

Name: HEWA_CommitmentsAndContingentLiabilitiesTables

Namespace Prefix: HEWA_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 20

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717

+ Details

Name: us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

Stockholders' Deficiency (Details) (USD $)	3 Months Ended
Stockholders' Deficiency (Details) (USD $)	Mar. 31, 2014
Number of options, outstanding
Outstanding, beginning of period (in shares)	2,543,150
Granted
Exercised
Forfeited	(29,000)
Outstanding, end of period (in shares)	2,514,150
Exercisable, March 31, 2014	1,398,475
Options, weighted average exercise price
Outstanding, beginning of period (in dollars per share)	$ 2.37
Granted
Exercised
Forfeited	$ 3.22
Outstanding, end of period (in dollars per share)	$ 2.36
Exercisable, March 31, 2014	$ 2.78
Weighted Average Remaining Life In Years
Weighted Average Remaining Life (in years) Outstanding	5 years 8 months 12 days
Weighted Average Remaining Life (in years) Exercisable	4 years 1 month 6 days

Stockholders' Deficiency (Details 4) (USD $)	Mar. 31, 2014
$0.25 - $0.35 [Member]
Outstanding Number of Warrants	1,900,000
Weighted Average Remaining Contractual Term	4 years 1 month 6 days
Weighted Average Exercise Price Outstanding	$ 0.27
Exercisable Number of Warrants	1,900,000
Weighted Average Exercise Price Exercisable	$ 0.27
$0.36 - $3.00 [Member]
Outstanding Number of Warrants	562,846
Weighted Average Remaining Contractual Term	2 years 4 months 24 days
Weighted Average Exercise Price Outstanding	$ 2.91
Exercisable Number of Warrants	312,846
Weighted Average Exercise Price Exercisable	$ 2.91
$3.01 - $4.95 [Member]
Outstanding Number of Warrants	30,000
Weighted Average Remaining Contractual Term	3 years 6 months
Weighted Average Exercise Price Outstanding	$ 4.95
Exercisable Number of Warrants	30,000
Weighted Average Exercise Price Exercisable	$ 4.95
0.25 - $4.95 [Member]
Outstanding Number of Warrants	2,492,846
Weighted Average Remaining Contractual Term	3 years 9 months 18 days
Weighted Average Exercise Price Outstanding	$ 0.92
Exercisable Number of Warrants	2,242,846
Weighted Average Exercise Price Exercisable	$ 0.70

Stockholders' Deficiency (Details 3) (USD $)	3 Months Ended
Stockholders' Deficiency (Details 3) (USD $)	Mar. 31, 2014
Number of warrants, outstanding
Outstanding, beginning of period (in shares)	2,342,846
Granted	150,000
Exercised
Forfeited
Exercisable, March 31, 2014	2,242,846
Warrants, weighted average exercise price
Outstanding, beginning of period (in dollars per share)	$ 0.96
Granted	$ 0.35
Exercised
Forfeited
Exercisable, March 31, 2014	$ 0.70
Weighted Average Remaining Life In Years
Weighted Average Remaining Life (in years) Outstanding	3 years 8 months 12 days
Weighted Average Remaining Life (in years) Exercisable	3 years 9 months 18 days
Aggregate Intrinsic Value
Aggregate Intrinsic Value Outstanding
Aggregate Intrinsic Value Exercisable

Stockholders' Deficiency (Details Narrative) (USD $)	3 Months Ended					12 Months Ended	3 Months Ended
Stockholders' Deficiency (Details Narrative) (USD $)	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014 Stock Warrants [Member]	Mar. 31, 2013 Stock Warrants [Member]	Mar. 31, 2014 Series B Preferred Stock [Member]	Dec. 31, 2013 Series B Preferred Stock [Member]	Mar. 31, 2014 Stock Option [Member]	Mar. 31, 2013 Stock Option [Member]
Preferred Stock Contractual Dividends					74,730	279,380
Weighted Average Fair Value			$ 0.23	$ 1.38
Selling, General And Administrative Expenses			$ 264	$ 504,777			$ 151,853	$ 312,444
Stock-Based Compensation Expense related to stock options, unamortized							1,476,372
Stock-Based Compensation Expense, amortized			3,685				584,803
Stock-based compensation expense warrants. unamortized			580,525
Weighted Average Remaining Period			1 year 6 months				1 year 6 months
Performance based option vesting			576,840				891,569
Salary expense	$ 87,500	$ 87,500

Commitments and Contingent Liabilities (Details) (USD $)	Mar. 31, 2014
Commitments And Contingent Liabilities Details
2014	$ 96,037
2015	128,049
2016	143,700
Total future minimum lease payments	$ 367,786

Commitments and Contingent Liabilities (Details Narrative) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013
Commitments And Contingent Liabilities Details Narrative
Monthly lease rate in 2014	$ 10,671
Monthly lease rate in 2015	10,671
Monthly lease rate in 2016	11,975
Lease expires date	Jan. 01, 2017
Deferred rent payable	43,704		46,254
Rent Expense	$ 49,229	$ 45,719

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)	Mar. 31, 2014	Dec. 31, 2013
Current assets:
Cash	$ 59,800	$ 67,744
Accounts receivable, net of allowance of $59,534 and $250,828 as of March 31, 2014 and December 31, 2013	74,767	307,211
Inventories - finished goods, net	246,151	277,300
Prepaid expenses and other current assets	40,612	59,143
Total current assets	421,330	711,398
Property and equipment, net of accumulated depreciation of $608,109 and $576,590 as of March 31, 2014 and December 31, 2013	593,116	624,634
Web development costs, net of accumulated amortization of $24,745 and $14,643 as of March 31, 2014 and December 31, 2013	108,544	83,780
Total assets	1,122,990	1,419,812
Current liabilities:
Accounts payable - trade	2,926,669	3,310,000
Accounts payable - related parties	78,246	83,691
Accrued expenses and other current liabilities	441,574	621,052
Deferred revenue	78,790	95,792
Current portion of equipment lease payable	58,266	56,323
Notes payable and other advances, net of debt discount of $212,830 as of March 31, 2014	487,170
Note payable and other advances - related parties	78,095	78,095
Redeemable preferred stock - Series C; par value $0.001 per share; 10,000 designated Series C: 10,000 issued and outstanding as of March 31, 2014 and December 31, 2013 (aggregate liquidation preference of $1,000,000)	1,000,000	1,000,000
Total current liabilities	5,148,810	5,244,953
Long term liabilities:
Notes payable, net of debt discount of $29,133 as of March 31, 2014 and $269,998 as of December 31, 2013	70,867	430,002
Long term portion of equipment lease payable	94,862	109,964
Total long term liabilities	165,729	539,966
Total liabilities	5,314,539	5,784,919
Commitments and contingencies
Preferred stock - par value $0.001 per share; authorized 1,000,000 shares; issued and outstanding as of March 31, 2014 and December 31, 2013 as follows:
Convertible preferred stock - Series A - 200,000 shares designated Series A; 44,443 shares available to be issued; no shares issued and outstanding
Convertible preferred stock - Series B - 625,000 shares designated Series B; 451,879 and 422,315 shares issued and outstanding as of March 31, 2014 and December 31, 2013, respectively (aggregate liquidation preference of $4,344,987 and $4,270,257 as of March 31, 2014 and December 31, 2013, respectively)	452	422
Common stock - par value $0.001 per share; authorized 50,000,000 shares; 27,729,592 and 27,708,303 shares issued and 26,550,380 and 26,529,091 shares outstanding as of March 31, 2014 and December 31, 2013, respectively	27,731	27,708
Additional paid-in capital	27,721,737	27,166,147
Employee advances	(10,715)	(9,001)
Treasury stock, at cost, 1,179,212 shares as of March 31, 2014 and December 31, 2013	(3,419,715)	(3,419,715)
Accumulated deficit	(28,511,039)	(28,130,668)
Total stockholders' deficiency	(4,191,549)	(4,365,107)
Total liabilities and stockholders' deficiency	$ 1,122,990	$ 1,419,812

Summary of Significant Accounting Policies (Details) (USD $)	Mar. 31, 2014	Dec. 31, 2013
Summary Of Significant Accounting Policies Details
Options	$ 2,514,150	$ 2,451,483
Warrants	2,492,846	6,047,119
Series B Convertible Preferred Stock	3,714,445	3,407,313
Total potentially dilutive shares	$ 8,721,441	$ 11,905,915

Notes Payable (Details Narrative) (USD $)	3 Months Ended
Notes Payable (Details Narrative) (USD $)	Mar. 31, 2014	Mar. 31, 2013
Amortization of debt discount	$ 54,035	$ 44,363
Loan Agreement [Member]
Face amount of loan	700,000
Current borrowed amount of loan	100,000
Note bears interest rate	7.50%
Aggregate number of Warrants Issued	1,050,000
Warrants issued Exercise Price	$ 0.35
Warrants issued	150,000
Fair value related to warrants	392,500
Fair value related to warrants as debt discount	26,000
Debt discount as interest expense, amortized	49,435
Debt discount as interest expense, unamortized	$ 212,830

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Mar. 31, 2014	Dec. 31, 2013
Current assets:
Property and equipment, net of accumulated depreciation	$ 608,109	$ 576,590
Web development costs, net of accumulated amortization	24,745	14,643
Current liabilities:
Current Portion Notes payable and other advances, net of debt discount	212,830
Redeemable preferred stock Series C, par value	0.001	0.001
Redeemable preferred stock Series C, shares designated	10,000	10,000
Redeemable preferred stock Series C, shares issued	10,000	10,000
Redeemable preferred stock Series C, shares outstanding	10,000	10,000
Redeemable preferred stock Series C, aggregate liquidation preference	1,000,000	1,000,000
Long term liabilities:
Current Portion Notes payable, net of debt discount	29,133	269,998
Stockholders' deficiency:
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, authorized	1,000,000	1,000,000
Preferred stock, shares issued	1,000,000	1,000,000
Preferred stock, shares outstanding	1,000,000	1,000,000
Series A Convertible preferred stock, shares designated	200,000	200,000
Series A Convertible preferred stock, shares available to be issued	44,443	44,443
Series A Convertible preferred stock, shares issued	0	0
Series A Convertible preferred stock, shares outstanding	0	0
Series B Convertible preferred stock, shares designated	625,000	625,000
Series B Convertible preferred stock, shares issued	451,879	422,315
Series B Convertible preferred stock, shares outstanding	451,879	422,315
Series B Convertible preferred stock, aggregate liquidation preference	$ 4,344,987	$ 4,270,257
Common stock, par value	$ 0.001	$ 0.001
Common stock, authorized	50,000,000	50,000,000
Common stock, shares issued	27,729,592	27,708,303
Common stock, shares outstanding	26,550,380	26,529,091
Treasury stock, shares	1,179,212	1,179,212

Document and Entity Information	3 Months Ended
Document and Entity Information	Mar. 31, 2014	May 07, 2014
Document And Entity Information
Entity Registrant Name	HealthWarehouse.com, Inc.
Entity Central Index Key	0000754813
Document Type	10-Q
Document Period End Date	Mar. 31, 2014
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Is Entity a Well-known Seasoned Issuer	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current	Yes
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		26,550,380
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2014

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Condensed Consolidated Statements Of Operations
Net sales	$ 1,716,964	$ 2,409,916
Cost of sales	731,408	1,235,156
Gross profit	985,556	1,174,760
Operating expenses:
Selling, general and administrative expenses	1,217,661	2,389,103
Loss from operations	(232,105)	(1,214,343)
Other income (expense):
Loss on extinguishment of debt		(2,792,900)
Interest expense	(73,536)	(71,123)
Total other expense	(73,536)	(2,864,023)
Net loss	(305,641)	(4,078,366)
Series B convertible contractual dividends	(74,730)	(69,840)
Series B convertible deemed dividends		(1,532,722)
Loss attributable to common stockholders	$ (380,371)	$ (5,680,928)
Per share data:
Net loss - basic and diluted	$ (0.01)	$ (0.26)
Series B convertible contractual dividends	$ 0.00	$ 0.00
Series B convertible deemed dividends		$ (0.10)
Net loss attributable to common stockholders - basic and diluted	$ (0.01)	$ (0.36)
Weighted average number of common shares outstanding - basic and diluted	26,546,832	15,609,892

Accrued Expenses and Other Current Liabilities (Details) (USD $)	Mar. 31, 2014	Dec. 31, 2013
Accrued Expenses And Other Current Liabilities Details
Deferred rent	$ 43,704	$ 46,254
Advertising	75,000	75,000
Salaries and benefits	178,393	132,048
Customer payables	19,697	39,618
Dividends payable	74,729	279,380
Accrued interest	46,429	45,616
Other	3,622	3,136
Total	$ 441,574	$ 621,052

Concentrations	3 Months Ended
Concentrations	Mar. 31, 2014
Concentrations
Note 8 - Concentrations	During the three months ended March 31, 2014, two vendors represented 57% and 16% of total inventory purchases. During the three months ended March 31, 2013, two vendors represented 30% and 11% of total inventory purchases, respectively.

Related Party Transactions (Details Narrative) (USD $)			24 Months Ended
Related Party Transactions (Details Narrative) (USD $)	Mar. 31, 2014	Dec. 31, 2013	Mar. 31, 2014 Related Party Outstanding [Member]
Principal repayments towards the outstanding advances			$ 235,000
Estimated value of collateral	$ 10,715	$ 9,001

Stockholders' Deficiency (Details 1) (USD $)	Mar. 31, 2014	Dec. 31, 2013
Outstanding Number of Options	2,514,150	2,543,150
Weighted Average Remaining Years of Contractual Life	4 years 1 month 6 days
Weighted Average Exercise Price Outstanding	$ 2.36	$ 2.37
Exercisable Number of Options	1,398,475
Weighted Average Exercise Price Exercisable	$ 2.78
0.30 - $2.20 [Member]
Outstanding Number of Options	1,339,400
Weighted Average Remaining Years of Contractual Life	2 years 7 months 6 days
Weighted Average Exercise Price Outstanding	$ 1.11
Exercisable Number of Options	573,725
Weighted Average Exercise Price Exercisable	$ 1.58
2.21 - $3.80 [Member]
Outstanding Number of Options	757,750
Weighted Average Remaining Years of Contractual Life	3 years 9 months 18 days
Weighted Average Exercise Price Outstanding	$ 3.23
Exercisable Number of Options	507,750
Weighted Average Exercise Price Exercisable	$ 2.95
3.81 - $6.99 [Member]
Outstanding Number of Options	417,000
Weighted Average Remaining Years of Contractual Life	7 years 6 months
Weighted Average Exercise Price Outstanding	$ 4.79
Exercisable Number of Options	317,000
Weighted Average Exercise Price Exercisable	$ 4.66

Stockholders' Deficiency (Details 2)	3 Months Ended
Stockholders' Deficiency (Details 2)	Mar. 31, 2014	Mar. 31, 2013
Stockholders Deficiency Details 2
Risk free interest rate	1.74%	0.88%
Dividend yield	0.00%	0.00%
Expected volatility	171.00%	164.30%
Expected life in years	5 years	5 years